Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCRL5,Fc receptor-like protein 5,32718,-0.109621658860902,0.0224965271966098,-0.153714852166258,-0.0655284655555471,1.11921933207617e-06
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL17,C-X-C motif chemokine 17,32833,-0.0737283227042066,0.0173775999793603,-0.107788418663753,-0.0396682267446605,2.23044116020252e-05
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MZB1,Marginal zone B- and B1-cell-specific protein,32738,-0.0847803502958662,0.0200235198620911,-0.124026449225565,-0.0455342513661676,2.31844919088708e-05
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HEG1,Protein HEG homolog 1,31417,-0.0462441968336532,0.011080188595137,-0.0679613664801216,-0.0245270271871847,3.03195409029487e-05
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MARCO,Macrophage receptor MARCO,32729,-0.0439328789003269,0.0105805818968374,-0.0646708194181282,-0.0231949383825255,3.32352008760554e-05
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMPRSS11D,Transmembrane protease serine 11D,31525,-0.059705589203745,0.0149003684111287,-0.0889103112895574,-0.0305008671179327,6.20802513597331e-05
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DEFB4A_DEFB4B,Beta-defensin 4A,32568,-0.237286384177471,0.0592290732178084,-0.353375367684376,-0.121197400670567,6.22041894158669e-05
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,31548,-0.0611587100740376,0.0156552492236177,-0.0918429985523282,-0.0304744215957469,9.44083471851996e-05
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPR15L,Protein GPR15L,31560,-0.101042801206878,0.0263054586452203,-0.15260150015151,-0.0494841022622463,0.000123450129580302
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SELE,E-selectin,32834,-0.0776367459937978,0.0204519693907919,-0.11772260599975,-0.0375508859878456,0.000147986554188006
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LTBP3,Latent-transforming growth factor beta-binding protein 3,32526,-0.0830741953075679,0.0221226772896418,-0.126434642795266,-0.03971374781987,0.000174364718345182
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",32834,-0.0442220272099597,0.0118636520837647,-0.0674747852941385,-0.020969269125781,0.00019456026011532
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIGLEC7,Sialic acid-binding Ig-like lectin 7,32729,-0.0421934052693164,0.011566443404261,-0.064863634341668,-0.0195231761969648,0.000265893121126849
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL20,C-C motif chemokine 20,32833,-0.123957859571123,0.0346593696081192,-0.191890224003037,-0.0560254951392095,0.000350111286494606
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TGFBI,Transforming growth factor-beta-induced protein ig-h3,32675,-0.0361097914274245,0.0108624689152697,-0.0574002305013531,-0.014819352353496,0.000890115994260787
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),POMC,Pro-opiomelanocortin,31388,-0.096180236318213,0.0293039119826737,-0.153615903804253,-0.0387445688321726,0.00103483221703361
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ICAM3,Intercellular adhesion molecule 3,32834,-0.0342342273775924,0.0104602058543157,-0.0547362308520511,-0.0137322239031336,0.00106888135896793
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GUCA2A,Guanylin,32678,0.0416967923569342,0.0128688119460297,0.0164739209427161,0.0669196637711524,0.00119912782067528
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBP7,Retinoid-binding protein 7,31560,-0.0815918315778014,0.0254691208090101,-0.131511308363461,-0.0316723547921415,0.00136293111769558
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPE,Carboxypeptidase E,32732,0.0500558667042691,0.0157639523217523,0.0191585201536345,0.0809532132549037,0.0015017440141297
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPA33,Cell surface A33 antigen,32668,0.169602868143797,0.0537953657351447,0.0641639513029132,0.275041784984681,0.00162288009564146
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LY96,Lymphocyte antigen 96,32647,-0.045011687571427,0.0143804955568846,-0.0731974588629209,-0.0168259162799332,0.00175348445425115
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WARS,"Tryptophan--tRNA ligase, cytoplasmic",32718,-0.0473982458760945,0.0152236124982459,-0.0772365263726564,-0.0175599653795326,0.00185491232715698
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD5L,CD5 antigen-like,31555,-0.0599144942895728,0.0192906421120823,-0.097724152829254,-0.0221048357498916,0.0019040110628332
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ICAM1,Intercellular adhesion molecule 1,32685,-0.03639216785553,0.0117187525290503,-0.0593609228124686,-0.0134234128985914,0.00190582582956788
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NXPH3,Neurexophilin-3,31355,0.0385043647893294,0.0124226777849167,0.0141559163308926,0.0628528132477662,0.00194551386601198
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DSG2,Desmoglein-2,32718,0.0335810366248587,0.0108443384648212,0.0123261332338092,0.0548359400159083,0.00196337446423194
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GP2,Pancreatic secretory granule membrane major glycoprotein GP2,32473,0.10647578765195,0.0344092642534748,0.039033629715139,0.17391794558876,0.00197848060007724
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,31356,-0.0516165366586807,0.0166830851013309,-0.0843153834572892,-0.0189176898600722,0.00198241554488173
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD300LF,CMRF35-like molecule 1,32794,-0.07608125365022,0.0246415040957276,-0.124378601677846,-0.0277839056225939,0.00202449458033279
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GGT1,Glutathione hydrolase 1 proenzyme,32704,-0.0624381804975899,0.0202774167075499,-0.102181917244388,-0.0226944437507921,0.00208194888651598
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AFM,Afamin,31598,-0.0244611815080421,0.00794541055580841,-0.0400341861974266,-0.00888817681865761,0.00208665074589956
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SUSD5,Sushi domain-containing protein 5,31369,0.0430741789694281,0.0140707597460512,0.0154954898671678,0.0706528680716884,0.00221190470437963
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCG2,Secretogranin-2,32765,0.0384028173757196,0.0125927794084845,0.01372096973509,0.0630846650163493,0.00229827056975844
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CFC1,Cryptic protein,32526,0.0592875888132061,0.019509008890504,0.0210499313878184,0.0975252462385938,0.00238084151045281
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA12,Carbonic anhydrase 12,32668,0.0386445576174557,0.0127733748964751,0.0136087428203646,0.0636803724145468,0.00249021602256186
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF17,Tumor necrosis factor receptor superfamily member 17,31417,-0.04846685208895,0.0160956171464999,-0.0800142616960899,-0.0169194424818101,0.00261092062800966
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL22,Interleukin-22,31548,-0.0829536236348244,0.0277481508352843,-0.137339999271982,-0.0285672479976671,0.00280301392414551
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGA5,Integrin alpha-5,32718,-0.0301684660120119,0.0101739516338326,-0.0501094112143238,-0.0102275208096999,0.00303228257503736
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFI30,Gamma-interferon-inducible lysosomal thiol reductase,31355,-0.0486218796220402,0.0164703871591833,-0.0809038384540396,-0.0163399207900409,0.00316621096637412
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARSA,Arylsulfatase A,32718,-0.0542411595425449,0.018396008157298,-0.0902973355308489,-0.0181849835542408,0.00320124277557716
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLITRK1,SLIT and NTRK-like protein 1,31355,0.0396270944213937,0.0135534537707083,0.0130623250308055,0.0661918638119819,0.00346862576179274
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GZMA,Granzyme A,32833,-0.0397079284486872,0.0136775684942746,-0.0665159626974654,-0.012899894199909,0.00370338867018267
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUDT16,U8 snoRNA-decapping enzyme,31546,-0.107674109595335,0.037113235505664,-0.180416051186436,-0.0349321680042331,0.00372753426432127
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OMG,Oligodendrocyte-myelin glycoprotein,32668,0.0779237795163361,0.0268638820837876,0.0252705706321125,0.13057698840056,0.00373264131208105
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPRB,Receptor-type tyrosine-protein phosphatase beta,31571,-0.0343038326130738,0.0118564155340478,-0.0575424070598075,-0.0110652581663402,0.00382319073735427
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCLY,Selenocysteine lyase,32777,-0.0572012564360936,0.0197954520054222,-0.0960003423667211,-0.0184021705054661,0.00386642430636808
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WDR46,WD repeat-containing protein 46,31548,-0.0466120408217193,0.0162230386349935,-0.0784091965463066,-0.014814885097132,0.0040744932856196
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRCP,Lysosomal Pro-X carboxypeptidase,32775,-0.0365216151417507,0.0127559799418737,-0.0615233358278232,-0.0115198944556782,0.00420499677637675
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPCAM,Epithelial cell adhesion molecule,32706,0.110759339032034,0.0387525414420516,0.0348043578056128,0.186714320258455,0.00427157047893096
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,32719,-0.0368914290426964,0.0129467795999725,-0.0622671170586424,-0.0115157410267504,0.00438934732590658
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGB6,Integrin beta-6,32596,0.0340342609644815,0.0120234343572166,0.010468329624337,0.057600192304626,0.00465580736781966
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COX6B1,Cytochrome c oxidase subunit 6B1,31571,-0.0373314796022659,0.0132895884589401,-0.0633790729817885,-0.0112838862227434,0.0049808775757448
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLITRK6,SLIT and NTRK-like protein 6,32598,0.0393055393944157,0.0140070555830629,0.0118517104516125,0.0667593683372189,0.00502522727686144
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSF,Cathepsin F,32720,0.0456550452559784,0.0163191925283146,0.0136694279004817,0.0776406626114751,0.00515903139631415
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGSF3,Immunoglobulin superfamily member 3,32668,-0.0397181361559798,0.0142273030523104,-0.0676036501385081,-0.0118326221734514,0.00525474725442755
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TGFBR3,Transforming growth factor beta receptor type 3,32834,0.035542214063057,0.0127785323626306,0.0104962906323011,0.0605881374938129,0.00542378765952183
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),JAM3,Junctional adhesion molecule C,31417,-0.0589244201775379,0.0211934740374651,-0.100463629290969,-0.0173852110641064,0.00544414653987981
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NLGN1,Neuroligin-1,31356,-0.0779518078558654,0.0281131426551462,-0.133053567459952,-0.0228500482517788,0.00557154680047645
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PON2,Serum paraoxonase/arylesterase 2,32598,-0.0383514010832233,0.0139012297395173,-0.0655978113726773,-0.0111049907937694,0.00581259382238097
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMNDC1,Survival of motor neuron-related-splicing factor 30,31560,-0.0740442739642689,0.026870246181086,-0.126709956479197,-0.0213785914493403,0.00587181948314665
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL17,C-C motif chemokine 17,32690,-0.102510558983681,0.0372604625709091,-0.175541065622663,-0.0294800523446989,0.00595005043492831
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENG,Endoglin,32834,-0.0185828072244491,0.00683343214116943,-0.0319763342211412,-0.00518928022775704,0.00655271025124174
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CFI,Complement factor I,31598,-0.0223605916530713,0.00826768267369622,-0.0385652496935159,-0.00615593361262674,0.00685408729754432
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRL,Prolactin,32806,0.0826347553108468,0.0306048242442073,0.0226492997922006,0.142620210829493,0.00694581058204832
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GIMAP8,GTPase IMAP family member 8,31326,-0.0572312790921124,0.0212008805469884,-0.0987850049642097,-0.015677553220015,0.00696050831994332
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCDH1,Protocadherin-1,32809,0.0234600665715835,0.00869820387661867,0.0064115869734109,0.0405085461697561,0.00700738686699078
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DGCR6,Protein DGCR6,31342,-0.0481610292405069,0.0178717537069234,-0.0831896665060767,-0.0131323919749371,0.00705855172945822
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VEGFB,Vascular endothelial growth factor B,31355,-0.0321559897276281,0.0119386285625404,-0.0555557017102072,-0.00875627774504896,0.00708760957737537
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPXM2,Inactive carboxypeptidase-like protein X2,31571,-0.0270966359947259,0.0100703554851463,-0.0468345327456127,-0.00735873924383907,0.00714489503128756
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGB2,Integrin beta-2,32678,-0.0311963322264155,0.0116029918652651,-0.0539381962823352,-0.00845446817049592,0.00718774041061946
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",31571,-0.0846307633872184,0.0315726324220745,-0.146513122934484,-0.0227484038399523,0.00736663323954284
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GZMH,Granzyme H,32598,-0.0831622394486242,0.031060243380255,-0.144040316473924,-0.0222841624233245,0.00743236179347645
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,32596,-0.0461069935399159,0.0172757705709502,-0.0799675038589782,-0.0122464832208535,0.00762448009028599
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD40LG,CD40 ligand,32833,-0.0856465164782653,0.0322028809954477,-0.148764163229343,-0.0225288697271877,0.00783744169069808
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPTXR,Neuronal pentraxin receptor,32729,0.037138019838788,0.0140042295446415,0.00968972993129068,0.0645863097462854,0.00801791858763413
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAMR1,Inactive serine protease PAMR1,32718,-0.0299456705566581,0.0113045047673044,-0.0521024999005747,-0.00778884121274142,0.00808727752056248
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BST2,Bone marrow stromal antigen 2,32806,-0.0570483794038507,0.0215925289153058,-0.09936973607785,-0.0147270227298513,0.00825511293101564
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PARP1,Poly [ADP-ribose] polymerase 1,32728,-0.0621043445052737,0.0235180256020943,-0.108199674685379,-0.0160090143251689,0.00828768771295761
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BAP18,Chromatin complexes subunit BAP18,31548,-0.0757045810755776,0.0287261284154421,-0.132007792769844,-0.019401369381311,0.00842090838791438
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APLP1,Amyloid-like protein 1,32729,0.0545485325307202,0.0207586933692529,0.0138614935269845,0.0952355715344559,0.0086101159955812
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACTA2,"Actin, aortic smooth muscle",32598,0.0465770711198979,0.0177491002081896,0.0117888347118463,0.0813653075279495,0.00870055156705134
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HIP1R,Huntingtin-interacting protein 1-related protein,31537,-0.0471588404760606,0.0180563223776287,-0.082549232336213,-0.0117684486159083,0.00902519181769781
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL10,C-X-C motif chemokine 10,32756,-0.0689790102187682,0.0265486570782229,-0.121014378092085,-0.0169436423454513,0.00938654269247569
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCAR,Immunoglobulin alpha Fc receptor,32728,-0.0494103569363337,0.0190408095014622,-0.0867303435591996,-0.0120903703134679,0.00947545501608573
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PECAM1,Platelet endothelial cell adhesion molecule,32718,-0.0318452503312611,0.0123239146854144,-0.0560001231146732,-0.00769037754784896,0.00978145241019706
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ELOA,Elongin-A,32668,-0.0576678627758885,0.0223880326665398,-0.101548406802307,-0.0137873187494704,0.0100160028853723
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANGPTL7,Angiopoietin-related protein 7,32794,0.0394054978470012,0.0153242772077907,0.00936991451973136,0.0694410811742711,0.0101436087229609
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",31342,0.0583029233302659,0.0226882221541232,0.0138340079081845,0.102771838752347,0.0101965545815738
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGFL4,Insulin growth factor-like family member 4,31355,0.0802281444218816,0.0312230516487242,0.0190309631903821,0.141425325653381,0.01020321540284
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AGRP,Agouti-related protein,32833,-0.0557858386876982,0.0217175486631491,-0.0983522340674704,-0.013219443307926,0.0102241396747056
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C2,Complement C2,32742,-0.024048555359063,0.00938005973419315,-0.0424334724380816,-0.00566363828004445,0.0103697571046175
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AGER,Advanced glycosylation end product-specific receptor,32684,0.041299264269293,0.0161739303113655,0.00959836085901664,0.0730001676795694,0.0106829370518055
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGAM,Integrin alpha-M,32718,-0.0329379235600229,0.0129396365231917,-0.0582996111454787,-0.00757623597456712,0.0109287458053191
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,32686,-0.0634125888494228,0.0249832366227666,-0.112379732630045,-0.0144454450688003,0.0111592954553676
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPR158,Probable G-protein coupled receptor 158,31555,0.0364836063163652,0.0144996495576266,0.00806429318341719,0.0649029194493133,0.011883921562529
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NCAM1,Neural cell adhesion molecule 1,32754,-0.0312480667347448,0.0124201812589422,-0.0555916220022715,-0.00690451146721813,0.0118899925898268
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLA2G2A,"Phospholipase A2, membrane associated",32720,-0.0575036973332129,0.0230070013210608,-0.102597419922492,-0.0124099747439336,0.0124583321234412
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAGEA3,Melanoma-associated antigen 3,31456,0.0926229942004244,0.0370776138534621,0.0199508710476387,0.16529511735321,0.012507635513638
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BHLHE40,Class E basic helix-loop-helix protein 40,31342,0.0711245617059945,0.028648086937754,0.0149743113079967,0.127274812103992,0.0130608985184716
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADGRF5,Adhesion G protein-coupled receptor F5,31571,-0.0294254348843003,0.0118684151430676,-0.0526875285647128,-0.00616334120388787,0.0131850363627588
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEPTIN3,Neuronal-specific septin-3,31555,-0.0777461017545868,0.0315009105192526,-0.139487886372322,-0.0160043171368516,0.0136063832881276
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WFDC2,WAP four-disulfide core domain protein 2,32238,-0.0356785428703751,0.014493945578052,-0.064086676203357,-0.00727040953739319,0.0138512279500598
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NID1,Nidogen-1,32727,-0.0381000621518577,0.0154951227398033,-0.0684705027218723,-0.00772962158184317,0.0139575539451812
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRAP1,Proline-rich acidic protein 1,31571,-0.0413539399604095,0.0168357439872158,-0.0743519981753525,-0.0083558817454666,0.014058778051126
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RRM2,Ribonucleoside-diphosphate reductase subunit M2,32526,-0.0501436734383103,0.0204225535317268,-0.0901718783604948,-0.0101154685161258,0.0140958661674933
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TDO2,"Tryptophan 2,3-dioxygenase",31356,-0.0402559744887104,0.0163955272893995,-0.0723912079759335,-0.0081207410014873,0.0140991651294828
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,32729,0.030479900808218,0.0124318623978156,0.00611345050849944,0.0548463511079365,0.0142352243512766
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRIP2,Cysteine-rich protein 2,32647,-0.0360696839936885,0.014714396208528,-0.0649099005624034,-0.00722946742497363,0.0142526977386239
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LY9,T-lymphocyte surface antigen Ly-9,32641,-0.0284952702734666,0.0116331149408479,-0.0512961755575286,-0.00569436498940467,0.0143250206389617
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PI3,Elafin,32596,-0.0521498152448791,0.0212921320657396,-0.0938823940937288,-0.0104172363960294,0.0143347944559201
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,31456,0.0518728572671373,0.021210185842004,0.0103008930168095,0.0934448215174651,0.0144813535630261
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ART3,Ecto-ADP-ribosyltransferase 3,32754,0.0326896693758481,0.0134451316862042,0.00633721127088784,0.0590421274808084,0.0150627613543153
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NHLRC3,NHL repeat-containing protein 3,31227,-0.0323200885799017,0.0132980388263509,-0.0583842446795496,-0.00625593248025388,0.0151042062576396
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MST1,Hepatocyte growth factor-like protein,31467,-0.0638373301000766,0.0262876052041474,-0.115361036300205,-0.0123136238999477,0.0151878218530683
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCDC28A,Coiled-coil domain-containing protein 28A,31356,-0.029499731445618,0.0121483062194322,-0.0533104116357051,-0.00568905125553083,0.0151931618136416
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IDO1,"Indoleamine 2,3-dioxygenase 1",31388,-0.0655842999515861,0.0270854247876422,-0.118671732535365,-0.0124968673678073,0.0154848825933663
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRR4,Proline-rich protein 4,31366,-0.0704351643628151,0.0291261262492449,-0.127522371811335,-0.013347956914295,0.0156176660167076
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),S100A11,Protein S100-A11,32652,-0.0475124598919,0.0196528425362136,-0.0860320312628786,-0.00899288852092135,0.0156439966308255
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACSL1,Long-chain-fatty-acid--CoA ligase 1,31313,-0.0361704734631039,0.0149985005873718,-0.0655675346143528,-0.00677341231185511,0.0159064571457911
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HDAC8,Histone deacetylase 8,31355,0.0624480467938882,0.0259469859122525,0.0115919544058734,0.113304139181903,0.0161189844440721
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ESR1,Estrogen receptor,31355,0.0587441133528752,0.024424117130677,0.0108728437767483,0.106615382929002,0.01618910221712
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",31571,-0.0620157515275932,0.0258107807200503,-0.112604881738892,-0.0114266213162946,0.0162976909662681
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FN1,Fibronectin,31598,-0.0262762576433409,0.0109573215997893,-0.0477526079789279,-0.00479990730775389,0.016505940064659
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MUC2,Mucin-2,31571,0.0895626743725249,0.0373724448817895,0.0163126824042174,0.162812666340832,0.0165766348293098
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RGS8,Regulator of G-protein signaling 8,32596,0.0635713263013352,0.0265649820719149,0.011503961440382,0.115638691162288,0.0167299543769293
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCGB3A2,Secretoglobin family 3A member 2,32739,-0.0748193834804965,0.0312935151504706,-0.136154673175419,-0.0134840937855741,0.0168282441401122
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCAN,Brevican core protein,32647,0.0330309488828207,0.0138162749062323,0.00595105006660527,0.0601108476990361,0.0168359491819665
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRP2,Low-density lipoprotein receptor-related protein 2,31356,-0.035984609409283,0.0150766086444861,-0.0655347623524757,-0.00643445646609037,0.0170211197901829
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GASK1A,Golgi-associated kinase 1A,31313,-0.0431016518152142,0.0180999939168137,-0.078577639892169,-0.00762566373825933,0.0172762650025488
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFNAR1,Interferon alpha/beta receptor 1,31560,-0.0255387215914619,0.0107552993976774,-0.0466191084109096,-0.00445833477201409,0.017595936826168
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,32596,-0.0408196220285842,0.0172278753593961,-0.0745862577330006,-0.00705298632416777,0.0178388801300715
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMOT,Angiomotin,31417,0.0398897410773765,0.0168647467992698,0.00683483735080777,0.0729446448039453,0.0180418640628272
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DSG4,Desmoglein-4,32641,0.0473088132175669,0.020016172453953,0.00807711520781911,0.0865405112273148,0.0181234435447672
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FRMD7,FERM domain-containing protein 7,31356,-0.0311682861616039,0.0131893243705006,-0.057019361927785,-0.00531721039542281,0.0181459585386096
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SELP,P-selectin,32754,-0.0553778889563636,0.0234625159209394,-0.101364420161405,-0.00939135775132235,0.0182830697848176
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GUCY2C,Heat-stable enterotoxin receptor,31456,-0.0833996751064547,0.0353544956205518,-0.152694486522736,-0.0141048636901731,0.0183516379097943
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLSTN2,Calsyntenin-2,32833,-0.037388699758584,0.0159982880468041,-0.0687453443303202,-0.00603205518684791,0.0194587862903324
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VIM,Vimentin,32598,-0.111563791384819,0.0478617157540313,-0.20537275426272,-0.0177548285069179,0.0197780474544329
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HGF,Hepatocyte growth factor,32833,-0.0325589717917441,0.0139881105002965,-0.0599756683723254,-0.00514227521116291,0.0199545431347013
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HAVCR1,Hepatitis A virus cellular receptor 1,32785,-0.0559957848681837,0.0240895527869807,-0.103211308330666,-0.00878026140570148,0.020121881613251
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CINP,Cyclin-dependent kinase 2-interacting protein,31456,-0.0429194458114099,0.0184720226832661,-0.0791246102706114,-0.00671428135220843,0.0201794374772772
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EREG,Proepiregulin,32636,-0.0757376046499853,0.0326231819915803,-0.139679041353483,-0.0117961679464879,0.0202778829965805
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C3,Complement C3,31197,-0.0428838749943076,0.0184957020993118,-0.0791354511089588,-0.0066322988796565,0.0204448418389074
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KHDC3L,KH domain-containing protein 3,31326,0.0655769093689807,0.0282932176735776,0.0101222027287686,0.121031616009193,0.02048922468831
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),L1CAM,Neural cell adhesion molecule L1,32720,-0.027295471203394,0.0118012992890554,-0.0504260178099425,-0.00416492459684537,0.0207497828099266
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BLNK,B-cell linker protein,31355,-0.0392555677522427,0.0170451260387677,-0.0726640147882273,-0.00584712071625804,0.0213039722483471
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCLRE1C,Protein artemis,31326,-0.0300427823932239,0.013045165837817,-0.0556113074353453,-0.00447425735110256,0.0213072120963956
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FTCD,Formimidoyltransferase-cyclodeaminase,31536,-0.0809745069786966,0.0353046920557398,-0.150171703407947,-0.0117773105494467,0.0218409234692559
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,31313,-0.0538899826518629,0.0235100851806559,-0.0999697496059485,-0.00781021569777725,0.0219214400531415
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLA2G10,Group 10 secretory phospholipase A2,32647,0.0553135814048727,0.0241478548943475,0.00798378581195158,0.102643376997794,0.0220089189648286
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,31313,-0.038545388431845,0.0168286491605735,-0.071529540786569,-0.00556123607712096,0.0220223200208376
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EGLN1,Egl nine homolog 1,32728,-0.0521826325632981,0.0227833672493852,-0.0968380323720931,-0.00752723275450314,0.0220224969851037
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TOR1AIP1,Torsin-1A-interacting protein 1,31388,-0.049906442020974,0.0217977419573246,-0.0926300162573302,-0.00718286778461774,0.0220765024194714
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACY1,Aminoacylase-1,32729,-0.0577393590701097,0.0252198429496964,-0.107170251251515,-0.00830846688870465,0.0220770875043597
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STAB2,Stabilin-2,31571,-0.0265552986779344,0.0116068182297313,-0.0493046624082078,-0.00380593494766109,0.0221699899258423
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BID,BH3-interacting domain death agonist,32728,-0.0624722722773348,0.0273467055753086,-0.11607181520494,-0.00887272934972996,0.0223684196990198
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF5A,Eukaryotic translation initiation factor 5A-1,32596,0.028181662973228,0.0123489248844084,0.00397777019978759,0.0523855557466685,0.0225065035009856
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPB2,Carboxypeptidase B2,31582,-0.0214577333153495,0.00940242705296365,-0.0398864903391583,-0.00302897629154077,0.0225076600954571
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NGFR,Tumor necrosis factor receptor superfamily member 16,31571,-0.0278005194633427,0.0121912980452594,-0.0516954636320512,-0.00390557529463418,0.0226136554692059
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MTIF3,"Translation initiation factor IF-3, mitochondrial",31560,-0.0828186071065697,0.0363207027532317,-0.154007184502904,-0.0116300297102356,0.0226228119866209
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC12A,C-type lectin domain family 12 member A,31355,-0.01888667585782,0.00831508586766901,-0.0351842441584513,-0.00258910755718875,0.0231525326149195
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL5,C-C motif chemokine 5,32754,-0.0958865223140443,0.0422320238883218,-0.178661289135155,-0.0131117554929337,0.0232029234283439
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AP1G2,AP-1 complex subunit gamma-like 2,31548,-0.0767897601105559,0.0338807094619176,-0.143195950655914,-0.0103835695651974,0.0234500216991344
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP1B4,Protein ATP1B4,31326,-0.0393914589200036,0.0173819158248792,-0.0734600139367669,-0.00532290390324029,0.0234656627756476
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TFF3,Trefoil factor 3,32693,0.0447528735458797,0.0197737566533121,0.00599631050538799,0.0835094365863715,0.0236447008421081
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ROBO1,Roundabout homolog 1,32721,-0.0215795950353432,0.00953610854309716,-0.0402703677798136,-0.00288882229087279,0.0236637853580619
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,31313,-0.0621115711095487,0.0274479256373671,-0.115909505358788,-0.00831363686030923,0.0236712693452006
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRRT3,Proline-rich transmembrane protein 3,31388,0.0344483813362975,0.0152643543079916,0.00453024689263403,0.0643665157799609,0.0240500020448474
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGFBP7,Insulin-like growth factor-binding protein 7,32834,-0.0263651246603303,0.0117210517238638,-0.0493383860391034,-0.00339186328155726,0.0245123341316411
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANPEP,Aminopeptidase N,32738,-0.0256924114598034,0.0114252823192552,-0.0480859648055436,-0.00329885811406329,0.0245538962468018
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GH2,Growth hormone variant,32526,-0.152981934479648,0.0680798963654634,-0.286418531355956,-0.0195453376033393,0.0246590734046792
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MME,Neprilysin,32668,-0.0721714837853245,0.032136895933345,-0.135159799814681,-0.00918316775596834,0.0247446177960658
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MASP1,Mannan-binding lectin serine protease 1,32636,-0.0215349251663452,0.00960428126927352,-0.0403593164541213,-0.00271053387856908,0.0249719394389321
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",31560,-0.0953025413893318,0.0425454515939096,-0.178691626513395,-0.0119134562652688,0.0251182252620775
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPGN,Epigen,31548,-0.0455800718186985,0.0203582898589798,-0.085482319942299,-0.00567782369509806,0.0251912477248348
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,32647,0.0313807849563045,0.0140185295886774,0.00390446696249672,0.0588571029501123,0.025211982731821
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MMP12,Macrophage metalloelastase,32736,-0.0469004174325407,0.0209638746817689,-0.0879896118088078,-0.00581122305627359,0.0252978794304799
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VEGFC,Vascular endothelial growth factor C,32720,-0.0512643342623469,0.0229275180963236,-0.0962022697311412,-0.00632639879355256,0.0253811327756647
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCER2,Coiled-coil domain-containing glutamate-rich protein 2,31388,0.0572184276742864,0.0256026254533573,0.00703728178570607,0.107399573562867,0.0254553937982389
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DBH,Dopamine beta-hydroxylase,31575,0.100664795697339,0.0451379371928377,0.0121944387993774,0.189135152595301,0.0257655148614689
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD27,CD27 antigen,32720,-0.0351214621866671,0.0157944766281119,-0.0660786363777665,-0.00416428799556766,0.0261968029955717
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB10,Ras-related protein Rab-10,31571,-0.0494578375751838,0.0222597266677338,-0.0930869018439421,-0.00582877330642561,0.0263221647314826
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HAO1,Hydroxyacid oxidase 1,32794,-0.1168695362504,0.0526263292901199,-0.220017141659035,-0.0137219308417652,0.0263933780017576
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MMP7,Matrilysin,32584,-0.0440325514699611,0.0198979211773744,-0.083032476977615,-0.00503262596230725,0.026928799523828
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CBLN4,Cerebellin-4,32794,-0.0278232220170946,0.0125799786532473,-0.0524799801774593,-0.00316646385672983,0.0270121572310927
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYH9,Myosin-9,31571,-0.102186715741629,0.0462239781990541,-0.192785713011775,-0.011587718471483,0.0270868111450659
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL27,C-C motif chemokine 27,32729,-0.0569422618623766,0.0257635432495816,-0.107438806631557,-0.00644571709319664,0.0271175883457454
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCAM,Basal cell adhesion molecule,32718,0.0213394121546964,0.00966509855057423,0.00239581899557088,0.0402830053138219,0.0272779199175711
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GOLM2,Protein GOLM2,32806,-0.0200005755978137,0.00906004604476375,-0.0377582658455506,-0.00224288535007673,0.027300397017543
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRP11,Low-density lipoprotein receptor-related protein 11,32729,0.0308576509665533,0.0139798332459206,0.0034571778045489,0.0582581241285578,0.0273187936884773
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LZTFL1,Leucine zipper transcription factor-like protein 1,31417,-0.0655622641122822,0.0297492411655475,-0.123870776796755,-0.00725375142780913,0.0275663618097808
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,31456,-0.0657401413868477,0.0298408191934625,-0.124228147006034,-0.00725213576766115,0.0276227349174877
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AIF1,Allograft inflammatory factor 1,32526,-0.0474272212835612,0.0215466284150692,-0.0896586129770968,-0.00519582959002569,0.0277521362319735
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIE1,Tyrosine-protein kinase receptor Tie-1,32834,0.0374160348782067,0.0169993058550801,0.00409739540224971,0.0707346743541637,0.0277590519297531
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GSTA1,Glutathione S-transferase A1,32720,-0.0770512009125992,0.035036209167151,-0.145722170880215,-0.00838023094498318,0.027890322119537
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,32598,-0.0769782261628893,0.0350076168237394,-0.145593155137419,-0.00836329718836014,0.0279111911082271
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KYNU,Kynureninase,32833,-0.041252759775069,0.0187884728672546,-0.0780781665948879,-0.00442735295525005,0.0281430888049153
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB44,Ras-related protein Rab-44,31548,-0.0417251416192785,0.0190060517229262,-0.078977002996214,-0.00447328024234307,0.0281675065202007
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FOSB,Protein fosB,32502,0.0355496010455735,0.0162027705314056,0.00379217080401854,0.0673070312871284,0.0282587327142924
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRIM26,Tripartite motif-containing protein 26,31326,-0.0522545599895005,0.0238401422182996,-0.0989812387373676,-0.00552788124163334,0.028419463874291
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACP5,Tartrate-resistant acid phosphatase type 5,32758,-0.0295391761084718,0.0135285116174437,-0.0560550588786616,-0.00302329333828212,0.0290268303829108
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",31313,-0.0398639565698206,0.018257331716437,-0.0756483267340371,-0.00407958640560407,0.0290338262032378
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FOLH1,Glutamate carboxypeptidase 2,31355,0.100595452340943,0.0461547267816673,0.0101321878488749,0.191058716833011,0.0293235987584024
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIAA1549,UPF0606 protein KIAA1549,31456,-0.0627851577748151,0.0288302402857266,-0.119292428734839,-0.00627788681479095,0.0294550544037817
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERBB2,Receptor tyrosine-protein kinase erbB-2,32720,-0.0222077624289704,0.0102035010517689,-0.0422066244904374,-0.00220890036750335,0.0295453680935021
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLAMF7,SLAM family member 7,32728,-0.0509152300348218,0.0234124845444271,-0.096803699741899,-0.00502676032774462,0.0296786266669278
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),INHBC,Inhibin beta C chain,32718,-0.0371386452349849,0.017078529360593,-0.0706125627817473,-0.00366472768822258,0.0296879049412415
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GP1BB,Platelet glycoprotein Ib beta chain,31313,-0.0610119334997327,0.0280994048509502,-0.116086767007595,-0.00593709999187023,0.0299407659485557
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ALPI,Intestinal-type alkaline phosphatase,31355,-0.108757011578724,0.0502377331868337,-0.207222968624918,-0.0102910545325305,0.0304308561097614
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KRT18,"Keratin, type I cytoskeletal 18",32668,-0.0724047494551374,0.0334486881899667,-0.137964178307472,-0.00684532060280256,0.030441167312079
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLRF1,Killer cell lectin-like receptor subfamily F member 1,31355,-0.0383335290196446,0.0177258843212703,-0.0730762622893343,-0.00359079574995486,0.030605520336318
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL21,C-C motif chemokine 21,32756,-0.0352109064261879,0.0163320531413126,-0.0672217305831606,-0.00320008226921521,0.0311151742688143
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HHEX,Hematopoietically-expressed homeobox protein HHEX,31548,-0.0688683073737996,0.0319692937978727,-0.13152812321763,-0.00620849152996901,0.031255333731558
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,32754,-0.0375168085323897,0.0174366789039945,-0.0716926991842188,-0.00334091788056057,0.0314554856632773
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPM3,Tropomyosin alpha-3 chain,31313,-0.0406842502076218,0.0189306796238568,-0.0777883822703811,-0.00358011814486253,0.0316572102923229
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJB8,DnaJ homolog subfamily B member 8,32598,0.0492882237235581,0.0229542356451214,0.00429792185912019,0.094278525587996,0.0318017105564847
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,31560,-0.0796222794680516,0.0370828044184663,-0.152304576128246,-0.00693998280785772,0.0318126093769137
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPINK5,Serine protease inhibitor Kazal-type 5,32718,0.0291165940953895,0.0135629259875069,0.00253325915987598,0.0556999290309029,0.031838011432402
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BPIFB2,BPI fold-containing family B member 2,31557,-0.0564170874109013,0.0263140187765986,-0.107992564213034,-0.00484161060876807,0.0320646330451277
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,31548,-0.0417332854197889,0.0194660151792088,-0.0798866751710381,-0.0035798956685397,0.0320717783408767
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DAPK2,Death-associated protein kinase 2,31355,-0.0497165365071328,0.0232541459803159,-0.095294662628552,-0.00413841038571351,0.0325518815992286
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAC3,Ras-related C3 botulinum toxin substrate 3,31356,-0.0585399284639577,0.0274274950803111,-0.112297818821367,-0.00478203810654788,0.0328463295970239
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FLRT2,Leucine-rich repeat transmembrane protein FLRT2,32647,0.0243550893573548,0.01141935711255,0.00197314941675675,0.0467370292979528,0.0329696019361627
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFSF14,Tumor necrosis factor ligand superfamily member 14,32647,-0.0505543033557256,0.0237076159066182,-0.0970212305326972,-0.00408737617875386,0.0330009877986176
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KDM3A,Lysine-specific demethylase 3A,31355,0.0819087962683772,0.0384652807413137,0.00651684601540245,0.157300746521352,0.033251899834582
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AP3S2,AP-3 complex subunit sigma-2,31548,-0.041391796205029,0.0194477697381969,-0.079509424891895,-0.00327416751816306,0.0333392099302901
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GUSB,Beta-glucuronidase,32758,-0.0511566294644461,0.0240524621228812,-0.0982994552252932,-0.00401380370359899,0.0334577359072546
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GFRA3,GDNF family receptor alpha-3,32616,0.0242921849069872,0.0114404623701019,0.00186887866158749,0.0467154911523869,0.0337519213310617
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CASP1,Caspase-1,32502,-0.0594046740413862,0.0279851552284939,-0.114255578289234,-0.00455376979353807,0.0338055977522323
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RARRES2,Retinoic acid receptor responder protein 2,32765,-0.0414585611169421,0.0195721920400725,-0.0798200575154842,-0.00309706471839995,0.0341825381975575
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NRP2,Neuropilin-2,32718,-0.0250226947297858,0.0118451400793463,-0.0482391692853046,-0.00180622017426699,0.0346726784007606
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FOXJ3,Forkhead box protein J3,31355,-0.0405266443448657,0.0192197742430056,-0.0781974018611567,-0.0028558868285747,0.0350129894920194
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPP1,Tripeptidyl-peptidase 1,32650,-0.0401123322279255,0.0190255415871442,-0.0774023937387281,-0.00282227071712295,0.0350297159557258
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SHBG,Sex hormone-binding globulin,31586,0.0451529739060172,0.0214823329266803,0.00304760136972383,0.0872583464423105,0.0355973522661878
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL7,C-C motif chemokine 7,32728,-0.0498175189049319,0.0237777564955572,-0.0964219216362239,-0.00321311617363986,0.036187625853738
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CST7,Cystatin-F,32725,-0.0813128995269128,0.038812233357364,-0.157384876907346,-0.0052409221464793,0.0361963867639667
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLA2G1B,Phospholipase A2,32818,0.0351663996093282,0.0167991149713566,0.00224013426546922,0.0680926649531872,0.0363461196384476
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBP5,Retinol-binding protein 5,32668,-0.0484031177597694,0.0231988702567375,-0.0938729034629749,-0.00293333205656392,0.0369672162080046
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VSIG10,V-set and immunoglobulin domain-containing protein 10,31548,-0.0314679965232799,0.0150919252413077,-0.061048169996243,-0.00188782305031679,0.0370941969124243
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,32772,-0.0502764836353567,0.0242110382756049,-0.0977301186555423,-0.00282284861517115,0.0378676849144051
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C8B,Complement component C8 beta chain,31598,-0.0255307091515075,0.0122981090395819,-0.049635002869088,-0.00142641543392707,0.0379281348511721
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DPEP1,Dipeptidase 1,32636,0.0406978030549853,0.0196050715650767,0.00227186278743494,0.0791237433225356,0.0379339703734329
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PVALB,Parvalbumin alpha,32763,-0.0981313073183846,0.0472852704480729,-0.190810437396607,-0.0054521772401617,0.0379870223455012
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),THY1,Thy-1 membrane glycoprotein,32806,0.0225228300043576,0.010878273611237,0.00120141372633313,0.0438442462823821,0.0384396322619207
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GRSF1,G-rich sequence factor 1,31284,-0.0695596161799348,0.0336774894169532,-0.135567495437163,-0.00355173692270651,0.0389138174348996
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBM17,Splicing factor 45,31555,-0.0657239781055191,0.0318352452341804,-0.128121058764513,-0.00332689744652565,0.0390034262821191
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",31555,-0.0778665860906496,0.0377501800813541,-0.151856939050104,-0.00387623313119552,0.0391764098110192
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GBP1,Guanylate-binding protein 1,31529,-0.0555037152033437,0.0269158033734652,-0.108258689815336,-0.0027487405913519,0.0392295727273811
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL28A1,Collagen alpha-1(XXVIII) chain,31356,-0.0668609173671869,0.0324237474018055,-0.130411462274726,-0.00331037245964808,0.0392328726045953
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),S100A14,Protein S100-A14,31555,0.0422418852584101,0.0206110272552841,0.00184427183805328,0.082639498678767,0.040449043871704
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,31313,-0.0593512739152051,0.028961564097809,-0.116115939546911,-0.00258660828349942,0.0404665710731831
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FURIN,Furin,32720,-0.0286565578505838,0.0140251330152633,-0.0561458185605,-0.00116729714066767,0.0410593005599318
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SUSD4,Sushi domain-containing protein 4,31548,0.0356578917084319,0.0174522162667705,0.00145154782556162,0.0698642355913021,0.0410693698458603
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FOLR3,Folate receptor gamma,32686,-0.155126405005791,0.0760191195409206,-0.304123879305996,-0.00612893070558704,0.0413179546023984
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANGPTL3,Angiopoietin-related protein 3,32727,-0.029436386923251,0.0144417676902667,-0.0577422515961739,-0.00113052225032824,0.0415514052965403
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRYM,Ketimine reductase mu-crystallin,31342,0.065117874027288,0.0320676236697149,0.00226533163464679,0.127970416419929,0.042326583316566
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCN1,CCN family member 1,32657,-0.0641688070848061,0.0316217510251136,-0.126147439094029,-0.00219017507558348,0.0424616935490251
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BOC,Brother of CDO,32598,0.019452049821075,0.0096099376488124,0.000616572029402684,0.0382875276127473,0.0429840734964681
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C4BPB,C4b-binding protein beta chain,32720,-0.0330665835678734,0.0163531819851297,-0.0651188202587277,-0.00101434687701921,0.0432035053989032
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENTR1,Endosome-associated-trafficking regulator 1,31388,-0.0498743517063079,0.0246676520816841,-0.0982229497864087,-0.00152575362620706,0.0432269075756191
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGFBP2,Fibroblast growth factor-binding protein 2,31571,-0.0417151142482528,0.0206332497504434,-0.0821562837591219,-0.00127394473738363,0.0432374497500444
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPINK6,Serine protease inhibitor Kazal-type 6,32794,-0.0446983464371426,0.0221093829754462,-0.0880327370690172,-0.00136395580526802,0.0432380094074026
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LPL,Lipoprotein lipase,32729,0.0390984945109498,0.0193414251674379,0.00118930118277143,0.0770076878391281,0.0432590578580769
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NAAA,N-acylethanolamine-hydrolyzing acid amidase,32604,0.0493022143897391,0.0244192019562321,0.00144057855552425,0.0971638502239539,0.0435183355516404
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRTAC1,Cartilage acidic protein 1,32834,-0.0245006360784762,0.0121505086791885,-0.0483156330896857,-0.000685639067266746,0.0437848863241475
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPKOW,G-patch domain and KOW motifs-containing protein,32502,-0.0236552739214516,0.0117417807412224,-0.0466691641742475,-0.000641383668655779,0.0439749714405241
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHGA,Chromogranin-A,31571,0.0654047817523302,0.0324871652875322,0.00172993778876707,0.129079625715893,0.0441230313245597
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZP4,Zona pellucida sperm-binding protein 4,31326,-0.0255944429770825,0.0127147197983215,-0.0505152937817927,-0.000673592172372273,0.0441528409870495
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL15,C-C motif chemokine 15,32834,-0.0352513057148023,0.01754652342232,-0.0696424916225495,-0.0008601198070552,0.0445649702515028
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LTA4H,Leukotriene A-4 hydrolase,32794,-0.0480089729980259,0.0239319180123569,-0.0949155323022454,-0.00110241369380639,0.0448794479247391
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RPA2,Replication protein A 32 kDa subunit,31355,-0.0266959589127716,0.013332632801639,-0.052827919203984,-0.000563998621559227,0.0452882103942706
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GLA,Alpha-galactosidase A,31402,-0.0307282623337961,0.0153657479373508,-0.0608451282910037,-0.000611396376588479,0.0455587932632583
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LTA,Lymphotoxin-alpha,32728,0.0322400804175086,0.016136919032684,0.000611719113447824,0.0638684417215693,0.0457571174689554
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSPA2,Heat shock-related 70 kDa protein 2,31548,-0.0282902601677905,0.0141640264110738,-0.0560517519334951,-0.000528768402085798,0.0458243339906923
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,31255,-0.0261066397316785,0.0130858852460897,-0.0517549748140143,-0.000458304649342618,0.0460770247289187
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD244,Natural killer cell receptor 2B4,32833,-0.0215903651215841,0.0108364754180202,-0.0428298569409037,-0.000350873302264527,0.0463597455443191
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL36A,Interleukin-36 alpha,31355,0.0483325374858205,0.0242617479246454,0.000779511553515508,0.0958855634181255,0.0463930968613765
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HCLS1,Hematopoietic lineage cell-specific protein,32833,-0.0452869031582954,0.0227687539564592,-0.0899136609129554,-0.000660145403635473,0.0467322393774015
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL19,C-C motif chemokine 19,32806,-0.0938690338802069,0.0472056552513532,-0.186392118172859,-0.00134594958755457,0.0467854600156648
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLSTN3,Calsyntenin-3,31548,-0.0250676904433351,0.01261729568882,-0.0497975899934222,-0.000337790893247876,0.0469831009492482
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LCN15,Lipocalin-15,31555,-0.051366656639027,0.02586778741617,-0.10206751997472,-0.00066579330333387,0.0470978185589523
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APCS,Serum amyloid P-component,31532,-0.0287712145199386,0.0144900317532049,-0.0571716767562201,-0.000370752283657128,0.0471147733788021
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL17RB,Interleukin-17 receptor B,32613,0.043420275174106,0.0219015830583964,0.000493172379649118,0.0863473779685629,0.0474525485259177
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINF1,Pigment epithelium-derived factor,31491,-0.0209805836361589,0.0106036433867957,-0.0417637246742784,-0.000197442598039398,0.0478946760837807
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CIRBP,Cold-inducible RNA-binding protein,31560,-0.0787896429318006,0.0399045648258878,-0.157002589990541,-0.00057669587306039,0.0483660604354999
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL28,C-C motif chemokine 28,32691,-0.0481295426867373,0.0243873359898895,-0.0959287212269207,-0.000330364146553963,0.0484644526020053
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),F2R,Proteinase-activated receptor 1,32739,-0.0474999223538186,0.0240753525481421,-0.0946876133481771,-0.000312231359459986,0.0485300723191356
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),JAM2,Junctional adhesion molecule B,32806,0.0202221715499082,0.0102543669731213,0.000123612282590512,0.0403207308172259,0.0486341296275996
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OMP,Olfactory marker protein,31342,0.0392758117172874,0.0200227438679879,3.12337360310888e-05,0.0785203896985438,0.0498507688790208
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFAIP2,Tumor necrosis factor alpha-induced protein 2,31560,-0.0397195774278115,0.0202847184434766,-0.0794776255770255,3.847072140261e-05,0.0502539304603489
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,32526,-0.0506222459484411,0.0258747003934055,-0.101336658719516,9.21668226337366e-05,0.0504456560340237
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SYTL4,Synaptotagmin-like protein 4,31571,-0.0587753456963391,0.0300772877515185,-0.117726829689315,0.00017613829663727,0.0507203082183194
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LXN,Latexin,32599,0.0545849804607103,0.0279624783318049,-0.000221477069627392,0.109391437991048,0.0509606589418637
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFASC,Neurofascin,32833,-0.021945959048026,0.0112512062537636,-0.0439983233054027,0.000106405209350617,0.0511425498360999
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CKB,Creatine kinase B-type,31571,0.0479131231572823,0.0245842363281463,-0.000271980045884364,0.096098226360449,0.0513391853896115
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ECI2,Enoyl-CoA delta isomerase 2,31313,-0.049488791778107,0.0254154449543061,-0.099303063888547,0.000325480332332921,0.0515490369942503
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RTKN2,Rhotekin-2,31313,-0.0426754171096003,0.0219168520837399,-0.0856324471937306,0.00028161297453002,0.0515541618923252
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),REG3G,Regenerating islet-derived protein 3-gamma,31548,-0.0326838596540016,0.0168018295133193,-0.0656154455001074,0.000247726192104239,0.0517805805246653
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEMA7A,Semaphorin-7A,32801,-0.0212586465851711,0.0109574830458616,-0.0427353133550599,0.000218020184717643,0.0523985665680827
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HGFAC,Hepatocyte growth factor activator,31505,-0.0229961195805761,0.0118529323383894,-0.0462278669638193,0.000235627802667171,0.0524017467155587
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",31560,-0.0830758813777191,0.0428237223884707,-0.167010377259122,0.00085861450368345,0.0524222307711874
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LATS1,Serine/threonine-protein kinase LATS1,31355,-0.068671478602852,0.0354139717547217,-0.138082863242107,0.000739906036402616,0.0525258011462075
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,32705,-0.0184343888217818,0.00953063275724114,-0.0371144290259744,0.000245651382410873,0.053117317735203
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1GALT1C1,C1GALT1-specific chaperone 1,31313,-0.0252506770782617,0.0130575607841489,-0.0508434962151935,0.00034214205867001,0.0531758591721244
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GHRHR,Growth hormone-releasing hormone receptor,32502,-0.0446293835537206,0.0230799670593814,-0.089866118990108,0.000607351882666932,0.0531844982941032
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL22,C-C motif chemokine 22,32587,-0.0407614022965611,0.0210991703769411,-0.0821157762353657,0.000592971642243485,0.0534046792963533
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADGRE5,Adhesion G protein-coupled receptor E5,32784,-0.0233115802335471,0.0120859998079621,-0.0470001398571528,0.000376979390058586,0.0537863060134054
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UMOD,Uromodulin,32812,0.0412067694983418,0.0213832568369342,-0.000704413902049277,0.0831179528987329,0.0540040513995887
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MTDH,Protein LYRIC,31355,-0.0737106235941034,0.0382541533255093,-0.148688764112102,0.00126751692389475,0.0540341040259166
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AGR2,Anterior gradient protein 2 homolog,32427,0.0773869476093045,0.0403172246185453,-0.00163481264304437,0.156408707861653,0.0549604271971672
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRSS22,Brain-specific serine protease 4,31355,0.0277654328767587,0.0144832588161556,-0.000621754402906231,0.0561526201564237,0.0552669109355008
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCARB1,Scavenger receptor class B member 1,32502,-0.0464311338518715,0.0242888145134777,-0.0940372102982879,0.00117494259454484,0.0559571961756792
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHI3L1,Chitinase-3-like protein 1,32516,-0.0593893085540836,0.0311433219944352,-0.120430219663177,0.00165160255500934,0.0565578439101493
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),JUN,Transcription factor AP-1,32596,0.041474685810696,0.0217707781407883,-0.00119603934524915,0.0841454109666411,0.0568047936768683
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LPO,Lactoperoxidase,32430,-0.0460246996410458,0.0242214070900477,-0.0934986575375392,0.0014492582554476,0.0574448386808757
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",31538,-0.0867861720906161,0.0457233994173241,-0.176404034948571,0.00283169076733922,0.0577244464111612
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CAMLG,Guided entry of tail-anchored proteins factor CAMLG,31356,-0.0424295668500413,0.0223787419041257,-0.0862919009821276,0.00143276728204504,0.0580015846326995
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GSN,Gelsolin,31557,0.0145862986097545,0.00769726361735509,-0.000500338080261464,0.0296729352997705,0.0581301139673445
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARSB,Arylsulfatase B,32668,-0.0430588055921777,0.0227246661621554,-0.0875991512700023,0.00148154008564691,0.0581509913908222
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VNN2,Vascular non-inflammatory molecule 2,32668,-0.0363385278799157,0.0191967019138989,-0.0739640636311576,0.00128700787132618,0.058396363085165
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPON1,Spondin-1,32721,-0.0242902911688357,0.0128327378772693,-0.0494424574082835,0.000861875070612174,0.0584120024463512
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NBL1,Neuroblastoma suppressor of tumorigenicity 1,32720,0.0195331676952168,0.0103376268058715,-0.000728580844291411,0.0397949162347249,0.0588546093368001
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCHE,Cholinesterase,31432,-0.0217790473881764,0.011542463239101,-0.0444022753368144,0.000844180560461566,0.0592169701199826
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDHR2,Cadherin-related family member 2,32668,-0.0568840394049696,0.0301620926877727,-0.116001741073004,0.00223366226306485,0.0593352787758701
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK6,Kallikrein-6,32710,0.0225484823691517,0.0119611759552234,-0.000895422503086166,0.0459923872413895,0.0594437710645419
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TREML1,Trem-like transcript 1 protein,31586,-0.0415871440321548,0.0220671235076427,-0.0848387061071344,0.00166441804282488,0.0595247776967421
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MMP15,Matrix metalloproteinase-15,31571,-0.0391742367407652,0.0207919664728846,-0.079926491027619,0.00157801754608857,0.0595884348038797
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPL,N-acetylneuraminate lyase,31571,-0.0346591373297085,0.0183971857192028,-0.0707176213393459,0.00139934667992898,0.0596110998972895
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SH2D1A,SH2 domain-containing protein 1A,32728,-0.0441874679433752,0.0234582559131929,-0.0901656495332332,0.00179071364648287,0.0596431542572049
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,31313,-0.0205673106058795,0.0109232037157138,-0.0419767898886786,0.00084216867691957,0.0597527063776835
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLXNB2,Plexin-B2,32789,-0.0183296381928596,0.00974001725067077,-0.0374200720041743,0.000760795618455139,0.0598834902887748
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGFBP6,Insulin-like growth factor-binding protein 6,32686,0.0210338304331398,0.011186566515519,-0.000891839937277386,0.0429595008035571,0.0601034027692347
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCARF1,Scavenger receptor class F member 1,32834,-0.0329640896178167,0.0175415896348526,-0.0673456053021278,0.00141742606649436,0.0602500803695764
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,32721,-0.025006471676727,0.0133135920375478,-0.0511011120703206,0.00108816871686662,0.0603775487598667
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCNE1,G1/S-specific cyclin-E1,31355,0.0758393043279041,0.040397601182243,-0.00333999398929222,0.1550186026451,0.060512785935571
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGLC2,Immunoglobulin lambda constant 2,31585,-0.0194296622996957,0.0103627242113386,-0.0397406017539194,0.000881277154527956,0.0608363370115763
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAP1A,Ras-related protein Rap-1A,31355,-0.0517304860669161,0.0276386727692952,-0.105902284694735,0.00244131256090242,0.0612911347889868
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FOLR1,Folate receptor alpha,32672,0.0204465123748335,0.0109324006740112,-0.000980992946228314,0.0418740176958954,0.0614798229346257
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPB1,Carboxypeptidase B,32834,0.0438336512574537,0.0234412384360924,-0.00211117607728741,0.0897784785921948,0.0615250282690099
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MDM1,Nuclear protein MDM1,31356,-0.0241970556069159,0.0129544769546583,-0.0495878304380462,0.00119371922421439,0.0618215853324431
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,32526,0.0978676216551943,0.0524656330546654,-0.0049650191319499,0.200700262442339,0.0621638502727792
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BATF,Basic leucine zipper transcriptional factor ATF-like,31356,-0.0650367425570756,0.0348766479017899,-0.133394972444584,0.00332148733043272,0.0622534395356865
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ASS1,Argininosuccinate synthase,31313,-0.0616628081707285,0.033100526835354,-0.126539840768022,0.00321422442656524,0.0625163415538393
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL16,C-C motif chemokine 16,32834,-0.0403828095261068,0.0216883655583435,-0.0828920060204601,0.00212638696824657,0.062641778872737
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NCF2,Neutrophil cytosol factor 2,32710,-0.0647184473619001,0.0348013371283607,-0.132929068133487,0.00349217340968683,0.062967645487696
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,31571,-0.0198017464385612,0.0106519687462611,-0.040679605181233,0.00107611230411068,0.0630687125565892
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEMIP2,Cell surface hyaluronidase,31355,-0.0263899087084258,0.0142007770624399,-0.054223431750808,0.00144361433395649,0.0631595579452759
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NOS3,"Nitric oxide synthase, endothelial",32502,-0.0372878395195149,0.020124815763928,-0.0767324784168137,0.00215679937778391,0.0639409595909714
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMAD5,Mothers against decapentaplegic homolog 5,32668,-0.0155709245758051,0.00841099689245565,-0.0320564784850182,0.000914629333407994,0.0641659080957014
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FUT8,"Alpha-(1,6)-fucosyltransferase",32647,-0.0438443371880662,0.0236866889875217,-0.0902702476036088,0.0025815732274764,0.0642014121802429
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL16,Pro-interleukin-16,32833,-0.0325307362752434,0.0175895535209737,-0.0670062611763518,0.00194478862586513,0.0644278864664529
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAYN,Layilin,32636,0.0237455324767518,0.0128850079990592,-0.00150908320140411,0.0490001481549078,0.0653801363431046
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIRT1,NAD-dependent protein deacetylase sirtuin-1,31355,0.0693759409243889,0.03767618917391,-0.00446938985647465,0.143221271705253,0.0656063183148146
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LCAT,Phosphatidylcholine-sterol acyltransferase,31586,-0.0170095163946469,0.00924246697323136,-0.0351247516621804,0.00110571887288657,0.0657529398094307
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,32723,-0.037336710276214,0.0202958673858759,-0.0771166103525308,0.00244318980010275,0.065857276364609
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NACC1,Nucleus accumbens-associated protein 1,31548,-0.0421780729239038,0.0229529573816397,-0.0871658693919176,0.00280972354410998,0.0661617456112301
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL13,C-X-C motif chemokine 13,32806,-0.0431879499073819,0.0235372755279507,-0.0893210099421652,0.00294511012740144,0.0665574512762337
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACVRL1,Serine/threonine-protein kinase receptor R3,32632,-0.0173762608568878,0.00947136515124329,-0.0359401365533246,0.00118761483954903,0.0665973488168175
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NAGA,Alpha-N-acetylgalactosaminidase,31340,0.0459926800424175,0.0251107947263472,-0.00322447762122311,0.0952098377060581,0.067052277799677
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),F9,Coagulation factor IX,32742,-0.0135140861983667,0.00737988290845761,-0.0279786566989436,0.00095048430221026,0.0671032735266552
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGFR4,Fibroblast growth factor receptor 4,31417,0.0401283759882768,0.0219226658396705,-0.00284004905747733,0.0830968010340309,0.0672218188344349
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRDX2,Peroxiredoxin-2,31462,0.047860881179093,0.0261551750856476,-0.00340326198877637,0.0991250243469623,0.067306741185138
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TOP2B,DNA topoisomerase 2-beta,31355,-0.0608516405926823,0.0333093491134601,-0.126137964855064,0.00443468366969962,0.0677600164694401
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EFHD1,EF-hand domain-containing protein D1,31555,0.0256285435204697,0.0140348101968353,-0.00187968446532743,0.0531367715062669,0.0678784740816405
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDGFB,Platelet-derived growth factor subunit B,32756,-0.064448510103917,0.0352951770141889,-0.133627057051727,0.0047300368438932,0.067885826637721
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,32447,-0.0640247972087206,0.0351361132804544,-0.132891579238411,0.00484198482096999,0.0684603961572709
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LGALS8,Galectin-8,32806,-0.0456150367491315,0.0250352049211758,-0.0946840383946361,0.00345396489637304,0.0684829438815553
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,31388,-0.0404159365949749,0.0222061377483325,-0.0839399665817066,0.00310809339175682,0.06879344558925
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NADK,NAD kinase,32729,-0.0420279898971772,0.0230945430088751,-0.0872932941945724,0.00323731440021804,0.0688195965097782
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BMP6,Bone morphogenetic protein 6,32582,-0.0310724997614854,0.0170785691257511,-0.0645464952479575,0.00240149572498673,0.0688869171679225
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPC1,Glypican-1,32794,0.0213958336710006,0.0117657629659553,-0.00166506174227178,0.044456729084273,0.0690238921957875
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STXBP1,Syntaxin-binding protein 1,31555,-0.0588030797011079,0.0323505430620574,-0.12221014410274,0.00460398470052456,0.069151243034352
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHP1,Calcineurin B homologous protein 1,31342,0.0571217277138466,0.0314372656689354,-0.00449531299726683,0.11873876842496,0.0692560495808634
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCPEP1,Retinoid-inducible serine carboxypeptidase,31361,-0.0381830884145144,0.0210242848595596,-0.0793906867392512,0.00302450991022242,0.0693884817906667
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KRT5,"Keratin, type II cytoskeletal 5",32502,-0.0372208090792047,0.0205187782156417,-0.0774376143818625,0.00299599622345306,0.0697143006118926
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MTSS2,Protein MTSS 2,31548,-0.0746244638622606,0.0411633284710092,-0.155304587665439,0.00605565994091742,0.06988823259428
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTNNA1,Catenin alpha-1,31342,0.0267857265690798,0.0147989708967081,-0.00222025638846807,0.0557917095266277,0.0703401969878651
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PNLIP,Pancreatic triacylglycerol lipase,31586,0.0459304119063452,0.0253795540772487,-0.00381351408506228,0.0956743378977527,0.0703748506629109
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANXA1,Annexin A1,31378,-0.0345513213101854,0.0191255326222232,-0.0720373652497429,0.00293472262937199,0.0708717034430046
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDHR1,Cadherin-related family member 1,32502,0.0308161242090523,0.0170624041257458,-0.00262618787740936,0.064258436295514,0.070940096509241
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIAA0319,Dyslexia-associated protein KIAA0319,31548,0.0227150098059041,0.0125955335771938,-0.00197223600539571,0.0474022556172038,0.07136175457804
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,32598,0.0416653994510921,0.0231140171386187,-0.00363807414060065,0.0869688730427848,0.0714850097094695
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SSNA1,Sjoegren syndrome nuclear autoantigen 1,31560,-0.0383661334823115,0.0212934638501713,-0.0801013226286471,0.00336905566402424,0.0716191531083067
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",31326,-0.0425004635327126,0.023603956691354,-0.0887642186477664,0.00376329158234118,0.0718117790451963
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPP3R1,Calcineurin subunit B type 1,32647,-0.0307070822349128,0.0170809501855266,-0.064185744598545,0.00277158012871943,0.0722527701090444
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SFTPD,Pulmonary surfactant-associated protein D,32729,-0.0484172576666651,0.0269329866699817,-0.101205911539829,0.00437139620649907,0.07225957727314
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZNF174,Zinc finger protein 174,31355,0.0287498531990886,0.0159991296710756,-0.00260844095621956,0.0601081473543967,0.0723816482017966
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EVI2B,Protein EVI2B,31326,-0.028898964256025,0.0160951772330529,-0.0604455116328087,0.00264758312075858,0.0726137698865788
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAMP3,Lysosome-associated membrane glycoprotein 3,32820,-0.0369531991851755,0.02058952704915,-0.0773086722015096,0.00340227383115849,0.0727261075010987
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,32526,-0.0549145687092179,0.0305984988079473,-0.114887626372794,0.00505848895435875,0.0727392507724565
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CELA2A,Chymotrypsin-like elastase family member 2A,31571,0.0443584366383969,0.0247549194602484,-0.00416120550369001,0.0928780787804838,0.0731875560401547
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MERTK,Tyrosine-protein kinase Mer,32833,0.0184250029039876,0.0103009808957987,-0.00176491965177787,0.0386149254597531,0.0737025232220965
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UPB1,Beta-ureidopropionase,31571,-0.068713505955566,0.0384215895759602,-0.144019821524448,0.00659280961331613,0.0737493363712515
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNM1,Dynamin-1,31560,-0.0846842118125023,0.0473754882400566,-0.177540168763013,0.00817174513800868,0.0738942330060001
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPO,Erythropoietin,32728,0.0558080014007166,0.0312434770234941,-0.00542921356533174,0.117045216366765,0.074096358436816
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,31555,-0.0576843539627655,0.0322944449715235,-0.120981466106952,0.00561275818142067,0.0741061597483913
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRELP,Prolargin,32702,0.0160717547337728,0.00900496616393,-0.00157797894752998,0.0337214884150756,0.0743336021547319
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANGPTL2,Angiopoietin-related protein 2,32723,-0.0288325938219902,0.0161624400376839,-0.0605109762958507,0.00284578865187026,0.0744699248739511
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DYNLT1,Dynein light chain Tctex-type 1,31356,-0.0590482957851896,0.0331087506994433,-0.123941447156099,0.00584485558571927,0.0745510983407995
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DPP4,Dipeptidyl peptidase 4,32536,-0.0216775855313813,0.0121669434143178,-0.0455247946234442,0.00216962356068157,0.0748365892930154
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,32795,-0.0207117413963148,0.0116321421633597,-0.0435107400364999,0.00208725724387026,0.0750181263889578
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC51B,Organic solute transporter subunit beta,31313,0.0556353419391787,0.0312511389779784,-0.00561689045765908,0.116887574336016,0.0750731572044339
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMBN,Ameloblastin,32596,0.0188047688850796,0.0105679303262609,-0.0019083745543918,0.039517912324551,0.0752059612683126
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP6V1G2,V-type proton ATPase subunit G 2,31313,0.071202412618618,0.0400760433631659,-0.00734663237318717,0.149751457610423,0.075661242101343
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PGA4,Pepsin A-4,31586,0.0457202130638268,0.025736360867859,-0.00472305423717677,0.0961634803648304,0.0756926486659832
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK13,Kallikrein-13,32507,-0.0306835637083935,0.0172820738164553,-0.0645564283886459,0.00318930097185887,0.075857769745671
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CR1,Complement receptor type 1,31559,-0.0256934004067021,0.0144737250428467,-0.0540619014906817,0.00267510067727752,0.0759084317634953
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEP20,Centrosomal protein 20,32526,-0.0546883764804278,0.0308475588431372,-0.115149591812977,0.00577283885212111,0.0762871717629876
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AK2,"Adenylate kinase 2, mitochondrial",31548,-0.0781208041527536,0.0441556196678679,-0.164665818701775,0.00842421039626742,0.0768975665727382
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,31555,-0.0625039241326107,0.0353455774633228,-0.131781255960723,0.00677340769550196,0.077039319032934
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,31560,-0.103341611651852,0.0584909196744887,-0.21798381421385,0.0113005909101457,0.0773017543161213
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARHGAP5,Rho GTPase-activating protein 5,31326,0.0550764764396361,0.0311752034378845,-0.00602692229861758,0.11617987517789,0.0773233967907571
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SORT1,Sortilin,32719,-0.0272364530619642,0.0154190091528896,-0.0574577110016278,0.00298480487769934,0.0773597690086793
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL25,C-C motif chemokine 25,32833,-0.0362138782785078,0.0205053623990333,-0.076404388580613,0.0039766320235974,0.0774183260934659
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),REN,Renin,32729,-0.047826990075225,0.0270812369169489,-0.100906214432445,0.00525223428199478,0.0774207952139734
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PGR,Progesterone receptor,31355,0.0780674834712609,0.0442090543466713,-0.00858226304821477,0.164717229990737,0.077458212839278
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACE,Angiotensin-converting enzyme,31586,-0.0188834066026798,0.010698632266195,-0.0398527258444221,0.00208591263906244,0.0775982288838668
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSS,Cathepsin S,30849,-0.0176829751680673,0.0100268440577453,-0.0373355895212482,0.0019696391851135,0.0778492021096288
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL11,C-X-C motif chemokine 11,32806,-0.0563183295184569,0.0319730531766196,-0.118985513744631,0.00634885470771749,0.078199623683049
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJB14,DnaJ homolog subfamily B member 14,31560,-0.0482741160275427,0.0274144305951168,-0.102006399993972,0.00545816793888619,0.0782947396562079
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTRL,Chymotrypsin-like protease CTRL-1,31548,0.0482386732796791,0.0273953219059518,-0.00545615765598635,0.101933504215345,0.0783058901657111
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD200,OX-2 membrane glycoprotein,32728,0.0182237896794742,0.0103712210751972,-0.00210380362791225,0.0385513829868607,0.0789267728819816
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MSMB,Beta-microseminoprotein,32696,-0.0472924011100358,0.0269293990504234,-0.100074023248866,0.00548922102879398,0.0790953039111034
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,31313,-0.0294468299233628,0.0167779460682635,-0.0623316042171592,0.00343794437043364,0.079284746891159
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA6,Carbonic anhydrase 6,32688,0.0449417813497504,0.0256494060560194,-0.00533105452004763,0.0952146172195485,0.0797815655857785
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAG3,Lymphocyte activation gene 3 protein,32668,-0.0286726863650153,0.0163834305239998,-0.060784210192055,0.0034388374620244,0.0801354083792128
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSD,Cathepsin D,32150,-0.0280598871684228,0.0160356262800565,-0.0594897146773335,0.00336994034048801,0.0801817728719361
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DUOX2,Dual oxidase 2,32598,0.0507428766047566,0.0290375485390222,-0.0061707185317269,0.10765647174124,0.0805872002976141
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LCP1,Plastin-2,31571,-0.0341970082814462,0.0195728581619005,-0.0725598102787712,0.00416579371587884,0.0806485689183554
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GUK1,Guanylate kinase,31313,-0.0294569472171708,0.0168659751588803,-0.0625142585285761,0.0036003640942345,0.0807599327046697
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATXN2,Ataxin-2,31342,-0.0793690532553827,0.0454535292446785,-0.168457970574952,0.00971986406418716,0.0808245040558569
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PKD2,Polycystin-2,31313,-0.0434917857973975,0.0249092668529729,-0.0923139488292244,0.00533037723442949,0.0808507171127231
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,31560,-0.0283838690781854,0.0162873720327943,-0.0603071182624621,0.0035393801060914,0.0814273917962303
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COPB2,Coatomer subunit beta',31313,-0.0312944622761307,0.0179599535152179,-0.0664959711659578,0.00390704661369642,0.0814696044454999
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL1B,Interleukin-1 beta,32547,-0.0402269167036312,0.0231292013664077,-0.0855601513817902,0.00510631797452786,0.0820303764472067
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CX3CL1,Fractalkine,32647,0.0232403071859262,0.0133708624386045,-0.00296658319373861,0.0494471975655909,0.0822228076630268
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLAT,Tissue-type plasminogen activator,32801,-0.0359844060514777,0.020711647095253,-0.0765792343581735,0.00461042225521825,0.0823511075390401
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPM1B,Protein phosphatase 1B,31355,0.0462823394925715,0.0266617168988012,-0.00597462562907883,0.0985393046142218,0.0826208551395509
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL6,Interleukin-6,32668,-0.0497201274047198,0.0286544012830533,-0.105882753919504,0.00644249911006475,0.0827464797477269
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1S,Complement C1s subcomponent,31598,-0.0151735431673214,0.00875815553953629,-0.0323395280248125,0.0019924416901697,0.083223636082864
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GZMB,Granzyme B,32728,-0.0465961200197008,0.0269091776034246,-0.0993381081224131,0.00614586808301144,0.0833783376426192
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYL4,Myosin light chain 4,31388,0.0386130358119562,0.0223311491572237,-0.00515601653620219,0.0823820881601147,0.0838302258261476
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AP3B1,AP-3 complex subunit beta-1,31560,-0.0549687025111632,0.031816133587957,-0.117328324343559,0.00739091932123254,0.0840822976442987
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NXPE4,NXPE family member 4,31313,-0.0247577795634911,0.0143353978473142,-0.052855159344227,0.0033396002172448,0.0842022379367306
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NEB,Nebulin,31313,-0.0278284507199291,0.0161229554538883,-0.0594294434095503,0.00377254196969204,0.0843862957135336
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZNRD2,Protein ZNRD2,31560,-0.0491480877167346,0.0284804032794127,-0.104969678144384,0.00667350271091424,0.0844449568401174
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,31555,0.0172361128740087,0.00998834505094231,-0.0023410434258382,0.0368132691738556,0.0844554962465918
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HMOX2,Heme oxygenase 2,32502,-0.0331475805397563,0.0192296750480453,-0.0708377436339252,0.00454258255441253,0.0847847281374394
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,32833,-0.0701461601127953,0.0406989368029684,-0.149916076246613,0.00962375602102278,0.0848257452934692
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINE1,Plasminogen activator inhibitor 1,32834,-0.0477597306577055,0.0277227658939448,-0.102096351809837,0.00657689049442634,0.0849660047948798
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUP50,Nuclear pore complex protein Nup50,31313,-0.023707597856106,0.0137783144919181,-0.0507130942602655,0.00329789854805348,0.0853566378290203
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SART1,U4/U6.U5 tri-snRNP-associated protein 1,31313,-0.0260281769553033,0.0151288526536336,-0.0556807281564251,0.00362437424581851,0.0853952760974777
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",32728,-0.0677366613617199,0.0394114510681063,-0.144983105455208,0.00950978273176849,0.0857029871666946
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GGH,Gamma-glutamyl hydrolase,32544,-0.0240733439598021,0.0140165734084058,-0.0515458278402775,0.00339913992067334,0.0859250812448594
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLC,Galectin-10,32720,-0.0483563138863689,0.0281654935464646,-0.10356068123744,0.0068480534647018,0.0860390261478006
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NOS2,"Nitric oxide synthase, inducible",31313,-0.028426417380674,0.0165911622666512,-0.0609450954233104,0.00409226066196248,0.0866903148386218
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RALB,Ras-related protein Ral-B,31355,0.0211072931972538,0.0123221343503772,-0.00304409012948556,0.0452586765239932,0.0867617050112736
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SH3BP1,SH3 domain-binding protein 1,31560,-0.0351612431715286,0.0205278819480125,-0.0753958917896331,0.00507340544657581,0.086779853300589
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NT5E,5'-nucleotidase,32720,-0.0381598791959832,0.0223515834710973,-0.0819689827993338,0.00564922440736744,0.0878094819829574
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ICAM5,Intercellular adhesion molecule 5,32729,-0.0310744108390647,0.018216206758451,-0.0667781760856287,0.00462935440749932,0.0880680128657798
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCN5,CCN family member 5,32718,0.0266619876244248,0.0156402383147306,-0.0039928794724472,0.0573168547212968,0.0882845810168653
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK1,Kallikrein-1,32610,0.0872881476813091,0.0512110867536023,-0.0130855823557515,0.18766187771837,0.088327408018334
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IMMT,MICOS complex subunit MIC60,31548,-0.0318730679788067,0.0187015030039269,-0.0685280138665034,0.00478187790889001,0.0883644994155412
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC2L,C-type lectin domain family 2 member L,31356,0.0363296660825711,0.0213224202959623,-0.005462277697515,0.0781216098626571,0.0884552913419785
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UNG,Uracil-DNA glycosylase,31548,-0.0245671226208357,0.0144285859026459,-0.0528471509900217,0.0037129057483503,0.0886702358519283
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCRL1,Fc receptor-like protein 1,32729,-0.0308409015219723,0.0181138721981685,-0.0663440910303826,0.00466228798643806,0.0886756884252776
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF9,Tumor necrosis factor receptor superfamily member 9,32647,-0.0267005838629841,0.0156955304100457,-0.0574638234666736,0.00406265574070546,0.0889486217493059
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RIPK4,Receptor-interacting serine/threonine-protein kinase 4,31313,-0.0478275421411633,0.0281179185038362,-0.102938662408682,0.00728357812635577,0.0889916291036172
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPPP3,Tubulin polymerization-promoting protein family member 3,32502,0.0272490949937198,0.0160332212252118,-0.00417601860769528,0.0586742085951348,0.0892535404106928
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TGOLN2,Trans-Golgi network integral membrane protein 2,31586,0.0175161645926889,0.01031338619816,-0.0026980723557047,0.0377304015410825,0.0894742129952046
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCAR2,Cell cycle and apoptosis regulator protein 2,31548,-0.039398288429147,0.0231984072215999,-0.0848671665834829,0.00607058972518878,0.0894880952009555
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDK5RAP3,CDK5 regulatory subunit-associated protein 3,31555,-0.0412478392513526,0.0242962913750561,-0.0888685703464625,0.00637289184375729,0.0896046345820521
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSMA1,Proteasome subunit alpha type-1,32526,0.0321065387719305,0.0189305453795969,-0.00499733017207939,0.0692104077159404,0.0899184583674923
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,32806,-0.0308489114350344,0.0181924398488382,-0.0665060935387572,0.00480827066868843,0.0899775963947595
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BTN3A2,Butyrophilin subfamily 3 member A2,32728,-0.0252218730127123,0.0148815150740999,-0.0543896425579481,0.00394589653252359,0.0901397894752386
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDCP1,CUB domain-containing protein 1,32647,-0.034391176002033,0.0202922147299004,-0.0741639168726378,0.00538156486857187,0.0901494506665255
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,32719,-0.0785186618646439,0.0463374555466696,-0.169340074736116,0.0123027510068285,0.0902061006408331
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AHSP,Alpha-hemoglobin-stabilizing protein,32706,0.0599526961699222,0.0354099317376407,-0.00945077003585348,0.129356162375698,0.0904708881293816
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOB,Apolipoprotein B-100,31586,-0.0160154317602168,0.0094634125882599,-0.0345637204332062,0.00253285691277261,0.0906190682575436
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL2,C-C motif chemokine 2,32632,0.0355603631877583,0.02101616390939,-0.00563131807464611,0.0767520444501628,0.0906722916568936
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSF2,Granulocyte-macrophage colony-stimulating factor,31313,-0.0254357348267509,0.0150374267389549,-0.0549090912351025,0.00403762158160064,0.0907840742111251
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADGRB3,Adhesion G protein-coupled receptor B3,32632,0.0227869345859437,0.0135040129461482,-0.00368093078850681,0.0492547999603942,0.0915582716953204
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL33,Interleukin-33,32596,0.0270935728279931,0.0160594751033461,-0.00438299837456525,0.0585701440305515,0.0916242273335234
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSRC1,Proline/serine-rich coiled-coil protein 1,32526,-0.0411348395343702,0.0243879308089253,-0.0889351839198638,0.00666550485112328,0.0916992801155177
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RANGAP1,Ran GTPase-activating protein 1,32526,0.0338213734921945,0.0200766950237719,-0.0055289487543984,0.0731716957387873,0.0921001160067325
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MOG,Myelin-oligodendrocyte glycoprotein,32794,0.021988295551611,0.0130741674816719,-0.0036370727124659,0.047613663815688,0.0926401940047157
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADGRD1,Adhesion G-protein coupled receptor D1,31417,-0.0271939623462559,0.0161890043395447,-0.0589244108517636,0.00453648615925173,0.0930415030807735
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL14,C-X-C motif chemokine 14,32596,-0.0437801464866937,0.0260646197434719,-0.0948668011838986,0.00730650821051131,0.0930559029373581
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OSM,Oncostatin-M,32685,-0.0491709985180272,0.0293231354408708,-0.106644343982134,0.00830234694607961,0.0936039067364908
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYO6,Unconventional myosin-VI,31555,-0.0263056509575675,0.0157008166279699,-0.0570792515483886,0.00446794963325358,0.0938901272363845
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DOC2B,Double C2-like domain-containing protein beta,31356,-0.0246035040815199,0.0147105064527712,-0.0534360967289514,0.00422908856591156,0.0944650613456842
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SUGP1,SURP and G-patch domain-containing protein 1,31560,-0.0287580328038134,0.0171983947989823,-0.0624668866098188,0.00495082100219196,0.0945383915542965
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPI,Glucose-6-phosphate isomerase,31586,-0.0333016551043576,0.0199290815054741,-0.0723626548550869,0.00575934464637168,0.0947605939426843
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CAT,Catalase,31478,0.037916295142837,0.0227260408566367,-0.00662674493617092,0.0824593352218449,0.095275972124409
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ALDH2,"Aldehyde dehydrogenase, mitochondrial",31548,0.0337596674373719,0.0202619511066124,-0.00595375673158849,0.0734730916063323,0.0957221415386069
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WIF1,Wnt inhibitory factor 1,32794,-0.0228015996452018,0.0136980383725449,-0.0496497548553897,0.00404655556498613,0.0960299114537792
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPY,Pro-neuropeptide Y,32794,-0.0447740294497078,0.0269528205241175,-0.0976015576769781,0.00805349877756255,0.0967083436043547
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GSTM4,Glutathione S-transferase Mu 4,31313,-0.0479563957924528,0.0289355713504359,-0.104670115639307,0.00875732405440151,0.0974906360602825
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,32738,0.0203971357555486,0.0123244308602885,-0.00375874873061684,0.044553020241714,0.0979565083541632
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL18,C-C motif chemokine 18,32608,-0.0483387137519189,0.0292141152989848,-0.105598379737929,0.00892095223409135,0.0980343214801487
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DIPK1C,Divergent protein kinase domain 1C,31356,-0.0300567735088914,0.0181819009907686,-0.065693299450798,0.00557975243301511,0.0983493342034655
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIMP1,Metalloproteinase inhibitor 1,32611,-0.0186160474736037,0.0112649908479719,-0.0406954295356287,0.00346333458842123,0.0984567846998083
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",31571,-0.0216577007042365,0.0131076263621736,-0.0473486483740967,0.00403324696562369,0.0985145945753267
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIAE,Sialate O-acetylesterase,32704,-0.0320709371858377,0.0194150109092063,-0.0701243585678821,0.0059824841962067,0.098597992955206
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RGMA,Repulsive guidance molecule A,32806,0.0206292782637842,0.0125029218034127,-0.00387644847090471,0.0451350049984731,0.0989869206752023
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,31571,-0.0436800067257405,0.0264765294266816,-0.0955740044020364,0.00821399095055535,0.0990320865815067
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GNLY,Granulysin,32718,-0.0345669043884344,0.0209576419864115,-0.0756438826818009,0.00651007390493223,0.0991073305680294
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD207,C-type lectin domain family 4 member K,32508,-0.0253432166813722,0.015405345640646,-0.0555376941370384,0.00485126077429402,0.0999871054605254
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJA2,DnaJ homolog subfamily A member 2,32801,-0.0554405584649106,0.0337448784921859,-0.121580520309595,0.0106994033797738,0.100432057788524
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,31417,-0.0440416741165192,0.0268127620307854,-0.0965946876968586,0.00851133946382009,0.100514807001081
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GAMT,Guanidinoacetate N-methyltransferase,31313,-0.0245845688882747,0.0149678861158045,-0.0539216256752516,0.00475248789870214,0.100531158889463
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARF6,ADP-ribosylation factor 6,31560,-0.0725817308842665,0.0442071992753848,-0.159227841464021,0.0140643796954877,0.100661270953204
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ECHS1,"Enoyl-CoA hydratase, mitochondrial",31388,-0.065989425718495,0.0402112814367312,-0.144803537334488,0.012824685897498,0.100825186009088
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CREG1,Protein CREG1,32602,-0.0254545489416629,0.0155137292825514,-0.0558614583354638,0.00495236045213789,0.10087997372108
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,32526,-0.0454993678998757,0.0277698695915333,-0.099928312299281,0.00892957649952957,0.101365471659
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DAAM1,Disheveled-associated activator of morphogenesis 1,31417,-0.055997350842606,0.0341794962638551,-0.122989163519762,0.0109944618345501,0.10139415709819
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GHRL,Appetite-regulating hormone,32729,0.0516068297564662,0.0315252165209147,-0.0101825946245266,0.113396254137459,0.10166561459683
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHL1,Neural cell adhesion molecule L1-like protein,32738,-0.0206651417509797,0.0126298086072105,-0.0454195666211122,0.00408928311915278,0.101829059491653
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNF43,E3 ubiquitin-protein ligase RNF43,31456,-0.0402781717047923,0.0246183056196852,-0.0885300507193753,0.00797370730979071,0.101858713456392
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TSPYL1,Testis-specific Y-encoded-like protein 1,31355,-0.028143706626273,0.0172031648870102,-0.061861909804813,0.00557449655226708,0.101889740743185
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERVV_1,,31313,-0.031521400727714,0.019269737538545,-0.0692900863032623,0.0062472848478342,0.10192406834431
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMY2B,Alpha-amylase 2B,32100,0.0320916416086503,0.0196339141319571,-0.00639083008998561,0.0705741133072863,0.102192010033679
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DPY30,Protein dpy-30 homolog,32772,-0.0400529023946213,0.0245149272157192,-0.0881021597374308,0.0079963549481883,0.102332624960562
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDGFRA,Platelet-derived growth factor receptor alpha,32729,0.0186858799523939,0.0114371410405243,-0.00373091648703366,0.0411026763918215,0.102338569729691
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",31355,0.0337343280156638,0.0206568739057918,-0.00675314483968815,0.0742218008710158,0.102494172823494
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CGA,Glycoprotein hormones alpha chain,32718,-0.0573227511155163,0.0351021984000848,-0.126123059979683,0.0114775577486499,0.102499378605255
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RYR1,Ryanodine receptor 1,31313,-0.023683629639973,0.0145198547045892,-0.0521425448609677,0.0047752855810218,0.102907191474455
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EEF1D,Elongation factor 1-delta,31571,-0.0622544760661203,0.0381685301304416,-0.137064795121786,0.0125558429895453,0.102922294068805
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TGFA,Protransforming growth factor alpha,32728,-0.0300229384473031,0.0184234108441825,-0.0661328237019008,0.00608694680729454,0.10321988062219
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),XIAP,E3 ubiquitin-protein ligase XIAP,31355,-0.0397681552314622,0.0245038460438963,-0.0877956934774988,0.00825938301457448,0.104645305776058
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TGM2,Protein-glutamine gamma-glutamyltransferase 2,32719,0.049867600834481,0.0307401180438329,-0.0103830305314315,0.110118232200394,0.104789282474905
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GART,Trifunctional purine biosynthetic protein adenosine-3,31555,0.0181377372522092,0.0111808752841244,-0.00377677830467466,0.0400522528090932,0.104799174772794
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CALY,Neuron-specific vesicular protein calcyon,31313,-0.0257516825876648,0.0158758313106286,-0.0568683119564968,0.00536494678116716,0.104831023678923
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MRPL28,"39S ribosomal protein L28, mitochondrial",31555,0.0254576840699508,0.0156969186371387,-0.00530827645884105,0.0562236445987427,0.10488139644287
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA14,Carbonic anhydrase 14,32794,0.0233476608328606,0.0143990547739977,-0.00487448652417483,0.051569808189896,0.104951787601206
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDAN1,Codanin-1,31548,0.0159931473712374,0.00986840374080382,-0.00334892396073805,0.0353352187032129,0.105135498065413
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BAG4,BAG family molecular chaperone regulator 4,31355,-0.0341550427021228,0.0210751381429215,-0.0754623134622489,0.00715222805800342,0.105138657996535
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PMM2,Phosphomannomutase 2,31313,-0.0412024606310557,0.0254381689621714,-0.0910612717969116,0.00865635053480019,0.105336861746652
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,32526,-0.0293712398809918,0.018135803122896,-0.064917414001868,0.00617493423988431,0.10537247772902
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OTUD7B,OTU domain-containing protein 7B,31555,-0.0431093388717099,0.0266299471588446,-0.0953040353030453,0.00908535755962564,0.105524976477883
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GLRX5,"Glutaredoxin-related protein 5, mitochondrial",31417,-0.0601958772416464,0.037201039453802,-0.133109914571098,0.0127181600878055,0.105677711897341
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LEO1,RNA polymerase-associated protein LEO1,31555,-0.019521532655776,0.0120770543887139,-0.0431925592576553,0.00414949394610327,0.106045595373741
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NECAP2,Adaptin ear-binding coat-associated protein 2,31313,-0.0446118697558992,0.0276012783094575,-0.0987103752424359,0.00948663573063752,0.106072388357849
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMY2A,Pancreatic alpha-amylase,32384,0.0308907817955494,0.0191204135316123,-0.00658522872641068,0.0683667923175094,0.1062196236867
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1QL2,Complement C1q-like protein 2,31355,-0.0285352292669506,0.017707676383902,-0.0632422749793985,0.00617181644549725,0.107121395177095
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPR37,Prosaposin receptor GPR37,32598,-0.0418658852052645,0.0259916740041452,-0.0928095662533891,0.00907779584286019,0.107272051070987
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HPSE,Heparanase,31474,-0.0629921333793066,0.0391175427569082,-0.139662517182847,0.0136782504242334,0.107367393441964
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",31555,-0.0283879663801889,0.0176413369215236,-0.0629649867463752,0.00618905398599733,0.107619498151719
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPIB,Peptidyl-prolyl cis-trans isomerase B,32725,-0.0637423026353052,0.0396790422616158,-0.141513225468072,0.0140286201974618,0.108211212670672
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KCNC4,Potassium voltage-gated channel subfamily C member 4,31342,-0.0376152971090717,0.0234172426671941,-0.083513092736772,0.00828249851862872,0.108248519607425
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPHS1,Nephrin,31355,-0.0232124518516643,0.0144706834918176,-0.0515749914956268,0.00515008779229831,0.108733712390682
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PKN3,Serine/threonine-protein kinase N3,31456,-0.0492275682081226,0.0307290727433705,-0.109456550785129,0.0110014143688835,0.109200114400474
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADA2,Adenosine deaminase 2,32669,-0.0269695647015866,0.0168485301973935,-0.0599926838884778,0.00605355448530463,0.109477630030196
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPAG1,Sperm-associated antigen 1,31555,-0.0401186130339072,0.0250645394508687,-0.08924511035761,0.00900788428979549,0.109503840999352
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA3,Carbonic anhydrase 3,32819,0.0406886520788526,0.0254374366533371,-0.00916872376168813,0.0905460279193933,0.109731961763083
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNX18,Sorting nexin-18,31560,-0.0303375021251272,0.0189729077602581,-0.0675244013352331,0.00684939708497858,0.109863708710591
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCN4B,Sodium channel subunit beta-4,31388,0.0279316339671927,0.0174805873955553,-0.00633031732809566,0.062193585262481,0.110114801062163
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GCC1,GRIP and coiled-coil domain-containing protein 1,31548,-0.0717516077854972,0.044918260172798,-0.159791397724181,0.0162881821531869,0.110221741815824
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VASP,Vasodilator-stimulated phosphoprotein,31586,-0.0481928235799322,0.0301976955316763,-0.107380306822018,0.0109946596621534,0.110549645509632
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DHODH,Dihydroorotate dehydrogenase,31313,0.0308509564160323,0.0193475141110158,-0.0070701712415587,0.0687720840736232,0.110850933299247
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL17C,Interleukin-17C,32596,-0.0436763213846557,0.0274044389737393,-0.0973890217731847,0.0100363790038733,0.111024155216345
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINE2,Glia-derived nexin,31571,-0.0425442501334904,0.0266975099809855,-0.094871369696222,0.00978286942924131,0.111074210631499
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDGFA,Platelet-derived growth factor subunit A,32834,-0.0470425718989043,0.0295335958605529,-0.104928419785588,0.0108432759877793,0.111229188003302
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TLR1,Toll-like receptor 1,31355,-0.0170107353038409,0.0106840091224068,-0.0379513931837581,0.00392992257607642,0.111389176803757
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LEG1,Protein LEG1 homolog,31155,-0.0450871224124199,0.0283246439458404,-0.100603424546267,0.0104291797214273,0.1114733415776
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,31571,-0.0226563670482023,0.0142396409451446,-0.0505660633006857,0.0052533292042811,0.111633210894926
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UHRF2,E3 ubiquitin-protein ligase UHRF2,31313,-0.0229010307769896,0.0144025380378285,-0.0511300053311334,0.00532794377715417,0.111861642683563
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PHACTR2,Phosphatase and actin regulator 2,31555,-0.0754289373185832,0.0474849929394814,-0.168499523479967,0.0176416488428004,0.112219039274308
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,32598,-0.0138593382320203,0.008726705973537,-0.0309636819401528,0.00324500547611223,0.112288083131809
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL24,C-C motif chemokine 24,32739,-0.0534520905120163,0.033680565307622,-0.119465998514955,0.0125618174909228,0.112541304178313
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ESYT2,Extended synaptotagmin-2,31548,-0.0546144241580033,0.0344160123475494,-0.1220698083592,0.0128409600431936,0.112578696011482
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VNN1,Pantetheinase,31586,-0.0477849738356702,0.0301167800928062,-0.10681386281757,0.0112439151462299,0.112631469751083
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDH2,Cadherin-2,32729,-0.0228816551117613,0.0144292240502661,-0.0511629342502829,0.00539962402676026,0.11282361369453
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENO3,Beta-enolase,31388,-0.0397080276839648,0.0250525787161276,-0.0888110819675749,0.00939502659964526,0.113011145015298
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAT,Linker for activation of T-cells family member 1,32833,-0.0497620241889096,0.0314785655573105,-0.111460012681238,0.0119359643034189,0.113953878282735
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BTNL10,Butyrophilin-like protein 10,31326,0.0253080075057116,0.0160480119678094,-0.00614609595119484,0.056762110962618,0.114833696401836
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EZR,Ezrin,32806,-0.0158424988128574,0.0100465469444084,-0.0355337308238978,0.0038487331981831,0.114851628494463
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LPA,Apolipoprotein(a),31410,0.116522608219526,0.0738985246397412,-0.0283185000743663,0.261363716513419,0.114885271137747
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TSPAN7,Tetraspanin-7,31342,-0.0627453192468616,0.039909967904665,-0.140968856340005,0.0154782178462818,0.115953036712459
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANXA11,Annexin A11,32716,-0.0425268466137168,0.0270600007769143,-0.0955644481364688,0.0105107549090352,0.116084650034492
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MEP1A,Meprin A subunit alpha,31560,-0.0465384189651087,0.0296171454207701,-0.104588023989818,0.0115111860596007,0.116146242573235
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SYAP1,Synapse-associated protein 1,31417,-0.0370845433044513,0.0236120701871624,-0.0833642008712896,0.009195114262387,0.116323107326903
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGDCC4,Immunoglobulin superfamily DCC subclass member 4,31571,0.0162952755978218,0.0103793391526987,-0.00404822914146769,0.0366387803371113,0.116462571768299
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NEFL,Neurofilament light polypeptide,32474,-0.0275950799354621,0.0175831406350894,-0.0620580355802374,0.00686787570931308,0.116590182430008
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJA4,DnaJ homolog subfamily A member 4,31548,0.0471780963078786,0.0300626509497306,-0.0117446995535933,0.106100892169351,0.116613177578537
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LBR,Delta(14)-sterol reductase LBR,32806,-0.0441244901786809,0.0281397371307008,-0.0992783749548545,0.0110293945974926,0.11690503612052
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",32720,0.0221367096226486,0.0141292841638638,-0.00555668733852444,0.0498301065838217,0.117214582799094
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCDH7,Protocadherin-7,31560,-0.0227912549408022,0.0145520855006381,-0.0513133425220529,0.0057308326404484,0.117346455597843
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL31,Interleukin-31,31355,-0.0378649751812645,0.0241890662382776,-0.0852755450082887,0.00954559464575963,0.117537072673351
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TOMM20,Mitochondrial import receptor subunit TOM20 homolog,31571,-0.0494105367239833,0.0316006801340614,-0.111347869786744,0.0125267963387771,0.11795470305973
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CASC3,Protein CASC3,31356,-0.0277757485024405,0.0177739986447658,-0.0626127858461815,0.00706128884130056,0.118161140425831
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HJV,Hemojuvelin,31555,-0.0271078249410539,0.0173490860211172,-0.0611120335424436,0.00689638366033585,0.118213022688426
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GIMAP7,GTPase IMAP family member 7,31417,-0.0219897347128563,0.0141170242607051,-0.0496591022638383,0.00567963283812565,0.119352202361379
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,32621,-0.0314683536642544,0.0202646135971831,-0.0711869963147333,0.00825028898622443,0.12048980714405
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",31388,-0.0322850465799041,0.0207933186217186,-0.0730399510784725,0.00846985791866433,0.120545356767916
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPHB6,Ephrin type-B receptor 6,32636,0.0188915666999469,0.0121693248280342,-0.00496030996300003,0.0427434433628939,0.120604433081326
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATXN2L,Ataxin-2-like protein,31555,-0.0302772374633136,0.019504683631878,-0.0685064173817945,0.0079519424551673,0.120630146981591
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MET,Hepatocyte growth factor receptor,32741,0.012265277475971,0.00791210544670962,-0.00324244919957987,0.0277730041515218,0.121131226100963
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL2,Interleukin-2,32596,-0.0196250700939177,0.0126682435310654,-0.0444548274148059,0.00520468722697046,0.121380739014187
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,31548,-0.0540331688572632,0.034891615760945,-0.122420735748715,0.0143543980341889,0.12151897948796
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PKLR,Pyruvate kinase PKLR,32716,0.0417377507906124,0.0269555696889573,-0.0110951657997439,0.0945706673809688,0.121564014839379
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,31548,-0.0398208346689018,0.0257172092759419,-0.090226564849748,0.0105848955119444,0.12156430215145
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDX39A,ATP-dependent RNA helicase DDX39A,31355,0.0152554234684331,0.00987138127181367,-0.00409248382432169,0.0346033307611879,0.122287086183209
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSF2RB,Cytokine receptor common subunit beta,31355,-0.0277120645710405,0.0179612103543244,-0.0629160368655164,0.00749190772343539,0.122901134563576
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",31388,-0.0165886454017478,0.0107583731617002,-0.0376750567986802,0.00449776599518463,0.123132928749654
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",32526,-0.0520143330876719,0.0337864645368325,-0.118235803579864,0.0142071374045197,0.123718276254172
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AGXT,Serine--pyruvate aminotransferase,32729,-0.0484466305690741,0.0314792722307132,-0.110146004141272,0.0132527430031237,0.123839733302716
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",31439,-0.0419662130896025,0.0273228777212724,-0.0955190534232965,0.0115866272440915,0.124595626879569
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SFRP4,Secreted frizzled-related protein 4,31417,0.0264161500412988,0.0172151314206032,-0.00732550754308348,0.0601578076256812,0.124955254748399
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,31388,0.0215015252358977,0.0140359055080255,-0.00600884955983223,0.0490119000316276,0.125590512335353
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OTOA,Otoancorin,31342,-0.0326406682954981,0.0213579506427709,-0.0745022515553291,0.00922091496433296,0.126488332861945
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FMNL1,Formin-like protein 1,32502,-0.0392878888045048,0.0257163628719106,-0.0896919600334496,0.0111161824244399,0.126613966724326
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADGRE1,Adhesion G protein-coupled receptor E1,31560,-0.0341428477213457,0.0223524795102684,-0.0779537075614717,0.00966801211878038,0.126684079091064
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLXNA4,Plexin-A4,32728,-0.0505028836258662,0.0331103220216503,-0.115399114788301,0.0143933475365685,0.127222136397171
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CBX2,Chromobox protein homolog 2,31313,-0.0252554152753402,0.0165575943355412,-0.0577083001730009,0.00719746962232044,0.127224962736253
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCRL2,Fc receptor-like protein 2,32796,-0.0293586659440383,0.0192486721456065,-0.0670860633494271,0.00836873146135054,0.127236951909808
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CR2,Complement receptor type 2,32754,-0.0283809737513837,0.0186185364481389,-0.0648733051897359,0.00811135768696855,0.127459436616915
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,31555,-0.0673996394361169,0.0442433105589338,-0.154116528131627,0.0193172492593933,0.127703258009352
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSPN,Persephin,32728,0.059158751119905,0.0388541105468258,-0.0169953055518736,0.135312807791684,0.127897800749963
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MPO,Myeloperoxidase,32718,-0.0292807746738873,0.0192354831398907,-0.066982321628073,0.00842077228029837,0.127987870170721
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF7,Fibroblast growth factor 7,31326,-0.050714274463299,0.0333221364876683,-0.116025661979129,0.0145971130525309,0.128066600349989
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB27B,Ras-related protein Rab-27B,31571,-0.0514125985444483,0.0337829086364369,-0.117627099471865,0.014801902382968,0.128087087874863
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCL2L1,Bcl-2-like protein 1,31548,-0.0628485286834864,0.0413337281655588,-0.143862635887982,0.0181655785210087,0.128422867624834
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPA1,Carboxypeptidase A1,32834,0.0366099404800758,0.0240804772143489,-0.0105877948600481,0.0838076758201996,0.128466745940273
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTAG1A_CTAG1B,Cancer/testis antigen 1,31439,-0.031905498312943,0.0209951283497933,-0.0730559498785378,0.00924495325265182,0.128637665306674
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPIE,Peptidyl-prolyl cis-trans isomerase E,31456,-0.0390296362012814,0.0256973258857353,-0.0893963949373227,0.0113371225347598,0.128849196115767
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SRP14,Signal recognition particle 14 kDa protein,32668,-0.0384529742035297,0.0253294942521822,-0.0880987829378068,0.0111928345307475,0.129022404540121
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SHC1,SHC-transforming protein 1,31326,-0.0728889541442432,0.0480176193056524,-0.167003487983322,0.0212255796948355,0.129066147377161
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GOLGA3,Golgin subfamily A member 3,31555,-0.0481586650351003,0.0317322543365006,-0.110353883534642,0.0140365534644409,0.129142071653983
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGSF21,Immunoglobulin superfamily member 21,31388,-0.0250360529055803,0.0165004686260167,-0.057376971412573,0.00730486560141235,0.12923460235084
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPXM1,Probable carboxypeptidase X1,32720,-0.042153355566188,0.0278293722224856,-0.0966989251222597,0.0123922139898837,0.129882195696557
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ART5,Ecto-ADP-ribosyltransferase 5,31342,0.0386248554163584,0.0255059944038104,-0.01136689361511,0.0886166044478268,0.12998079696187
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FUS,RNA-binding protein FUS,32506,-0.0248350122656815,0.0164207543603541,-0.0570196908119756,0.00734966628061266,0.130464606269999
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK12,Kallikrein-12,32526,-0.0848411523800374,0.0561183466889049,-0.194833111890291,0.0251508071302162,0.13061470177083
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DGKZ,Diacylglycerol kinase zeta,32596,0.0224421165154577,0.0148491461910936,-0.0066622100190859,0.0515464430500012,0.130737881810372
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPN1,Tyrosine-protein phosphatase non-receptor type 1,32647,-0.0485574183537963,0.0322102487155146,-0.111689505836205,0.0145746691286122,0.131714768844135
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",31548,-0.0244942153960342,0.0162627998028173,-0.0563693030095561,0.00738087221748776,0.132069764079568
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL1RL1,Interleukin-1 receptor-like 1,32801,-0.0287325450187843,0.019088154044307,-0.0661453269456261,0.00868023690805751,0.132293777148491
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF4E,Eukaryotic translation initiation factor 4E,31355,-0.0565856215894532,0.0376513206264763,-0.130382210017347,0.0172109668384404,0.132910718882537
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CORO1A,Coronin-1A,32563,-0.0558810409396297,0.0372315702672441,-0.128854918663428,0.0170928367841687,0.133416474365252
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,31342,0.0206350949336574,0.0137668518775228,-0.00634793474628739,0.0476181246136021,0.133942507079913
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",31313,-0.0404516243923018,0.0270008046331493,-0.0933732014732745,0.0124699526886709,0.134133084149615
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC6A,C-type lectin domain family 6 member A,32526,-0.0285908620738222,0.0190991719175882,-0.0660252390322951,0.00884351488465063,0.134437827748012
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPTX1,Neuronal pentraxin-1,32718,-0.0249350817927714,0.0166666453719815,-0.0576017067218552,0.00773154313631237,0.134661447484429
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GET3,ATPase GET3,31571,0.034610708759797,0.0231459367855446,-0.0107553273398704,0.0799767448594645,0.134870443883906
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,32526,-0.0420079053105691,0.0280970108226959,-0.0970780465230531,0.013062235901915,0.134924159559421
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ROBO4,Roundabout homolog 4,31388,-0.0110307520466061,0.00737980912378199,-0.0254951779292188,0.00343367383600657,0.135029314299973
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UXS1,UDP-glucuronic acid decarboxylase 1,32526,0.0331514206940471,0.0221976796839995,-0.0103560314865919,0.0766588728746861,0.135352351425021
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLIP2,CAP-Gly domain-containing linker protein 2,32728,-0.0687734653726641,0.0460838022400991,-0.159097717763258,0.0215507870179301,0.135641264934551
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TSPAN15,Tetraspanin-15,31313,-0.0300518904324583,0.0201474145697601,-0.069540822989188,0.00943704212427151,0.135846271976072
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",32668,-0.0274289833726571,0.0183893492161083,-0.0634721078362294,0.00861414109091512,0.135847980099743
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HDDC2,5'-deoxynucleotidase HDDC2,31560,0.0271453094833702,0.0182069971238877,-0.00854040487944976,0.0628310238461902,0.136021539518789
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL18R1,Interleukin-18 receptor 1,32833,-0.0199137381028903,0.0133605260149238,-0.0461003690921409,0.00627289288636039,0.136130442554393
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AHSG,Alpha-2-HS-glycoprotein,31586,-0.016904465729342,0.0113446656293714,-0.03914001036291,0.00533107890422601,0.136243875752055
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNRPB2,U2 small nuclear ribonucleoprotein B'',31548,-0.0280540283722167,0.018828499964492,-0.0649578883026211,0.00884983155818758,0.136271355139911
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUMB,Protein numb homolog,31355,-0.052051921161772,0.0349852262579278,-0.120622964627311,0.0165191223037665,0.136838916869721
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LBP,Lipopolysaccharide-binding protein,32754,-0.0351629404252105,0.0236355423962527,-0.0814886035218658,0.0111627226714449,0.136861638929395
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,32720,-0.0583010142409094,0.0392823159518579,-0.135294353506551,0.018692325024732,0.137803589781043
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LETM1,Mitochondrial proton/calcium exchanger protein,31555,-0.0326864949699725,0.0220475887141156,-0.075899768849639,0.010526778909694,0.138236861966657
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANXA3,Annexin A3,32795,-0.0423127421788742,0.0285516622217775,-0.098274000133558,0.0136485157758097,0.138383213714427
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CAPG,Macrophage-capping protein,32650,-0.0359472222247281,0.0242804115942701,-0.0835368289494974,0.0116423845000413,0.138774901111181
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLSTN1,Calsyntenin-1,32502,-0.0308043684309069,0.0208067047429605,-0.0715855097271095,0.00997677286529565,0.138775776047531
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),F2,Prothrombin,31598,-0.00902323316829204,0.00609481358675796,-0.0209690677983376,0.00292260146175357,0.138786627033684
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FASLG,Tumor necrosis factor ligand superfamily member 6,32833,0.0223389046163348,0.0151022922386639,-0.00726158817144638,0.0519393974041159,0.139129157585905
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NAA80,N-alpha-acetyltransferase 80,31356,-0.0741593760899682,0.0501580546040448,-0.172469163113896,0.0241504109339596,0.139312322229048
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MORF4L1,Mortality factor 4-like protein 1,31456,-0.0247947758812161,0.0167710121542575,-0.0576659597035608,0.00807640794112855,0.13933405028042
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,32647,-0.0572003542334271,0.0387014728178356,-0.133055240956385,0.0186545324895306,0.139446542519621
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GJA8,Gap junction alpha-8 protein,31326,-0.0385299774437153,0.0260798719089309,-0.0896465263852198,0.0125865714977892,0.139614994961826
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LELP1,Late cornified envelope-like proline-rich protein 1,31342,-0.0447297046408055,0.0302846306551677,-0.104087580724934,0.0146281714433231,0.139723874972579
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NME1,Nucleoside diphosphate kinase A,31355,-0.013021652808986,0.00882347033439671,-0.0303156546644035,0.00427234904643157,0.140040350788879
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PROS1,Vitamin K-dependent protein S,31598,-0.014969242163915,0.0101638163134639,-0.0348903221383042,0.00495183781047417,0.140846348246026
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TACSTD2,Tumor-associated calcium signal transducer 2,31716,0.0177740857401106,0.0120765957947721,-0.00589604201764265,0.0414442134978638,0.141120495787368
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RGCC,Regulator of cell cycle RGCC,31555,-0.0458331509286243,0.0311947148892282,-0.106974792111512,0.0153084902542629,0.141803125634099
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GBP4,Guanylate-binding protein 4,32502,0.029334171505799,0.0199721612341202,-0.00981126451307666,0.0684796075246747,0.141936196936635
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SRPX,Sushi repeat-containing protein SRPX,31571,-0.0207140648447139,0.0141036546421787,-0.0483572279433843,0.00692909825395641,0.141954444502701
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),POLR2A,DNA-directed RNA polymerase II subunit RPB1,31355,-0.0180007806875529,0.0122563506732791,-0.0420232280071799,0.00602166663207419,0.141958835728844
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CELA3A,Chymotrypsin-like elastase family member 3A,32824,0.0335791682894926,0.0228880750356457,-0.0112814587803731,0.0784397953593582,0.142383063710803
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,31313,-0.0184954707861438,0.0126093003148397,-0.0432096994032295,0.00621875783094198,0.142469444736676
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EFCAB14,EF-hand calcium-binding domain-containing protein 14,31560,-0.0162300231865156,0.011066835550667,-0.0379210208658228,0.00546097449279164,0.142540441739973
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SORCS2,VPS10 domain-containing receptor SorCS2,32526,0.0205051755724748,0.0139890700423537,-0.00691340171053847,0.0479237528554881,0.142739126557437
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LDLRAP1,Low density lipoprotein receptor adapter protein 1,31555,-0.0593376996931598,0.0405048928084709,-0.138727289597763,0.0200518902114431,0.142975030198819
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MSRA,Mitochondrial peptide methionine sulfoxide reductase,32720,-0.0439427787350634,0.0300130412703618,-0.102768339624972,0.0148827821548458,0.143195870169287
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGB7,Integrin beta-7,32794,-0.0276287579421108,0.0188893254573001,-0.064651835838419,0.00939431995419737,0.143594204631839
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VWF,von Willebrand factor,32834,0.0440812907276509,0.0301584827985125,-0.0150293355574336,0.103191917012736,0.143870847242346
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SWAP70,Switch-associated protein 70,31560,-0.0225124373933158,0.015421099310733,-0.0527377920423524,0.0077129172557208,0.144373069485836
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BMPER,BMP-binding endothelial regulator protein,31417,-0.0139714646957548,0.00958226881582714,-0.032752711574776,0.00480978218326635,0.144867234620642
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,31571,-0.0162483329848033,0.0111556664917212,-0.0381134393085769,0.00561677333897025,0.145292571761359
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRIAP1,TP53-regulated inhibitor of apoptosis 1,32794,-0.0382563059107143,0.0262817989355504,-0.089768631824393,0.0132560200029645,0.145532898965024
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SUSD2,Sushi domain-containing protein 2,32718,-0.0168865781377128,0.0116053514622149,-0.0396330670036539,0.00585991072822835,0.145685810422728
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",32721,0.0196226363396596,0.0134893325524601,-0.00681645546316219,0.0460617281424814,0.145793825501596
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SKAP2,Src kinase-associated phosphoprotein 2,32756,-0.062156174860178,0.0427317074637532,-0.145910321489134,0.0215979717687784,0.145824172458817
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEP152,Centrosomal protein of 152 kDa,31326,-0.0251994381072973,0.0173518589028561,-0.0592090815568952,0.00881020534230064,0.14647090659526
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDI2,Protein DDI1 homolog 2,31417,0.0464369186455804,0.0319798172390461,-0.0162435231429499,0.109117360434111,0.146523783799929
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LYPD8,Ly6/PLAUR domain-containing protein 8,32526,0.0309524532817594,0.0213304589457225,-0.0108552462518566,0.0727601528153754,0.14679050577586
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MMP9,Matrix metalloproteinase-9,32708,-0.0363562568945617,0.0250706951229325,-0.0854948193355094,0.012782305546386,0.147052269678982
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATF2,Cyclic AMP-dependent transcription factor ATF-2,32502,-0.0404033558647231,0.0278815794407954,-0.0950512515686821,0.0142445398392358,0.147344348665362
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL3,C-C motif chemokine 3,32728,-0.0364057966307088,0.025143148028469,-0.085686366766508,0.0128747735050903,0.147668884568077
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",32709,-0.0381786310070347,0.026414569716609,-0.0899511876515884,0.013593925637519,0.148391475883057
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STX5,Syntaxin-5,31355,-0.0236582191787555,0.0163725318678177,-0.0557483816396783,0.00843194328216724,0.148501224506457
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHCHD6,MICOS complex subunit MIC25,31548,-0.0169189002633146,0.0117149793583828,-0.0398802598057448,0.00604245927911568,0.148720424903959
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL4,Interleukin-4,32596,-0.0532436090921347,0.0368763234036309,-0.125521202963251,0.0190339847789819,0.148819096754168
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC44A4,Choline transporter-like protein 4,31356,-0.0411536462227508,0.028504652358025,-0.0970227648444798,0.0147154723989783,0.148850564875362
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRDX6,Peroxiredoxin-6,32794,0.0351621986382673,0.0243663331398535,-0.0125958143158456,0.0829202115923803,0.149037266335956
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DUSP29,Dual specificity phosphatase 29,31356,-0.0398223993752952,0.0276201451923885,-0.0939578839523766,0.0143130852017862,0.149403908363268
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FIS1,Mitochondrial fission 1 protein,32702,-0.0463963835188999,0.0322135440023065,-0.109534929763421,0.0167421627256209,0.149824829164878
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCND2,G1/S-specific cyclin-D2,31456,0.022710614955289,0.0157829194704308,-0.00822390720675545,0.0536451371173334,0.150209788521576
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",31456,-0.0293103522472947,0.0203953301294788,-0.069285199301073,0.0106644948064837,0.15072765861728
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NCLN,Nicalin,32596,0.0317761696990279,0.022117854572582,-0.0115748252632327,0.0751271646612886,0.150846159519573
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NEDD9,Enhancer of filamentation 1,31355,-0.020318447702549,0.014165396214503,-0.0480826242829749,0.00744572887787699,0.151507853949896
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TERF1,Telomeric repeat-binding factor 1,31355,-0.0175845186912678,0.0122659503883016,-0.041625781452339,0.00645674406980344,0.151726942005924
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRDX5,"Peroxiredoxin-5, mitochondrial",32833,-0.040227582898597,0.0281110470338112,-0.0953252350848669,0.0148700692876729,0.152458162387629
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGFBP3,Fibroblast growth factor-binding protein 3,31548,-0.0217551156865588,0.0152139582504091,-0.0515744738573607,0.00806424248424313,0.152773589400883
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRIM24,Transcription intermediary factor 1-alpha,31439,-0.0390845556256858,0.0273494024602004,-0.0926893844476785,0.014520273196307,0.153021702436754
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TXNDC5,Thioredoxin domain-containing protein 5,32806,-0.0399149364894007,0.0279490456192946,-0.0946950659032181,0.0148651929244167,0.153288673512486
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NELL1,Protein kinase C-binding protein NELL1,32720,0.0238686719390411,0.0167151837908591,-0.00889308829104276,0.056630432169125,0.153337617983357
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EFNA1,Ephrin-A1,32704,0.0149693604491444,0.010483643246126,-0.00557858031326258,0.0355173012115515,0.153362371515871
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),XCL1,Lymphotactin,32794,-0.0315361419744099,0.0220998613474295,-0.0748518702153717,0.0117795862665519,0.153619539331435
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AZU1,Azurocidin,32498,-0.0459261218179898,0.0321987581703598,-0.109035687831895,0.0171834441959155,0.153808647414026
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK3,Prostate-specific antigen,31571,-0.0462425241458803,0.0324637703499794,-0.10987151403184,0.0173864657400793,0.154361114531326
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARHGEF1,Rho guanine nucleotide exchange factor 1,31548,-0.0534054376473339,0.0374926246474623,-0.12689098195636,0.0200801066616923,0.154364025304833
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FAS,Tumor necrosis factor receptor superfamily member 6,32801,-0.0188459326338309,0.0132345293615904,-0.0447856101825481,0.00709374491488632,0.154482182406923
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCDH12,Protocadherin-12,31555,-0.0148935467226945,0.0104643928955242,-0.0354037567979219,0.00561666335253293,0.15470148054729
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FOXO3,Forkhead box protein O3,32526,0.0573103905063152,0.0403096829966695,-0.021696588167157,0.136317369179787,0.155134114937125
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DPEP2,Dipeptidase 2,32668,-0.0167322086256608,0.0117743931418391,-0.0398100191836655,0.00634560193234388,0.155332508632637
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEMA6C,Semaphorin-6C,31355,0.0157087879118358,0.0110803270684907,-0.0060086531424059,0.0374262289660776,0.156314452299391
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HRAS,GTPase Hras,31448,-0.0567716356658389,0.0400653812154625,-0.135299782848145,0.0217565115164675,0.156531348875272
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DEFB118,Beta-defensin 118,31342,-0.0352762593159581,0.0249377345883377,-0.0841542191090999,0.0136017004771838,0.157235186342293
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUCB2,Nucleobindin-2,32782,-0.0218097723337403,0.0154210963874059,-0.0520351212530559,0.00841557658557534,0.157314141846895
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,31313,-0.0222735469399375,0.015751274749916,-0.0531460454497729,0.00859895156989796,0.157380476417581
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFSF11,Tumor necrosis factor ligand superfamily member 11,32728,-0.0353990822814229,0.0250447041415666,-0.0844867023988934,0.0136885378360477,0.157562715446377
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),XPNPEP2,Xaa-Pro aminopeptidase 2,32720,0.0568947806782235,0.0402695774299141,-0.0220335910844082,0.135823152440855,0.157735630138116
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD80,T-lymphocyte activation antigen CD80,31571,-0.0193013798587428,0.0136704527822996,-0.0460954673120501,0.00749270759456442,0.15801830354093
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),YTHDF3,YTH domain-containing family protein 3,32596,-0.0490263877457989,0.0347329305236594,-0.117102931572171,0.0190501560805735,0.158125585213841
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGB1,Integrin beta-1,32709,-0.0124600027879539,0.0088293822552809,-0.0297655920083045,0.00484558643239662,0.158221522689799
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ASPN,Asporin,31571,-0.0157332400662652,0.0111727993406523,-0.0376319267739436,0.00616544664141324,0.159120013035299
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD40,Tumor necrosis factor receptor superfamily member 5,32708,-0.0290497427038946,0.0206864445312304,-0.0695951739851063,0.011495688577317,0.160267963614321
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAMTSL2,ADAMTS-like protein 2,31571,-0.0188912815537944,0.0134558670692898,-0.0452647810096025,0.00748221790201356,0.160375848788463
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NRP1,Neuropilin-1,32765,-0.0158058965753225,0.0112644725412701,-0.037884262756212,0.00627246960556692,0.160602958599348
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHIT1,Chitotriosidase-1,32755,-0.0847296203843445,0.0604621987732162,-0.203235529979848,0.0337762892111593,0.161139786451254
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCGN,Secretagogin,32596,0.0247459654090012,0.0176594891817743,-0.00986663338727644,0.0593585642052789,0.161164589275562
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPHA1,Ephrin type-A receptor 1,32733,0.0189218414497764,0.0135052598376561,-0.00754846783202963,0.0453921507315825,0.161227515502867
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MANF,Mesencephalic astrocyte-derived neurotrophic factor,32756,-0.0694318433329571,0.0495673405563855,-0.166583830823473,0.0277201441575584,0.161321364672384
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGFBP3,Insulin-like growth factor-binding protein 3,32754,-0.0155794375253804,0.0111285100406882,-0.0373913172051293,0.00623244215436849,0.161561021830821
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTGR1,Prostaglandin reductase 1,31571,-0.0464888974995297,0.0332164763036739,-0.111593191054731,0.0186153960556712,0.161681323762698
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AZI2,5-azacytidine-induced protein 2,31555,-0.0324529423050494,0.0232534396558724,-0.0780296840305593,0.0131237994204605,0.162869525017472
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DSG3,Desmoglein-3,32764,0.0192202671382297,0.0137832059494621,-0.00779481652271613,0.0462353507991754,0.163210514271831
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PIGR,Polymeric immunoglobulin receptor,32603,-0.0208885414194544,0.0149871696406965,-0.0502633939152195,0.00848631107631077,0.163425034073048
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBM19,Probable RNA-binding protein 19,31313,-0.0271737938164902,0.019501805825825,-0.0653973332351072,0.0110497456021269,0.163540764402581
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD163,Scavenger receptor cysteine-rich type 1 protein M130,32754,-0.0244767799595776,0.0175771305198388,-0.0589279557784617,0.00997439585930639,0.163795080794235
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD86,T-lymphocyte activation antigen CD86,31560,-0.0168371301175677,0.0121002991159311,-0.0405537163847926,0.00687945614965732,0.164124978359083
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),YJU2,Splicing factor YJU2,31548,-0.0190164735414033,0.0136846741397875,-0.0458384348553868,0.00780548777258017,0.164685056639271
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL6R,Interleukin-6 receptor subunit alpha,32675,-0.0191694404725357,0.0137975449877679,-0.0462126286485608,0.00787374770348936,0.164765374172953
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),F11R,Junctional adhesion molecule A,32718,-0.0322410979141464,0.0232203451295757,-0.0777529743681148,0.013270778539822,0.165024361878233
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATRN,"Attractin, Isoform 2",31598,-0.00943222666376536,0.00681108220880827,-0.0227819477930296,0.00391749446549886,0.166142778082724
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UBAC1,Ubiquitin-associated domain-containing protein 1,32668,0.0198269689721692,0.0143233551056032,-0.00824680703481311,0.0479007449791515,0.166319879605167
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,31548,-0.0415972124685033,0.0300645322780274,-0.100523695733437,0.0173292707964303,0.166521897073155
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TCN2,Transcobalamin-2,32817,-0.0165886937175858,0.0119997884296936,-0.0401082790397852,0.00693089160461352,0.166878622319813
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GDF15,Growth/differentiation factor 15,32834,-0.023039892328574,0.0166678042924039,-0.0557087887416857,0.00962900408453765,0.166914256716117
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIGLEC8,Sialic acid-binding Ig-like lectin 8,31388,-0.0262590417280166,0.0190357525090308,-0.063569116645717,0.0110510331896839,0.167794227868731
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNPEP,Aspartyl aminopeptidase,31548,0.0328512426864239,0.02382704074836,-0.0138497571803616,0.0795522425532095,0.16801571173594
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPRC,Receptor-type tyrosine-protein phosphatase C,31571,-0.0127479994726314,0.00924658501584063,-0.030871306103679,0.00537530715841629,0.168036179039638
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF8,Tumor necrosis factor receptor superfamily member 8,32806,-0.0249402096702284,0.0180909636059683,-0.0603984983379262,0.0105180789974694,0.168052464494618
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLXNB3,Plexin-B3,32701,-0.027031448772079,0.0196122059798328,-0.0654713724925512,0.0114084749483933,0.168146422131388
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPESP1,Sperm equatorial segment protein 1,31571,-0.0163590557922326,0.0118706857942802,-0.0396255999490217,0.00690748836455649,0.168210745396085
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP5IF1,"ATPase inhibitor, mitochondrial",32756,-0.0623768879172121,0.0453270323302228,-0.151217871284449,0.0264640954500245,0.168809207250519
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MUC16,Mucin-16,32668,0.104400302080065,0.0758983402362569,-0.0443604447829987,0.253161048943128,0.169002749878767
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDKN2D,Cyclin-dependent kinase 4 inhibitor D,32668,-0.0533574382599771,0.0388086878435024,-0.129422466433242,0.0227075899132876,0.169202428513002
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RP2,Protein XRP2,32668,-0.0239074301889852,0.0174445100084438,-0.058098669805535,0.0102838094275647,0.170570642651181
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TSHB,Thyrotropin subunit beta,32729,-0.0419996231028636,0.0306606066850377,-0.102094412205538,0.0180951659998103,0.170776646126268
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMOC1,SPARC-related modular calcium-binding protein 1,32794,-0.0182665580451609,0.0133485899146588,-0.0444297942778921,0.0078966781875703,0.171213168104064
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MPHOSPH8,M-phase phosphoprotein 8,32598,-0.042692354231243,0.0312083973253757,-0.103860812988979,0.0184761045264935,0.171354608406229
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNCG,Gamma-synuclein,32647,-0.0361023590959938,0.0263922914891524,-0.0878312504147325,0.0156265322227448,0.171374284842144
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLXDC2,Plexin domain-containing protein 2,31548,-0.0158721137563516,0.0116054671095124,-0.038618829290996,0.00687460177829273,0.171464423321036
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HTR1B,5-hydroxytryptamine receptor 1B,31342,0.0242029370350147,0.0177028440041227,-0.0104946372130658,0.0589005112830951,0.171610623437331
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYDGF,Myeloid-derived growth factor,31571,-0.0574106927532658,0.0420081148744499,-0.139746597907188,0.024925212400656,0.171772623893138
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],32668,0.0319786394755198,0.0234160896732235,-0.0139168962839983,0.0778741752350379,0.172077593636368
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSDL2,Hydroxysteroid dehydrogenase-like protein 2,31388,-0.0269550599325727,0.0197423246258737,-0.0656500161992852,0.0117398963341397,0.172185825057252
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",31555,-0.0457593451169752,0.0335335130091729,-0.111485030614954,0.0199663403810036,0.1724232712485
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYH4,Myosin-4,31313,-0.0262938476170608,0.0192807222444655,-0.0640840632162133,0.0114963679820916,0.172691323496559
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VWC2L,von Willebrand factor C domain-containing protein 2-like,31555,0.0263435428011372,0.0193242749598778,-0.0115320361202233,0.0642191217224978,0.172848102716596
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VPS4B,Vacuolar protein sorting-associated protein 4B,31548,-0.0539845513276089,0.0396109679879723,-0.131622048584035,0.0236529459288169,0.172963787912927
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERP29,Endoplasmic reticulum resident protein 29,31417,-0.0670937681197046,0.049282622907364,-0.163687709018138,0.0295001727787288,0.173425307284636
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCUN1D1,DCN1-like protein 1,31342,0.0418761602409302,0.0308165105350658,-0.0185242004077987,0.102276520889659,0.174223312109651
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CFHR2,Complement factor H-related protein 2,31541,0.0321606835603273,0.0236683136816614,-0.0142292112557291,0.0785505783763837,0.174247476302456
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PADI2,Protein-arginine deiminase type-2,32596,0.0318777193272481,0.0234768619168914,-0.0141369300298591,0.0778923686843554,0.174550919499609
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",31548,-0.0553827890542691,0.0408058724054239,-0.1353622989689,0.0245967208603616,0.174749268702892
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSF3,Granulocyte colony-stimulating factor,32596,-0.0266521634195412,0.0196538372491456,-0.0651736844278666,0.0118693575887842,0.175108961941629
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",31571,-0.0491325012893288,0.036314886559908,-0.120309678946749,0.0220446763680908,0.176108846090639
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAMDC4,Apical endosomal glycoprotein,31548,-0.0311926215305299,0.0230613904350438,-0.0763929467832157,0.0140077037221559,0.176226214191817
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LSP1,Lymphocyte-specific protein 1,32728,-0.0226002381836844,0.016720652935444,-0.0553727179371546,0.0101722415697858,0.176526229805497
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB11FIP3,Rab11 family-interacting protein 3,31571,-0.0602079356780787,0.0445585609673081,-0.147542715174003,0.0271268438178452,0.17666808340332
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,32647,-0.0302713444798482,0.0224037812032513,-0.0741827556382208,0.0136400666785245,0.176675377315735
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DKK3,Dickkopf-related protein 3,32834,0.0160491819995147,0.0118835421817222,-0.00724256067666073,0.0393409246756902,0.176877347038766
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNF168,E3 ubiquitin-protein ligase RNF168,31355,0.0235978163864409,0.0174893011511874,-0.0106812138698864,0.0578768466427681,0.177290518676213
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RELT,Tumor necrosis factor receptor superfamily member 19L,32718,-0.0145199151499388,0.0107680918375927,-0.0356253751516204,0.00658554485174285,0.177557668371481
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAMTSL4,ADAMTS-like protein 4,31388,-0.0133739517718449,0.00992357770189748,-0.032824164067564,0.00607626052387415,0.177797195451303
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFIC,Nuclear factor 1 C-type,31555,-0.0242176447091276,0.0179726955814654,-0.0594441280487999,0.0110088386305446,0.177869000804502
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANXA2,Annexin A2,31274,-0.0399121807072298,0.0296558532464048,-0.0980376530701833,0.0182132916557236,0.178393673942934
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL5RA,Interleukin-5 receptor subunit alpha,32728,-0.0296512722280374,0.022047851028845,-0.0728650602445736,0.0135625157884989,0.178704853352542
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLAMF6,SLAM family member 6,32526,-0.0209398320687104,0.0155924996717343,-0.0515011314253096,0.00962146728788877,0.179325731304533
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSMD5,26S proteasome non-ATPase regulatory subunit 5,31356,0.0294525102161518,0.0219517568163158,-0.0135729331438271,0.0724779535761307,0.179736321242025
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCDH9,Protocadherin-9,31560,-0.0188497663416353,0.01407417494407,-0.0464351492320125,0.00873561654874196,0.180507384215403
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ESPL1,Separin,31326,-0.0295932945934092,0.0221190461479793,-0.0729466250434487,0.0137600358566303,0.180966502684247
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPD52L2,Tumor protein D54,31417,-0.0602042870728559,0.0450180697350775,-0.148439703753608,0.0280311296078959,0.181153221723088
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAPK13,Mitogen-activated protein kinase 13,31326,-0.0242310559195499,0.0181413226186058,-0.0597880482520173,0.0113259364129175,0.181693628762292
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD93,Complement component C1q receptor,32376,0.0168713770659913,0.0126379866541887,-0.00789907677621856,0.0416418309082011,0.181920711074328
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGA11,Integrin alpha-11,32728,-0.0185196212942351,0.0138854161004824,-0.0457350368511807,0.00869579426271045,0.182321293813655
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FAP,Prolyl endopeptidase FAP,32834,-0.0147904015164458,0.0110933372170437,-0.0365333424618514,0.00695253942895982,0.182477418472521
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RASSF2,Ras association domain-containing protein 2,32526,-0.031235020513091,0.0234320200623997,-0.0771617798353945,0.0146917388092124,0.182564916554778
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CYB5R2,NADH-cytochrome b5 reductase 2,31457,-0.0312135769001692,0.0234219035154173,-0.0771205077903872,0.0146933539900488,0.182681369402108
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRC1,Protein regulator of cytokinesis 1,31548,-0.0270679756081686,0.0203460633673817,-0.0669462598082367,0.0128103085918995,0.18343288775477
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SSBP1,"Single-stranded DNA-binding protein, mitochondrial",31355,-0.0196139770423487,0.0147559830691221,-0.048535703857828,0.00930774977313061,0.183815203929518
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPLX2,Complexin-2,31326,-0.0165970732767172,0.0124897684577774,-0.0410770194539609,0.0078828729005264,0.183936897812919
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RLN2,Prorelaxin H2,31407,-0.0779183226309526,0.0587793431811389,-0.193125835265985,0.0372891900040797,0.185009951941802
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CALB1,Calbindin,32668,0.022688523140997,0.0171352975446566,-0.01089666004653,0.0562737063285239,0.185510480080793
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP5F1D,"ATP synthase subunit delta, mitochondrial",31313,0.0291501999136956,0.0220285062479691,-0.0140256723323239,0.0723260721597151,0.185778071722175
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,31355,0.017911975786743,0.013561906705649,-0.00866936135632915,0.0444933129298151,0.186622909031788
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),B4GALT1,"Beta-1,4-galactosyltransferase 1",32756,0.0142602559283345,0.0107997589584733,-0.0069072716302732,0.0354277834869422,0.186727619153986
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD177,CD177 antigen,32701,0.0672116466135871,0.0509242230276297,-0.0325998305205671,0.167023123747741,0.186923796395835
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MLN,Promotilin,32728,-0.0475570352088861,0.0360784571669507,-0.118270811256109,0.0231567408383373,0.187485473500778
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCDHB15,Protocadherin beta-15,31548,-0.0220167206676366,0.0167025668370639,-0.0547537516682818,0.0107203103330085,0.187488058444405
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STEAP4,Metalloreductase STEAP4,31342,-0.040449227740046,0.0307483229973831,-0.100715940814917,0.0198174853348249,0.188384314541821
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SDHB,Succinate dehydrogenase,31560,-0.0373139493265886,0.0283673225714158,-0.0929139015665635,0.0182860029133863,0.188419725448082
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),P4HB,Protein disulfide-isomerase,32649,-0.0210667063288194,0.0160303645004357,-0.0524862207496734,0.0103528080920347,0.188821572724034
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSB,Cathepsin B,32727,0.0274574957045608,0.0209146358271647,-0.013535190516682,0.0684501819258035,0.189272049625811
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LONP1,"Lon protease homolog, mitochondrial",31388,-0.0476496357580852,0.0363203251767987,-0.118837473104611,0.0235382015884401,0.189584580045654
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GSTT2B,Glutathione S-transferase theta-2B,31548,-0.128749360998883,0.0983432557983502,-0.32150214236365,0.0640034203658831,0.190511350291102
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FYB1,FYN-binding protein 1,32706,-0.0490329963932432,0.0374598984991716,-0.122454397451619,0.0243884046651331,0.190586535407952
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADH1B,All-trans-retinol dehydrogenase,31417,-0.0415011392970176,0.031706027315541,-0.103644952835478,0.0206426742414427,0.190596058966791
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL9,C-X-C motif chemokine 9,32756,-0.0349997339885327,0.0267693127233255,-0.0874675869262506,0.0174681189491852,0.191091228814924
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MMUT,"Methylmalonyl-CoA mutase, mitochondrial",31313,-0.0276325323295347,0.0211689677349628,-0.0691237090900619,0.0138586444309924,0.191820095419722
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FLT1,Vascular endothelial growth factor receptor 1,32646,0.0120487904610393,0.00924425574482479,-0.00606995079881731,0.0301675317208959,0.192478756003138
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAG,Myelin-associated glycoprotein,31356,-0.0251638647744071,0.0193082776950628,-0.0630080890567302,0.0126803595079159,0.192523233810496
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDIA4,Protein disulfide-isomerase A4,31571,-0.0331747313180171,0.0254682008823925,-0.0830924050475065,0.0167429424114722,0.192752232296606
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NCR1,Natural cytotoxicity triggering receptor 1,32712,0.0187600797582856,0.0144033695909023,-0.00947052463988289,0.046990684156454,0.192786735348652
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRKAB1,5'-AMP-activated protein kinase subunit beta-1,32596,0.0294658841862566,0.0226230507809721,-0.0148752953444486,0.0738070637169618,0.192789509343492
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD300LG,CMRF35-like molecule 9,32718,0.0192775854808106,0.0148160845498847,-0.00976194023696341,0.0483171111985846,0.193249341544041
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NIT2,Omega-amidase NIT2,31548,-0.0404676176134462,0.0311237795595851,-0.101470225550233,0.0205349903233406,0.193566129642764
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,31571,-0.0380188115499585,0.0292609399794957,-0.09537025390977,0.019332630809853,0.193878992874235
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),METAP2,Methionine aminopeptidase 2,32786,-0.0305683198655616,0.0235584090827994,-0.0767428016678485,0.0156061619367253,0.194473995904434
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BIN2,Bridging integrator 2,32718,-0.0480267164117213,0.0370281579782296,-0.120601906049051,0.0245484732256087,0.19465385984987
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VIT,Vitrin,31571,0.0192957647384443,0.0148796630288202,-0.00986837479804321,0.0484599042749319,0.194743029260124
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GRPEL1,"GrpE protein homolog 1, mitochondrial",32668,-0.0323738495805855,0.0249728435811793,-0.081320622999697,0.016572923838526,0.194884704024952
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPRN2,Receptor-type tyrosine-protein phosphatase N2,32623,0.0163790834640759,0.0126495019002166,-0.00841394026034869,0.0411721071885006,0.195409478865321
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,32834,-0.0118215852738426,0.0091307480045236,-0.0297178513627089,0.00607468081502363,0.195456830261816
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLMP,CXADR-like membrane protein,32794,0.010791543422316,0.00833851711021263,-0.00555195011370079,0.0271350369583327,0.195636649651237
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIAA1549L,UPF0606 protein KIAA1549L,31456,-0.0148844686462562,0.0115098429454324,-0.0374437608193037,0.00767482352679139,0.195983032714766
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AFP,Alpha-fetoprotein,32618,0.035602300713631,0.0275765681326617,-0.0184477728263859,0.089652374253648,0.196725792582058
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARFIP1,Arfaptin-1,31555,-0.0371297576110277,0.0287638166830412,-0.0935068383097884,0.019247323087733,0.196794658901066
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADGRE2,Adhesion G protein-coupled receptor E2,32756,-0.0147324831716324,0.0114291682342593,-0.0371336529107805,0.00766868656751582,0.197422924948055
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL16,C-X-C motif chemokine 16,32817,0.0119535128006015,0.00928684627882438,-0.00624870590589432,0.0301557315070973,0.198077199246212
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACOT13,Acyl-coenzyme A thioesterase 13,31560,-0.0606865453249375,0.0471824090267637,-0.153164067017394,0.0317909763675194,0.198408018651944
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GSAP,Gamma-secretase-activating protein,32526,0.0451343450181264,0.0351099042866958,-0.0236810673837973,0.11394975742005,0.198646367560381
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD4,T-cell surface glycoprotein CD4,32710,-0.0156736447735453,0.0121936442641594,-0.0395731875312977,0.00822589798420707,0.198688054370815
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC39A5,Zinc transporter ZIP5,32728,-0.0276946557356673,0.021592350674059,-0.070015663056823,0.0146263515854885,0.19966079394381
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EDNRB,Endothelin receptor type B,31355,0.0239909975447716,0.0187105213200408,-0.0126816242425083,0.0606636193320516,0.19980527255545
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOF,Apolipoprotein F,31586,0.0140222553737626,0.0109372583851948,-0.00741477106121926,0.0354592818087445,0.199858981239038
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BEX3,Protein BEX3,31326,-0.0247336372333557,0.0193469991475424,-0.0626537555625387,0.0131864810958274,0.20114026744557
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STC1,Stanniocalcin-1,32806,-0.0222152267563948,0.0173804121611215,-0.0562808345921929,0.0118503810794034,0.201220516823564
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C19orf12,Protein C19orf12,32502,-0.0332482048325919,0.0260125484516201,-0.0842327997977672,0.0177363901325834,0.201227264919954
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ASAH1,Acid ceramidase,31512,-0.0246868088678017,0.019337596414261,-0.0625884978397532,0.0132148801041498,0.201774328434997
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLMAP,Sarcolemmal membrane-associated protein,31560,-0.0449443144564933,0.0352095342059915,-0.113955001500237,0.0240663725872501,0.201823905261667
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD63,CD63 antigen,32632,-0.0267874260888655,0.0210082427317589,-0.067963581843113,0.014388729665382,0.202310722680436
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD226,CD226 antigen,31355,-0.0223258434632687,0.0175158715352151,-0.0566569516722903,0.012005264745753,0.202488074946726
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MORN4,MORN repeat-containing protein 4,31326,-0.0419994978108792,0.0329548839738891,-0.106591070399702,0.0225920747779434,0.202542078311944
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SGSH,N-sulphoglucosamine sulphohydrolase,31480,-0.0293138976457363,0.0230015959925368,-0.0743970257911084,0.0157692304996357,0.202550334244219
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APP,Amyloid-beta precursor protein,32700,-0.0345292727870285,0.0270946565235995,-0.0876347995732835,0.0185762539992264,0.202557250166497
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VAMP8,Vesicle-associated membrane protein 8,31355,-0.0469103700477355,0.0368223315128426,-0.119082139812907,0.025261399717436,0.202715240850231
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FBN2,Fibrillin-2,31356,-0.0318194539795709,0.0249824425794473,-0.0807850414352877,0.0171461334761459,0.202818942439421
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BRDT,Bromodomain testis-specific protein,31313,-0.0195595474150694,0.0153807402896327,-0.0497057983827494,0.0105867035526106,0.203522647101342
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGFBP1,Insulin-like growth factor-binding protein 1,32819,0.0635650667696658,0.0500425981032694,-0.0345184255127422,0.161648559052074,0.204039562742375
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,32756,0.0220984541652247,0.0174026523529051,-0.0120107444464692,0.0562076527769186,0.204177502962494
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,31456,-0.0602564163719297,0.0474855018631308,-0.153328000023666,0.0328151672798068,0.204500116958696
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",31388,-0.0306861086674143,0.0241944444653572,-0.0781072198195145,0.0167350024846859,0.204725708849671
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LDLR,Low-density lipoprotein receptor,32742,-0.0272456639813043,0.0214853407238037,-0.0693569317999594,0.0148656038373509,0.204793761492906
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OGN,Mimecan,32718,0.0200315597760051,0.0158129536969541,-0.0109618294700249,0.0510249490220352,0.205266677446794
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GP6,Platelet glycoprotein VI,32706,-0.045865310636236,0.0362062306364266,-0.116829522683632,0.02509890141116,0.205267497154599
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IST1,IST1 homolog,31503,-0.0522527909525166,0.0412493060431924,-0.133101430797174,0.0285958488921406,0.205281280131236
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,32668,-0.0155292514388796,0.012263853923734,-0.0395664051293981,0.00850790225163903,0.205452806203916
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IKZF2,Zinc finger protein Helios,32526,0.049230793953952,0.0389099042588674,-0.027032618393428,0.125494206301332,0.205815396583132
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LGALS3BP,Galectin-3-binding protein,31598,-0.0158150846646312,0.012501690509417,-0.0403183980630884,0.00868822873382602,0.205896629113268
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAGED1,Melanoma-associated antigen D1,32526,0.0252749060329279,0.0199948370093427,-0.0139149745053839,0.0644647865712397,0.206238320241266
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLRD1,Natural killer cells antigen CD94,32833,-0.0234529054941169,0.0186011866856387,-0.0599112313979688,0.013005420409735,0.207403441037271
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VASN,Vasorin,32598,0.0140919955462717,0.0111929241492365,-0.00784613578623183,0.0360301268787752,0.208060607054515
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL26,C-C motif chemokine 26,32728,-0.0458750473915331,0.0364667909579785,-0.117349957669171,0.0255998628861047,0.20842662052189
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VGF,Neurosecretory protein VGF,31555,0.0153485557690818,0.0122042721718215,-0.00857181768768828,0.0392689292258519,0.208560888461692
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFSF10,Tumor necrosis factor ligand superfamily member 10,32833,-0.0136039230320673,0.0108200287230467,-0.0348111793292388,0.00760333326510424,0.208681061742165
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDC42BPB,Serine/threonine-protein kinase MRCK beta,31560,-0.0537366819393545,0.0427585851470876,-0.137543508827646,0.0300701449489371,0.208883738350778
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPN1,Epsin-1,31456,-0.021755259790895,0.0173187658084802,-0.0557000407755162,0.0121895211937262,0.209094109260302
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,31555,-0.0518390910552604,0.0412833226500452,-0.132754403449349,0.0290762213388282,0.209266199383595
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL18,Interleukin-18,32663,-0.0236910972597464,0.0188773977906613,-0.0606907969294426,0.0133086024099498,0.209512786535245
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HARS1,"Histidine--tRNA ligase, cytoplasmic",32718,-0.039763927631145,0.0316916845813136,-0.10187962941052,0.0223517741482296,0.209616538579478
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LMNB1,Lamin-B1,31543,-0.0318556579491682,0.025406581158879,-0.0816525570205709,0.0179412411222346,0.209940173085365
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MDK,Midkine,32692,-0.0259447615154745,0.0206929476815689,-0.0665029389713496,0.0146134159404005,0.209948883812474
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CFP,Properdin,31598,-0.0114455041114703,0.00913863354479007,-0.0293572258592588,0.00646621763631826,0.210450859562778
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGFBP2,Insulin-like growth factor-binding protein 2,32817,0.0322538133770962,0.0257542946781549,-0.0182246041920874,0.0827322309462798,0.210469081055182
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,31355,-0.0179598423698051,0.0143540835840964,-0.046093846194634,0.0101741614550238,0.210900240573789
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FXN,"Frataxin, mitochondrial",32794,-0.0377627390188403,0.0302097835774354,-0.0969739148306138,0.0214484367929331,0.211326128012571
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GGT5,Glutathione hydrolase 5 proenzyme,32647,-0.0118238061830487,0.00946500867753784,-0.0303752231910228,0.00672761082492552,0.211620674428044
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MANSC1,MANSC domain-containing protein 1,32720,0.0138570124274032,0.0110934832921193,-0.00788621482515062,0.035600239679957,0.211656804580772
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL9,Interleukin-9,31456,-0.0288217952303999,0.0230870377479272,-0.0740723892163371,0.0164287987555374,0.211924079383291
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMSB10,Thymosin beta-10,32718,-0.0394762517219331,0.0316333473712528,-0.101477612569589,0.0225251091257224,0.212089117882705
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,32728,-0.0614810994508846,0.0493071285291744,-0.158123071368066,0.0351608724662972,0.212466794144616
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNMBP,Dynamin-binding protein,32647,-0.0319780054710629,0.0256578641461947,-0.0822674191976044,0.0183114082554787,0.212678786703731
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZNRF4,E3 ubiquitin-protein ligase ZNRF4,31548,-0.0273608374311408,0.0219714197237269,-0.0704248200896456,0.015703145227364,0.213062317976666
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLTP,Phospholipid transfer protein,32806,0.0181054221042508,0.0145532626788921,-0.0104189727463778,0.0466298169548793,0.213502739817449
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GIPC3,PDZ domain-containing protein GIPC3,31560,-0.0509221588533216,0.0409493330702573,-0.131182851671026,0.0293385339643827,0.21370654242407
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACTN2,Alpha-actinin-2,31313,-0.0306226017883687,0.0246395802093678,-0.0789161789987296,0.0176709754219922,0.213972689812434
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ALPP,"Alkaline phosphatase, placental type",32668,-0.0548717894771689,0.0441795572167019,-0.141463721621905,0.0317201426675669,0.214263122180738
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GNPDA1,Glucosamine-6-phosphate isomerase 1,31388,0.0174857054074556,0.0140799810008769,-0.0101110573542631,0.0450824681691743,0.214317993435715
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGF2R,Cation-independent mannose-6-phosphate receptor,32718,-0.0119589030757955,0.00965106771238295,-0.0308749957920661,0.0069571896404751,0.21533112800073
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C9orf40,Uncharacterized protein C9orf40,31560,0.0418641742585306,0.0337989525777035,-0.0243817727937682,0.10811012131083,0.215522748336326
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARHGAP45,Rho GTPase-activating protein 45,31417,-0.0420938765257339,0.0340700122308018,-0.108871100498106,0.0246833474466377,0.216678773844967
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DTD1,D-aminoacyl-tRNA deacylase 1,31417,-0.0451134388523229,0.0365456214950444,-0.11674285698261,0.0265159792779641,0.217076745172102
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CADPS,Calcium-dependent secretion activator 1,31356,0.0224015174438955,0.0181508757503581,-0.0131741990268064,0.0579772339145974,0.217173100313004
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPHB4,Ephrin type-B receptor 4,32834,0.0117298826911186,0.00950895712590438,-0.00690767327565396,0.0303674386578912,0.217398682616041
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MRI1,Methylthioribose-1-phosphate isomerase,31356,0.0347145720090861,0.0281462480868891,-0.0204520742412165,0.0898812182593888,0.217478624880208
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRPAP1,Alpha-2-macroglobulin receptor-associated protein,32806,-0.0283671663258655,0.0230560772846502,-0.0735570778037799,0.0168227451520489,0.21859644415466
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TSPAN8,Tetraspanin-8,31560,0.0499493884373595,0.0406522051991105,-0.0297289337528971,0.129627710627616,0.219221636028933
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL12RB2,Interleukin-12 receptor subunit beta-2,31355,0.0213328523549223,0.0173865006495151,-0.0127446889181273,0.0554103936279719,0.219869430759611
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA1,Carbonic anhydrase 1,32534,0.0308316130413362,0.0251393705928365,-0.0184415533206234,0.0801047794032958,0.220071169456595
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCN2,CCN family member 2,32716,-0.0295741386391357,0.0241227110628771,-0.0768546523223749,0.0177063750441034,0.220236033825948
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPRH,Receptor-type tyrosine-protein phosphatase H,31560,-0.0248080155662309,0.0202599737492042,-0.0645175641146712,0.0149015329822094,0.220807124242089
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TP53BP1,TP53-binding protein 1,31355,0.0440291824171619,0.0360250156295571,-0.0265798482167701,0.114638213051094,0.221676647792743
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),THBS2,Thrombospondin-2,32718,-0.0180097497995646,0.0147470899393449,-0.0469140460806805,0.0108945464815513,0.222027315031659
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFKB1,Nuclear factor NF-kappa-B p105 subunit,31313,-0.0378418133910323,0.0310237747672571,-0.0986484119348562,0.0229647851527916,0.222591362755451
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HMOX1,Heme oxygenase 1,32632,-0.0233335175924044,0.0191463615137056,-0.0608603861592674,0.0141933509744586,0.222993888737152
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MEPE,Matrix extracellular phosphoglycoprotein,32702,0.012348217798263,0.0101339138031888,-0.00751425325598717,0.0322106888525131,0.223064892203838
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MTPN,Myotrophin,32598,-0.0163595605921689,0.0134274949334834,-0.0426774506617964,0.00995832947745854,0.223119021578297
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,32728,-0.0198023498438904,0.0162572354613334,-0.0516665313481038,0.0120618316603231,0.223232139007991
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EVI5,Ecotropic viral integration site 5 protein homolog,31355,-0.0461436583789102,0.0378930727478325,-0.120414080964662,0.0281267642068415,0.223363654909059
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CMC1,COX assembly mitochondrial protein homolog,31571,-0.0458488140971493,0.0376768584305281,-0.119695456620984,0.0279978284266859,0.223681073475146
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,31355,-0.0296660894175793,0.0243894797287065,-0.077469469685844,0.0181372908506854,0.223890773253509
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),F12,Coagulation factor XII,31598,-0.0209019788976726,0.0171900618223078,-0.0545945000693958,0.0127905422740507,0.224047195589337
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,31555,0.0589084246033957,0.0484508589163742,-0.0360552588726977,0.153872108079489,0.224083707797261
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),YARS1,"Tyrosine--tRNA ligase, cytoplasmic",31560,-0.0739604339102056,0.0608972903536442,-0.193319123003348,0.045398255182937,0.224589865227752
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRAF3,"TNF receptor-associated factor 3, Isoform 2",31355,0.019247374217135,0.015850458970105,-0.0118195253642708,0.0503142737985408,0.224667545079602
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DBI,Acyl-CoA-binding protein,32675,-0.0398205608698696,0.0328311381722971,-0.104169591687572,0.0245284699478326,0.225204361772001
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADGRG2,Adhesion G-protein coupled receptor G2,32729,0.0134755512879444,0.0111178837371744,-0.00831550083691747,0.0352666034128063,0.225521388038714
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDNF,Cerebral dopamine neurotrophic factor,32668,0.0157258888620654,0.0129837853455151,-0.00972233041514419,0.0411741081392749,0.225853381130612
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DPT,Dermatopontin,32834,0.0130913952756229,0.0108131055302824,-0.00810229156373057,0.0342850821149764,0.226043407044593
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FOLR2,Folate receptor beta,32806,0.0142838455610484,0.0118001691937595,-0.00884448605872011,0.037412177180817,0.226127496224455
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TXNRD1,"Thioredoxin reductase 1, cytoplasmic",32718,-0.0232359142615414,0.0192225423968667,-0.0609120973594003,0.0144402688363174,0.226777853866687
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NECTIN1,Nectin-1,31355,-0.0156485126074235,0.0129549880028123,-0.0410402890929356,0.00974326387808855,0.227118419896692
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RCC1,Regulator of chromosome condensation,31548,0.0262987361748556,0.0217804521331655,-0.0163909500061488,0.06898842235586,0.227297285363931
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NAPRT,Nicotinate phosphoribosyltransferase,31548,0.0161507830102462,0.0133894805839499,-0.0100925989342956,0.042394164954788,0.227766229871389
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KCTD5,BTB/POZ domain-containing protein KCTD5,31402,-0.0224756442052423,0.0186343527905494,-0.0589989756747191,0.0140476872642346,0.227801225677512
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MFAP3,Microfibril-associated glycoprotein 3,32598,-0.0238438228186717,0.0197692207522542,-0.06259149549309,0.0149038498557467,0.227808359483422
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSCA,Prostate stem cell antigen,31560,-0.127687060246388,0.105922416123202,-0.335294995847864,0.0799208753550872,0.228056168250616
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPD1,Glycerol-3-phosphate dehydrogenase,31548,-0.0263160559771418,0.0218470120739141,-0.0691361996420134,0.0165040876877299,0.228409948767127
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDAP1,28 kDa heat- and acid-stable phosphoprotein,31571,-0.0488192606688371,0.0405453846507222,-0.128288214584253,0.0306496932465785,0.22860158566764
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYOM1,Myomesin-1,31342,-0.0233134237958927,0.0193826245561794,-0.0613033679260043,0.0146765203342189,0.229091725668107
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRHR1,Corticotropin-releasing factor receptor 1,32598,0.0305987957790893,0.0254427522596083,-0.019268998649743,0.0804665902079216,0.229143315338541
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KRT14,"Keratin, type I cytoskeletal 14",32204,-0.0144742706543931,0.0120402458777193,-0.0380731525747229,0.00912461126593676,0.229336666686175
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OSBPL2,Oxysterol-binding protein-related protein 2,31548,-0.0205798771769647,0.0171257341284296,-0.0541463160686868,0.0129865617147574,0.22951945637941
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDA1,DET1- and DDB1-associated protein 1,31313,-0.0190322295110977,0.0158472359372184,-0.0500928119480457,0.0120283529258503,0.229796731394644
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPRC5C,G-protein coupled receptor family C group 5 member C,31548,-0.0274043581926505,0.0228420069804538,-0.0721746918743399,0.0173659754890389,0.230279196137737
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",32502,0.0243977732420529,0.0203392835548965,-0.0154672225255442,0.06426276900965,0.230351135949141
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C5,Complement C5,31598,-0.00758269644510952,0.00632794759183707,-0.0199854737251102,0.00482008083489114,0.230842059649688
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,31355,-0.0156987824178014,0.0131010379775127,-0.0413768168537264,0.00997925201812361,0.230843820731531
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TXK,Tyrosine-protein kinase TXK,31456,0.0381678369150162,0.0318535077795825,-0.0242650383329654,0.100600712162998,0.230864771796888
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPMT,Thiopurine S-methyltransferase,32526,0.0357540202766134,0.029918940920996,-0.0228871039285388,0.0943951444817657,0.232108164701538
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL20,Interleukin-20,32596,0.0251291056381447,0.0210308346801289,-0.0160913303349079,0.0663495416111973,0.23217040804286
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADA,Adenosine deaminase,32833,-0.0177989471481079,0.0149109824646578,-0.0470244727788371,0.0114265784826213,0.232634577124147
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ROBO2,Roundabout homolog 2,32806,-0.0110364157275128,0.00925682685297743,-0.0291797963593486,0.00710696490432296,0.233196385494437
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL6,C-X-C motif chemokine 6,32833,-0.0377207747738984,0.0316417735133661,-0.099738650860096,0.0242971013122991,0.233245923713791
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCXR,L-xylulose reductase,32720,-0.0263205162060255,0.0220812152899987,-0.0695996981744229,0.0169586657623719,0.233298363565781
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HPCAL1,Hippocalcin-like protein 1,32833,-0.0363398674933138,0.0304984230377965,-0.096116776647395,0.0234370416607674,0.233476052924657
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIRREL1,Kin of IRRE-like protein 1,31342,-0.029682608142681,0.0249126072234568,-0.0785113183006563,0.0191461020152944,0.233507171772922
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,32777,-0.0167269311780576,0.0140481075223288,-0.0442612219218221,0.0108073595657068,0.233807279258778
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FEN1,Flap endonuclease 1,32526,-0.0319549094166066,0.0268376585947903,-0.0845567202623955,0.0206469014291824,0.233814097846063
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RASA1,Ras GTPase-activating protein 1,32502,0.0158289491531828,0.0133162827840579,-0.0102709651035707,0.0419288634099363,0.234593838011165
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBPMS,RNA-binding protein with multiple splicing,31355,0.033938820955555,0.0285568490990446,-0.0220326032785724,0.0899102451896823,0.234687843611444
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BDNF,Brain-derived neurotrophic factor,31571,-0.0406564465343517,0.0342695331329764,-0.107824731474985,0.026511838406282,0.235511607662445
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL24A1,Collagen alpha-1(XXIV) chain,31560,-0.0273847129785831,0.0231206626704729,-0.07270121181271,0.0179317858555438,0.236281048762164
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPME1,Protein phosphatase methylesterase 1,32668,0.0294618225806967,0.0248772638018796,-0.0192976144709874,0.0782212596323808,0.236331390429768
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LGMN,Legumain,32756,-0.0173883355339623,0.0147073014673673,-0.0462146464100021,0.0114379753420776,0.237121170649433
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNF4,E3 ubiquitin-protein ligase RNF4,31456,-0.031551492619922,0.0266936741046827,-0.0838710938651001,0.0207681086252561,0.237249095189566
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL5A1,Collagen alpha-1(V) chain,31417,-0.0190037291471508,0.0160789243291856,-0.0505184208323547,0.0125109625380531,0.237281374399289
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCN1,Ficolin-1,31575,-0.0272284995487512,0.0230666880715634,-0.0724392081690155,0.0179822090715131,0.237867542162647
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LYPD1,Ly6/PLAUR domain-containing protein 1,32502,0.0307353669475804,0.0260474347810362,-0.0203176052232506,0.0817883391184115,0.238041948898687
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,32834,-0.0132662009582168,0.0112461232983859,-0.0353086026230531,0.00877620070661949,0.238180921785283
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDKN1A,Cyclin-dependent kinase inhibitor 1,32668,-0.05171819779389,0.0438616532267865,-0.137687038118392,0.0342506425306115,0.238381834352899
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRKG1,cGMP-dependent protein kinase 1,31417,-0.061896407116498,0.0525109791425809,-0.164817926235957,0.0410251120029607,0.238541750725475
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAD23B,UV excision repair protein RAD23 homolog B,32526,0.0227766443725175,0.0193259053903833,-0.0151021301926338,0.0606554189376688,0.238607738398211
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPB41L5,Band 4.1-like protein 5,31356,0.0314932075091318,0.02672210290771,-0.0208821141899798,0.0838685292082434,0.23861671240468
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HPGDS,Hematopoietic prostaglandin D synthase,32526,0.0178574767370194,0.0151675467022801,-0.0118709147994496,0.0475858682734885,0.239089075403493
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PALM,Paralemmin-1,31517,0.0141790145919621,0.0120496516676632,-0.0094383026766578,0.0377963318605819,0.239345568280672
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,32668,-0.0222901356668625,0.018956022247714,-0.059443939272382,0.014863667938657,0.239671910063764
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SF3B4,Splicing factor 3B subunit 4,32668,-0.0358137851423266,0.0304886690532468,-0.0955715764866902,0.0239440062020371,0.240162981507316
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",31388,-0.0377575387068614,0.0321434219236362,-0.100758645677188,0.0252435682634656,0.240168586860438
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINA1,Alpha-1-antitrypsin,31470,-0.00403177669252862,0.00343664580272669,-0.0107676024658729,0.00270404908081568,0.240763548965212
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GIPC2,PDZ domain-containing protein GIPC2,31548,0.0142729762691297,0.0121685692776203,-0.00957741951500609,0.0381233720532654,0.240857043966602
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJA1,DnaJ homolog subfamily A member 1,31326,-0.0231467248520827,0.0197377835304702,-0.0618327805718044,0.0155393308676389,0.24094895097023
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC1A4,Neutral amino acid transporter A,31356,-0.0256961403355892,0.0219229456278642,-0.068665113766203,0.0172728330950246,0.24118947684676
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD274,Programmed cell death 1 ligand 1,32647,-0.015814637267226,0.0135135463972869,-0.0423011882059084,0.0106719136714564,0.241919921594803
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BMP4,Bone morphogenetic protein 4,32632,-0.0220310925873206,0.0188330667630821,-0.0589439034429615,0.0148817182683203,0.242109589812037
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMPD3,Sphingomyelin phosphodiesterase 3,31355,0.0294023592442098,0.0251597281410273,-0.0199107079122037,0.0787154264006232,0.242590766793617
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DKK1,Dickkopf-related protein 1,32806,-0.0287546082620619,0.0246278719901006,-0.0770252373626591,0.0195160208385354,0.243013934826308
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLA2,Src-like-adapter 2,31555,-0.0511246906192929,0.0438156460626625,-0.137003356902111,0.0347539756635257,0.243321821431901
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FHIP2A,FHF complex subunit HOOK interacting protein 2A,31313,0.022819811427026,0.019581626970632,-0.0155601774354127,0.0611998002894647,0.243907153714267
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NEXN,Nexilin,31586,-0.0334425153023571,0.0287233780416763,-0.0897403362640427,0.0228553056593284,0.244340011915603
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TJAP1,Tight junction-associated protein 1,32720,-0.0395475254872384,0.0339787270576213,-0.106145830520176,0.0270507795456993,0.244499637257432
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJB1,DnaJ homolog subfamily B member 1,32668,-0.0417279675219601,0.0358694668423074,-0.112032122532883,0.0285761874889625,0.244727823237196
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDCD5,Programmed cell death protein 5,32806,-0.0279908046160744,0.0240610442100786,-0.0751504512678286,0.0191688420356797,0.244728856441234
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GDNF,Glial cell line-derived neurotrophic factor,32502,-0.0181412799360774,0.0156076592533618,-0.0487322920726665,0.0124497322005117,0.245132778728613
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SAG,S-arrestin,31342,-0.0258218380677713,0.0222366023494936,-0.0694055786727787,0.0177619025372361,0.24558490529844
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AIF1L,Allograft inflammatory factor 1-like,31388,-0.028235167907983,0.0243252882824659,-0.0759127329416162,0.0194423971256503,0.245787252483838
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANKRA2,Ankyrin repeat family A protein 2,31326,0.02663328662038,0.0229513376369184,-0.01835133514798,0.07161790838874,0.245913260423305
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDGFRB,Platelet-derived growth factor receptor beta,32834,0.0166483393643195,0.0143484380036043,-0.0114745991227449,0.0447712778513839,0.245961898036291
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STX4,Syntaxin-4,32668,-0.0290313718882249,0.025064474515623,-0.0781577419388459,0.0200949981623962,0.246786202028053
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AGT,Angiotensinogen,31586,0.010628817510131,0.00917675431539305,-0.00735762094803938,0.0286152559683014,0.246804862502168
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FKBPL,FK506-binding protein-like,31560,-0.0285515567578338,0.0246644545626528,-0.0768938877006333,0.0197907741849657,0.247063477778948
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BRK1,Protein BRICK1,32502,-0.0209718471752124,0.0181254739303399,-0.0564977760786786,0.0145540817282537,0.247289151891962
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DAG1,Dystroglycan,32756,-0.0230264530988663,0.0199086000360523,-0.0620473091695288,0.0159944029717963,0.24746346560678
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAPGEF2,Rap guanine nucleotide exchange factor 2,31456,-0.0253491434214941,0.0219335985982646,-0.0683389966740928,0.0176407098311045,0.247831218325062
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNER,Delta and Notch-like epidermal growth factor-related receptor,32689,-0.0119554747418257,0.0103509980931622,-0.0322434310044236,0.00833248152077229,0.248118838506475
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD84,SLAM family member 5,32728,-0.014842161208254,0.0128597502000628,-0.0400472716003771,0.0103629491838691,0.248467213235184
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EFNB2,Ephrin-B2,31356,-0.0293788042611735,0.0254608464658278,-0.0792820633341959,0.020524454811849,0.248585469121315
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPNMB,Transmembrane glycoprotein NMB,32489,-0.0132313260748045,0.0114721078072535,-0.0357166573770213,0.00925400522741233,0.248799754512265
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL5,C-X-C motif chemokine 5,32697,-0.0539902944932815,0.0468301291509539,-0.145777347629151,0.0377967586425881,0.248984030641174
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ELN,Elastin,31571,-0.01604251687202,0.0139252297755117,-0.0433359672320229,0.0112509334879829,0.249337544433109
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHGB,Secretogranin-1,32780,0.0181705196446371,0.0157838153789943,-0.0127657584981917,0.049106797787466,0.249675835002991
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL23,C-C motif chemokine 23,32756,-0.0192211569702004,0.0167092768930247,-0.0519713396805288,0.0135290257401279,0.250039528627561
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL11,Interleukin-11,32596,-0.0302858566040259,0.0263534133289735,-0.081938546728814,0.0213668335207621,0.250496942512217
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TBC1D23,TBC1 domain family member 23,32668,-0.0427003414326608,0.0371669627271122,-0.115547588377801,0.030146905512479,0.250637092594379
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PNLIPRP1,Inactive pancreatic lipase-related protein 1,31548,0.0367698230754013,0.0320102025298725,-0.0259701738831487,0.0995098200339514,0.250719264985792
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPINK2,Serine protease inhibitor Kazal-type 2,31417,-0.0174644203137824,0.0152113026643586,-0.0472785735359252,0.0123497329083604,0.250954841906671
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EDF1,Endothelial differentiation-related factor 1,31555,-0.0345300548554028,0.0300792669582442,-0.0934854180935614,0.0244253083827559,0.251017201154748
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",32728,0.0205860530713651,0.0179433912171083,-0.0145829937141671,0.0557550998568974,0.251297807756661
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MCEMP1,Mast cell-expressed membrane protein 1,31355,-0.0435424103056194,0.0379984232291243,-0.118019319834703,0.0309344992234643,0.251872929348935
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),JPT2,Jupiter microtubule associated homolog 2,31560,-0.0418397374332995,0.0365294930895446,-0.113437543888807,0.0297580690222079,0.252092062031183
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TCTN3,Tectonic-3,31571,-0.0141498866997963,0.0123566534348509,-0.038368927432104,0.0100691540325114,0.252193794437791
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNF,Tumor necrosis factor,32580,-0.0180021270569251,0.0157282993785963,-0.048829593838974,0.0128253397251237,0.252419071749185
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLAMF1,Signaling lymphocytic activation molecule,32596,-0.0272324885932406,0.023814801475624,-0.0739094994854636,0.0194445222989824,0.252857804116102
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SSB,Lupus La protein,32502,-0.0262434827787722,0.022959282104051,-0.0712436757027122,0.0187567101451678,0.253051749673348
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GLI2,Zinc finger protein GLI2,31355,0.0161781961464749,0.0141619241585066,-0.0115791752041981,0.0439355674971479,0.253335607805517
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA4,Carbonic anhydrase 4,32834,0.01086646075236,0.00951426838301714,-0.00778150527835358,0.0295144267830736,0.253433543100128
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNAP29,Synaptosomal-associated protein 29,32720,-0.0428306336350612,0.037522506367454,-0.116374746115271,0.0307134788451487,0.253707252990162
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD22,B-cell receptor CD22,32833,-0.0188470629371449,0.0165232312187956,-0.0512325961259844,0.0135384702516945,0.25405009434271
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CES2,Cocaine esterase,32668,-0.0255084581313111,0.0223795432949642,-0.0693723629894409,0.0183554467268188,0.254395885868203
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMOC2,SPARC-related modular calcium-binding protein 2,32756,-0.0176352064480778,0.0154736883620938,-0.0479636356377816,0.012693222741626,0.254446198636532
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,31388,-0.00984427712023231,0.00864186603802949,-0.0267823345547701,0.0070937803143055,0.254681888796336
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,32806,-0.0245476805679884,0.0215510795163744,-0.0667877964200823,0.0176924352841054,0.254714281013295
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGSF9,Protein turtle homolog A,31571,-0.0392121615499735,0.0344549684154333,-0.106743899644223,0.0283195765442759,0.255126665232273
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTF1,Cardiotrophin-1,32598,-0.0394796712360469,0.0347112996417892,-0.107513818533954,0.0285544760618598,0.255413862570302
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRELD1,Protein disulfide isomerase CRELD1,31417,-0.0174063093042643,0.015312669915159,-0.047419142337976,0.0126065237294473,0.25568890986891
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FABP4,"Fatty acid-binding protein, adipocyte",32834,0.0223798728583725,0.0196939435370532,-0.0162202564742519,0.0609800021909968,0.255826435098416
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WASHC3,WASH complex subunit 3,31548,-0.0364038887499712,0.0320575164722828,-0.0992366210356455,0.0264288435357031,0.256167597242189
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD33,Myeloid cell surface antigen CD33,32720,-0.0365188134748609,0.032164749822385,-0.0995617231267355,0.0265240961770138,0.256252058714241
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP5PO,"ATP synthase subunit O, mitochondrial",32502,0.0199832464389079,0.01760983850767,-0.0145320370361254,0.0544985299139411,0.256500078506869
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINI2,Serpin I2,31560,0.0269943618284121,0.0239089776214326,-0.0198672343095958,0.0738559579664199,0.258913138717448
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL18A1,Collagen alpha-1(XVIII) chain,32764,-0.010451277621607,0.00927412809301848,-0.0286285686839232,0.00772601344070925,0.25980315595913
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DIABLO,"Diablo homolog, mitochondrial",32696,-0.0510928265578827,0.0453909953165494,-0.14005917737832,0.0378735242625541,0.260358702487013
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMPD3,AMP deaminase 3,31548,0.034171504774881,0.0303601259429879,-0.0253343420733753,0.0936773516231372,0.260395849898403
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,31555,-0.0234491504743428,0.0208384336261011,-0.0642924803815009,0.0173941794328153,0.260503915220559
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINA4,Kallistatin,31470,-0.0108485175438128,0.00966266234501779,-0.0297873357400477,0.00809030065242208,0.261589508337388
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VEGFD,Vascular endothelial growth factor D,32817,0.016030212148436,0.0142791332544885,-0.0119568890303615,0.0440173133272335,0.261623903275991
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDRG1,p53 and DNA damage-regulated protein 1,31356,-0.024334526997962,0.0217181659357314,-0.0669021322319956,0.0182330782360715,0.262549943668198
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOH,Beta-2-glycoprotein 1,32718,-0.0163135076022068,0.0145719024878021,-0.044874436478299,0.0122474212738854,0.262949557358008
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMEM106A,Transmembrane protein 106A,31548,-0.0330049457239446,0.0294961702284645,-0.0908174393717351,0.0248075479238459,0.263193449481971
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL19,Interleukin-19,32506,-0.0314631870538359,0.0281291360633177,-0.0865962937379386,0.0236699196302668,0.263373225971448
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TYMP,Thymidine phosphorylase,32673,-0.0310655116171628,0.0278107356596595,-0.0855745535100954,0.0234435302757698,0.264010634552462
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBKS,Ribokinase,32503,-0.0232598662979968,0.0208305540450964,-0.0640877522263857,0.0175680196303921,0.264186788120568
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPIND1,Heparin cofactor 2,31582,-0.0130554398521893,0.0116949118816675,-0.0359774671402576,0.00986658743587895,0.26431348589336
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OGA,Protein O-GlcNAcase,31560,-0.0330501517355216,0.0296180725031605,-0.0911015738417163,0.025001270370673,0.264509236668456
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),REST,RE1-silencing transcription factor,31326,0.0165938193109014,0.0148866071270529,-0.0125839306581223,0.0457715692799251,0.265022991638237
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL4R,Interleukin-4 receptor subunit alpha,32728,0.0163145003524088,0.0146416540940712,-0.0123831416719707,0.0450121423767882,0.265201056386918
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD248,Endosialin,31571,0.0182667506757115,0.0163979579216196,-0.0138732468506628,0.0504067482020859,0.26532893652076
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DAB2,Disabled homolog 2,32794,-0.0513474784681193,0.0461652022131305,-0.141831274805855,0.0391363178696165,0.266058440340979
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIA1,Nucleolysin TIA-1 isoform p40,32502,-0.0557888264838317,0.0501822161976429,-0.154145970231212,0.0425683172635484,0.2662873150821
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C7,Complement component C7,31417,-0.0148453644895585,0.0133752066673693,-0.0410607695576023,0.0113700405784854,0.267070264256751
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPN6,Tyrosine-protein phosphatase non-receptor type 6,32739,-0.0409179658068379,0.0368716039563245,-0.113186309561234,0.0313503779475581,0.267140292972472
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD82,CD82 antigen,31456,0.0189837362323027,0.0171189365580585,-0.0145693794214919,0.0525368518860973,0.267494633954216
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VTCN1,V-set domain-containing T-cell activation inhibitor 1,32526,0.0147964146073517,0.0133545625342074,-0.0113785279596948,0.0409713571743983,0.267906817135762
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD14,Monocyte differentiation antigen CD14,32525,-0.0186955700192209,0.016878237235221,-0.0517769150002539,0.0143857749618122,0.268033750173509
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EGF,Pro-epidermal growth factor,32688,-0.0473058075108897,0.0427083514418271,-0.131014176336871,0.0364025613150914,0.268044169757798
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BLVRB,Flavin reductase,32718,0.0302146804221533,0.0273082619268764,-0.0233095129545244,0.083738873798831,0.268570490512378
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MESD,LRP chaperone MESD,32718,-0.0553240886314269,0.0500496469512257,-0.153421396655829,0.0427732193929756,0.269023171754644
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",31388,-0.0206900085983064,0.0187211924732731,-0.0573835458459217,0.016003528649309,0.269123374835991
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FABP5,Fatty acid-binding protein 5,32778,-0.0313791174636665,0.0284130864312934,-0.0870687668690016,0.0243105319416687,0.269453961877162
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,31417,-0.0270798473998958,0.0245475445572263,-0.0751930347320594,0.0210333399322678,0.269993203001063
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNC,Tenascin,32754,-0.0211644664137545,0.0192131708968491,-0.0588222813715787,0.0164933485440697,0.270682682345636
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDH4,Cadherin-4,31342,-0.0210291578292874,0.0191386616085566,-0.0585409345820583,0.0164826189234835,0.271899866920879
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOC1,Apolipoprotein C-I,31582,-0.0169730313880969,0.0154473358392662,-0.0472498096330587,0.0133037468568649,0.271903725127764
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),S100A12,Protein S100-A12,32581,-0.033720913381416,0.0307064523682409,-0.0939055600231681,0.0264637332603361,0.272160459159807
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RANBP2,E3 SUMO-protein ligase RanBP2,31342,0.0149362946815685,0.013602067090911,-0.0117237568166171,0.0415963461797541,0.2722005007075
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BANK1,B-cell scaffold protein with ankyrin repeats,32728,-0.0471245086023769,0.0429675528178473,-0.131340912125358,0.0370918949206038,0.272782050447438
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RIDA,2-iminobutanoate/2-iminopropanoate deaminase,31417,-0.0228441070912959,0.0208345963039675,-0.0636799158470721,0.0179917016644803,0.272916538398192
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EGFLAM,Pikachurin,31560,-0.0143228170622081,0.0130688920082883,-0.0399378453984531,0.0112922112740369,0.273136108609703
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TSC1,Hamartin,31355,0.0349586256462366,0.0319093384242825,-0.0275836776653572,0.0975009289578304,0.273306153745071
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ICOSLG,ICOS ligand,32668,0.00838248561374175,0.0076518336175365,-0.00661510827662978,0.0233800795041133,0.273333213029223
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYL3,Myosin light chain 3,31388,-0.033693244567831,0.0307676635839679,-0.093997865192408,0.0266113760567461,0.273513897341795
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DENND2B,DENN domain-containing protein 2B,31313,-0.0214713974333925,0.0196142705171162,-0.0599153676469401,0.0169725727801552,0.273691161312455
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPRK,Receptor-type tyrosine-protein phosphatase kappa,31560,-0.00974537558028374,0.00890874114261589,-0.0272065082198109,0.00771575705924341,0.274027954877942
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MZT1,Mitotic-spindle organizing protein 1,32526,-0.0234561544353431,0.0214662359012984,-0.0655299768018881,0.0186176679312018,0.274555945876458
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),USO1,General vesicular transport factor p115,32668,-0.0401640052220146,0.0367646252080577,-0.112222670629808,0.0318946601857784,0.274659375142276
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPBP,Platelet basic protein,31544,-0.0382910070812292,0.0351165086913951,-0.107119364116364,0.0305373499539051,0.275571599889812
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHRM1,Muscarinic acetylcholine receptor M1,31356,-0.0158190964645996,0.0145082853605393,-0.0442553357712567,0.0126171428420575,0.275594424488924
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFNW1,Interferon omega-1,31313,-0.0160807488235675,0.0147507412873124,-0.0449922017466998,0.0128307040995648,0.275675505096787
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLRK1,NKG2-D type II integral membrane protein,31548,-0.020333713753183,0.0186862743897289,-0.0569588115570516,0.0162913840506857,0.27655723460923
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,32526,-0.0158357018803686,0.0145540838401317,-0.0443617062070268,0.0126903024462896,0.27659932189372
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA8,Carbonic anhydrase-related protein,31355,0.0115521027598616,0.0106210194424626,-0.0092650953473652,0.0323693008670883,0.276778346422587
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AKR1B1,Aldo-keto reductase family 1 member B1,32526,-0.0334618975809535,0.0307763089897182,-0.0937834632008012,0.0268596680388941,0.276951472664109
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NRTN,Neurturin,32596,-0.0224812356467104,0.0207009590374343,-0.0630551153600816,0.0180926440666608,0.277509082891277
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANGPTL1,Angiopoietin-related protein 1,32593,0.0130469171474221,0.0120193126773001,-0.0105109357000861,0.0366047699949303,0.277731948948164
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CETN3,Centrin-3,31560,-0.0357077831042775,0.032901806036766,-0.100195322936339,0.0287797567277839,0.27783014330155
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",31555,-0.0325705535353645,0.0300376698638524,-0.0914443864685151,0.0263032793977861,0.278255328004554
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STAT2,Signal transducer and activator of transcription 2,31355,-0.0353381890237035,0.0326401301652841,-0.0993128441476605,0.0286364661002534,0.27899384458989
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERBB3,Receptor tyrosine-protein kinase erbB-3,32667,-0.00852043944645739,0.00787433300233049,-0.0239541321310252,0.00691325323811037,0.279258954095032
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,31548,-0.0185333095516433,0.0171393541841475,-0.0521264437525724,0.0150598246492858,0.27958396108538
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),METAP1D,"Methionine aminopeptidase 1D, mitochondrial",32728,-0.0369829262949558,0.034211886897239,-0.104038224613544,0.0300723720236326,0.279728114597357
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEP350,Centrosome-associated protein 350,31326,-0.0160827349918658,0.0148950715243611,-0.0452770751796135,0.0131116051958819,0.280294934526036
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PMS1,PMS1 protein homolog 1,31356,-0.0227433981970722,0.0211006492064637,-0.064100670641741,0.0186138742475967,0.281134043754538
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NGRN,Neugrin,31548,-0.00987668856092544,0.00916663412618673,-0.0278432914482514,0.00808991432640054,0.281308279330253
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPINK8,Serine protease inhibitor Kazal-type 8,31313,-0.0158697439522317,0.0147337618780732,-0.0447479172332551,0.0130084293287917,0.28147018107507
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HYOU1,Hypoxia up-regulated protein 1,32834,0.00929890562254108,0.00863918239917226,-0.00763389187983655,0.0262317031249187,0.281793395138613
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RPS10,40S ribosomal protein S10,31313,-0.0194722321702648,0.018094950898768,-0.0549383359318502,0.0159938715913206,0.281911053976669
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TARS1,"Threonine--tRNA ligase 1, cytoplasmic",31548,-0.0158835922483738,0.0147678591768925,-0.0448285962350831,0.0130614117383356,0.282161665325736
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CC2D1A,Coiled-coil and C2 domain-containing protein 1A,32647,-0.0328909782876001,0.0305832652513282,-0.0928341781802035,0.0270522216050033,0.282199825164199
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGAX,Integrin alpha-X,31456,0.0227779104258738,0.0212009793026638,-0.0187760090073472,0.0643318298590947,0.282686480861934
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,32526,0.026676595261503,0.0249108395301951,-0.0221486502176793,0.0755018407406854,0.28425185154435
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PKD1,Polycystin-1,31571,-0.0114832326808026,0.0107314401848689,-0.0325168554431456,0.00955039008154046,0.284627984893232
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CFB,Complement factor B,31461,-0.0147234522662915,0.013765086072688,-0.04170302096876,0.0122561164361771,0.284823016063371
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DTNB,Dystrobrevin beta,31536,-0.0200576234690222,0.0187566885838881,-0.0568207330934429,0.0167054861553985,0.284941806837335
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GMFG,Glia maturation factor gamma,31571,-0.0318939378246787,0.0298357881961956,-0.0903720826892221,0.0265842070398648,0.285110981250152
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",32668,-0.0307872558865571,0.0288024249121838,-0.0872400087144374,0.0256654969413231,0.285138644095788
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,32693,0.0816939122335523,0.0764599954927855,-0.0681676789323072,0.231555503399412,0.285345414870088
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TXNDC9,Thioredoxin domain-containing protein 9,31548,-0.0235222614519479,0.0220216882324689,-0.0666847703875869,0.0196402474836911,0.285490587497982
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC1B,C-type lectin domain family 1 member B,32806,-0.042310147893554,0.0396873598686009,-0.120097373236012,0.0354770774489038,0.286413433690159
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HIP1,Huntingtin-interacting protein 1,31313,0.0150349913343143,0.0141057511890754,-0.0126122809962736,0.0426822636649022,0.286513916382179
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDH6,Cadherin-6,32729,0.0164778302381002,0.0154729459290739,-0.0138491437828847,0.0468048042590851,0.286929991163328
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,32729,-0.0365374444958718,0.034325714833574,-0.103815845569677,0.0307409565779333,0.287161294022239
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF21,Tumor necrosis factor receptor superfamily member 21,32806,0.0115516290364357,0.0108594163269296,-0.00973282696434628,0.0328360850372177,0.287473811868793
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSIP1,PC4 and SFRS1-interacting protein,32728,-0.0284187616319303,0.0267252228441029,-0.080800198406372,0.0239626751425113,0.287643801129353
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HEXIM1,Protein HEXIM1,32728,-0.0352231596552117,0.0331388536513216,-0.100175312811802,0.0297289935013787,0.287857996057915
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PEPD,Xaa-Pro dipeptidase,31586,0.0115626939464603,0.0108827563336515,-0.0097675084674966,0.0328928963604172,0.288051750187973
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MPI,Mannose-6-phosphate isomerase,32668,-0.0374442376442998,0.0352994026955257,-0.10663106692753,0.0317425916389306,0.288827513185581
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,32754,0.0183565816457534,0.0173081720705825,-0.0155674356125882,0.0522805989040951,0.288912753742597
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GORASP2,Golgi reassembly-stacking protein 2,31560,-0.0206499809146366,0.0194709944291961,-0.0588131299958609,0.0175131681665878,0.2889273048831
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC13A1,Solute carrier family 13 member 1,31548,0.0262786141371715,0.0247928011213494,-0.0223152760606733,0.0748725043350162,0.289210103023187
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNTN4,Contactin-4,32718,-0.0102336835085355,0.00966876707865222,-0.0291844669826939,0.00871709996562284,0.289889706442376
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DLK1,Protein delta homolog 1,32834,0.0240155738765732,0.0227117202903578,-0.020499397892528,0.0685305456456745,0.290353500252086
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATG16L1,Autophagy-related protein 16-1,31560,-0.0377481589948351,0.0357032170204172,-0.107726464354853,0.0322301463651826,0.290418753590896
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINB8,Serpin B8,32833,-0.0248422717253741,0.0235116137024182,-0.0709250345821138,0.0212404911313656,0.290724554588137
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARAF,Serine/threonine-protein kinase A-Raf,31456,-0.0294003101993993,0.0278258575093835,-0.0839389909177911,0.0251383705189924,0.290735836094421
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GRIK2,"Glutamate receptor ionotropic, kainate 2",31555,-0.0171426477913489,0.0162282569484591,-0.0489500314103286,0.0146647358276309,0.290843513002236
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,31555,-0.0291504457976689,0.0276000994302495,-0.083246640680958,0.0249457490856202,0.290922903919633
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZPR1,Zinc finger protein ZPR1,31342,-0.0417454327110134,0.0395448604961996,-0.119253359283565,0.0357624938615378,0.291163380875629
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCRG1,Scrapie-responsive protein 1,31571,-0.0118528590781035,0.0112408823018366,-0.0338849883897031,0.0101792702334962,0.291713612213844
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PALM3,Paralemmin-3,31313,0.0338593632809903,0.0321413567739452,-0.0291376959959423,0.0968564225579229,0.292168222676389
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BECN1,Beclin-1,31388,-0.0267025850721205,0.0253548048407443,-0.0763980025599794,0.0229928324157383,0.292302936689534
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CACYBP,Calcyclin-binding protein,31402,-0.044912185227599,0.0427053483420115,-0.128614667977942,0.0387902975227436,0.292981970361859
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WFDC12,WAP four-disulfide core domain protein 12,32773,-0.0272549183777777,0.0259178065487456,-0.078053819213319,0.0235439824577636,0.293015991098511
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NCS1,Neuronal calcium sensor 1,32794,-0.0121461224282292,0.0115600631272467,-0.0348038461576328,0.0105116013011745,0.293426242149844
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TCL1A,T-cell leukemia/lymphoma protein 1A,32630,-0.0412483433234038,0.0392703180402236,-0.118218166682242,0.0357214800354343,0.293577216803011
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TK1,"Thymidine kinase, cytosolic",31456,0.0195070969044907,0.0185759961063514,-0.0169018554639581,0.0559160492729395,0.29369457375674
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,32668,0.0163989411814311,0.0156202758783051,-0.014216799540047,0.0470146819029091,0.293816047172565
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TFPI,Tissue factor pathway inhibitor,32695,-0.0137038157825127,0.0130556374133398,-0.0392928651126586,0.0118852335476332,0.29390896926342
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF5,Eukaryotic translation initiation factor 5,31313,0.0190004003469789,0.018115033056651,-0.016505064444057,0.0545058651380149,0.294269789395123
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,32647,-0.0318299067345066,0.0303512821093598,-0.0913184196688518,0.0276586061998385,0.294337212505141
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NELL2,Protein kinase C-binding protein NELL2,32756,-0.0121350653653274,0.0115735830074298,-0.0348192880598898,0.010549157329235,0.294430278399586
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,32806,-0.0307032172571308,0.0293002147663674,-0.0881316381992108,0.0267252036849493,0.294720505514597
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LTB,Lymphotoxin-beta,31548,0.0148222940320741,0.0141685870097249,-0.0129481365069867,0.0425927245711349,0.295530318022384
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERC2,ERC protein 2,31356,-0.0329352894492987,0.0315352321701883,-0.0947443445028678,0.0288737656042704,0.296335611492018
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ABO,Histo-blood group ABO system transferase,31586,0.0624427227368258,0.0598516475023158,-0.0548665063677132,0.179751951841365,0.296845890292432
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMAD2,Mothers against decapentaplegic homolog 2,31548,-0.0302570843434228,0.0290073877057516,-0.087111564246696,0.0265973955598505,0.296943108570322
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),INHBB,Inhibin beta B chain,31417,-0.0215164637042948,0.0206560136313045,-0.0620022504216516,0.0189693230130619,0.297604447089237
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NOMO1,Nodal modulator 1,32718,-0.0101309647979675,0.00973239409639576,-0.0292064572269032,0.00894452763096822,0.297925773950184
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNX2,Sorting nexin-2,31548,0.0346414374067109,0.0333266598273677,-0.0306788158549299,0.0999616906683517,0.298627619298322
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MUCL3,Mucin-like protein 3,31326,-0.0186778392409994,0.0179803138570942,-0.0539192544009039,0.0165635759189052,0.298934267945517
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TF,Serotransferrin,31598,-0.00943964313829714,0.00908764552235264,-0.0272514283621083,0.00837214208551404,0.29896108598014
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,31548,-0.0210315728040454,0.0202493854301688,-0.0607203682471762,0.0186572226390854,0.299010577482385
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",31388,-0.0398036905974956,0.0383251615355523,-0.114921007207178,0.0353136260121869,0.299034143674622
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD300C,CMRF35-like molecule 6,32806,-0.0140032027121144,0.0134942243023868,-0.0404518823447927,0.0124454769205638,0.299429297045772
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINB9,Serpin B9,32647,-0.0139503596423687,0.0134572637996835,-0.0403265966897484,0.012425877405011,0.299931438682868
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL1A,Interleukin-1 alpha,32596,-0.0235944792956446,0.0227713148378383,-0.0682262563778077,0.0210372977865186,0.300161228942462
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD302,CD302 antigen,32668,-0.0122305243610936,0.011826061868035,-0.0354096056224422,0.0109485569002551,0.301070626042799
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYCBP2,E3 ubiquitin-protein ligase MYCBP2,31555,-0.0279054170517642,0.0269888891030572,-0.0808036396937563,0.0249928055902279,0.301187611468355
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANXA4,Annexin A4,32681,-0.0310540302337297,0.0300383267378187,-0.0899291506398544,0.027821090172395,0.301251661317192
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PNMA2,Paraneoplastic antigen Ma2,31342,0.0193297463225722,0.0187134543637849,-0.0173486242304463,0.0560081168755906,0.301668596044429
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,31560,0.0143620861377067,0.0139173879472618,-0.0129159942389265,0.0416401665143399,0.30212668499981
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STC2,Stanniocalcin-2,32704,0.0110254056451656,0.0106909989024462,-0.009928952203629,0.0319797634939603,0.302438073121017
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,31560,-0.0278802903335714,0.027045216277915,-0.0808889142382848,0.0251283335711421,0.302630900833666
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL7,Interleukin-7,32728,-0.0274344483036388,0.0266604333490506,-0.079688897667778,0.0248200010605004,0.303492540113088
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGA6,Integrin alpha-6,32728,-0.0223872243317265,0.0217604193349845,-0.065037646228296,0.0202631975648431,0.303599459798207
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TWF2,Twinfilin-2,31571,-0.0360941596256721,0.0350866364741547,-0.104863967115015,0.0326756478636711,0.303645746553214
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEPTIN7,Septin-7,31456,-0.021939170954272,0.0213387819670134,-0.0637631836096182,0.0198848417010742,0.303918573178692
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINB1,Leukocyte elastase inhibitor,32691,-0.0378462284000126,0.0368831173446258,-0.110137138395479,0.0344446815954539,0.304866655733564
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPSAB1,Tryptase alpha/beta-1,32818,0.0220924421349789,0.0215534332859005,-0.0201522871053861,0.064337171375344,0.305387077701583
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMPRSS15,Enteropeptidase,32668,-0.0373384621520902,0.036453406652371,-0.108787139190737,0.034110214886557,0.305731601475915
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SAFB2,Scaffold attachment factor B2,31555,0.011407810174098,0.0111643327066124,-0.0104742819308622,0.0332899022790582,0.306903662767617
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SSH3,Protein phosphatase Slingshot homolog 3,31326,0.012508315129661,0.0122481191156755,-0.0114979983370629,0.036514628596385,0.307172057418994
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLA2G4A,Cytosolic phospholipase A2,32756,-0.0368566197333951,0.0361214584292345,-0.107654678254695,0.0339414387879046,0.307589068636181
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPT1,Palmitoyl-protein thioesterase 1,31356,-0.0330973376807422,0.0324855859725602,-0.0967690861869602,0.0305744108254758,0.308315858087425
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMARCA2,Probable global transcription activator SNF2L2,32502,0.0301669504947866,0.0296448004987062,-0.0279368584826776,0.0882707594722508,0.308890135553992
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC4A1,Band 3 anion transport protein,31571,0.0200680280431489,0.0197404238740206,-0.0186232027499316,0.0587592588362293,0.30937774368543
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCGB1A1,Uteroglobin,32733,0.0225651805047921,0.0222079779840375,-0.0209624563439214,0.0660928173535055,0.309616890621217
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,31571,-0.0167907945303997,0.0165282692172003,-0.0491862021961123,0.0156046131353128,0.309716782104062
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GRN,Progranulin,32676,-0.0102315044539911,0.0100740862333495,-0.0299767134713561,0.00951370456337398,0.309835364296475
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NOP56,Nucleolar protein 56,31313,-0.04676173261221,0.0460452069695796,-0.137010338272586,0.043486873048166,0.309871283481157
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BRSK2,Serine/threonine-protein kinase BRSK2,31555,-0.0163699699983333,0.0161390300026091,-0.0480024688034473,0.0152625288067806,0.310467026173035
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL17D,Interleukin-17D,32596,-0.013390030885823,0.0132030409663545,-0.0392679911798778,0.0124879294082318,0.31053323892887
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCYT2,Ethanolamine-phosphate cytidylyltransferase,31560,-0.0321239830197179,0.0316822338590297,-0.0942211613834161,0.0299731953439804,0.310641753512068
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCG3,Secretogranin-3,32721,0.0133422028123396,0.0131649598818181,-0.0124611185560239,0.0391455241807031,0.310866620764926
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MMP8,Neutrophil collagenase,32795,-0.0303854550429508,0.029981989112756,-0.0891501537039525,0.0283792436180508,0.310869394558272
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SHPK,Sedoheptulokinase,31456,-0.0174767846602304,0.0172766049565793,-0.0513389303751259,0.0163853610546651,0.311767904637372
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HNF1A,Hepatocyte nuclear factor 1-alpha,31356,-0.0317275795181251,0.0313740283900912,-0.0932206751627039,0.0297655161264536,0.31192038220784
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OPTC,Opticin,32668,0.018879546323147,0.0186755753956234,-0.0177245814522748,0.0554836740985688,0.312081627784464
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL32,Interleukin-32,32728,-0.0177544968209324,0.0175728726923234,-0.0521973272978862,0.0166883336560213,0.312362152167406
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,31456,-0.021233340717305,0.0210511362363341,-0.0624935677405199,0.0200268863059099,0.313172091472527
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANGPT2,Angiopoietin-2,32794,-0.0159600128963822,0.0158381530840288,-0.0470027929410786,0.0150827671483143,0.313628645156176
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NINJ1,Ninjurin-1,32526,0.0238481217459665,0.0236703067700871,-0.0225456795234043,0.0702419230153372,0.31371685031404
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SBSN,Suprabasin,31553,0.0141888921719903,0.0140917861035043,-0.0134310085908781,0.0418087929348586,0.314018840409963
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRRC37A2,Leucine-rich repeat-containing protein 37A2,31560,-0.0176097408758571,0.0174900737921581,-0.0518902855084869,0.0166708037567726,0.31404234578331
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DRAXIN,Draxin,32647,0.0175305630624232,0.0174142010779373,-0.0166012710503338,0.0516623971751803,0.314115326662251
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCN2A,Sodium channel protein type 2 subunit alpha,31342,0.0208121542775229,0.0206894651323849,-0.0197391973819516,0.0613635059369974,0.314481760047605
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STX1B,Syntaxin-1B,31356,0.0182962781621323,0.0182162732917538,-0.0174076174897052,0.0540001738139697,0.315222151391774
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DEFB103A_DEFB103B,Beta-defensin 103,31301,-0.017085275157773,0.0170273186405499,-0.0504588196932509,0.0162882693777049,0.315698729670121
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SUSD1,Sushi domain-containing protein 1,32598,-0.0196394343371433,0.019606816941974,-0.0580687955434124,0.0187899268691258,0.316533842002527
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COMT,Catechol O-methyltransferase,32481,-0.0349960391766306,0.0349459530985636,-0.103490107249815,0.033498028896554,0.316645505708134
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AIFM1,"Apoptosis-inducing factor 1, mitochondrial",32649,-0.0428530843951416,0.0428242076357445,-0.126788531361201,0.0410823625709176,0.317011840550315
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LACTB2,Endoribonuclease LACTB2,32729,-0.0272247381740308,0.0272586334973467,-0.0806516598288305,0.0262021834807688,0.317939897252661
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPHA10,Ephrin type-A receptor 10,32502,-0.0266047962862699,0.0266401855733267,-0.0788195600099902,0.0256099674374504,0.317981772488304
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPHA4,Ephrin type-A receptor 4,31417,0.0115551187253551,0.0115907705828063,-0.0111627916169452,0.0342730290676554,0.318833264293526
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ALCAM,CD166 antigen,32834,0.00772048590847483,0.00775668192799652,-0.00748261067039834,0.022923582487348,0.319600892853359
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNIP1,TNFAIP3-interacting protein 1,31548,-0.0364491978160938,0.0366219448705095,-0.108228209762292,0.0353298141301049,0.319629985318299
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,32718,0.0100566759574362,0.0101106363852122,-0.00976017135757975,0.0298735232724522,0.319927363368179
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMOD4,Tropomodulin-4,31326,-0.0168911428438676,0.0169940869558071,-0.0501995532772495,0.0164172675895143,0.320283143163026
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TBCB,Tubulin-folding cofactor B,32647,-0.0411517538967039,0.0414046112627451,-0.122304791971684,0.0400012841782765,0.320302323545045
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUDC,Nuclear migration protein nudC,32833,-0.026143094250525,0.026339844459,-0.0777691893901649,0.025483000889115,0.320965660128796
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LYN,Tyrosine-protein kinase Lyn,32668,-0.0345776115676166,0.0349029533148544,-0.102987400064731,0.0338321769294981,0.321869720563135
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACE2,Angiotensin-converting enzyme 2,32598,-0.0199915045769037,0.0201832391923172,-0.0595506533938454,0.0195676442400381,0.321957066826056
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BTN1A1,Butyrophilin subfamily 1 member A1,31533,0.0163095987819767,0.0164703287219253,-0.0159722455129969,0.0485914430769503,0.322087443414863
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TEX33,Testis-expressed protein 33,31456,-0.0167359088823282,0.0169040943413964,-0.0498679337914653,0.0163961160268088,0.322180918865756
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GABARAP,Gamma-aminobutyric acid receptor-associated protein,31548,-0.0199787135514181,0.020189752083155,-0.059550627634402,0.0195932005315657,0.322426608647218
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HTRA2,"Serine protease HTRA2, mitochondrial",32720,-0.0251652955187896,0.0254362981201746,-0.0750204398343318,0.0246898487967525,0.322520984615444
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL2RA,Interleukin-2 receptor subunit alpha,32669,-0.0158683800802753,0.0160679868520054,-0.0473616343102058,0.0156248741496552,0.323386801849879
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CYB5A,Cytochrome b5,31326,-0.0296308118676337,0.0300056617311548,-0.0884419088606972,0.0291802851254298,0.323425976768568
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OLFM4,Olfactomedin-4,31157,-0.0500296063081677,0.0506648324000384,-0.149332677812243,0.0492734651959075,0.323448851146363
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AHNAK2,Protein AHNAK2,31388,0.0120185862139546,0.0121751453065129,-0.0118446985868107,0.0358818710147199,0.323605202112381
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA11,Carbonic anhydrase-related protein 11,32526,0.0130246017921343,0.0132090035288206,-0.0128650451243541,0.0389142487086227,0.324141163546488
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VPS28,Vacuolar protein sorting-associated protein 28 homolog,31456,-0.0278334667732959,0.0282548781033919,-0.0832130278559441,0.0275460943093522,0.324613519222703
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCAMP3,Secretory carrier-associated membrane protein 3,32668,-0.0343494181982398,0.0349084864277595,-0.102770051596648,0.0340712152001688,0.325150039962335
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPON2,Spondin-2,32693,-0.0133220319367526,0.0135441551840168,-0.0398685760974255,0.0132245122239204,0.325339132872896
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,31530,-0.0335364273477378,0.0341121628395625,-0.10039626651328,0.0333234118178046,0.325578269256532
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NRGN,Neurogranin,31586,-0.0375427863616036,0.0381934160044559,-0.112401881730337,0.03731630900713,0.325655506760354
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDIA5,Protein disulfide-isomerase A5,31326,0.0252545708513177,0.0257009785444737,-0.0251193470958508,0.0756284887984863,0.325821064082987
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PEAR1,Platelet endothelial aggregation receptor 1,32834,-0.00914373667401244,0.00931097040115585,-0.0273932386602779,0.00910576531225303,0.326107077047839
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EXOSC10,Exosome component 10,31313,-0.0251984332988969,0.0256829695894536,-0.0755370536942259,0.0251401870964321,0.326558539410333
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MPRIP,Myosin phosphatase Rho-interacting protein,31531,-0.0183531069977505,0.0187093139387478,-0.0550233623176963,0.0183171483221953,0.326642918885175
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MIA,Melanoma-derived growth regulatory protein,32720,-0.0145838582172653,0.0148735042379456,-0.0437359265236387,0.0145682100891082,0.326853294895173
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GFER,FAD-linked sulfhydryl oxidase ALR,32526,-0.0261042286350924,0.0266235632657164,-0.0782864126358966,0.0260779553657118,0.326869986630585
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,31586,-0.0176740686384014,0.0180414755622285,-0.0530353607403693,0.0176872234635664,0.327296784268538
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",32526,0.0207024024039926,0.021154492554202,-0.0207604030022433,0.0621652078102285,0.327790584415802
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDCD1,Programmed cell death protein 1,32785,-0.0160350620301008,0.0163957891297927,-0.0481708087244946,0.0161006846642929,0.328101427494088
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,31571,-0.0360865446397918,0.0369698483056935,-0.108547447318951,0.0363743580393675,0.329041836621067
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PROCR,Endothelial protein C receptor,31313,-0.0157351841507457,0.0161227960655724,-0.0473358644392676,0.0158654961377762,0.329116574032551
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AKR7L,Aflatoxin B1 aldehyde reductase member 4,31355,0.0290286911019655,0.0297449698246414,-0.0292714497543317,0.0873288319582626,0.329135937669095
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VWC2,Brorin,32621,0.015221722874404,0.015604665378813,-0.0153634212680695,0.0458068670168774,0.329359194003574
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MIF,Macrophage migration inhibitory factor,32701,-0.0270915516420683,0.0277907109503461,-0.0815613451047466,0.02737824182061,0.329665322157374
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MVK,Mevalonate kinase,32596,-0.031960226532637,0.0327865164886494,-0.0962217988503899,0.0323013457851159,0.329687523259713
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HBEGF,Proheparin-binding EGF-like growth factor,32777,-0.0291544471268753,0.0299201463757584,-0.0877979340233617,0.0294890397696112,0.329880146735577
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACP1,Low molecular weight phosphotyrosine protein phosphatase,31355,0.0180831915857508,0.0185651742218403,-0.0183045498890561,0.0544709330605577,0.330068934756775
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,32718,-0.0147383282027725,0.0151501377007464,-0.0444325980962354,0.0149559416906905,0.330670277918399
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD58,Lymphocyte function-associated antigen 3,32679,0.00691987101784212,0.00711469272390729,-0.00702492672101618,0.0208646687567004,0.33077037107376
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AGRN,Agrin,32756,-0.0129061745311835,0.0133064609244623,-0.0389868379431297,0.0131744888807627,0.332113790052
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,31356,-0.0208378417152757,0.0214914867756841,-0.0629611557956165,0.0212854723650652,0.332284246106724
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CBLIF,Cobalamin binding intrinsic factor,32719,0.0266285090167567,0.0274974165029676,-0.0272664273290598,0.0805234453625732,0.332870878691899
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCDH17,Protocadherin-17,32729,0.0138863318033587,0.0143449885771684,-0.0142298458078915,0.0420025094146088,0.333057436894809
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STOML2,"Stomatin-like protein 2, mitochondrial",31326,0.0379050830292912,0.0391613290717771,-0.0388511219513918,0.114661288009974,0.333115048097225
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STX8,Syntaxin-8,32728,-0.0193662025457248,0.0200260912705602,-0.0586173414360228,0.0198849363445732,0.333546135138468
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CALCB,Calcitonin gene-related peptide 2,31548,0.0152438564612741,0.01577734223026,-0.0156797343100355,0.0461674472325838,0.333981214163187
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NCAN,Neurocan core protein,32806,0.014496474264911,0.015033886830192,-0.0149699439222654,0.0439628924520874,0.334945035952085
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MMP1,Interstitial collagenase,32398,-0.0363645446491522,0.0377537600147302,-0.110361914278023,0.0376328249797191,0.335472809026021
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),M6PR,Cation-dependent mannose-6-phosphate receptor,31388,-0.0165272177979712,0.0171585102862242,-0.0501578979589706,0.0171034623630283,0.335473989622049
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FABP1,"Fatty acid-binding protein, liver",32702,-0.0369595093148425,0.0383870561750358,-0.112198139417913,0.0382791207882278,0.335668325086265
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTS,6-pyruvoyl tetrahydrobiopterin synthase,32460,-0.0216623248506872,0.0225027405741501,-0.0657676963760214,0.0224430466746469,0.33574888740483
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),THPO,Thrombopoietin,32598,-0.0151747442086132,0.0157651390789574,-0.0460744168033698,0.0157249283861434,0.335799729969001
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSH,Pro-cathepsin H,32571,-0.0284439629322282,0.029587924044082,-0.0864362940586289,0.0295483681941725,0.336409487464041
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VSIG2,V-set and immunoglobulin domain-containing protein 2,31548,0.0215954851899311,0.0224767395049174,-0.0224589242397071,0.0656498946195693,0.336686671519199
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TUBB3,Tubulin beta-3 chain,31342,-0.0112066700007498,0.0116690074031422,-0.0340779245109086,0.011664584509409,0.336895522545434
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CFHR4,Complement factor H-related protein 4,31585,-0.0287327210906101,0.0299314422576739,-0.0873983479156511,0.0299329057344308,0.337109867355539
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AKR1B10,Aldo-keto reductase family 1 member B10,31356,0.0243158531431626,0.0253639354158535,-0.0253974602719104,0.0740291665582355,0.337751779334959
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CST1,Cystatin-SN,30548,0.0401821935530473,0.0419268506612931,-0.0419944337430872,0.122358820849182,0.337901751414275
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WASF1,Wiskott-Aldrich syndrome protein family member 1,32598,-0.0367400902764505,0.0383564865456179,-0.111918803905862,0.0384386233529606,0.338160568886194
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPTLC1,Serine palmitoyltransferase 1,31548,-0.0143893474184976,0.0150297722396321,-0.0438477010081765,0.0150690061711812,0.33840075775524
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),METAP1,Methionine aminopeptidase 1,32502,0.0120198548581077,0.0125566549415704,-0.0125911888273702,0.0366308985435856,0.338467987111371
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSNK1D,Casein kinase I isoform delta,31355,0.0256001598473994,0.0267607720562061,-0.0268509533827647,0.0780512730775634,0.338784848939565
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RETN,Resistin,32714,0.015762014224685,0.0164900999656925,-0.0165585817080724,0.0480826101574423,0.339175585155555
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GLP1R,Glucagon-like peptide 1 receptor,31342,0.0144641041594777,0.0151449437777458,-0.0152199856449041,0.0441481939638594,0.339585751200393
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LECT2,Leukocyte cell-derived chemotaxin-2,31571,-0.0256264304891347,0.0268401213607424,-0.0782330683561898,0.0269802073779204,0.339718527495642
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERI1,3'-5' exoribonuclease 1,31456,-0.0138999211318476,0.0145608494931789,-0.0424391861384783,0.014639343874783,0.339805731709647
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DKKL1,Dickkopf-like protein 1,32668,-0.0332326048938899,0.0348158388402934,-0.101471649020865,0.0350064392330851,0.33984391863488
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL36G,Interleukin-36 gamma,31330,0.0268691905126045,0.0281506787586891,-0.0283061398544261,0.0820445208796351,0.339872859965222
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRNN,Cornulin,32429,0.0255594677434823,0.0267810303489389,-0.0269313517404379,0.0780502872274025,0.339914695734975
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DBNL,Drebrin-like protein,32756,-0.036260439412597,0.0380033000655608,-0.110746907541096,0.0382260287159023,0.340039096305072
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOL1,Apolipoprotein L1,31586,-0.0244622006809961,0.0256412568110421,-0.0747190640306385,0.0257946626686464,0.34010477001055
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF19,Tumor necrosis factor receptor superfamily member 19,32794,0.0114093235571813,0.0119594931115982,-0.0120312829415512,0.0348499300559138,0.340110844375901
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,31356,-0.0210035127309093,0.0220279464930705,-0.0641782878573274,0.0221712623955089,0.340370627678196
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFNL1,Interferon lambda-1,32502,-0.0172424192092833,0.0180871517894182,-0.052693236716543,0.0182083982979765,0.340466506713639
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BTN2A1,Butyrophilin subfamily 2 member A1,32756,0.00938488305465472,0.00984671184719738,-0.00991467216585214,0.0286844382751616,0.34056622809116
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TDRKH,Tudor and KH domain-containing protein,32502,-0.0328783009671653,0.0345135773100164,-0.100524912494798,0.0347683105604669,0.340809621156537
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EHD3,EH domain-containing protein 3,31388,-0.0462421913166159,0.0486590246900647,-0.141613879709143,0.049129497075911,0.341974477864242
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL10RB,Interleukin-10 receptor subunit beta,32756,-0.0108415011339699,0.0114096383526221,-0.0332043923051093,0.0115213900371695,0.342033657091126
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PGLYRP1,Peptidoglycan recognition protein 1,32784,-0.0159786644704593,0.0168325749001127,-0.0489705112746801,0.0170131823337615,0.342508829217381
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL11,Eotaxin,32833,-0.0148903249374319,0.0156910139024301,-0.045644712186195,0.0158640623113312,0.342660666488397
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TGFB2,Transforming growth factor beta-2 proprotein,31548,0.0209928348047524,0.0221244152951197,-0.0223710191736821,0.064356688783187,0.342724816018281
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ID4,DNA-binding protein inhibitor ID-4,31456,-0.0176505687624869,0.0186252049042629,-0.0541559703748421,0.0188548328498683,0.343327055035184
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD3G,T-cell surface glycoprotein CD3 gamma chain,31355,-0.0331326437690588,0.034986802753079,-0.101706777165093,0.035441489626976,0.343667247411408
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD79B,B-cell antigen receptor complex-associated protein beta chain,32833,-0.0164236209348722,0.0173469582259601,-0.0504236590577539,0.0175764171880096,0.343780273586552
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNASET2,Ribonuclease T2,32787,-0.0099436247993429,0.0105063574649152,-0.0305360854305766,0.0106488358318908,0.34395041855228
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIRT2,NAD-dependent protein deacetylase sirtuin-2,32668,-0.0343512006115382,0.0363547390325334,-0.105606489115304,0.0369040878922272,0.344741359548055
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD74,HLA class II histocompatibility antigen gamma chain,32806,-0.013035405381723,0.0138014386654034,-0.0400862251659138,0.0140154144024677,0.344941686921308
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),THTPA,Thiamine-triphosphatase,31530,-0.0345585780900622,0.0366647257160836,-0.106421440493586,0.0373042843134617,0.34593744973687
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PMVK,Phosphomevalonate kinase,32489,-0.0426702816699194,0.045273957793523,-0.131407238945224,0.0460666756053857,0.345967883982127
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFSF12,Tumor necrosis factor ligand superfamily member 12,32833,0.0111946924153235,0.0118832540656852,-0.0120964855534195,0.0344858703840665,0.346189261520864
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCBP2,Poly(rC)-binding protein 2,31555,-0.0282381706042992,0.0299865274683986,-0.0870117644423604,0.0305354232337621,0.346378247133095
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VWA1,von Willebrand factor A domain-containing protein 1,32786,-0.0164727518418824,0.0174972209725766,-0.0507673049481326,0.0178218012643678,0.34649997896947
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,31388,0.0142062050236035,0.0150992418730983,-0.0153883090476691,0.0438007190948761,0.346809094844486
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TXNL1,Thioredoxin-like protein 1,31326,0.0384734322232786,0.0409366664489632,-0.0417624340166892,0.118709298463246,0.34733611249129
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD59,CD59 glycoprotein,32390,0.00790740350389198,0.0084146306715149,-0.00858527261227722,0.0244000796200612,0.34738739971881
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EFNA4,Ephrin-A4,32632,-0.010528506640776,0.0112218278489996,-0.0325232892248153,0.0114662759432633,0.34815887307082
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MCAM,Cell surface glycoprotein MUC18,32754,0.012458971019613,0.0132893328838346,-0.0135881214327027,0.0385060634719288,0.348518313346793
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),THOP1,Thimet oligopeptidase,32693,-0.0121868633994881,0.0130014965578019,-0.0376697966527797,0.0132960698538036,0.34860771475311
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AKR1C4,Aldo-keto reductase family 1 member C4,32598,0.0202431628799523,0.0216720720044008,-0.0222340982486734,0.0627204240085779,0.350295248309086
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RGL2,Ral guanine nucleotide dissociation stimulator-like 2,31456,0.0238402134500972,0.0255293827791292,-0.0261973767969961,0.0738778036971905,0.350419053127723
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TCOF1,Treacle protein,31571,-0.012273003753957,0.013163445773933,-0.0380733574708658,0.0135273499629517,0.3511823122607
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CGN,Cingulin,31356,-0.0145952144352863,0.0156674003209087,-0.0453033190642674,0.0161128901936948,0.351590961812724
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SH3GL3,Endophilin-A3,31408,-0.0322838666905215,0.0346776570306253,-0.100252074470547,0.0356843410895041,0.351898733015989
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BTLA,B- and T-lymphocyte attenuator,31326,-0.033933580477161,0.0364696317447709,-0.105414058696912,0.03754689774259,0.352162383393128
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MEGF11,Multiple epidermal growth factor-like domains protein 11,31313,0.0128379999472957,0.0137992959874635,-0.0142086201881328,0.0398846200827242,0.352226596611074
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",32596,0.0233065809722177,0.0250782992126399,-0.0258468854845564,0.0724600474289918,0.352732095124997
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CWC15,Spliceosome-associated protein CWC15 homolog,31520,-0.0244649965731064,0.0263282038935862,-0.0760682762045353,0.0271382830583226,0.352798403474121
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNN,Tenascin-N,31571,-0.0167028102914947,0.0179754067659857,-0.0519346075528268,0.0185289869698374,0.352812737213041
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MITD1,MIT domain-containing protein 1,32647,-0.0370826743903238,0.0399127233962408,-0.115311612246956,0.0411462634663081,0.352865861896352
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD69,Early activation antigen CD69,32686,-0.0336047017195725,0.0361785583854052,-0.104514676154967,0.0373052727158218,0.352988680344175
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SHISA5,Protein shisa-5,31571,-0.00892962305079439,0.00964178371629159,-0.0278275191347259,0.00996827303313712,0.354403211102157
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,31342,0.02490932768698,0.0269082524988478,-0.0278308472107617,0.0776495025847217,0.354624841754308
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BLMH,Bleomycin hydrolase,32834,-0.0120568668237369,0.0130266505828925,-0.0375891019662062,0.0134753683187324,0.354702765665196
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZCCHC8,Zinc finger CCHC domain-containing protein 8,31313,-0.0236112949243541,0.025513575787736,-0.0736179034683166,0.0263953136196084,0.354766812335483
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,31313,0.0182288077563794,0.0196983023749182,-0.0203798648984604,0.0568374804112191,0.354787874115458
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMBP,Protein AMBP,32785,0.00723822509781912,0.00782221825016523,-0.00809332267250474,0.022569772868143,0.354813188793281
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD109,CD109 antigen,32718,0.0126117327123583,0.0136377175957934,-0.0141181937753968,0.0393416592001135,0.355111489838876
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,31417,-0.0104987588199936,0.0113612807702987,-0.0327668691297791,0.011769351489792,0.355472956551455
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GTPBP2,GTP-binding protein 2,31356,-0.0310243350059402,0.0335839549237141,-0.0968488866564198,0.0348002166445394,0.355628292486015
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PER3,Period circadian protein homolog 3,31355,-0.0447615023387159,0.0484622340825073,-0.13974748114043,0.0502244764629983,0.35570518580179
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SRC,Proto-oncogene tyrosine-protein kinase Src,32701,-0.0458342414201766,0.0497496288206908,-0.143343513908731,0.0516750310683773,0.35691992095427
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",31326,-0.01977158035059,0.0214711742801237,-0.0618550819396325,0.0223119212384524,0.357162158461523
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGAL,Integrin alpha-L,31355,-0.0166056602763874,0.0180424188160366,-0.0519688011558191,0.0187574806030443,0.357410240610971
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMS,Spermine synthase,31342,0.0240000856347362,0.0260875414036914,-0.027131495516499,0.0751316667859713,0.357611481935039
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOA1,Apolipoprotein A-I,31598,-0.0104150820059367,0.0113323452474152,-0.0326264786908705,0.0117963146789971,0.358093908597715
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SULT2A1,Bile salt sulfotransferase,32728,-0.0214762318902039,0.0233683020405217,-0.0672781038896264,0.0243256401092187,0.358103505731263
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NBN,Nibrin,32596,-0.0203011490422238,0.022110860341287,-0.0636384353111463,0.0230361372266988,0.35856420652766
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,32794,0.00953374132230865,0.0103959775719898,-0.0108423747187914,0.0299098573634087,0.359135645613094
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BOLA1,BolA-like protein 1,31342,-0.0211640354058296,0.023079538888956,-0.0663999316281834,0.0240718608165241,0.359169965880183
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPTN,Neuroplastin,32526,-0.0321249710583848,0.0350716684400725,-0.100865441200927,0.0366154990841572,0.359702510728537
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DPP6,Dipeptidyl aminopeptidase-like protein 6,32668,0.0123669524268852,0.0135069138039151,-0.0141065986287883,0.0388405034825587,0.359900936705664
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,31555,-0.0120261676206348,0.0131389442680348,-0.0377784983859831,0.0137261631447134,0.360059168111872
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSMG4,Proteasome assembly chaperone 4,31355,0.0218202673056461,0.0238409535182857,-0.024908001590194,0.0685485362014861,0.36009348688872
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRTAP,Cartilage-associated protein,31356,0.0188880460399472,0.0206531623186221,-0.0215921521045521,0.0593682441844464,0.360465052879247
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",31388,-0.0265287783253567,0.0291044058902788,-0.0835734138703031,0.0305158572195897,0.362059138927382
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPC2,NPC intracellular cholesterol transporter 2,31451,-0.011174218747875,0.012261423008717,-0.0352066078449603,0.0128581703492103,0.362149770031235
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",31548,0.0202543854177645,0.0222364913135401,-0.0233291375567742,0.0638379083923032,0.36239639925205
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CERT,Ceramide transfer protein,32502,-0.0225425732039947,0.0248293173409284,-0.0712080351922143,0.026122888784225,0.363955607686396
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TLR2,Toll-like receptor 2,31456,0.0087924933074895,0.00968947730152565,-0.0101988822035008,0.0277838688184798,0.364209823129051
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AFAP1,Actin filament-associated protein 1,31417,-0.0324201992643574,0.0357329860286494,-0.10245685188051,0.0376164533517954,0.364282118697398
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEP85,Centrosomal protein of 85 kDa,32526,-0.0237956595106668,0.0262390317037483,-0.0752241616500134,0.0276328426286798,0.364495343929188
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCGB2A2,Mammaglobin-A,31313,-0.0113376882726775,0.0125201254701793,-0.0358771341942289,0.0132017576488739,0.365199607053673
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCTPP1,dCTP pyrophosphatase 1,32729,0.0117357053485334,0.0129604812335674,-0.0136668378692588,0.0371382485663256,0.365225582659185
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPM1F,Protein phosphatase 1F,31571,-0.0199859359424819,0.0220928003352657,-0.0632878245996026,0.0233159527146388,0.365686676906145
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RTN4R,Reticulon-4 receptor,32794,0.0122021846349403,0.0135103704565055,-0.0142781414598104,0.0386825107296909,0.366459110761307
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CST3,Cystatin-C,32737,-0.00972972126595507,0.0107730555522335,-0.0308449101483327,0.0113854676164226,0.366469016437288
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PGF,Placenta growth factor,32833,-0.00893022985414419,0.00989027056511105,-0.0283151601617619,0.0104547004534735,0.366586863829256
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,31154,-0.0406430626820527,0.0450408901984262,-0.128923207470968,0.0476370821068627,0.366895871432546
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),USP47,Ubiquitin carboxyl-terminal hydrolase 47,31313,0.0321609583982786,0.0356410925324317,-0.0376955829652874,0.102017499761845,0.366896877108629
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,32728,-0.0369843410437297,0.0409993464911649,-0.117343060166413,0.0433743780789535,0.367043399025159
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPM,Carboxypeptidase M,32764,-0.0127256082817781,0.0141073309744548,-0.0403759769917096,0.0149247604281534,0.367051304773695
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBM25,RNA-binding protein 25,31326,0.0174503502176157,0.0193662383537502,-0.0205074769557346,0.0554081773909661,0.367579787955258
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLB,Beta-klotho,32502,0.0272323895224672,0.0302358719045096,-0.0320299194103716,0.086494698455306,0.367791596915983
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",31370,0.0299196192460961,0.0332385666928392,-0.0352279714718687,0.0950672099640609,0.368070518785596
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KEL,Kell blood group glycoprotein,32502,0.0130250137951463,0.014481003098534,-0.0153577522779804,0.0414077798682731,0.368435299939031
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PXDNL,Peroxidasin-like protein,31548,-0.0212914579162598,0.0236791602201231,-0.0677026119477011,0.0251196961151815,0.368593259984546
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPINT1,Kunitz-type protease inhibitor 1,32687,-0.00922164698487807,0.0102577533364426,-0.0293268435243055,0.0108835495545494,0.368680987249916
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAXX,Protein PAXX,31417,-0.0174749872268595,0.0194445257898719,-0.0555862577750085,0.0206362833212895,0.368835852271017
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LYPLA2,Acyl-protein thioesterase 2,31342,-0.0395170842235927,0.0439755750319693,-0.125709211286253,0.0466750428390672,0.368887012007873
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SORBS1,Sorbin and SH3 domain-containing protein 1,31555,-0.0136022815451915,0.0151450697029781,-0.0432866181630286,0.0160820550726455,0.369142935981433
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRACR2A,EF-hand calcium-binding domain-containing protein 4B,32526,-0.0317522515448614,0.035360873884942,-0.101059564359348,0.0375550612696251,0.369237833647458
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLG,Plasminogen,31399,-0.00820329927665301,0.00914864136139023,-0.0261346363449779,0.00972803779167184,0.369924421180131
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMAD3,Mothers against decapentaplegic homolog 3,31548,-0.0191408916436374,0.0213563443295289,-0.060999326529514,0.0227175432422392,0.370140617405381
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNXB,Tenascin-X,32718,-0.0094567398216855,0.0105570337907094,-0.030148526051476,0.011235046408105,0.370396634334666
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDCL2,Phosducin-like protein 2,31326,0.020069380224343,0.0224310267277965,-0.0238954321621381,0.0640341926108241,0.370968201669868
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GYS1,"Glycogen [starch] synthase, muscle",32598,-0.0335931121695924,0.03756003384076,-0.107210778497482,0.0400245541582972,0.371140835478387
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMPD1,Sphingomyelin phosphodiesterase,32762,-0.0179586880603202,0.0200856453081994,-0.057326552864391,0.0214091767437506,0.371289562309369
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FUOM,Fucose mutarotase,31417,-0.0234397832750693,0.0262470095668183,-0.0748839220260331,0.0280043554758945,0.371861050435034
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,32526,-0.0213788606219641,0.0239428111354657,-0.0683067704474769,0.0255490492035487,0.371928261307795
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA2,Carbonic anhydrase 2,32696,0.0254710658763064,0.0285374542445494,-0.0304623444430104,0.0814044761956232,0.372123242073312
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),REG4,Regenerating islet-derived protein 4,32721,-0.0170578717795131,0.0191121490274743,-0.0545176838733627,0.0204019403143365,0.372141414809016
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,32491,-0.0164330694991926,0.018421334230197,-0.0525388845903788,0.0196727455919936,0.372381741016384
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK8,Kallikrein-8,32399,-0.0128153329418655,0.0143660262385686,-0.0409727443694599,0.015342078485729,0.372386821131727
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VPS53,Vacuolar protein sorting-associated protein 53 homolog,32668,-0.0281858867194493,0.0315965444748355,-0.0901151138901269,0.0337433404512283,0.372387292134196
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CAPN3,Calpain-3,31548,-0.0138779625426736,0.0155576195237449,-0.0443708968092136,0.0166149717238665,0.372401353252726
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTX3,Pentraxin-related protein PTX3,32728,0.0182503760268424,0.0204752122334932,-0.0218810399508043,0.0583817920044891,0.372770969221269
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIGLEC6,Sialic acid-binding Ig-like lectin 6,32794,-0.0119421666173998,0.0134079619733286,-0.0382217720851238,0.0143374388503242,0.37312633093917
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANXA10,Annexin A10,32502,0.0285599901644531,0.0320672080336906,-0.0342917375815805,0.0914117179104866,0.373152950287719
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGSF8,Immunoglobulin superfamily member 8,32729,-0.0111682890689263,0.0125411024092237,-0.0357488497910049,0.0134122716531522,0.373202906845612
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,31598,-0.00713982123265199,0.00803358416142464,-0.0228856461890443,0.00860600372374031,0.374166864981776
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),B2M,Beta-2-microglobulin,31598,-0.0118993847202669,0.0133905542257528,-0.0381448710027424,0.0143461015622086,0.374224104105293
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TARBP2,RISC-loading complex subunit TARBP2,32502,-0.0286918001216797,0.0322975618896707,-0.0919950214254344,0.034611421182075,0.374372890652607
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GRK5,G protein-coupled receptor kinase 5,32598,-0.019169108622729,0.0215985769698403,-0.0615023194836159,0.0231641022381579,0.374824936048257
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DHPS,Deoxyhypusine synthase,31548,-0.0155007082654318,0.0174949927207946,-0.0497908939981893,0.0187894774673256,0.375640781945095
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,32733,-0.0229959068177849,0.0259656546990134,-0.0738885900278513,0.0278967763922814,0.375842101612559
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACP6,Lysophosphatidic acid phosphatase type 6,32786,-0.0239390597338489,0.0270389928551877,-0.0769354857300167,0.0290573662623189,0.375989996930758
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF21,Fibroblast growth factor 21,32786,-0.0434610816782759,0.0491365422675131,-0.139768704522602,0.0528465411660497,0.376452272458239
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MFGE8,Lactadherin,32718,-0.015946164981086,0.0180506427588492,-0.0513254247884305,0.0194330948262584,0.377037368264945
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),QPCT,Glutaminyl-peptide cyclotransferase,32732,-0.00941317416473319,0.0106673954095904,-0.0303212691675303,0.011494920838064,0.377571041790343
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FAM13A,Protein FAM13A,31560,-0.0250766399165411,0.0284504105537076,-0.0808394446018079,0.0306861647687257,0.378120348546698
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NMI,N-myc-interactor,31513,-0.0260868425509055,0.0296115607064441,-0.0841255015355359,0.0319518164337249,0.378362711637353
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CBS,Cystathionine beta-synthase,31388,-0.0189681244708354,0.0215387981183027,-0.0611841687827086,0.0232479198410378,0.378535855349595
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MEP1B,Meprin A subunit beta,32729,0.0414764746931506,0.0471094205800546,-0.0508579896437565,0.133810939030058,0.378651099866161
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTRC,Chymotrypsin-C,32707,0.0219834055756481,0.0250012686774793,-0.0270190810322113,0.0709858921835076,0.379267070042192
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CIAPIN1,Anamorsin,32720,-0.0228705991301291,0.026040006210263,-0.0739090113022447,0.0281678130419864,0.379811801423375
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PON3,Serum paraoxonase/lactonase 3,32756,0.0101954592260243,0.0116123041252474,-0.0125646568594605,0.0329555753115092,0.379974150189097
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOA2,Apolipoprotein A-II,31586,-0.0173382214270283,0.0197514842661732,-0.0560511305887278,0.0213746877346712,0.380069433290423
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD34,Hematopoietic progenitor cell antigen CD34,32771,-0.00863598341888451,0.00984626602256174,-0.0279346648231055,0.0106626979853365,0.380465705469442
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DUSP13,Dual specificity protein phosphatase 13 isoform A,31548,-0.0151222440862285,0.0172468591402944,-0.0489260880012056,0.0186815998287485,0.380616439218215
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINB6,Serpin B6,32773,-0.021800055435469,0.0248806125457899,-0.0705660560252172,0.0269659451542792,0.380952297429606
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GSTA3,Glutathione S-transferase A3,32526,-0.0277254445273274,0.0316489767811809,-0.089757439018442,0.0343065499637872,0.381038153688135
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ESAM,Endothelial cell-selective adhesion molecule,32834,0.0110674858832967,0.0126342435943462,-0.0136956315616219,0.0358306033282152,0.381058278198552
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VSTM2B,V-set and transmembrane domain-containing protein 2B,31456,0.0160562862749461,0.0183300705299503,-0.0198706519637565,0.0519832245136487,0.381083105513971
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLA2G7,Platelet-activating factor acetylhydrolase,32718,-0.0110320033955493,0.0125963315846715,-0.0357208133015056,0.0136568065104069,0.381156639339157
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCR,Breakpoint cluster region protein,32728,-0.032583600366793,0.0372811517587701,-0.105654657813982,0.0404874570803964,0.382143765458471
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMPRSS5,Transmembrane protease serine 5,32599,0.0134206092908117,0.0153773334933467,-0.0167189643561479,0.0435601829377713,0.382821866195941
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LSM8,U6 snRNA-associated Sm-like protein LSm8,31456,-0.0311077386164683,0.0356507422205247,-0.100983193368697,0.0387677161357602,0.382925530469646
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CYTH3,Cytohesin-3,31326,0.0270270024363825,0.0309929109311387,-0.0337191029886494,0.0877731078614143,0.383215577246418
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCN3A,Sodium channel protein type 3 subunit alpha,31356,-0.0139028547486025,0.0159526352966367,-0.0451700199300104,0.0173643104328054,0.383504563676539
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL10,Interleukin-10,32596,0.0290194612828886,0.0333145849199916,-0.036277125160295,0.0943160477260721,0.383737807902176
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",31388,-0.0245450717895733,0.0281826440643409,-0.0797830541556814,0.0306929105765348,0.383820891277514
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRISP2,Cysteine-rich secretory protein 2,32794,0.020113106309422,0.023099054899773,-0.0251610412941331,0.0653872539129771,0.383923423593019
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KRT8,"Keratin, type II cytoskeletal 8",31342,-0.023320435321678,0.0267895347853788,-0.0758279235010204,0.0291870528576645,0.384052184383121
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD2AP,CD2-associated protein,32729,-0.0226091024433855,0.0260346639845058,-0.073637043853017,0.0284188389662459,0.385186275958439
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,31326,-0.0220923479065959,0.025443773137508,-0.0719621432561114,0.0277774474429197,0.385268362281377
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDH15,Cadherin-15,32795,0.0185744905110452,0.0213937219779231,-0.023357204565684,0.0605061855877745,0.385296376139345
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NDRG1,Protein NDRG1,32502,-0.0248732095825934,0.0286577245926553,-0.0810423497841979,0.0312959306190111,0.385450819890518
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AGR3,Anterior gradient protein 3,32512,-0.0206379903060066,0.0237836240720747,-0.0672538934872729,0.0259779128752598,0.385561017483177
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KCNIP4,Kv channel-interacting protein 4,32502,0.0180884435328736,0.0208494800264998,-0.022776537319066,0.0589534243848131,0.385652284831049
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF9,Fibroblast growth factor 9,31311,-0.0146459438858544,0.0168874626753956,-0.0477453707296298,0.018453482957921,0.385823506551577
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRTG,Protogenin,32794,0.00881210869661827,0.0101636086272628,-0.0111085642128169,0.0287327816060534,0.385951278026704
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDX58,Antiviral innate immune response receptor RIG-I,32526,-0.0210601172965823,0.0243227079252123,-0.0687326248299984,0.0266123902368338,0.38658961637231
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENO1,Alpha-enolase,32708,-0.0279976129665115,0.0323447076751284,-0.0913932400097632,0.0353980140767401,0.386732448007617
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DPP7,Dipeptidyl peptidase 2,32658,-0.0216776402038472,0.0250760192760517,-0.0708266379849085,0.027471357577214,0.387349515812473
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TYRO3,Tyrosine-protein kinase receptor TYRO3,32729,-0.00994898684842112,0.0115209718664329,-0.0325300917066296,0.0126321180097873,0.387856032412092
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",31355,0.0165433183267142,0.0191740138403528,-0.0210377488003772,0.0541243854538056,0.388275642386257
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",32598,-0.0317307483941891,0.0367931009374515,-0.103845226231594,0.0403837294432159,0.388485454339916
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,31456,-0.0244145281790039,0.0283801752422343,-0.0800396716537831,0.0312106152957752,0.389669030459095
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SELENOP,Selenoprotein P,31598,-0.00799982999155172,0.00930815694175633,-0.0262438175973941,0.0102441576142907,0.390122798530245
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MFAP5,Microfibrillar-associated protein 5,32834,0.0138592719259905,0.0161391448721344,-0.017773452023393,0.045491995875374,0.390508873483649
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ASGR1,Asialoglycoprotein receptor 1,32647,-0.0102213485008612,0.0119089310322627,-0.0335628533240961,0.0131201563223737,0.390754273305524
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TACC3,Transforming acidic coiled-coil-containing protein 3,32668,-0.0413427905221822,0.0481828948018888,-0.135781264333884,0.0530956832895199,0.390894417380161
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CASP3,Caspase-3,32834,-0.0311521959505901,0.0363116097896396,-0.102322951138284,0.0400185592371035,0.390963510258836
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GAGE2A,G antigen 2A,31326,0.0217069692249787,0.0253073526077982,-0.0278954418863058,0.0713093803362632,0.391067058995971
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GDF2,Growth/differentiation factor 2,32729,-0.0123777632510967,0.0144359990392951,-0.040672321368115,0.0159167948659217,0.39123410472678
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,32728,-0.0355737716657248,0.041515667727573,-0.116944480411768,0.0457969370803184,0.391536673826758
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAPPA,Pappalysin-1,32596,-0.0164657556169837,0.0192173744372827,-0.0541318095140578,0.0212002982800903,0.391570034573435
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTTG1,Securin,31456,-0.0153157761874632,0.0178765134025371,-0.0503537424564359,0.0197221900815094,0.391607823726019
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SETMAR,Histone-lysine N-methyltransferase SETMAR,32618,-0.0108030382944897,0.0126300595150644,-0.0355579549440159,0.0139518783550365,0.392384455377636
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,31548,-0.0383373416166131,0.0448248420595546,-0.12619403205334,0.049519348820114,0.392428357033069
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,32526,-0.0171058182578038,0.020001158326192,-0.0563080885771402,0.0220964520615325,0.392441175846308
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL4,C-C motif chemokine 4,32725,-0.0217369676924083,0.0254510344151668,-0.0716209951461352,0.0281470597613186,0.393089223398673
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,31456,-0.0292119080411955,0.0342046001723384,-0.0962529243789787,0.0378291082965877,0.393112814905334
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMED10,Transmembrane emp24 domain-containing protein 10,31313,0.0178553057530504,0.0209501317559166,-0.0232069524885461,0.0589175639946469,0.394088010646338
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MATN2,Matrilin-2,32721,-0.0103574830602223,0.0121604197030373,-0.0341919056781753,0.0134769395577307,0.394382930430009
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAMA4,Laminin subunit alpha-4,32756,-0.0117346029648177,0.0137797613104458,-0.0387429351332916,0.0152737292036561,0.394468803623568
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TG,Thyroglobulin,31548,0.038093971069087,0.0447452351421881,-0.0496066898096016,0.125794631947776,0.394600045239073
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BAG3,BAG family molecular chaperone regulator 3,32632,0.0134650789311915,0.0158165345301868,-0.0175353287479745,0.0444654866103575,0.394609704097124
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRHBP,Corticotropin-releasing factor-binding protein,32702,-0.00982129211717946,0.0115503563124631,-0.0324599904896072,0.0128174062552482,0.395180178658709
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",32728,-0.0338633779807056,0.0398339293370009,-0.111937879481227,0.0442111235198162,0.39528470175952
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MTUS1,Microtubule-associated tumor suppressor 1,31456,-0.0198310489051608,0.0233417479107354,-0.0655808748102021,0.0259187769998805,0.3955766732105
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RILPL2,RILP-like protein 2,31571,-0.0347626474699373,0.0409281985045888,-0.114981916538931,0.0454566215990568,0.39570910078896
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DARS1,"Aspartate--tRNA ligase, cytoplasmic",32636,-0.0252768908680718,0.0297627314633427,-0.0836118445362234,0.0330580628000799,0.395748704897132
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",32668,-0.0338463691120006,0.0398611082551951,-0.111974141292183,0.0442814030681819,0.395844510311911
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTGDS,Prostaglandin-H2 D-isomerase,32656,0.00975513064699284,0.011491778862813,-0.0127687559241205,0.0322790172181062,0.395971682910776
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ABRAXAS2,BRISC complex subunit Abraxas 2,31313,-0.0238642193541398,0.0281157351955827,-0.0789710603374818,0.0312426216292023,0.396028098568265
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL12,Stromal cell-derived factor 1,32596,-0.0140936886262945,0.016618149126402,-0.0466652609140425,0.0184778836614535,0.396411001065566
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDLIM7,PDZ and LIM domain protein 7,32756,-0.0440952500053534,0.0520312764118085,-0.146076551772498,0.0578860517617913,0.396752743790336
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNASE6,Ribonuclease K6,31531,-0.00967319852561072,0.0114221578683971,-0.032060627947669,0.0127142308964476,0.397088358780689
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATF4,Cyclic AMP-dependent transcription factor ATF-4,31326,-0.0116678001858401,0.0137800727570336,-0.0386767427896259,0.0153411424179457,0.397180896657746
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CMIP,C-Maf-inducing protein,31548,-0.0293219270706594,0.0346456258593849,-0.0972273537550538,0.0385834996137351,0.39739027729675
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STK11,Serine/threonine-protein kinase STK11,32598,-0.025282368675533,0.0299114765486461,-0.0839088627108793,0.0333441253598133,0.398000141162686
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CASP2,Caspase-2,32728,-0.0234814150137309,0.0277841482394464,-0.0779383455630459,0.0309755155355841,0.398057086073974
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL15A1,Collagen alpha-1(XV) chain,31571,-0.00871818094838518,0.0103191693287026,-0.0289437528326423,0.011507390935872,0.398219142318832
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIMP3,Metalloproteinase inhibitor 3,32756,-0.0451701649942345,0.053471771638924,-0.149974837406525,0.0596345074180565,0.398274345275349
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENAH,Protein enabled homolog,32596,0.0162372659443565,0.0192310789007101,-0.0214556487010354,0.0539301805897483,0.398511368435859
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RELB,Transcription factor RelB,31355,0.0176050488313882,0.0208651360753828,-0.023290617876362,0.0585007155391385,0.398833630898019
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RABEP1,Rab GTPase-binding effector protein 1,31417,-0.0272276865240568,0.0322809792261501,-0.090498405807311,0.0360430327591974,0.398998412881459
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),S100G,Protein S100-G,31555,0.0159997096130055,0.0189841381272714,-0.0212092011164464,0.0532086203424574,0.399370097446074
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSMD1,26S proteasome non-ATPase regulatory subunit 1,31555,-0.0172181408263728,0.020430060698396,-0.057261059795229,0.0228247781424834,0.399375108683747
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ELAC1,Zinc phosphodiesterase ELAC protein 1,31555,-0.0296531975959286,0.0351878899548718,-0.0986214619074773,0.0393150667156202,0.399416672310688
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SOST,Sclerostin,32719,-0.0132895443936146,0.0157807037040608,-0.0442197236535738,0.0176406348663445,0.399732944861885
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DOK1,Docking protein 1,31548,-0.0475633666117333,0.056508100110402,-0.158319242828121,0.0631925096046546,0.399977137344921
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ALDH1A1,Retinal dehydrogenase 1,32718,0.0186466848796589,0.0221603298734639,-0.0247875616723302,0.0620809314316481,0.400121750463534
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNAP23,Synaptosomal-associated protein 23,32729,-0.0299713204964977,0.0356499306424292,-0.0998451845556588,0.0399025435626635,0.4005320235238
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUDT5,ADP-sugar pyrophosphatase,32718,-0.0179258442098258,0.0213384421091719,-0.0597491907438027,0.0238975023241511,0.40089025870922
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,32780,0.0102044860908433,0.0121562828426748,-0.0136218282807992,0.0340308004624859,0.401244202772992
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIL1,Nucleotide exchange factor SIL1,31388,-0.0117466578259374,0.0140152012552419,-0.0392164522862115,0.0157231366343368,0.401980410997991
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",31355,0.0209068199132464,0.0249571036633562,-0.0280091032669319,0.0698227430934246,0.402220203914627
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DPP10,Inactive dipeptidyl peptidase 10,32728,-0.0116787700532534,0.0139527078771863,-0.0390260774925386,0.0156685373860318,0.402600880097054
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAMP2,Lysosome-associated membrane glycoprotein 2,32444,-0.00670268951642497,0.0080090181843151,-0.0224003651576826,0.00899498612483263,0.402676134995806
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPR,Nucleoprotein TPR,31313,-0.0173315786358602,0.0207393095410662,-0.0579806253363499,0.0233174680646296,0.403357602913611
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLEKHO1,Pleckstrin homology domain-containing family O member 1,31548,-0.0241239687811159,0.0289182913840934,-0.0808038198939389,0.0325558823317071,0.404187778667699
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIGLEC15,Sialic acid-binding Ig-like lectin 15,32502,-0.027405168482345,0.0328519873089695,-0.0917950636079252,0.0369847266432352,0.404190651202386
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GKN1,Gastrokine-1,32330,0.00937369850793265,0.0112439540786971,-0.0126644514863136,0.0314118485021789,0.404492917457068
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,32526,-0.0262040436396943,0.0314364961934804,-0.0878195761789159,0.0354114888995273,0.40455485484767
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHRDL2,Chordin-like protein 2,32729,0.0192425864400697,0.0231087950641646,-0.0260506518856928,0.0645358247658323,0.405038983457919
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCRL3,Fc receptor-like protein 3,32596,-0.0179322699948834,0.0215601015987451,-0.0601900691284237,0.0243255291386569,0.4055818265431
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP6AP2,Renin receptor,32526,-0.0135898212391166,0.0163438758300675,-0.0456238178660489,0.0184441753878157,0.405717990760258
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NTF3,Neurotrophin-3,32728,-0.0116246679432285,0.0140100553337359,-0.0390843763973509,0.0158350405108939,0.406709562925029
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MSR1,Macrophage scavenger receptor types I and II,32806,-0.0153025549810052,0.0184429078583899,-0.0514506543834495,0.020845544421439,0.406716016345832
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINF2,Alpha-2-antiplasmin,31462,-0.00467915468620304,0.00565185533549228,-0.0157567911437679,0.00639848177136183,0.407754761847791
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GC,Vitamin D-binding protein,31598,0.00889877976092805,0.0107616018967946,-0.0121939599567895,0.0299915194786456,0.408318653431637
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DXO,Decapping and exoribonuclease protein,31548,-0.0156350280485788,0.0189773539934998,-0.0528306418758385,0.0215605857786808,0.41003433171893
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL3,Interleukin-3,31326,0.0208602713862108,0.0253211876133589,-0.0287692563359725,0.0704897991083942,0.410064328288705
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAMP1,Lysosome-associated membrane glycoprotein 1,31365,-0.00910768329827411,0.0110636325028264,-0.0307924030038139,0.0125770364072657,0.41041523374089
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,32739,-0.0257817352618577,0.0313233466332412,-0.0871754946630104,0.035612024139295,0.410482516757589
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),XRCC4,DNA repair protein XRCC4,32502,-0.0125613624069962,0.0152716270726727,-0.0424937514694347,0.0173710266554422,0.410798349440682
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TOP1MT,"DNA topoisomerase I, mitochondrial",31326,-0.0163090011711107,0.0198326483234223,-0.0551809918850184,0.022562989542797,0.410914809722651
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TBC1D5,TBC1 domain family member 5,32728,-0.0264640576109707,0.0321938186646404,-0.0895639421936659,0.0366358269717246,0.411085938818896
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPRING1,SREBP regulating gene protein,31326,0.0207814427848337,0.0253015539173553,-0.0288096028931826,0.07037248846285,0.411472902815602
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDC37,Hsp90 co-chaperone Cdc37,32720,-0.0282973004667048,0.0345400127479066,-0.0959957254526017,0.039401124519192,0.412659305672489
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,31355,-0.0272495333152597,0.0332735750232585,-0.0924657403608464,0.037966673730327,0.412838595112307
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJB6,DnaJ homolog subfamily B member 6,31349,-0.0288592092083879,0.0352959301946784,-0.0980392323899575,0.0403208139731817,0.413591302628755
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RTBDN,Retbindin,32668,0.0095965156078596,0.0117505832644609,-0.0134346275904837,0.0326276588062029,0.414131014379847
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADGRG1,Adhesion G-protein coupled receptor G1,32668,-0.0183081858678734,0.0224275395821416,-0.062266163448871,0.0256497917131242,0.414335728246708
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ISM1,Isthmin-1,32728,0.0132017585655944,0.0161808871484636,-0.0185127802453943,0.0449162973765831,0.414587279314047
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NECTIN2,Nectin-2,32719,0.00932150259983871,0.0114406886225527,-0.0131022471003645,0.0317452523000419,0.415227242570529
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OPLAH,5-oxoprolinase,31388,0.0233370018602816,0.0286788565640869,-0.0328735570053288,0.079547560725892,0.415822265956413
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEBPA,CCAAT/enhancer-binding protein alpha,31355,0.0125656821416393,0.0154456241072014,-0.0177077411084754,0.042839105391754,0.415932543787919
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MGLL,Monoglyceride lipase,32739,-0.0291812793963983,0.0359185081339469,-0.0995815553389341,0.0412189965461376,0.416566626030764
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HTR1A,5-hydroxytryptamine receptor 1A,31342,-0.0254908383249087,0.0313772900013478,-0.0869903267275503,0.036008650077733,0.416589310760675
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CST6,Cystatin-M,32482,0.0154635296181504,0.0190371622109793,-0.0218493083153691,0.0527763675516699,0.416652701799582
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMPRSS11B,Transmembrane protease serine 11B,31342,-0.0255733917919767,0.0315522191202837,-0.0874157412677327,0.0362689576837793,0.417672850103518
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNASE4,Ribonuclease 4,31319,-0.00889212760962134,0.0109923666721071,-0.0304371662869512,0.0126529110677085,0.418577422161441
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GFRA2,GDNF family receptor alpha-2,32668,0.00682959650693975,0.00844287291505936,-0.00971843440657659,0.0233776274204561,0.418583847886776
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FABP9,Fatty acid-binding protein 9,32728,0.0183742363434644,0.0227223176403891,-0.0261615062316981,0.062909978918627,0.418742387552303
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MINK1,Misshapen-like kinase 1,31548,-0.030969012639899,0.0383059390202028,-0.106048653119497,0.0441106278396984,0.418847937912471
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNTN5,Contactin-5,32736,-0.0118987028694142,0.0147194950921915,-0.0407489132501094,0.0169515075112811,0.418903010549475
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RWDD1,RWD domain-containing protein 1,32806,-0.0210980595500177,0.0261035621091092,-0.0722610412838719,0.0300649221838364,0.418971357880309
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PNMA1,Paraneoplastic antigen Ma1,31388,-0.0193741848584985,0.0239847661856011,-0.0663843265822767,0.0276359568652797,0.419248274316455
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),XG,Glycoprotein Xg,32789,-0.00989583253069285,0.0122547299263062,-0.0339151031862531,0.0141234381248674,0.419393494359513
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYH7B,Myosin-7B,31326,-0.0144197769625924,0.0178679608057095,-0.0494409801417831,0.0206014262165982,0.419681466670805
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LGALS3,Galectin-3,32752,0.00985487889655892,0.0122321197062428,-0.0141200757276769,0.0338298335207947,0.420462851826645
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DGKA,Diacylglycerol kinase alpha,31355,-0.0182607071789253,0.0226700573675081,-0.0626940196192412,0.0261726052613907,0.420557371014771
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFT20,Intraflagellar transport protein 20 homolog,31356,0.0147254320768325,0.0183086573043751,-0.0211595362397427,0.0506104003934077,0.421256213093876
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPINT2,Kunitz-type protease inhibitor 2,32756,-0.0134487559876886,0.0167231599882817,-0.0462261495647207,0.0193286375893436,0.421303288541165
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMED1,Transmembrane emp24 domain-containing protein 1,31456,-0.0184018435903577,0.0228920662117985,-0.0632702933654828,0.0264666061847674,0.4215073469808
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MICALL2,MICAL-like protein 2,31356,-0.0230095444761321,0.0286659372565556,-0.0791947814989811,0.0331756925467169,0.422185769484786
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAT2,Linker for activation of T-cells family member 2,32668,-0.0411288960310415,0.0512944136949882,-0.141665946873218,0.0594081548111354,0.422678614576133
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VEGFA,Vascular endothelial growth factor A,32801,-0.0188200004517994,0.0234793473179569,-0.0648395211949948,0.0271995202913961,0.42283141722878
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PON1,Serum paraoxonase/arylesterase 1,31586,-0.00860172075439931,0.0107334712158214,-0.0296393243374092,0.0124358828286106,0.422929239916322
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GATA3,Trans-acting T-cell-specific transcription factor GATA-3,31326,-0.0090643267677686,0.0113158586945742,-0.0312434098091341,0.0131147562735968,0.423140562925944
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNCA,Alpha-synuclein,31417,-0.0380852168787618,0.0475843784071036,-0.131350598556685,0.0551801647991612,0.423520303233574
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEP164,Centrosomal protein of 164 kDa,32596,0.0202415143628693,0.0252974818446252,-0.0293415500525961,0.0698245787783346,0.423651737484995
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,32718,-0.0115228159324096,0.0144241559501391,-0.0397941615946822,0.016748529729863,0.424395638246092
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGB1BP2,Integrin beta-1-binding protein 2,32598,-0.0369177172053679,0.0462656188196837,-0.127598330091948,0.0537628956812121,0.424920354291634
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FZD8,Frizzled-8,31342,-0.013795512691896,0.0172890719859823,-0.0476820937844213,0.0200910684006293,0.424934977088539
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFAIP8,Tumor necrosis factor alpha-induced protein 8,32596,-0.0119167617289648,0.014938785607512,-0.0411967815196883,0.0173632580617588,0.425062693440612
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AHNAK,Neuroblast differentiation-associated protein AHNAK,31388,0.0106928611935369,0.0134075313897959,-0.0155859003304631,0.0369716227175369,0.425170489895126
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,31548,-0.0277142321314333,0.0347559370946516,-0.0958358688369505,0.040407404574084,0.425245926468277
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DYNLT3,Dynein light chain Tctex-type 3,31548,-0.0145538156727689,0.0182523488012551,-0.0503284193232289,0.0212207879776911,0.42526270111366
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLRB1,Killer cell lectin-like receptor subfamily B member 1,32833,-0.0116049459960798,0.0145880387257397,-0.0401975018985295,0.0169876099063699,0.426337328853203
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINA7,Thyroxine-binding globulin,31598,0.00611080135145053,0.00768504268966112,-0.00895188232028527,0.0211734850231863,0.426547639964448
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPN9,Tyrosine-protein phosphatase non-receptor type 9,31335,0.0127488914963869,0.0160401934165482,-0.0186898876000475,0.0441876705928214,0.426749798035339
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CREBZF,CREB/ATF bZIP transcription factor,31326,-0.00884981824810404,0.011144446391803,-0.0306929331760378,0.0129932966798298,0.427161758222735
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCS,Copper chaperone for superoxide dismutase,32647,0.0155454081088692,0.0195820848930235,-0.0228354782814569,0.0539262944991952,0.427299142731755
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,31598,-0.00856849664109939,0.0108034234865276,-0.0297432066746934,0.0126062133924946,0.42772762360471
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SAMD9L,Sterile alpha motif domain-containing protein 9-like,32728,-0.0237705157819221,0.0300082735229885,-0.0825867318869796,0.0350457003231353,0.428304861665647
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FAM3C,Protein FAM3C,32719,0.00919649070720957,0.0116195723744691,-0.0135778711467498,0.031970852561169,0.42869358806463
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJC9,DnaJ homolog subfamily C member 9,31560,-0.0254459070157996,0.0321643331458739,-0.0884879999817124,0.0375961859501132,0.428897251806278
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PGD,"6-phosphogluconate dehydrogenase, decarboxylating",31571,-0.0176094560709264,0.0222654288358627,-0.0612496965892172,0.0260307844473644,0.429033791087196
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FLT4,Vascular endothelial growth factor receptor 3,32720,0.0111458216474132,0.0141021709848177,-0.0164944334828295,0.0387860767776558,0.429337475759907
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL8,C-C motif chemokine 8,32785,-0.0198320283133598,0.0251118172828637,-0.0690511901877727,0.0293871335610531,0.429695448967667
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNASEH2A,Ribonuclease H2 subunit A,31555,0.0167252549299958,0.021178237039917,-0.0247840896682414,0.0582345995282331,0.429705228328431
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",32526,-0.0258332406374363,0.0327395872306286,-0.0900028316094684,0.0383363503345959,0.430103131991807
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEZ6,Seizure protein 6 homolog,31356,-0.00996062141388772,0.0126252321380886,-0.0347060764045413,0.0147848335767659,0.430168750374724
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),THBD,Thrombomodulin,32729,0.00865996597784596,0.01097881452456,-0.0128585104902916,0.0301784424459835,0.430256538199185
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGFR2,Fibroblast growth factor receptor 2,32720,-0.0069888494970065,0.00886448555295674,-0.0243632411808017,0.0103855421867887,0.43047798792225
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEZ6L2,Seizure 6-like protein 2,32668,-0.00754166303979305,0.00957472128217785,-0.0263081167528616,0.0112247906732755,0.430914477271052
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANGPTL4,Angiopoietin-related protein 4,32739,-0.0145745964169773,0.0185053070131637,-0.0508449981627782,0.0216958053288235,0.430957536667425
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MB,Myoglobin,32834,0.0165673573304422,0.0210760187163833,-0.024741639353669,0.0578763540145534,0.43184358433686
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DOK2,Docking protein 2,32729,-0.039735096159144,0.0505862511256026,-0.138884148365325,0.0594139560470371,0.432186135127873
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,31560,-0.00988833768616899,0.0126044576162184,-0.0345930746139571,0.0148163992416191,0.432764369098764
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTGES2,Prostaglandin E synthase 2,31298,-0.0179972375132763,0.0229735796851827,-0.0630254536962344,0.0270309786696817,0.433423965964437
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEC31A,Protein transport protein Sec31A,31388,-0.0251030500670433,0.032058414916331,-0.087937543303052,0.0377314431689655,0.4336277269345
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RICTOR,Rapamycin-insensitive companion of mTOR,31355,-0.015725605122946,0.0200998652997876,-0.0551213411105297,0.0236701308646376,0.43401972710713
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLAUR,Urokinase plasminogen activator surface receptor,32641,-0.00859839684578049,0.0109997628526883,-0.0301579320370495,0.0129611383454885,0.434418271318561
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNPY4,Protein canopy homolog 4,32668,-0.0243779758406206,0.0311915026446732,-0.08551332102418,0.0367573693429388,0.434495245262588
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,31313,-0.00663727441133604,0.00849567275676687,-0.0232887930145991,0.010014244191927,0.434678204997705
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSF1R,Macrophage colony-stimulating factor 1 receptor,31586,-0.0130174754938078,0.0166940307668943,-0.0457377757969207,0.0197028248093051,0.43555117190399
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDSN,Corneodesmosin,32810,0.0135453179108543,0.0174290410261746,-0.0206156025004479,0.0477062383221566,0.437079354910503
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CFH,Complement factor H,31153,-0.0075662826928901,0.00974417622567257,-0.0266648680952083,0.0115323027094281,0.43748325162972
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,31456,-0.0344842484508602,0.0444346270033417,-0.12157611737741,0.0526076204756894,0.437733579048672
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PQBP1,Polyglutamine-binding protein 1,32526,-0.0180459844780509,0.0232651609697849,-0.0636456999788293,0.0275537310227274,0.437967636912974
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AHCY,Adenosylhomocysteinase,32729,-0.0213901825081123,0.0275982204944239,-0.0754826946771831,0.0327023296609585,0.438326887795646
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",31388,-0.0118494725678101,0.0152909939980965,-0.0418198208040792,0.018120875668459,0.438404490435973
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BACH1,Transcription regulator protein BACH1,32728,-0.0233024938508632,0.030100675816597,-0.0822998184513933,0.0356948307496668,0.438861636663555
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SAP18,Histone deacetylase complex subunit SAP18,31456,-0.0240042657831203,0.0310111273598512,-0.0847860754084286,0.036777543842188,0.438923356597588
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VAMP5,Vesicle-associated membrane protein 5,32598,-0.0170709816675169,0.0220740276882025,-0.0603360759363938,0.0261941126013599,0.43933532507686
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRSS27,Serine protease 27,32696,0.0125266903705146,0.0162036665784205,-0.0192324961231896,0.0442858768642187,0.439497183914646
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARHGEF12,Rho guanine nucleotide exchange factor 12,32728,-0.0325476385768547,0.0421069438584165,-0.115077248539351,0.0499819713856417,0.43955744565037
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPPB,Natriuretic peptides B,32598,0.0400665010024482,0.0518681925719806,-0.0615951564386338,0.14172815844353,0.439858390322976
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,31560,0.0267608529631954,0.0346524664919499,-0.0411579813610263,0.0946796872874171,0.439981774413337
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEL1L,Protein sel-1 homolog 1,31388,-0.0100660275000344,0.0130421982131617,-0.0356287359978314,0.0154966809977626,0.440254442241953
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APRT,Adenine phosphoribosyltransferase,32635,-0.0150878780201505,0.0195521132354363,-0.0534100199616057,0.0232342639213046,0.440327689528322
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD276,CD276 antigen,32702,0.0110270089777658,0.0142961074386914,-0.0169933616020694,0.039047379557601,0.440532280354501
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ECE1,Endothelin-converting enzyme 1,32502,-0.010980367346286,0.0142358109164583,-0.0388825567425442,0.0169218220499722,0.440538299476537
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERBB4,Receptor tyrosine-protein kinase erbB-4,32720,0.00741471716160013,0.00961928915715932,-0.0114390895864321,0.0262685239096324,0.440835621355238
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SFTPA1,Pulmonary surfactant-associated protein A1,32526,0.0178639402294136,0.0232168110450585,-0.0276410094189011,0.0633688898777283,0.441653194590048
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSDE1,Cold shock domain-containing protein E1,31313,0.0384891624568688,0.0500496418822117,-0.0596081356322662,0.136586460546004,0.441905962305289
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,31388,0.0136412610185834,0.0177510723658084,-0.021150840818401,0.0484333628555678,0.442228953821976
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSPB1,Heat shock protein beta-1,32588,-0.0219562853953644,0.0286098506297989,-0.0780315926297702,0.0341190218390414,0.442841926177309
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARHGAP25,Rho GTPase-activating protein 25,32526,0.0192604358612011,0.0251199178509403,-0.0299746031266418,0.0684954748490441,0.443257238058236
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMAD1,Mothers against decapentaplegic homolog 1,32526,-0.0261057791033892,0.0340491549229493,-0.0928421227523699,0.0406305645455915,0.443275688530394
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TCN1,Transcobalamin-1,31437,-0.0107072039357209,0.0139725353992537,-0.0380933733182582,0.0166789654468164,0.443519559453199
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CAPS,Calcyphosin,31548,0.0281933366775917,0.036802389358148,-0.0439393464643784,0.100326019819562,0.443656065933287
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,32636,-0.0351774890184965,0.045925485219402,-0.125191440048525,0.0548364620115315,0.443715464650686
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC39A14,Zinc transporter ZIP14,32502,0.00991731486935866,0.012962035405588,-0.0154882745255938,0.0353229042643112,0.444230063910118
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RALY,RNA-binding protein Raly,31548,0.0156925209786135,0.0205447770668557,-0.0245752420724237,0.0559602840296506,0.444997684918401
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CASP7,Caspase-7,31548,-0.0267980826948877,0.035094994869168,-0.0955842726384569,0.0419881072486816,0.44513681590352
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,32596,0.0130832301838341,0.0171363982664469,-0.0205041104184019,0.0466705707860701,0.44520013935945
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYL6B,Myosin light chain 6B,31356,0.0292918391906446,0.0383767952188517,-0.0459266794383047,0.104510357819594,0.445326678559992
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SELPLG,P-selectin glycoprotein ligand 1,32728,-0.00867615001490692,0.011372486459133,-0.0309662234748076,0.0136139234449938,0.445539128575488
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ORM1,Alpha-1-acid glycoprotein 1,31568,-0.00627470651186042,0.00822578402042161,-0.0223972431918868,0.00984783016816593,0.445600335073293
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNF149,E3 ubiquitin-protein ligase RNF149,31388,0.00943762001086292,0.0123964143744305,-0.0148593521630209,0.0337345921847467,0.446490680941975
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,32647,-0.0295487732291723,0.0388137202351336,-0.105623664890034,0.0465261184316895,0.446500053611007
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRUNE2,Protein prune homolog 2,31456,-0.00870046941288648,0.0114351495061705,-0.0311133624449807,0.0137124236192077,0.44676840738411
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EGFL7,Epidermal growth factor-like protein 7,32526,-0.0125834445484704,0.0165505549904558,-0.0450225323297638,0.019855643232823,0.447093886593883
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RPGR,X-linked retinitis pigmentosa GTPase regulator,31356,-0.0128130058704034,0.0168544998642659,-0.0458478256043646,0.0202218138635579,0.447151327830056
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNTNAP4,Contactin-associated protein-like 4,31356,0.0325967655609373,0.042923450438307,-0.0515331972981443,0.116726728420019,0.447627478995865
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDH17,Cadherin-17,32729,0.0207082669417073,0.0272759460093719,-0.0327525872366616,0.0741691211200762,0.447745017833091
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEND1,Cell cycle exit and neuronal differentiation protein 1,31342,0.0186492306704272,0.0245861708708354,-0.0295396642364101,0.0668381255772646,0.448160513383753
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GBP2,Guanylate-binding protein 2,32596,-0.0185175579548472,0.0244160667228932,-0.0663730487317178,0.0293379328220235,0.448221895558225
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMN,Protein amnionless,32596,0.014684342714406,0.019389837770241,-0.0233197393152664,0.0526884247440784,0.448877646459015
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNNI3,"Troponin I, cardiac muscle",32598,0.0262353380096358,0.034645535385752,-0.0416699113464382,0.0941405873657097,0.448920409006286
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLPS,Colipase,32706,-0.021379016851748,0.0282726410192883,-0.0767933932495532,0.0340353595460571,0.449565422389737
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NAGK,N-acetyl-D-glucosamine kinase,31370,-0.0182835002989297,0.0241826246786753,-0.0656814446691333,0.029114444071274,0.449637306809098
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TAX1BP1,Tax1-binding protein 1,31548,-0.0198229877186835,0.0262382581403757,-0.0712499736738199,0.0316039982364529,0.44997255029981
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PARD3,Partitioning defective 3 homolog,31456,0.0234712506749496,0.0310743020558585,-0.037434381354533,0.0843768827044322,0.450076388973714
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MATN3,Matrilin-3,32632,0.00960126291902326,0.0127201469259164,-0.0153302250557728,0.0345327508938194,0.450384727610198
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LMOD2,Leiomodin-2,31342,-0.0200732940896634,0.0265968654491606,-0.0722031503700181,0.0320565621906914,0.450438325503616
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMED8,Protein TMED8,31560,-0.0322163211298494,0.0427007883208765,-0.115909866238767,0.0514772239790685,0.450592130449618
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA13,Carbonic anhydrase 13,32606,-0.0328926326609453,0.043619044410506,-0.118385959705537,0.0526006943836464,0.450816206360247
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLIT2,Slit homolog 2 protein,32502,-0.0159588928409461,0.0211979047136229,-0.0575067860796469,0.0255890003977548,0.451559138339026
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EBI3_IL27,Interleukin-27,32786,-0.00929525316802868,0.0123648276123047,-0.033530315288146,0.0149398089520886,0.452221527776196
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFNGR1,Interferon gamma receptor 1,32756,0.00613823934107186,0.00817111452911999,-0.00987714513600332,0.022153623818147,0.452544946681466
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OPHN1,Oligophrenin-1,31548,-0.0335501786751074,0.0446905873257327,-0.121143729833543,0.0540433724833286,0.45284333890067
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TFPI2,Tissue factor pathway inhibitor 2,32698,-0.0117227724058939,0.0156286698689528,-0.0423549653490414,0.0189094205372537,0.453225731395945
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLSCR3,Phospholipid scramblase 3,31534,-0.0186476401901392,0.0248641242657793,-0.0673813237510666,0.0300860433707882,0.453288669590543
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD2,T-cell surface antigen CD2,31313,-0.0117856438115868,0.0157240841584444,-0.0426048487621378,0.0190335611389642,0.453562591374452
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",32668,-0.0105983159184472,0.0141431983459846,-0.038318984676577,0.0171223528396826,0.453661594531015
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CALB2,Calretinin,32502,0.00895721244874227,0.0119596723945194,-0.0144837454445158,0.0323981703420003,0.453906929518088
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,32754,-0.0130541396192565,0.0174543246700267,-0.0472646159725088,0.0211563367339957,0.45453851701501
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEMA4C,Semaphorin-4C,32668,-0.00856163292953751,0.011452937360491,-0.0310093901560999,0.0138861242970249,0.454752137251527
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RSPO1,R-spondin-1,32647,-0.0106679383281301,0.0142831840384317,-0.0386629790434563,0.0173271023871961,0.455151171984753
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP6V1D,V-type proton ATPase subunit D,32668,0.00811561648585511,0.0108949745487204,-0.0132385336296369,0.0294697666013472,0.456354827176712
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UROS,Uroporphyrinogen-III synthase,31356,0.020610946982747,0.0277061616826233,-0.0336931299151946,0.0749150238806885,0.45695301404323
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ABL1,Tyrosine-protein kinase ABL1,32668,-0.0210941332289351,0.0283563271861072,-0.0766725345137053,0.034484268055835,0.456959775345516
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRG2,Bone marrow proteoglycan,31571,0.0157162945595353,0.02113146196027,-0.025701370882594,0.0571339600016645,0.457056988979719
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LCN2,Neutrophil gelatinase-associated lipocalin,32464,0.0112869771981267,0.0151805548132293,-0.0184669102358028,0.0410408646320562,0.457189966897996
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDK1,Cyclin-dependent kinase 1,31326,0.0115459083130373,0.0155298740579672,-0.0188926448405783,0.041984461466653,0.457223968830342
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DEFB104A_DEFB104B,Beta-defensin 104,31342,-0.0176377348459251,0.0237239875596901,-0.0641367504629176,0.0288612807710674,0.457229149456216
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MED21,Mediator of RNA polymerase II transcription subunit 21,31313,-0.0160952579301694,0.0216861938971716,-0.0586001979686257,0.0264096821082869,0.457996126916077
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FST,Follistatin,32739,0.0155184768117536,0.0209221094684965,-0.0254888577464996,0.0565258113700068,0.458272858918998
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TLR4,Toll-like receptor 4,31355,-0.00837085124653951,0.0113143741537884,-0.0305470245879647,0.0138053220948857,0.459418933677615
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHMP6,Charged multivesicular body protein 6,31571,-0.0174397809206632,0.0235762550150305,-0.0636492407501231,0.0287696789087966,0.459493624254624
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FLI1,Friend leukemia integration 1 transcription factor,32526,-0.0335928312260059,0.045414065319315,-0.122604399251863,0.0554187367998515,0.459501455342375
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,32598,-0.0111038372481958,0.0150193879052834,-0.0405418375425513,0.0183341630461597,0.459744556159959
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RPE,Ribulose-phosphate 3-epimerase,31456,0.0220252369617147,0.029800253152093,-0.0363832592163875,0.0804337331398169,0.459871766021832
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OBP2B,Odorant-binding protein 2b,32611,-0.019022830571714,0.0257901528580417,-0.0695715301734757,0.0315258690300476,0.460777006433809
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FH,"Fumarate hydratase, mitochondrial",31342,-0.0260437612167314,0.0354026000591094,-0.0954328573325859,0.043345334899123,0.461969562634065
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTHRC1,Collagen triple helix repeat-containing protein 1,31571,0.00830239056975745,0.0113050761315838,-0.0138555586481468,0.0304603397876617,0.462730408114639
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CASP8,Caspase-8,32777,-0.0186674612149619,0.0254414053576686,-0.0685326157159924,0.0311976932860685,0.463124482273812
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RLN1,Prorelaxin H1,31555,-0.023995142439795,0.0327071627221401,-0.0881011813751897,0.0401108964955997,0.463193143176952
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAMTOR5,Ragulator complex protein LAMTOR5,31548,0.0125722252064117,0.017138166672174,-0.0210185814710495,0.0461630318838728,0.463226806248496
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KYAT1,Kynurenine--oxoglutarate transaminase 1,32712,-0.0172028538115854,0.0234642218524078,-0.0631927286423046,0.0287870210191338,0.463484813524998
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TGFBR2,TGF-beta receptor type-2,32720,0.00879945457419856,0.0120073396207173,-0.0147349310824073,0.0323338402308044,0.463675621728374
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARNT,Aryl hydrocarbon receptor nuclear translocator,32596,0.0115111254344717,0.0157154300356943,-0.0192911174354892,0.0423133683044326,0.463899674330078
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BPIFA2,BPI fold-containing family A member 2,31115,0.0331956922806425,0.0453362152095385,-0.055663289530053,0.122054674091338,0.464063217619956
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPP1,Osteopontin,32817,-0.0134256165557096,0.018336489803604,-0.0493651365707735,0.0225139034593543,0.464077685654779
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,32598,0.00913543396631068,0.0124804188680795,-0.015326187015125,0.0335970549477464,0.464199576618583
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SHMT1,"Serine hydroxymethyltransferase, cytosolic",32739,-0.0259967101111031,0.0355282410738901,-0.0956320626159277,0.0436386423937215,0.464359046210997
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,31355,-0.0111434867756922,0.0152297883360727,-0.0409938719143947,0.0187068983630104,0.464380559395762
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINH1,Serpin H1,31456,-0.0392068910996015,0.0535932722064271,-0.144249704624199,0.0658359224249955,0.464457494696665
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NOTCH1,Neurogenic locus notch homolog protein 1,32834,-0.00467953790667613,0.00640409837785136,-0.0172315707272648,0.00787249491391254,0.464975460593555
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAPK9,Mitogen-activated protein kinase 9,32728,-0.0129256008385187,0.017715795422856,-0.0476485598673163,0.021797358190279,0.465648591461897
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OXT,Oxytocin-neurophysin 1,32806,0.0418079055525025,0.0573714937612648,-0.0706402222195765,0.154256033324582,0.466190425492187
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMOTL2,Angiomotin-like protein 2,31522,0.0147972485410273,0.0203236457335697,-0.0250370970967693,0.0546315941788238,0.4665866076129
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,31417,-0.012810577417251,0.0175966624078323,-0.0473000357366023,0.0216788809021004,0.466628934824184
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,31456,-0.021643633782944,0.0297363703615454,-0.079926919691573,0.036639652125685,0.466727505606806
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL9A1,Collagen alpha-1(IX) chain,32728,0.0130471662808104,0.0179527164164061,-0.0221401578953455,0.0482344904569663,0.467397289425538
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,32647,-0.0131222785440016,0.0180578668647833,-0.0485156975989769,0.0222711405109737,0.467441777663865
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,31313,-0.0148319542361119,0.0204193667821509,-0.0548539131291276,0.0251900046569038,0.467636625084896
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VIPR1,Vasoactive intestinal polypeptide receptor 1,31388,-0.00747393082964798,0.0102923547072642,-0.0276469460558858,0.0126990843965898,0.467761209499174
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA7,Carbonic anhydrase 7,31456,-0.0106893421876581,0.0147301781786684,-0.0395604914178482,0.018181807042532,0.46805954937
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KAZN,Kazrin,31560,-0.0311626583694183,0.0430469047449836,-0.115534591669586,0.0532092749307495,0.469134802390708
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDC25A,M-phase inducer phosphatase 1,31326,-0.012175788562466,0.0168413847048521,-0.0451849025839761,0.0208333254590441,0.469721959821702
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LY75,Lymphocyte antigen 75,32728,-0.0113108920062694,0.0156838768045965,-0.0420512905432786,0.0194295065307398,0.470818032890297
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTP4A3,Protein tyrosine phosphatase type IVA 3,31355,-0.0159743700298247,0.0221735889573991,-0.059434604386327,0.0274858643266776,0.471286878112207
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARL13B,ADP-ribosylation factor-like protein 13B,31313,-0.0208184664965952,0.0289383439553627,-0.0775376206491062,0.0359006876559158,0.471912331024843
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),THRAP3,Thyroid hormone receptor-associated protein 3,31313,-0.034763531110075,0.0483324478376779,-0.129495128871924,0.0599680666517737,0.472004120373639
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP6V1F,V-type proton ATPase subunit F,32491,-0.019759650735704,0.0275452443175298,-0.0737483295980624,0.0342290281266543,0.47317601452051
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RHOC,Rho-related GTP-binding protein RhoC,32590,-0.0347284563279088,0.0484268195297252,-0.12964502260617,0.0601881099503527,0.473311400465639
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,32598,-0.00979188861098393,0.0136553726944595,-0.0365564190921245,0.0169726418701567,0.473348693561917
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PILRB,Paired immunoglobulin-like type 2 receptor beta,32729,-0.0166588030661944,0.0232388582719711,-0.0622069652792577,0.0288893591468689,0.473484802486661
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCN4,CCN family member 4,32794,-0.0117256252539906,0.0163731164324463,-0.0438169334615853,0.0203656829536042,0.473916775260917
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSNK2A1,Casein kinase II subunit alpha,31555,0.0134258831032368,0.0187495308468508,-0.0233231973565907,0.0501749635630644,0.473972933192922
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TTF2,Transcription termination factor 2,31356,-0.0149849047316265,0.0209457913122146,-0.0560386557035671,0.026068846240314,0.474375770859501
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MANSC4,MANSC domain-containing protein 4,31313,-0.0185125660341615,0.0259121900933903,-0.0693004586172066,0.0322753265488835,0.474980837381691
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL2A1,Collagen alpha-1(II) chain,31388,-0.0236286174629066,0.0330765017826629,-0.0884585609569259,0.0412013260311128,0.475025110797581
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL18RAP,Interleukin-18 receptor accessory protein,32587,-0.0496833977004293,0.0696286582113775,-0.186155567794729,0.0867887723938705,0.475525732787025
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMIGO2,Amphoterin-induced protein 2,32668,-0.00656491590290655,0.00920152834765463,-0.0245999114643096,0.0114700796584965,0.475580497144432
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ELAVL4,ELAV-like protein 4,31342,-0.0250114296275236,0.0351402144839508,-0.0938862500160671,0.0438633907610199,0.476635058432527
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DSCAM,Down syndrome cell adhesion molecule,31555,-0.0105646091365306,0.0148573250159227,-0.0396849661677392,0.0185557478946779,0.477061951304295
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NCAM2,Neural cell adhesion molecule 2,32718,-0.0076156350959836,0.0107174066985342,-0.0286217522251105,0.0133904820331433,0.477359763810158
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,32487,-0.0170081685834987,0.0239565752711306,-0.0639630561149147,0.0299467189479174,0.477749207090985
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRRC59,Leucine-rich repeat-containing protein 59,31571,-0.0138855012597847,0.0195590041268951,-0.0522211493484992,0.0244501468289297,0.477769727744037
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LMNB2,Lamin-B2,31548,-0.00801891404792612,0.0113144573205552,-0.0301952503962143,0.0141574223003621,0.478512507082395
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FBLN2,Fibulin-2,31571,0.00898909689567628,0.0127041279285944,-0.0159109938443687,0.0338891876357213,0.479231898723644
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GMPR2,GMP reductase 2,31417,-0.0197203927089945,0.027872000071242,-0.0743495128486288,0.0349087274306399,0.479256398461543
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VWA5A,von Willebrand factor A domain-containing protein 5A,31326,0.0242902969777583,0.0343653658954811,-0.0430658201773847,0.0916464141329014,0.479697345427411
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HEBP1,Heme-binding protein 1,32598,0.0161603688000136,0.0228638167003376,-0.0286527119326481,0.0609734495326753,0.479703555607207
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLIN1,Perilipin-1,32502,0.0100462925453065,0.0142145888146474,-0.0178143015314024,0.0379068866220153,0.479735139071415
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PF4,Platelet factor 4,31548,-0.0283312273730277,0.0401008729603465,-0.106928938375307,0.0502664836292513,0.479899273407142
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APPL2,DCC-interacting protein 13-beta,31417,-0.032879439114117,0.0465538808324364,-0.124125045545692,0.0583661673174584,0.480044293634442
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB37,Ras-related protein Rab-37,32596,-0.0244618561622171,0.0346479395564111,-0.0923718176927827,0.0434481053683486,0.480199590345756
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,32833,-0.0101756286921235,0.0144166429410761,-0.0384322488566327,0.0180809914723856,0.480315224049447
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NTRK2,BDNF/NT-3 growth factors receptor,32729,-0.00726057654298338,0.0102973867136787,-0.0274434545017935,0.0129223014158268,0.480773220144041
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNASE10,Inactive ribonuclease-like protein 10,31388,0.0138434658732105,0.0196562144453337,-0.0246827144396435,0.0523696461860645,0.481280610730769
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CANT1,Soluble calcium-activated nucleotidase 1,32710,-0.00562536690468593,0.00799056303187352,-0.021286870447158,0.0100361366377862,0.481450475414932
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TREH,Trehalase,31571,-0.0220848643797748,0.031383988202712,-0.0835974812570902,0.0394277524975406,0.481641823105807
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJC6,Putative tyrosine-protein phosphatase auxilin,31388,-0.0247763459653609,0.0352186541417298,-0.0938049080831514,0.0442522161524296,0.481765560963184
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUDT15,Nucleotide triphosphate diphosphatase NUDT15,31313,0.014898209143802,0.0212146141730383,-0.026682434635353,0.0564788529229569,0.482537959531594
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL22RA1,Interleukin-22 receptor subunit alpha-1,32596,-0.0122394169396477,0.0174325520546891,-0.0464072189668382,0.0219283850875429,0.482634715388764
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZHX2,Zinc fingers and homeoboxes protein 2,31548,-0.0100587157509451,0.014333334015377,-0.0381520504210841,0.0180346189191939,0.482843334227138
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL2RB,Interleukin-2 receptor subunit beta,32596,0.0108640751903771,0.0154905534336136,-0.0194974095395055,0.0412255599202598,0.483112339294785
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NID2,Nidogen-2,32718,-0.0210997124285426,0.0300854516907955,-0.0800671977425018,0.0378677728854166,0.483117954275065
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",31571,-0.0217915656909641,0.031092250472143,-0.0827323766163643,0.0391492452344362,0.483406498426017
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NLGN2,Neuroligin-2,31342,-0.0135271896407067,0.0193247322751585,-0.0514036649000174,0.0243492856186039,0.483953041339972
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPRM,Receptor-type tyrosine-protein phosphatase mu,32711,-0.00696868935795557,0.00996159349117005,-0.0264934126006489,0.0125560338847377,0.484223209773023
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AXL,Tyrosine-protein kinase receptor UFO,32754,0.00780351438607188,0.0111636173054414,-0.0140771755325933,0.0296842043047371,0.484562142393569
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SAA4,Serum amyloid A-4 protein,31598,-0.00967907904125503,0.0138475730686505,-0.03682032225581,0.0174621641732999,0.484589941495715
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRH,Corticoliberin,32515,-0.0248038849087793,0.0355017108083006,-0.0943872380930484,0.0447794682754898,0.484778738212881
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBP1,Retinol-binding protein 1,31356,0.0206277731247924,0.0295314164885568,-0.0372538031927789,0.0785093494423636,0.484884560513925
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFX1,Transcriptional repressor NF-X1,31313,0.0192351748066963,0.0275629609918977,-0.0347882287374231,0.0732585783508157,0.485284551587654
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,32729,-0.0140031000438061,0.0200801312348353,-0.0533601572640833,0.0253539571764712,0.485595192435983
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HYAL1,Hyaluronidase-1,32673,-0.0065087594115683,0.00935029984848013,-0.0248353471145894,0.0118178282914528,0.486383512714096
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL24,Interleukin-24,32596,0.0134306934542137,0.0193704980750663,-0.0245354827729161,0.0513968696813436,0.488103227968936
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LTBR,Tumor necrosis factor receptor superfamily member 3,32648,0.00748788848281132,0.0107995411461466,-0.013679212163636,0.0286549891292586,0.488106709150064
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF4B,Eukaryotic translation initiation factor 4B,32647,-0.0163830985239351,0.0236452483571788,-0.0627277853040055,0.0299615882561353,0.488409043303297
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HBQ1,Hemoglobin subunit theta-1,32794,0.0173082196561807,0.0249879342423355,-0.031668131458797,0.0662845707711583,0.488539013373707
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OCLN,Occludin,31555,-0.0124452840061552,0.0179673179502625,-0.0476612271886698,0.0227706591763594,0.488542397739947
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NXPH1,Neurexophilin-1,32502,0.0104222326984086,0.0150545264621795,-0.0190846391674632,0.0399291045642803,0.488768216757753
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",31456,-0.0210018387569729,0.0303379225621587,-0.080464166978804,0.0384604894648581,0.488792980412891
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLPBP,Pyridoxal phosphate homeostasis protein,32729,-0.0194440002545747,0.0280893074564194,-0.0744990428691568,0.0356110423600074,0.488816859085914
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LYAR,Cell growth-regulating nucleolar protein,32526,0.0153177613777978,0.0221691997523755,-0.0281338701368581,0.0587693928924537,0.489616807564119
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MN1,Transcriptional activator MN1,31356,-0.0168468316074942,0.0244241401891033,-0.0647181463781367,0.0310244831631483,0.490365535027987
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPP1R9B,Neurabin-2,32833,-0.026863783310567,0.0389581963874872,-0.103221848230042,0.0494942816089078,0.490492483964129
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EP300,Histone acetyltransferase p300,31355,-0.00861603074566371,0.0125051085554677,-0.0331260435143805,0.0158939820230531,0.490844044126558
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OGFR,Opioid growth factor receptor,32668,0.00942173144504685,0.013678624145023,-0.0173883718791983,0.036231834769292,0.490972102783153
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENSA,Alpha-endosulfine,31548,-0.0153256453696413,0.0222608256760241,-0.0589568636946486,0.0283055729553661,0.491185131137982
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLURP1,Secreted Ly-6/uPAR-related protein 1,31518,-0.010508711679118,0.0152737631647454,-0.040445287482019,0.019427864123783,0.491458669850976
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LPCAT2,Lysophosphatidylcholine acyltransferase 2,32668,-0.0115445307098679,0.0168047840864419,-0.0444819075192939,0.0213928460995582,0.492114162760298
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK7,Kallikrein-7,31206,-0.0113810471640255,0.016586984469936,-0.0438915367251001,0.0211294423970492,0.492644444843458
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FAM3B,Protein FAM3B,32668,0.0100959130084631,0.0147260751406177,-0.0187671942671475,0.0389590202840737,0.492995594089413
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPART,Spartin,31417,-0.0222166741166415,0.0324384174274465,-0.0857959722744366,0.0413626240411536,0.493435773611876
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARG2,"Arginase-2, mitochondrial",31548,-0.0121065431663042,0.0176811867281588,-0.0467616691534956,0.0225485828208871,0.493545515213725
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL3RA,Interleukin-3 receptor subunit alpha,32596,0.00892269247646413,0.0130368456464241,-0.0166295249905272,0.0344749099434554,0.493727440237434
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EDA2R,Tumor necrosis factor receptor superfamily member 27,32794,-0.00977847045535292,0.0142959645114444,-0.037798560897784,0.0182416199870782,0.493991549230515
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TBCC,Tubulin-specific chaperone C,32647,-0.0228261745288592,0.033425842575714,-0.0883408259772586,0.0426884769195402,0.494694339723389
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,31456,0.0179497335562904,0.0262984836072011,-0.0335952943138238,0.0694947614264046,0.494919176089587
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,32833,0.0100150706786828,0.014689306154585,-0.0187759693843038,0.0388061107416694,0.495387251486312
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RARRES1,Retinoic acid receptor responder protein 1,32526,0.00937159895797176,0.0137548117794839,-0.0175878321298167,0.0363310300457602,0.49567939069254
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNAPIN,SNARE-associated protein Snapin,31555,-0.0163942600492752,0.024088420228539,-0.0636075636972117,0.0308190435986613,0.4961534793559
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,31571,-0.017556916359052,0.0258001479357118,-0.0681252063130472,0.0330113735949431,0.496210421593797
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CKAP4,Cytoskeleton-associated protein 4,32788,0.00702132573936902,0.0103558336209767,-0.0132761081577454,0.0273187596364834,0.497784944873111
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,32806,0.0127418240365238,0.0188268445333095,-0.0241587912487629,0.0496424393218105,0.49855657013235
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK15,Kallikrein-15,31541,-0.0139513480815606,0.0206200197650314,-0.0543665868210221,0.026463890657901,0.498684993754914
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TALDO1,Transaldolase,31553,-0.0126533531840244,0.0187100384674318,-0.0493250285801907,0.0240183222121419,0.498878864089847
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD3E,T-cell surface glycoprotein CD3 epsilon chain,31456,-0.00944253135619963,0.0139676623916912,-0.0368191496439143,0.017934086931515,0.499043427175971
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AKT2,RAC-beta serine/threonine-protein kinase,31555,-0.0353679519914304,0.0524539460547385,-0.138177686258718,0.067441782275857,0.500161990599906
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZBTB16,Zinc finger and BTB domain-containing protein 16,32526,0.0197027005856764,0.0292476442749892,-0.0376226821933024,0.0770280833646553,0.500551278971911
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IDS,Iduronate 2-sulfatase,32833,-0.00238644956674527,0.00355332401125602,-0.00935096462880708,0.00457806549531653,0.501849008530407
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,31560,0.0135977566820079,0.0202563288241654,-0.0261046478133563,0.0533001611773721,0.502059534366001
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SDK2,Protein sidekick-2,31417,-0.0103368181919073,0.0154021679551762,-0.0405250673840527,0.019851431000238,0.502159833320228
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMTN,Smoothelin,31530,-0.0271210135584005,0.0404202684549114,-0.106344739730027,0.0521027126132258,0.5022562832321
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARHGEF5,Rho guanine nucleotide exchange factor 5,31342,-0.0208556604318788,0.0311290914146894,-0.08186867960467,0.0401573587409123,0.502895480167866
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPRS,Receptor-type tyrosine-protein phosphatase S,32834,0.00666843123676779,0.0099815295489505,-0.0128953666791752,0.0262322291527108,0.504101565103776
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,32668,-0.00770041626425408,0.0115404112634142,-0.0303196223405458,0.0149187898120377,0.504625685500197
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VCAM1,Vascular cell adhesion protein 1,32742,-0.00725577121910299,0.0108841388166758,-0.0285886832997876,0.0140771408615816,0.505021252590255
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD55,Complement decay-accelerating factor,32412,0.00679469655692858,0.0102100743123593,-0.0132170490952957,0.0268064422091529,0.505755448042865
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPARCL1,SPARC-like protein 1,32718,0.00755076430481024,0.0113621684977032,-0.014719085950688,0.0298206145603085,0.506353673778463
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNTN1,Contactin-1,32834,-0.00719677636912755,0.0108398354030522,-0.0284428537591098,0.0140493010208547,0.50675899347583
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COMP,Cartilage oligomeric matrix protein,32630,-0.0090195849447246,0.0135860262640187,-0.0356481964222012,0.017609026532752,0.506780149295589
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC4D,C-type lectin domain family 4 member D,32728,-0.0165327751537242,0.0249319208535141,-0.0653993400266118,0.0323337897191634,0.507272998325831
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LGALS1,Galectin-1,32729,-0.00913447759361055,0.0137901118779364,-0.0361630968743658,0.0178941416871447,0.507736413858259
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,32598,-0.015153657397879,0.0228992599204158,-0.060036206841894,0.029728892046136,0.508146885472577
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,32728,0.0106248609335631,0.0160654228100508,-0.0208633677741365,0.0421130896412628,0.508405322215939
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,32598,0.0134123808412102,0.0202908029377431,-0.0263575929167664,0.0531823545991867,0.508624680559204
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERBIN,Erbin,32668,-0.0278564958703247,0.0422090755928527,-0.110586284032316,0.0548732922916667,0.509293800597668
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD300A,CMRF35-like molecule 8,31417,-0.00784770405893459,0.0118989158220383,-0.0311695790701297,0.0154741709522605,0.509574932663979
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OSTN,Osteocrin,31356,-0.0118630851630082,0.0179974063051707,-0.0471380015211428,0.0234118311951263,0.509816316482198
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAVS,Mitochondrial antiviral-signaling protein,32526,-0.0250297984526326,0.0379778122905921,-0.0994663105421931,0.049406713636928,0.509872359453761
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSPA1A,Heat shock 70 kDa protein 1A,32733,-0.0194829650337704,0.0295622149371115,-0.0774249063105089,0.0384589762429682,0.509881040293886
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPVL,Probable serine carboxypeptidase CPVL,32773,-0.0109107340461659,0.0165568640883924,-0.0433621876594149,0.0215407195670833,0.509922076928261
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TAP1,Antigen peptide transporter 1,31456,-0.0159771943115654,0.0242698196103687,-0.0635460407478881,0.0315916521247572,0.510355480547427
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FABP3,"Fatty acid-binding protein, heart",31571,-0.0132295482053298,0.0201067420499775,-0.0526387626232857,0.0261796662126261,0.510579762232972
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RGS10,Regulator of G-protein signaling 10,31555,-0.0163166732927796,0.024818342255767,-0.0649606241140829,0.0323272775285238,0.51091505183684
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSAP,Prosaposin,31502,-0.00753158657856658,0.011456929905609,-0.0299871691935603,0.0149239960364271,0.510954723521818
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLGN,Calmegin,31356,-0.0118843506597629,0.0180879829913574,-0.0473367973228234,0.0235680960032977,0.511181684482863
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),REG1B,Lithostathine-1-beta,32834,-0.0147690162568326,0.0224899141623142,-0.0588492480149685,0.0293112155013032,0.511393829834566
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FOS,Proto-oncogene c-Fos,31311,-0.00985832549526799,0.0150224166040317,-0.0393022620391701,0.0195856110486341,0.511689345643497
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGLON5,IgLON family member 5,31326,-0.0247519298605162,0.0377465781531141,-0.0987352230406199,0.0492313633195875,0.512011825762406
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CASP10,Caspase-10,32502,-0.0193125457765302,0.0294721888186067,-0.0770780358609993,0.0384529443079388,0.51230472112642
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SH3GLB2,Endophilin-B2,31548,-0.0181995133265815,0.0278280518744434,-0.0727424950004907,0.0363434683473276,0.513132121643314
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAN2B2,Epididymis-specific alpha-mannosidase,31571,-0.0158848751903312,0.0242898222937348,-0.0634929268860513,0.0317231765053889,0.513149041461492
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,32647,-0.0161303219653689,0.024684460312799,-0.064511864178455,0.0322512202477172,0.513476487626195
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),THSD1,Thrombospondin type-1 domain-containing protein 1,31297,0.00911636588536987,0.0139638022188145,-0.0182526864635065,0.0364854182342463,0.513868659143591
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",32618,0.0106226267615182,0.0163394551080737,-0.0214027052503063,0.0426479587733427,0.515630964768219
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD300E,CMRF35-like molecule 2,32770,-0.0102817987180351,0.0158181780502478,-0.0412854276965207,0.0207218302604505,0.515709674086357
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD209,CD209 antigen,32746,-0.0102594394586907,0.0157968345988829,-0.0412212352725011,0.0207023563551197,0.516056764553434
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TGFBR1,TGF-beta receptor type-1,31355,-0.00619395269995749,0.00955607172134173,-0.0249238532737873,0.0125359478738723,0.51689528562672
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AKT3,RAC-gamma serine/threonine-protein kinase,32484,-0.015500824652323,0.0239279545978233,-0.0623996156640567,0.0313979663594107,0.51712356765548
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRADD,Death domain-containing protein CRADD,32636,-0.0202289038833209,0.0312532088619443,-0.0814851932527318,0.0410273854860899,0.517481610068247
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,31417,-0.0230242465584954,0.0355912163031969,-0.0927830305127613,0.0467345373957706,0.517711062968933
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL1,Growth-regulated alpha protein,32690,-0.0249748538634455,0.038617124962019,-0.100664418789003,0.0507147110621117,0.517823502683957
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNST,Consortin,32729,-0.0286858506792835,0.0443566296312745,-0.115624844756582,0.0582531433980145,0.517836753987818
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DLG4,Disks large homolog 4,31548,-0.0191673164488745,0.0296779253058587,-0.0773360500483576,0.0390014171506086,0.518399524348369
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCC,Netrin receptor DCC,31356,-0.00621157827191627,0.00961945653286127,-0.0250657130763244,0.0126425565324918,0.518473549143736
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,31326,-0.0219616251526331,0.0340633664953405,-0.0887258234835004,0.0448025731782342,0.51912291522723
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TCL1B,T-cell leukemia/lymphoma protein 1B,32598,-0.0208636887072884,0.0324072443930645,-0.0843818877176949,0.042654510303118,0.519723936275616
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA9,Carbonic anhydrase 9,32794,0.0112267724237538,0.0174747576590603,-0.0230237525880044,0.0454772974355119,0.520593281545189
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPINK4,Serine protease inhibitor Kazal-type 4,32728,0.0164324587622675,0.0255929499366775,-0.0337297231136205,0.0665946406381554,0.520844497798259
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NAMPT,Nicotinamide phosphoribosyltransferase,32526,-0.0139154138283013,0.0216957564969653,-0.0564390965623533,0.0286082689057506,0.52128711209274
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CILP,Cartilage intermediate layer protein 1,31571,-0.0140987194561828,0.0219903732743326,-0.0571998510738747,0.0290024121615091,0.521456349807161
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PFDN6,Prefoldin subunit 6,31356,-0.0169521911291089,0.0264632584765274,-0.0688201777431027,0.0349157954848849,0.521806411078685
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA5A,"Carbonic anhydrase 5A, mitochondrial",32598,-0.0237842172773783,0.0371887532834281,-0.0966741737128974,0.0491057391581407,0.522479338807568
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDH1,Cadherin-1,32426,-0.0108865059743204,0.0170358104036006,-0.0442766943653777,0.0225036824167368,0.522816223787293
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD83,CD83 antigen,32728,-0.00841906837961715,0.0131905760403512,-0.0342725974187056,0.0174344606594713,0.523318395029555
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPHX2,Bifunctional epoxide hydrolase 2,32598,0.0160116910376516,0.025127496004856,-0.0332382011318661,0.0652615832071693,0.523999593496654
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMIGO1,Amphoterin-induced protein 1,31356,-0.0139765074727758,0.0219923022799245,-0.0570814199414278,0.0291284049958763,0.525109926576557
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CUZD1,CUB and zona pellucida-like domain-containing protein 1,31356,-0.00987783744469932,0.0155557082517327,-0.0403670256180954,0.0206113507286968,0.525449359841138
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD200R1,Cell surface glycoprotein CD200 receptor 1,32694,0.00889767400863674,0.0140148877785707,-0.0185715060373618,0.0363668540546353,0.525527682283565
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STK4,Serine/threonine-protein kinase 4,32729,-0.0227949293405318,0.0360034773529665,-0.0933617449523462,0.0477718862712825,0.526664211820086
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GLT8D2,Glycosyltransferase 8 domain-containing protein 2,32502,-0.0118701635482438,0.0187784640043292,-0.048675952996729,0.0249356259002414,0.527327941988169
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIRPB1,Signal-regulatory protein beta-1,32679,-0.011324298841581,0.0179236828107751,-0.0464547171507002,0.0238061194675382,0.527529719391685
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MXRA8,Matrix remodeling-associated protein 8,31417,0.00778498947303737,0.0123226217331518,-0.0163673491239402,0.0319373280700149,0.527560174983517
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC14A,C-type lectin domain family 14 member A,32718,0.00774741681217808,0.0122807433988817,-0.0163228402496301,0.0318176738739863,0.528149034558476
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VMO1,Vitelline membrane outer layer protein 1 homolog,32668,0.0171431975409758,0.0271776430797735,-0.0361249828953803,0.0704113779773318,0.528198731019427
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD1C,T-cell surface glycoprotein CD1c,32720,-0.00608989386696939,0.00966146112335053,-0.0250263576687364,0.0128465699347976,0.528495965618278
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,32647,-0.018234890107238,0.0289556561209889,-0.0749879761043762,0.0385181958899002,0.528873053485718
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",31356,-0.020625270360923,0.0327848190195604,-0.0848835156392613,0.0436329749174154,0.529295958057681
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1R,Complement C1r subcomponent,31598,-0.00509968051028237,0.00810805118057884,-0.0209914608242169,0.0107920998036521,0.529390528452998
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DIPK2B,Divergent protein kinase domain 2B,31417,0.00697981584781714,0.0110981459148871,-0.0147725501453616,0.0287321818409959,0.529422215609237
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FARSA,Phenylalanine--tRNA ligase alpha subunit,31356,-0.0182260685555645,0.0290299307858309,-0.0751247328957931,0.0386725957846642,0.530129762434907
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,31417,-0.0157131318328706,0.0250613546616245,-0.0648333869696547,0.0334071233039135,0.530687004780867
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBPMS2,RNA-binding protein with multiple splicing 2,31388,-0.0269456906316687,0.0430174998458582,-0.111259990329551,0.0573686090662135,0.53107878621976
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFKBIE,NF-kappa-B inhibitor epsilon,32526,-0.0125742804786996,0.020078570278285,-0.0519282782241383,0.026779717266739,0.531164993608439
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LIPF,Gastric triacylglycerol lipase,31388,0.0155191469168345,0.0248127025712956,-0.0331137501229048,0.0641520439565739,0.531693601064439
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLA2G15,Phospholipase A2 group XV,32720,-0.00672554815177833,0.0107609385806248,-0.0278169877698029,0.0143658914662462,0.531989499286932
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TOP1,DNA topoisomerase 1,31560,0.0297174425888019,0.0475558304792738,-0.0634919851505747,0.122926870328178,0.532057912455578
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCTD,Deoxycytidylate deaminase,31417,-0.0247343630302198,0.0395986694967514,-0.102347755243853,0.052879029183413,0.532235334089912
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC4A,C-type lectin domain family 4 member A,32728,-0.00894292565666853,0.0143260833244132,-0.0370220489725185,0.0191361976591814,0.5324855167
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD99L2,CD99 antigen-like protein 2,32718,-0.00607042179770575,0.00972998016683933,-0.0251411829247108,0.0130003393292993,0.532716941859427
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOM,Apolipoprotein M,32742,-0.00677777057637388,0.0108639642751126,-0.0280711405555945,0.0145155994028468,0.532724802983399
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MFAP4,Microfibril-associated glycoprotein 4,31417,0.00811406297746602,0.0130059183157766,-0.0173775369214561,0.0336056628763881,0.53272872839419
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINA12,Serpin A12,32490,0.0306944136313118,0.0493119489297098,-0.0659570062709193,0.127345833533543,0.53365991080982
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BABAM1,BRISC and BRCA1-A complex member 1,31355,0.00738380224514033,0.0118673897208943,-0.0158762816078124,0.0306438860980931,0.533834148108451
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BAG6,Large proline-rich protein BAG6,32598,-0.00945383216057819,0.0152062671368994,-0.0392581157489009,0.0203504514277446,0.534151224303611
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,32745,-0.0122980053484027,0.0197974599992016,-0.0511010269468378,0.0265050162500323,0.534489850432541
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTBS,Di-N-acetylchitobiase,31479,-0.00705204919485982,0.011360975635238,-0.0293195614399263,0.0152154630502066,0.534798704948681
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",32668,-0.00867438400717445,0.013980160892935,-0.0360754993573271,0.0187267313429782,0.534959105389804
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD36,Platelet glycoprotein 4,31355,-0.0118374179055796,0.0190863317415286,-0.0492466281189756,0.0255717923078164,0.535142392081892
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARHGAP30,Rho GTPase-activating protein 30,31456,0.0100032159491853,0.016139077556086,-0.0216293760607432,0.0416358079591139,0.535399260791509
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL31RA,Interleukin-31 receptor subunit alpha,31322,0.0104596303229374,0.016875620579136,-0.0226165860121691,0.043535846658044,0.535403684824641
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OFD1,Oral-facial-digital syndrome 1 protein,31456,-0.0173001437772242,0.0279618586860472,-0.0721053868018766,0.0375050992474282,0.536129220979452
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDON,Cell adhesion molecule-related/down-regulated by oncogenes,32721,-0.00677995737191585,0.0109602454393258,-0.0282620384329944,0.0147021236891627,0.536198836119436
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FXYD5,FXYD domain-containing ion transport regulator 5,32596,0.0166346693682766,0.0269231487834887,-0.0361347022473611,0.0694040409839144,0.536685382894081
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEMA4D,Semaphorin-4D,32806,-0.00751349263122152,0.0121743134464865,-0.031375146986335,0.016348161723892,0.537145263841232
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDC26,Anaphase-promoting complex subunit CDC26,31548,-0.01807915571912,0.0293013310874404,-0.0755097646505031,0.0393514532122632,0.537247720089445
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRIM1,Cysteine-rich motor neuron 1 protein,32756,0.00498375457796787,0.00809069180195318,-0.0108740013538604,0.0208415105097961,0.537919381310542
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGBP1,Immunoglobulin-binding protein 1,31555,-0.0156945953383369,0.0255353523704776,-0.0657438859844731,0.0343546953077992,0.538822399490107
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),F3,Tissue factor,32732,0.00677931228519074,0.0110465520286121,-0.0148719296908889,0.0284305542612704,0.539426731477349
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MTR,Methionine synthase,31313,0.0163135949610115,0.0266128466587713,-0.0358475844901803,0.0684747744122033,0.539897032854762
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATOX1,Copper transport protein ATOX1,32720,-0.018204463441041,0.0297215817483359,-0.0764587636677794,0.0400498367856973,0.540222836970208
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZFYVE19,Abscission/NoCut checkpoint regulator,31560,-0.0228439517172461,0.0373703553432926,-0.0960898481900996,0.0504019447556075,0.541028716043098
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BSG,Basigin,32820,0.00465075290530754,0.00762978155844601,-0.0103036189492466,0.0196051247598617,0.542173699620067
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SKAP1,Src kinase-associated phosphoprotein 1,32636,0.0179788705112804,0.0295052735752447,-0.0398514656961992,0.07580920671876,0.542312018051003
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANG,Angiogenin,32695,-0.00852715835978804,0.0140023244957156,-0.0359717143713907,0.0189173976518146,0.542552274697229
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NARS1,"Asparagine--tRNA ligase, cytoplasmic",31555,-0.0118310047848583,0.0194345384732857,-0.0499227001924983,0.0262606906227817,0.5427003015488
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINA5,Plasma serine protease inhibitor,31495,-0.00794795350447907,0.0130734663166067,-0.0335719474850282,0.0176760404760701,0.543241780241887
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPTP,Ceramide-1-phosphate transfer protein,31313,-0.0102727133916212,0.0169138961028159,-0.0434239497531403,0.0228785229698978,0.543634867498372
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL6ST,Interleukin-6 receptor subunit beta,32729,-0.00431509492135403,0.00711155753503895,-0.0182537476900304,0.00962355784732231,0.544017677004871
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITM2A,Integral membrane protein 2A,32728,0.0146344777455929,0.0241360341260409,-0.0326721491414472,0.061941104632633,0.544309066030766
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GM2A,Ganglioside GM2 activator,31397,0.0091077702627672,0.0150525929464205,-0.020395311912217,0.0386108524377514,0.545155211686056
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",31342,-0.0119468626756284,0.0197650835436764,-0.0506864264212342,0.0267927010699773,0.54556760772848
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MSLNL,Mesothelin-like protein,31356,0.0090676356344108,0.0150116937711648,-0.0203552841570721,0.0384905554258937,0.545836562507579
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TBC1D17,TBC1 domain family member 17,32502,0.0110560335498055,0.0183366751226016,-0.0248838496904936,0.0469959167901046,0.546560122063667
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PILRA,Paired immunoglobulin-like type 2 receptor alpha,32718,-0.0102076168132962,0.0169654953473976,-0.0434599876941954,0.0230447540676031,0.547409722481724
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJB2,DnaJ homolog subfamily B member 2,31417,0.0135674610553824,0.0225811526923799,-0.0306915982216822,0.057826520332447,0.547970440944352
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FRZB,Secreted frizzled-related protein 3,32616,-0.00645409454908087,0.0107540223374317,-0.0275319783304471,0.0146237892322854,0.548417587790495
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,31548,-0.0117151868515802,0.0195270855598687,-0.0499882745489228,0.0265579008457624,0.548560248252348
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),REG1A,Lithostathine-1-alpha,32682,-0.011657119094488,0.0194411479975144,-0.0497617691696163,0.0264475309806403,0.548781156836132
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MNDA,Myeloid cell nuclear differentiation antigen,32720,-0.0248378279313619,0.0414821760435787,-0.106142892976776,0.0564672371140523,0.54934888712234
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OTUD6B,Deubiquitinase OTUD6B,31560,-0.0146492841883016,0.0244711337585521,-0.0626127063550637,0.0333141379784605,0.549433728610382
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",31342,-0.0136430978728529,0.0228317882193074,-0.0583934027826954,0.0311072070369895,0.550159405736556
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRAF2,TNF receptor-associated factor 2,32728,0.0173329896274305,0.029022444305325,-0.0395510012110065,0.0742169804658676,0.550371030468319
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOA4,Apolipoprotein A-IV,31598,0.0088953470461192,0.0149076465055548,-0.0203236401047682,0.0381143341970066,0.550727192703473
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAMA1,Laminin subunit alpha-1,31313,0.0131272345755501,0.0220362344002457,-0.0300637848489315,0.0563182540000317,0.55138617468888
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPP1R2,Protein phosphatase inhibitor 2,32729,-0.0197592158582089,0.033175706964462,-0.0847836015085544,0.0452651697921366,0.55146241158422
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSPG5,Chondroitin sulfate proteoglycan 5,31342,-0.0118468679536981,0.0199066812130828,-0.0508639631313404,0.0271702272239443,0.551781130015427
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COMMD9,COMM domain-containing protein 9,31548,0.00990070874510354,0.0166568247315278,-0.022746667728691,0.0425480852188981,0.552266429813722
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GRP,Gastrin-releasing peptide,31388,0.0130613669062362,0.0219762502315342,-0.0300120835475708,0.0561348173600432,0.5523025193631
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFKB2,Nuclear factor NF-kappa-B p100 subunit,31456,-0.0145216635628258,0.0244855628048439,-0.06251336666032,0.0334700395346683,0.553151667090546
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD70,CD70 antigen,32728,0.010249240837032,0.0173107727381942,-0.0236798737298287,0.0441783554038927,0.553816812378215
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCARF2,Scavenger receptor class F member 2,32806,0.00675284277471773,0.0114281692932971,-0.0156463690401445,0.02915205458958,0.554606016113104
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DLGAP5,Disks large-associated protein 5,31555,-0.0128013249975618,0.0216685426126795,-0.0552716685184136,0.02966901852329,0.554685701559316
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COCH,Cochlin,31571,-0.0112090654558125,0.0189743781944482,-0.0483988467169309,0.025980715805306,0.554706966172372
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,32526,0.0288051267190083,0.0487860845313755,-0.0668155989624878,0.124425852400504,0.554912869121748
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OSMR,Oncostatin-M-specific receptor subunit beta,32765,-0.00483403660152422,0.00819771384005043,-0.0209015557280231,0.0112334825249746,0.555419454802421
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C2CD2L,Phospholipid transfer protein C2CD2L,32491,0.0101874749890725,0.017319937603191,-0.0237596027131818,0.0441345526913268,0.55641779935876
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARHGAP1,Rho GTPase-activating protein 1,32526,0.011335545264546,0.0192796555255202,-0.0264525795654736,0.0491236700945656,0.556578675025355
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VSIG4,V-set and immunoglobulin domain-containing protein 4,32704,0.00901750912905637,0.0153505520882066,-0.0210695729638285,0.0391045912219412,0.556924072253259
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PACS2,Phosphofurin acidic cluster sorting protein 2,31313,-0.0151301941728788,0.0257859596683747,-0.0656706751228932,0.0354102867771356,0.557382038902122
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DMP1,Dentin matrix acidic phosphoprotein 1,31388,0.0146127653704059,0.0249049124594098,-0.0342008630500372,0.063426393790849,0.557394394749174
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GFAP,Glial fibrillary acidic protein,32517,-0.0104374490317458,0.0177952458377435,-0.0453161308737232,0.0244412328102315,0.557534568841932
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCARE,Photoreceptor cilium actin regulator,31342,0.0209649324261842,0.0358582359129083,-0.0493172099631162,0.0912470748154845,0.558792929649837
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),F11,Coagulation factor XI,31472,0.00698221864255783,0.0119653011735469,-0.0164697716575941,0.0304342089427098,0.559547869555771
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPM1A,Protein phosphatase 1A,32526,0.00761485732481584,0.013051155187653,-0.0179654068429841,0.0331951214926158,0.559597297443115
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSD17B3,Testosterone 17-beta-dehydrogenase 3,31313,-0.0116771654467091,0.0200323662691233,-0.0509406033341909,0.0275862724407726,0.559968203116005
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HRG,Histidine-rich glycoprotein,31555,-0.00767342172001808,0.0132051047818591,-0.0335554270924619,0.0182085836524258,0.561193378067892
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AKAP12,A-kinase anchor protein 12,31417,-0.00517132230142038,0.00889981595045712,-0.0226149615643163,0.0122723169614756,0.561217704747372
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAEP,Glycodelin,32647,0.0343051593404986,0.0590704277187281,-0.0814728789882083,0.150083197669206,0.561423755268718
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DKK4,Dickkopf-related protein 4,32634,-0.0109536028287042,0.0188723561271711,-0.0479434208379596,0.0260362151805512,0.561656690645812
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLITRK2,SLIT and NTRK-like protein 2,32794,0.00928843454007951,0.0160089160703255,-0.0220890409577584,0.0406659100379174,0.56179179856831
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,31337,-0.00692672975247206,0.01199667760114,-0.0304402178507065,0.0165867583457624,0.563695210279553
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,31388,-0.00644088183131533,0.0111568397361411,-0.0283082877141519,0.0154265240515213,0.563751762166001
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAPT,Microtubule-associated protein tau,32502,0.012261462672238,0.0212977872298647,-0.0294822002982969,0.0540051256427728,0.564822600067358
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TXLNA,Alpha-taxilin,32647,-0.0209851400153917,0.0364525065348407,-0.0924320528236795,0.0504617727928961,0.564843251528064
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DOCK9,Dedicator of cytokinesis protein 9,31342,-0.0270785103943185,0.0470419245776691,-0.11928068256655,0.0651236617779129,0.564885953890131
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NOTCH3,Neurogenic locus notch homolog protein 3,32834,0.0079609741329619,0.0138356338446217,-0.0191568682024966,0.0350788164684204,0.565037653814543
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,32720,-0.00814900174786094,0.0141702730396787,-0.0359227369056312,0.0196247334099094,0.565253651387946
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,32526,-0.01532015572348,0.0266656739953067,-0.0675848767542812,0.0369445653073212,0.565625994868636
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",31555,-0.0111723311550359,0.0194478339561495,-0.049290085709089,0.0269454233990172,0.565661928211138
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL20RA,Interleukin-20 receptor subunit alpha,32596,0.00997175229528122,0.0173888834720836,-0.0241104593100027,0.0440539639005651,0.566351026924661
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TAFA5,Chemokine-like protein TAFA-5,32668,0.00784139041523306,0.0137091137245493,-0.0190284724848835,0.0347112533153496,0.567347573738849
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SDCCAG8,Serologically defined colon cancer antigen 8,31548,-0.0269334873737553,0.0471212331683396,-0.119291104383701,0.0654241296361903,0.567624222317491
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),USP8,Ubiquitin carboxyl-terminal hydrolase 8,32598,-0.022602231830032,0.0395528026759953,-0.100125725074983,0.0549212614149188,0.567713064351151
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD72,B-cell differentiation antigen CD72,31417,-0.00977318891724874,0.017102728636649,-0.0432945370450807,0.0237481592105832,0.567718191036763
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAMB1,Laminin subunit beta-1,31388,-0.00721946141692298,0.0126369646648775,-0.0319879121600829,0.017548989326237,0.567815313956158
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GRAP2,GRB2-related adapter protein 2,32729,-0.030158479610025,0.0528847864221741,-0.133812660997486,0.0734957017774362,0.568510666351057
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGFBPL1,Insulin-like growth factor-binding protein-like 1,32729,0.00763675151657408,0.0134155360535463,-0.0186576991483766,0.0339312021815248,0.569203052551192
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPY,Pancreatic prohormone,32682,-0.0234362412881324,0.0411992658115851,-0.104186802278839,0.0573143197025743,0.569471778932646
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),REPS1,RalBP1-associated Eps domain-containing protein 1,31355,-0.00941030591712868,0.0165960014119247,-0.0419384686845011,0.0231178568502437,0.57071588776439
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HDGF,Hepatoma-derived growth factor,32784,0.0217041702879642,0.0383368468284088,-0.0534360494957171,0.0968443900716454,0.571310228347426
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANGPT1,Angiopoietin-1,32685,-0.0194674744345101,0.0343985673301592,-0.086888666401622,0.0479537175326019,0.571449961349281
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CFHR5,Complement factor H-related protein 5,31471,-0.00982381106725347,0.0173997400423981,-0.0439273015503538,0.0242796794158469,0.57236571629207
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF3,Fibroblast growth factor 3,31355,-0.00717874414270402,0.0127379472317976,-0.0321451207170273,0.0177876324316193,0.573062641571345
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP6V1G1,V-type proton ATPase subunit G 1,31388,-0.0169758962549287,0.0301250858147175,-0.0760210644517751,0.0420692719419177,0.57310197059795
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MCFD2,Multiple coagulation factor deficiency protein 2,32701,-0.0103596348977286,0.0183966054321923,-0.0464169815448255,0.0256977117493683,0.573362329667604
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NRCAM,Neuronal cell adhesion molecule,32729,-0.00630719717075749,0.0112459177202444,-0.0283491959024364,0.0157348015609215,0.574918560214753
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF4,Tumor necrosis factor receptor superfamily member 4,32820,-0.00822299658945737,0.0147058939827969,-0.0370465487957393,0.0206005556168246,0.576064235051614
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCL7B,B-cell CLL/lymphoma 7 protein family member B,31548,0.0106154290605694,0.0189878266530529,-0.0266007111794144,0.0478315693005531,0.576133653317032
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GALNT7,N-acetylgalactosaminyltransferase 7,32668,-0.00473501236850907,0.00846993371337821,-0.0213360824467304,0.0118660577097122,0.576150195437266
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LHB,Lutropin subunit beta,32526,-0.019820319288864,0.0354663098967493,-0.0893342866864926,0.0496936481087646,0.576279074261265
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),USP28,Ubiquitin carboxyl-terminal hydrolase 28,31548,-0.00832585213941641,0.0148993999026151,-0.037528675948542,0.0208769716697092,0.576311406846421
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRDX1,Peroxiredoxin-1,32468,0.0202894108820856,0.0364662240189903,-0.0511843881951354,0.0917632099593067,0.577959326814626
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCBD1,Pterin-4-alpha-carbinolamine dehydratase,31402,-0.0111477831210606,0.0200382586734272,-0.0504227701209779,0.0281272038788567,0.578005243293976
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATRAID,All-trans retinoic acid-induced differentiation factor,31560,-0.00671152027180517,0.0120776567235613,-0.0303837274499853,0.016960686906375,0.57843400193657
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),YES1,Tyrosine-protein kinase Yes,32668,-0.0260738306332343,0.0469770149490369,-0.118148779933347,0.0660011186668781,0.578885643133105
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GGCT,Gamma-glutamylcyclotransferase,31564,-0.0112242611112322,0.0202453485998564,-0.0509051443669508,0.0284566221444864,0.579313113262255
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB2B,Ras-related protein Rab-2B,31548,-0.0140914048125551,0.0255083513173595,-0.0640877733945798,0.0359049637694695,0.580674505265946
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MARS1,"Methionine--tRNA ligase, cytoplasmic",31402,-0.0196895862263138,0.0356623041305765,-0.0895877023222438,0.0502085298696161,0.58088797717255
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,31417,-0.0049330975672257,0.0089564624870148,-0.0224877640417747,0.0126215689073233,0.581796402174523
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC5A,C-type lectin domain family 5 member A,32696,-0.00647200427219457,0.0117550096186249,-0.0295118231246995,0.0165678145803103,0.581939561112695
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,31456,0.0100790999889078,0.0183533481103445,-0.0258934623073673,0.046051662285183,0.582905239307936
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),REEP4,Receptor expression-enhancing protein 4,31555,-0.0142008377631034,0.0258641593583192,-0.0648945901054091,0.0364929145792023,0.582983855989473
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL14,C-C motif chemokine 14,32695,-0.00890044614935417,0.0162353147429242,-0.0407216630454856,0.0229207707467773,0.583558004452597
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDIA3,Protein disulfide-isomerase A3,31417,-0.00570356516873848,0.0104176470722712,-0.02612215343039,0.014715023092913,0.584057807911033
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLUL1,Clusterin-like protein 1,32720,0.0101092616204804,0.0184877540297976,-0.0261267362779229,0.0463452595188836,0.584524052288056
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGF1R,Insulin-like growth factor 1 receptor,32668,-0.00467210684955776,0.00856845752699219,-0.0214662836024625,0.0121220699033469,0.585582923612167
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDR1,Epithelial discoidin domain-containing receptor 1,32806,0.00507418436718495,0.0093065085415735,-0.0131665723742991,0.023314941108669,0.58560917623956
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,32647,-0.0120049624083758,0.0220544746266188,-0.0552317326765486,0.0312218078597971,0.586226651179997
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GLB1,Beta-galactosidase,32647,-0.00935751911189052,0.0172325882067302,-0.0431333919970818,0.0244183537733007,0.587134637318338
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANXA5,Annexin A5,32472,0.00669869457477897,0.0123457998264638,-0.0174990730850902,0.0308964622346481,0.587426888603132
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PYY,Peptide YY,31313,0.0206524962787385,0.0380640075198035,-0.0539529584600763,0.0952579510175533,0.587440173405301
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL25,Interleukin-25,31297,-0.00772066254641437,0.0142514617903965,-0.0356535276555916,0.0202122025627628,0.588010202656782
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SDC1,Syndecan-1,32729,-0.00857098876290668,0.0158287444528215,-0.0395953278904369,0.0224533503646235,0.588188629793055
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",32502,0.0120707460870784,0.0223380957153901,-0.0317119215150862,0.055853413689243,0.588958617207348
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AXIN1,Axin-1,32728,-0.020973330735584,0.0388307376975772,-0.0970815766228353,0.0551349151516673,0.589126551082339
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RABGAP1L,Rab GTPase-activating protein 1-like,32596,0.0134970367371503,0.0250029869382371,-0.0355088176617944,0.0625028911360951,0.589337019451187
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LPP,Lipoma-preferred partner,31313,-0.015048807403494,0.027954796043848,-0.069840207649436,0.039742592842448,0.590367738065669
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,31555,0.0083232108149977,0.0155276094087523,-0.0221109036261567,0.0387573252561521,0.591955698470165
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD46,Membrane cofactor protein,32660,-0.00611512496615699,0.0114084906018688,-0.0284757665458198,0.0162455166135058,0.59196155700046
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LUZP2,Leucine zipper protein 2,31548,0.00963205998226495,0.0179802202762248,-0.0256091717591357,0.0448732917236656,0.592179248118189
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,31560,0.0375631589022613,0.0701261407530931,-0.0998840769738012,0.175010394778324,0.592215033443643
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CYTL1,Cytokine-like protein 1,31571,-0.00514952811317157,0.00961853303147939,-0.0240018528548712,0.013702796628528,0.592405582626733
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EDDM3B,Epididymal secretory protein E3-beta,31548,-0.0117436517575044,0.0219571095026168,-0.0547795863826332,0.0312922828676245,0.592772462762668
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,31313,0.0112290516975436,0.021015779755684,-0.0299618766235971,0.0524199800186844,0.593139377547894
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),A1BG,Alpha-1B-glycoprotein,31598,-0.00376209603827588,0.00704895495164096,-0.0175780477434922,0.0100538556669404,0.593557687330683
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PHLDB2,Pleckstrin homology-like domain family B member 2,31326,-0.0205100925934672,0.0384648231529695,-0.0959011459732874,0.0548809607863531,0.593899336727298
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TBR1,T-box brain protein 1,31356,-0.0106374753287438,0.019950988451632,-0.0497414126939426,0.028466462036455,0.593924538093587
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIF20B,Kinesin-like protein KIF20B,31342,-0.0170913232779475,0.0320665927609565,-0.0799418450894223,0.0457591985335272,0.59405309449064
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINA3,Alpha-1-antichymotrypsin,31574,-0.00327183122566242,0.00614621120478773,-0.0153184051870464,0.00877474273572153,0.594510692283613
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,32702,-0.00645177876623911,0.0121400313716063,-0.0302462402545875,0.0173426827221093,0.595122665542375
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,31355,0.0105416517250453,0.0198507219717097,-0.0283657633395058,0.0494490667895963,0.595402456320323
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,32834,0.0151132216295088,0.0284713692203318,-0.0406906620423415,0.0709171053013591,0.59555545225968
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCDC2C,Doublecortin domain-containing protein 2C,31326,-0.0137115346761594,0.0258825180802701,-0.0644412701134888,0.03701820076117,0.59629377563543
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIF22,Kinesin-like protein KIF22,31313,-0.0271404047985785,0.0512362687350698,-0.127563491519315,0.0732826819221583,0.596328238427824
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KCNH2,Potassium voltage-gated channel subfamily H member 2,31356,-0.0168286666194795,0.0318021139261083,-0.0791608099146518,0.0455034766756927,0.59670446010114
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TST,Thiosulfate sulfurtransferase,32492,-0.0162872284936413,0.030903505895988,-0.0768581000497778,0.0442836430624951,0.598182843634493
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNU13,NHP2-like protein 1,31313,-0.0148830319848051,0.028251706961353,-0.0702563776290569,0.0404903136594467,0.598347355664093
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IKBKG,NF-kappa-B essential modulator,32728,-0.0195434599715615,0.0371210040460336,-0.0923006279017874,0.0532137079586644,0.598568028341469
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPINK1,Serine protease inhibitor Kazal-type 1,32718,-0.0085301484758451,0.0162078363837655,-0.0402975077880256,0.0232372108363354,0.598694494763272
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCN2,Ficolin-2,32684,-0.00889556757560829,0.016903381994122,-0.0420261962840873,0.0242350611328707,0.598721053539759
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,32770,-0.0221265782252335,0.0420925616231813,-0.104627999006669,0.0603748425562019,0.599134202589026
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GH1,Somatotropin,32719,0.0393024128888925,0.0748237816724633,-0.107352199189136,0.185957024966921,0.599411208421744
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,31548,-0.00807385331622434,0.0153772020401297,-0.0382131693148785,0.0220654626824298,0.599561160215273
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRKL,Crk-like protein,32716,-0.0229159774004433,0.0436600188054276,-0.108489614259081,0.0626576594581948,0.599684421840057
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLTA,Clathrin light chain A,32598,0.0102812130602685,0.0196014573956835,-0.0281376434352711,0.0487000695558082,0.599935304228977
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEP170,Centrosomal protein of 170 kDa,31388,-0.0171126528275235,0.0326336276341957,-0.081074562990547,0.0468492573355001,0.600024777916755
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZP3,Zona pellucida sperm-binding protein 3,31388,0.056311964175659,0.107500123319645,-0.154388277530845,0.267012205882163,0.600411076497954
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",32636,-0.0207742468402895,0.0396712179944922,-0.0985298341094942,0.0569813404289152,0.600527969315445
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UROD,Uroporphyrinogen decarboxylase,31417,-0.0151117832864824,0.0289340365288315,-0.0718224948829922,0.0415989283100274,0.60148794191025
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNDP1,Beta-Ala-His dipeptidase,32754,-0.00975961549030421,0.0187003689507679,-0.0464123386338092,0.0268931076532008,0.601756941343393
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DAND5,DAN domain family member 5,31355,-0.0120858717864755,0.0232155305022551,-0.0575883115708955,0.0334165679979445,0.602664830854421
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NCK2,Cytoplasmic protein NCK2,32756,-0.0226524809102745,0.0435629147834762,-0.108035793885888,0.062730832065339,0.603080270384208
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ULBP2,UL16-binding protein 2,32647,0.00770877150625314,0.0148724064344295,-0.0214411451052286,0.0368586881177349,0.604243109249181
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,31388,-0.016575507010108,0.0319831930927025,-0.079262565471805,0.0461115514515889,0.604294347264338
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDX1,ATP-dependent RNA helicase DDX1,31560,-0.0109368803530809,0.0211172983568425,-0.0523267851324922,0.0304530244263303,0.604535271340428
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TFAP2A,Transcription factor AP-2-alpha,31342,0.0126222286665479,0.0243955319909249,-0.0351930140356648,0.0604374713687606,0.604892815568915
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PECR,Peroxisomal trans-2-enoyl-CoA reductase,31388,-0.00604792825290064,0.0117093841679975,-0.0289983212221757,0.0169024647163744,0.60551854236465
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,31313,0.0120944897391562,0.0234391408199391,-0.0338462262679245,0.0580352057462368,0.605872902292821
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RRP15,RRP15-like protein,31342,0.0195109711336676,0.0378257076446123,-0.0546274158497726,0.0936493581171078,0.606000643949106
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TFRC,Transferrin receptor protein 1,32756,-0.00822615478051649,0.0159755850534812,-0.0395383014853397,0.0230859919243067,0.606621432298876
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,31313,-0.00725716298718185,0.0141226387272008,-0.0349375348924955,0.0204232089181318,0.607359967848409
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IRAK4,Interleukin-1 receptor-associated kinase 4,32728,-0.0219216630209305,0.0427062112999239,-0.105625837168781,0.0617825111269202,0.607745022376798
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CASP9,Caspase-9,31355,0.0130249243676977,0.0254106276847124,-0.0367799058943387,0.0628297546297341,0.608261770379608
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARTN,Artemin,32596,-0.00971014169056954,0.0189502327255054,-0.0468525978325602,0.0274323144514211,0.608382477969115
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TXNDC15,Thioredoxin domain-containing protein 15,32720,-0.00565540260170219,0.0110451469462098,-0.0273038906162734,0.015993085412869,0.608645562999389
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),INSR,Insulin receptor,31355,0.00356288975359036,0.00696892818349617,-0.0100962094860621,0.0172219889932429,0.609188537650559
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SHD,SH2 domain-containing adapter protein D,31298,0.0178601061575003,0.0349498466933308,-0.0506415933614281,0.0863618056764288,0.60935150848015
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSO,Cathepsin O,32833,-0.00641492812903913,0.0125564180802351,-0.0310255075662999,0.0181956513082216,0.609441785182972
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MENT,Protein MENT,31417,-0.00460137927132197,0.00901304564871875,-0.0222669487428107,0.0130641902001668,0.609699071676915
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGA2,Integrin alpha-2,31417,0.00697870494908884,0.0136776928743259,-0.0198295730845899,0.0337869829827676,0.609908531170271
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLAMF8,SLAM family member 8,32526,-0.0109175749155047,0.0214050686440865,-0.0528715094579141,0.0310363596269048,0.610032052262957
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ASAH2,Neutral ceramidase,32647,-0.0108659722713163,0.0213165177648672,-0.0526463470904559,0.0309144025478234,0.610243452652165
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,32794,0.00704191859275388,0.0138174956578595,-0.0200403728966507,0.0341242100821585,0.610317799368651
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FZD10,Frizzled-10,31356,-0.0127583219683007,0.0250549508378936,-0.0618660256105722,0.0363493816739708,0.610617492894245
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LY6D,Lymphocyte antigen 6D,32652,-0.00745513217128442,0.014648300247613,-0.0361658006566059,0.0212555363140371,0.610805796840445
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSL,Cathepsin L1,32729,-0.00488500021015733,0.00960934075542248,-0.0237193080907854,0.0139493076704707,0.61121385371965
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FABP6,Gastrotropin,32584,0.0112350285903809,0.0221159547230179,-0.0321122426667342,0.054582299847496,0.611462267859831
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNPY2,Protein canopy homolog 2,32598,0.0125574478219252,0.0247286562390829,-0.0359107184066772,0.0610256140505277,0.611599728474274
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),JCHAIN,Immunoglobulin J chain,32596,-0.0125640017640385,0.024816594815566,-0.061204527602548,0.0360765240744709,0.61267694576262
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SAT2,Thialysine N-epsilon-acetyltransferase,31456,-0.0144692365523102,0.028580432899192,-0.0704868850347266,0.0415484119301062,0.612686214254158
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BTD,Biotinidase,31598,-0.00435449247194095,0.00860434641868088,-0.0212190114525555,0.0125100265086736,0.612814512607493
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNR,Tenascin-R,32647,0.00864470386285536,0.0171005483658489,-0.0248723709342086,0.0421617786599193,0.613204911737501
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FDX2,"Ferredoxin-2, mitochondrial",31313,0.0118771133375248,0.0234966543009475,-0.0341763290923323,0.0579305557673819,0.613235957385188
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AKT1S1,Proline-rich AKT1 substrate 1,32502,0.0138469501066247,0.0274107006686783,-0.0398780232039849,0.0675719234172342,0.613455230735159
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRSS2,Trypsin-2,32754,0.0105682723021124,0.0209214907763857,-0.0304378496196036,0.0515743942238283,0.613473345465049
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB6B,Ras-related protein Rab-6B,32502,-0.00976011106151326,0.0193359993594886,-0.047658669806111,0.0281384476830845,0.613737667268647
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GAS6,Growth arrest-specific protein 6,32776,0.00525741714873976,0.0104250315168407,-0.015175644624268,0.0256904789217475,0.61405806848087
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB33A,Ras-related protein Rab-33A,31313,-0.0141803708631392,0.0281640165464274,-0.0693818432941369,0.0410211015678585,0.614632938269979
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TEX101,Testis-expressed protein 101,31356,-0.0101267868608209,0.020217969069319,-0.0497540062366861,0.0295004325150443,0.61646991951261
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GAD2,Glutamate decarboxylase 2,31355,-0.00943260301055722,0.018835515829629,-0.04635021403663,0.0274850080155156,0.616534936091491
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBP2,Retinol-binding protein 2,32668,0.0157497924384562,0.0314589200890635,-0.0459096909361084,0.0774092758130207,0.616632569629314
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,31326,0.00891617065381833,0.017852039202883,-0.0260738261838323,0.043906167491469,0.617478316206177
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIGLEC1,Sialoadhesin,32756,-0.00840568006984173,0.0168414050306854,-0.0414148339299852,0.0246034737903017,0.617715640144947
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UBE2Z,Ubiquitin-conjugating enzyme E2 Z,31355,0.0125308184489841,0.0251565970733271,-0.0367761118147371,0.0618377487127052,0.618419282047378
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NT5C3A,Cytosolic 5'-nucleotidase 3A,32716,-0.0178226534673303,0.035811651472794,-0.0880134903540066,0.0523681834193461,0.618723720302089
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPRR,Receptor-type tyrosine-protein phosphatase R,31548,0.00744269765776535,0.0149644643403971,-0.0218876524494129,0.0367730477649436,0.61895076574273
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FHIT,Bis(5'-adenosyl)-triphosphatase,32502,-0.0150136274027749,0.0301941660043199,-0.074194192771242,0.0441669379656921,0.619035262239761
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJC21,DnaJ homolog subfamily C member 21,31548,0.00796231643039735,0.0160301168521114,-0.0234567125997411,0.0393813454605358,0.619407899829673
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEPTIN9,Septin-9,32668,-0.00581056587001817,0.0117131102347253,-0.0287682619300797,0.0171471301900433,0.619854795830988
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRND,Prion-like protein doppel,31548,0.0104645267648044,0.0210981011737061,-0.0308877515356595,0.0518168050652683,0.619912984301104
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STX7,Syntaxin-7,31355,0.0102648738614919,0.0207555476854362,-0.0304159996019631,0.0509457473249468,0.620924892032766
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATXN10,Ataxin-10,32502,-0.014569275559589,0.0296340876514802,-0.0726520873564901,0.0435135362373122,0.622986998570862
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LEPR,Leptin receptor,32729,0.00624716724297917,0.0127237819220333,-0.0186914453242062,0.0311857798101645,0.623450251358212
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNF41,E3 ubiquitin-protein ligase NRDP1,32526,-0.0135600267558334,0.0276879317032958,-0.0678283728942933,0.0407083193826264,0.624326734775277
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL13,Interleukin-13,32596,-0.00975784469549806,0.0199789115128843,-0.0489165112607512,0.0294008218697551,0.625273685500548
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DRG2,Developmentally-regulated GTP-binding protein 2,32668,-0.011387350969783,0.0233268518804978,-0.0571079806555585,0.0343332787159926,0.62544517625457
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HLA_E,,32728,-0.00549368710715596,0.0112568929737714,-0.027557197335748,0.0165698231214361,0.625541561720513
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRTAM,Cytotoxic and regulatory T-cell molecule,32647,-0.00980275710661651,0.0201033707654505,-0.0492053638068995,0.0295998495936665,0.625832902538759
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",31355,0.00558387431247465,0.0114517022763314,-0.0168614621491348,0.0280292107740841,0.625845955070358
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCSK9,Proprotein convertase subtilisin/kexin type 9,32834,0.00773024596147754,0.0158571290927406,-0.023349727060294,0.0388102189832491,0.625920618829524
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HMBS,Porphobilinogen deaminase,32794,0.00875347677804762,0.0179588613163765,-0.0264458914020503,0.0439528449581456,0.625973921579468
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),INSL3,Insulin-like 3,31548,-0.0146913589939324,0.030227495997468,-0.0739372511489697,0.044554533161105,0.626962348961427
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,31235,-0.0104697417480473,0.0215826751282355,-0.0527717849993888,0.0318323015032942,0.627620279304947
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL1A1,Collagen alpha-1(I) chain,32834,-0.00490261224534816,0.0101311401717273,-0.0247596469819336,0.0149544224912373,0.628457894104666
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NOS1,"Nitric oxide synthase, brain",32502,0.0106881308298035,0.0221011514452019,-0.0326301260027921,0.0540063876623992,0.628681578073322
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),F7,Coagulation factor VII,32738,-0.00582372622946672,0.0120602454526239,-0.0294618073166097,0.0178143548576762,0.629188439860403
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPPP2,Tubulin polymerization-promoting protein family member 2,31456,-0.0162546840541288,0.0336928993824023,-0.0822927668436374,0.0497833987353797,0.629509807289736
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGA,Fibrinogen alpha chain,31403,-0.00614204817822457,0.0127687052099905,-0.0311687103898059,0.0188846140333568,0.630513698492656
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,31560,-0.0215932174827401,0.0448964481315026,-0.109590255820485,0.0664038208550049,0.630561414643029
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL17F,Interleukin-17F,32596,-0.0157945706400334,0.0328532652708755,-0.0801869705709494,0.0485978292908827,0.630698368037531
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IDUA,Alpha-L-iduronidase,32794,-0.00910809852236528,0.018991550417329,-0.0463315373403302,0.0281153402955997,0.631532912844494
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RET,Proto-oncogene tyrosine-protein kinase receptor Ret,32668,-0.0076000851361187,0.0158561817439447,-0.0386782013542502,0.0234780310820128,0.631727377329172
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLK,STE20-like serine/threonine-protein kinase,31456,0.015460506301352,0.0322564548882849,-0.0477621452796864,0.0786831578823905,0.631739296445192
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIRREL2,Kin of IRRE-like protein 2,32502,0.00763106171906247,0.0159300964266247,-0.023591927277122,0.038854050715247,0.631926386877642
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,32720,-0.0121644400178564,0.0254070358138133,-0.0619622302129304,0.0376333501772177,0.632105297542484
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GGA1,ADP-ribosylation factor-binding protein GGA1,32502,0.0139227890224139,0.0290868959216211,-0.0430875269839634,0.0709331050287912,0.632191280279181
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL3A1,Collagen alpha-1(III) chain,31571,-0.00456425898549843,0.00953766297061422,-0.0232580784079023,0.0141295604369054,0.632271590165679
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDH5,Cadherin-5,32834,0.00584795629896315,0.0123022958580141,-0.0182645435827445,0.0299604561806708,0.634545622342923
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIF1C,Kinesin-like protein KIF1C,31313,0.00726802059826674,0.015290558154711,-0.0227014733849668,0.0372375145815002,0.634567592353809
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,31456,0.00771757571469264,0.0162514482694959,-0.0241352628935192,0.0395704143229045,0.634882302332988
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VSNL1,Visinin-like protein 1,31548,-0.00752270638989433,0.0158627062516137,-0.0386136106430571,0.0235681978632684,0.635343293588412
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,31338,-0.00704989133210395,0.0148727585572743,-0.0362004981043616,0.0221007154401537,0.63550397605693
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",31417,-0.0203862497596613,0.0430236281350017,-0.104712560904265,0.0639400613849421,0.63562879407339
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WAS,Wiskott-Aldrich syndrome protein,32596,0.0131548198029846,0.0277861437915802,-0.0413060220285125,0.0676156616344817,0.635917599640308
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),YWHAQ,14-3-3 protein theta,31417,-0.0145355545403559,0.0307086003056725,-0.0747244111394741,0.0456533020587622,0.635985563083668
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARMCX2,Armadillo repeat-containing X-linked protein 2,31342,-0.0122125438030259,0.0258297831194483,-0.0628389187171445,0.0384138311110928,0.636363523856626
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TDP1,Tyrosyl-DNA phosphodiesterase 1,31548,-0.0139412833489528,0.0295418703165383,-0.071843349169368,0.0439607824714623,0.63700009016326
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHMP1A,Charged multivesicular body protein 1a,32647,-0.0152337808769141,0.0323485677976526,-0.0786369737603132,0.048169412006485,0.637705287201342
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPRF,Receptor-type tyrosine-protein phosphatase F,32834,0.00541425204377611,0.0115132240551597,-0.0171516671043368,0.027980171191889,0.63817801325253
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,32502,-0.0213466053089691,0.0453998346233503,-0.110330281170736,0.0676370705527975,0.63823024508274
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SRPK2,SRSF protein kinase 2,32728,-0.0161028981356414,0.0342512008912313,-0.0832352518824547,0.051029455611172,0.638265755006192
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),POSTN,Periostin,31571,0.0073537612697253,0.0156737032953047,-0.023366697189072,0.0380742197285226,0.638955468863069
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SOX2,Transcription factor SOX-2,31543,-0.00460839613741584,0.00982906463651478,-0.0238733628249848,0.0146565705501531,0.639187310840336
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),REXO2,"Oligoribonuclease, mitochondrial",31313,-0.00971827124831362,0.0207678942623629,-0.0504233440025448,0.0309868015059176,0.639836263036702
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,31571,0.00754571948568025,0.0161341036593513,-0.0240771236866483,0.0391685626580088,0.640021259208928
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDHD2,Phospholipase DDHD2,31555,-0.0128699595105379,0.0275740160756048,-0.0669150310187233,0.0411751119976475,0.640697480349214
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,32817,0.00509359709935954,0.0109320478887248,-0.0163332167625411,0.0265204109612602,0.641275101128301
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TSC22D1,TSC22 domain family protein 1,31555,0.0131130424724593,0.0281605317416738,-0.0420815997412213,0.0683076846861399,0.641476915886438
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFNGR2,Interferon gamma receptor 2,32647,-0.00991651410571613,0.0213034785674009,-0.051671332097822,0.0318383038863897,0.64159354873742
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD164L2,CD164 sialomucin-like 2 protein,31356,-0.00691773762666614,0.0148817294509706,-0.0360859273505685,0.0222504520972363,0.642054031683671
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLHL41,Kelch-like protein 41,31555,0.00967477052901206,0.020821249725341,-0.0311348789326563,0.0504844199906804,0.642189183189122
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),S100P,Protein S100-P,32598,-0.010535678752809,0.0226824499516243,-0.0549932806579927,0.0339219231523746,0.642311213651101
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLRC1,NKG2-A/NKG2-B type II integral membrane protein,31342,-0.0117452958968459,0.0253043717215111,-0.0613418644710076,0.0378512726773159,0.642546091445356
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGR,Tyrosine-protein kinase Fgr,32502,-0.0111004084692509,0.0239739401391679,-0.05808933114202,0.0358885142035182,0.643361848704989
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STAMBP,STAM-binding protein,32636,-0.0122602536496899,0.0265106097370755,-0.0642210487343579,0.039700541434978,0.643758698183308
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,31356,0.020047833116776,0.0434950956090016,-0.0652025542768671,0.105298220510419,0.644868159396838
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC27A4,Long-chain fatty acid transport protein 4,32502,-0.0126034631701118,0.0273570134233315,-0.0662232094798415,0.041016283139618,0.645023163462183
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AOC3,Membrane primary amine oxidase,32754,-0.00565171032414189,0.012274356894914,-0.0297094498381734,0.0184060291898896,0.645205521701076
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNAP25,Synaptosomal-associated protein 25,31342,0.00903866347232109,0.0196438762033582,-0.0294633338862609,0.0475406608309031,0.645438960291357
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPR101,Probable G-protein coupled receptor 101,31342,0.0115052776772168,0.0250164824570711,-0.0375270279386426,0.0605375832930761,0.645595699836359
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),QSOX1,Sulfhydryl oxidase 1,31440,-0.00829950816755684,0.0180646707246909,-0.043706262787951,0.0271072464528373,0.645936338977008
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SARG,Specifically androgen-regulated gene protein,31546,-0.0209021556826817,0.0455235263913121,-0.110128267409653,0.06832395604429,0.646138987591214
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC7A,C-type lectin domain family 7 member A,32833,-0.0110002079146864,0.0240975478216983,-0.0582314016452151,0.0362309858158423,0.648051146230542
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TREM2,Triggering receptor expressed on myeloid cells 2,32702,0.00949369970492292,0.0208105802757364,-0.0312950376355204,0.0502824370453663,0.64826037640531
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ECSCR,Endothelial cell-specific chemotaxis regulator,31342,0.00945943167222312,0.0208538923467581,-0.0314141973274229,0.0503330606718691,0.650126246418322
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFSF8,Tumor necrosis factor ligand superfamily member 8,31571,-0.00663697748280148,0.014649226432954,-0.0353494612913914,0.0220755063257884,0.650518336328334
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRSS8,Prostasin,32673,-0.00740484819322238,0.0163463850994036,-0.0394437629880534,0.0246340666016087,0.650562723905139
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RABEPK,Rab9 effector protein with kelch motifs,32526,0.0111967692075469,0.0248199899254061,-0.0374504110462492,0.0598439494613429,0.651915067143364
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,32834,0.00493623350196689,0.0109462835229194,-0.0165184822029551,0.0263909492068889,0.652036024028156
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DTX3,Probable E3 ubiquitin-protein ligase DTX3,32668,-0.00433596783459599,0.00963326135845157,-0.0232171600971611,0.0145452244279691,0.652646652475943
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ICAM2,Intercellular adhesion molecule 2,32834,0.00572731765600353,0.0127358554319792,-0.0192349589906757,0.0306895943026828,0.652937436319926
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLF4,Krueppel-like factor 4,31342,-0.00772411412148124,0.0171826294536519,-0.0414020678506389,0.0259538396076764,0.653062112007781
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TREML2,Trem-like transcript 2 protein,32718,-0.00606120156763562,0.0135020797463344,-0.0325252778704511,0.0204028747351798,0.653508474646891
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPPED1,Serine/threonine-protein phosphatase CPPED1,32806,-0.0122835230642811,0.027365555317011,-0.0659200114856226,0.0413529653570605,0.653537728016173
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,31555,0.00484577060155253,0.0108130220710194,-0.0163477526576454,0.0260392938607505,0.654063250672431
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LTBP2,Latent-transforming growth factor beta-binding protein 2,32834,-0.00557182314491539,0.0124439780093856,-0.0299620200433111,0.0188183737534804,0.654342584598398
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDH22,Cadherin-22,31456,0.00531351353560706,0.0119105055984611,-0.0180310774373767,0.0286581045085908,0.655523356627264
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KHK,Ketohexokinase,31388,-0.0120311465329159,0.0270452449521452,-0.0650398266391205,0.0409775335732888,0.656439095330401
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FSTL1,Follistatin-related protein 1,31388,0.00429597345271005,0.00966380796737614,-0.0146450901633472,0.0232370370687673,0.656663180873339
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACRBP,Acrosin-binding protein,31548,-0.00701562589899532,0.0157984139406167,-0.0379805172226041,0.0239492654246135,0.657003365456909
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,31342,0.00997781597427237,0.0224711399826748,-0.0340656183917703,0.054021250340315,0.657035161181477
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KRT6C,"Keratin, type II cytoskeletal 6C",31313,-0.00721152588352842,0.0163103244330622,-0.0391797617723304,0.0247567100052735,0.658397223486679
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MRPL24,"39S ribosomal protein L24, mitochondrial",31313,0.00735522233525196,0.0166430790976711,-0.0252652126961833,0.0399756573666872,0.658546318258341
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCNA,Proliferating cell nuclear antigen,31326,-0.012274736932101,0.0277859249850517,-0.0667351499028023,0.0421856760386003,0.658674985257607
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAP2,Microtubule-associated protein 2,31548,-0.00831330520837685,0.0188296423426932,-0.0452194042000555,0.0285927937833018,0.658862781838762
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PROK1,Prokineticin-1,32728,-0.0116176550535322,0.0263181724245552,-0.0632012730056603,0.039965962898596,0.658911824628541
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GBA,Lysosomal acid glucosylceramidase,31356,-0.0100311910294741,0.0227294766059801,-0.0545809651771951,0.0345185831182469,0.658987122490581
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK11,Kallikrein-11,32636,0.00529914356732775,0.0120175465797105,-0.0182552477289048,0.0288535348635603,0.659259671151395
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BGN,Biglycan,32515,0.0213217788118213,0.0483592648704439,-0.0734623803342488,0.116105937957891,0.659293727398048
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RRAS,Ras-related protein R-Ras,31356,-0.0240150469305162,0.0544819364553278,-0.130799642382959,0.0827695485219263,0.659378354282288
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NT5C1A,Cytosolic 5'-nucleotidase 1A,31548,0.005630421389714,0.0127747641255201,-0.0194081162963054,0.0306689590757334,0.659409555396294
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,31356,0.00843213788745986,0.0191431839031472,-0.0290885025627087,0.0459527783376284,0.659604153624675
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STX6,Syntaxin-6,32526,0.0124852835262218,0.0283712432328703,-0.043122353210204,0.0680929202626476,0.659898647339575
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CFD,Complement factor D,31598,-0.00330506354767019,0.00751109824049169,-0.0180268160990339,0.0114166890036935,0.659932009298462
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IMPA1,Inositol monophosphatase 1,32647,-0.0109893848835964,0.0249960565321022,-0.0599816556865167,0.0380028859193239,0.660205240390671
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL2RG,Cytokine receptor common subunit gamma,31548,0.00691451901791353,0.0157313085710369,-0.0239188457813188,0.0377478838171458,0.660283596501327
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDKL5,Cyclin-dependent kinase-like 5,31342,0.0096947071009125,0.0220713155039072,-0.0335650712867456,0.0529544854885706,0.660496965118519
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIGLEC5,Sialic acid-binding Ig-like lectin 5,32718,-0.0205566601149057,0.0468254641685169,-0.112334569885199,0.0712212496553873,0.660667890492768
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTRB1,Chymotrypsinogen B,32718,0.00963089477348149,0.021943110020698,-0.0333776008670866,0.0526393904140496,0.660742595284451
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,32728,-0.014847216582733,0.0338414607081116,-0.0811764795706316,0.0514820464051657,0.660868891356548
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSF3R,Granulocyte colony-stimulating factor receptor,31355,0.0056548641462445,0.0128976156458586,-0.0196244625196384,0.0309341908121274,0.661078107290343
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),POF1B,Protein POF1B,31355,-0.00837127070231786,0.0191205627444735,-0.0458475736814858,0.0291050322768501,0.661532954844984
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",31388,-0.00581355229137503,0.0132798648730383,-0.0318420874425301,0.0202149828597801,0.661564168683337
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BOLA2_BOLA2B,BolA-like protein 2,31388,0.0101543713433547,0.023197737700358,-0.035313194549347,0.0556219372360564,0.66159377707303
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MMP13,Collagenase 3,32502,-0.00573567115133927,0.0131167547853692,-0.031444510530663,0.0199731682279844,0.661920517141406
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,31356,-0.00914696217710709,0.0209262533743012,-0.0501624187907374,0.0318684944365232,0.662048063168624
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AARSD1,Alanyl-tRNA editing protein Aarsd1,32668,0.0101017447022458,0.0231917212855383,-0.0353540290174093,0.0555575184219008,0.66315545115161
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DTYMK,Thymidylate kinase,31571,-0.0124599505682067,0.0286231078368008,-0.0685612419283363,0.043641340791923,0.663348964423959
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSF1,Macrophage colony-stimulating factor 1,32756,0.0046057082785682,0.0105890824454028,-0.0161488933144214,0.0253603098715578,0.663610171512726
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMC3,Structural maintenance of chromosomes protein 3,31326,-0.00992930859210451,0.0229134717908586,-0.0548397133021874,0.0349810961179784,0.664780785985958
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DFFA,DNA fragmentation factor subunit alpha,32833,-0.0121132920487517,0.0279598677164962,-0.0669146327730843,0.0426880486755809,0.664851902285248
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GIT1,ARF GTPase-activating protein GIT1,31355,-0.0174167161996942,0.0402908563995381,-0.0963867947427888,0.0615533623434004,0.665554239009821
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,32748,0.0100938674345535,0.0233575829659031,-0.0356869951786167,0.0558747300477236,0.665646366287794
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PNLIPRP2,Pancreatic lipase-related protein 2,32702,0.0505231612146425,0.118498460053893,-0.181733820490988,0.282780142920273,0.669854952725455
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GP5,Platelet glycoprotein V,31417,-0.00638749346140352,0.015031176839957,-0.0358486000677193,0.0230736131449123,0.670885472264088
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MELTF,Melanotransferrin,31571,-0.00506806900781727,0.0119400886250848,-0.0284706427129836,0.018334504697349,0.671243495909961
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BIRC2,Baculoviral IAP repeat-containing protein 2,32526,-0.0110359145279364,0.0260526167655641,-0.062099043388442,0.0400272143325691,0.671867338411349
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DMD,Dystrophin,31388,-0.009255590519601,0.0218600624793956,-0.0521013129792165,0.0335901319400145,0.672014203541762
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FADD,FAS-associated death domain protein,32729,-0.0133616553732449,0.0315595841192506,-0.0752184402469761,0.0484951295004864,0.672029256524975
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MED18,Mediator of RNA polymerase II transcription subunit 18,32526,-0.0134626868401681,0.031808686774005,-0.0758077129172179,0.0488823392368818,0.672131167044209
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD160,CD160 antigen,32833,0.00770255856629505,0.0182182716738499,-0.0280052539144507,0.0434103710470409,0.672456393481461
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL15,Interleukin-15,32728,0.00552004866746767,0.0130865413658356,-0.0201295724095702,0.0311696697445055,0.673173113219885
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TJP3,Tight junction protein ZO-3,31342,-0.00759025782947034,0.0180316165477561,-0.0429322262630722,0.0277517106041315,0.673809805163838
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,31342,0.0128037130361466,0.030458337477555,-0.0468946284198611,0.0725020544921543,0.674228650191561
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GBP6,Guanylate-binding protein 6,31313,-0.00761111412179002,0.0181472674982529,-0.0431797584183656,0.0279575301747856,0.67492986687218
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNLZ,DNL-type zinc finger protein,31342,0.0157110990389104,0.0375486788996393,-0.0578843116043826,0.0893065096822034,0.67565244905309
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STAT5B,Signal transducer and activator of transcription 5B,32668,-0.0236365431215443,0.0564972683188701,-0.13437118902653,0.0870981027834412,0.675689651014591
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VCPKMT,Protein-lysine methyltransferase METTL21D,31326,-0.014832014663707,0.0354779795848763,-0.0843688546500645,0.0547048253226506,0.675913407550527
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),F10,Coagulation factor X,31586,0.00436935590214254,0.0104626461545111,-0.0161374305606992,0.0248761423649842,0.676240377545597
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WFDC1,WAP four-disulfide core domain protein 1,31386,-0.00934159850769675,0.0223959652029564,-0.0532376903054913,0.0345544932900978,0.67660927763299
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NGF,Beta-nerve growth factor,32647,0.00204844192989816,0.00493136758140966,-0.00761703852966478,0.0117139223894611,0.67786639790467
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGAV,Integrin alpha-V,32794,-0.0027797605923591,0.00669362791576996,-0.0158992713072682,0.01033975012255,0.677943546278936
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ALMS1,Alstrom syndrome protein 1,31456,0.00773516098473772,0.0186331340929328,-0.0287857818374106,0.044256103806886,0.678058933881835
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCL2,Apoptosis regulator Bcl-2,31560,-0.0090605019470572,0.0218549228462934,-0.0518961507257923,0.0337751468316779,0.678464691760375
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPTBN2,"Spectrin beta chain, non-erythrocytic 2",31342,-0.00546105102343294,0.0132103872417857,-0.0313534100173328,0.020431307970467,0.679332246040815
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,31560,-0.0202173370717445,0.0490059656279966,-0.116269029702618,0.0758343555591289,0.679948933549301
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GFRAL,GDNF family receptor alpha-like,31322,0.0105460856509399,0.0255789571668296,-0.0395886703960461,0.0606808416979258,0.680134784520183
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),REG3A,Regenerating islet-derived protein 3-alpha,32834,0.0100385048285668,0.0243551281609428,-0.037697546366881,0.0577745560240146,0.680223114950122
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,32598,0.00444515573616019,0.010793507697673,-0.0167101193512789,0.0256004308235993,0.680469687020624
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPRKB,EKC/KEOPS complex subunit TPRKB,31326,0.0105178533943487,0.0255462340688714,-0.0395527653806392,0.0605884721693366,0.680557690949415
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDX4,Probable ATP-dependent RNA helicase DDX4,31355,-0.00937255714537544,0.0227677425201145,-0.0539973324847998,0.0352522181940489,0.680600796644281
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COMMD1,COMM domain-containing protein 1,31388,-0.0106409374386998,0.0259345853712526,-0.0614727247663548,0.0401908498889553,0.681598217221977
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PHLDB1,Pleckstrin homology-like domain family B member 1,31560,0.00902013157858435,0.022016353467124,-0.0341319212169788,0.0521721843741475,0.682036375237816
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SAT1,Diamine acetyltransferase 1,31313,-0.00837593832566467,0.0204456368367688,-0.0484493865257315,0.0316975098744021,0.682060736233975
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BTC,Probetacellulin,32526,0.0125127251602578,0.030554243612964,-0.0473735923211517,0.0723990426416673,0.682164580653818
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TFF1,Trefoil factor 1,32679,0.0125218306551364,0.030610242974697,-0.0474742455752698,0.0725179068855426,0.682495862316887
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DUSP3,Dual specificity protein phosphatase 3,32502,0.0143999402676763,0.0352147673348609,-0.0546210037086512,0.0834208842440037,0.682610221191707
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC34A3,Sodium-dependent phosphate transport protein 2C,31326,-0.00813595638841775,0.0199048356127335,-0.0471494341893754,0.0308775214125399,0.6827402125371
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FAM171B,Protein FAM171B,31548,0.00459895216978941,0.0112547175595378,-0.0174602942469047,0.0266581985864835,0.682826705317828
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IZUMO1,Izumo sperm-egg fusion protein 1,31326,0.00793603596379086,0.0194277177543902,-0.0301422908348139,0.0460143627623956,0.682925401143116
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSE,Cathepsin E,31417,0.00870162187188053,0.0213412953856261,-0.0331273170839466,0.0505305608277076,0.683478798277818
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TBCA,Tubulin-specific chaperone A,31417,-0.0146049801347981,0.0358728418584603,-0.0849157501773802,0.055705789907784,0.683922607978266
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WNT9A,Protein Wnt-9a,32596,-0.0046131820780895,0.0113327566232568,-0.0268253850596729,0.0175990209034939,0.683969346760086
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINA9,Serpin A9,32624,-0.0120124542732714,0.0296571867272076,-0.0701405402585984,0.0461156317120556,0.685455333924246
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SFRP1,Secreted frizzled-related protein 1,32619,0.00703547788194058,0.0174195467302841,-0.0271068337094162,0.0411777894732973,0.686307812105577
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF16,Fibroblast growth factor 16,31355,-0.00804532875740626,0.0199259586468577,-0.0471002077052474,0.0310095501904349,0.686399857830562
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFSF13,Tumor necrosis factor ligand superfamily member 13,32756,0.00433213207564502,0.010751040736981,-0.0167399077688377,0.0254041719201277,0.686994676252404
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSZ,Cathepsin Z,32716,0.00511063908830234,0.0126874839113813,-0.0197568293780049,0.0299781075546096,0.687098092775283
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MMP10,Stromelysin-2,32698,0.00964613648872563,0.023995878457917,-0.0373857852887917,0.0566780582662429,0.687700085026817
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,31355,0.00765967070237838,0.019056779240372,-0.0296916166087508,0.0450109580135075,0.68774007514889
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRIM21,E3 ubiquitin-protein ligase TRIM21,32728,-0.0122881893502863,0.0305909218407887,-0.0722463961582322,0.0476700174576596,0.687918930463012
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PBLD,Phenazine biosynthesis-like domain-containing protein,32502,-0.00843732918836923,0.0210165020707519,-0.0496296732470429,0.0327550148703045,0.68808985845222
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SHH,Sonic hedgehog protein,31355,-0.0070955423352684,0.0176893140187505,-0.0417665978120194,0.0275755131414826,0.688343015990652
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TAGLN3,Transgelin-3,31326,-0.0102453073970762,0.0256345478549487,-0.0604890211927757,0.0399984063986233,0.689412528161386
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HNRNPK,Heterogeneous nuclear ribonucleoprotein K,32559,-0.0129503617147839,0.0325327390112386,-0.0767145301768115,0.0508138067472438,0.690587125971479
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCUN1D2,DCN1-like protein 2,31326,-0.0135988066926282,0.0342718679019267,-0.0807716677804046,0.0535740543951482,0.6915321124826
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FSTL3,Follistatin-related protein 3,32688,0.00472465379541044,0.0119175353137907,-0.0186337154196193,0.0280830230104401,0.691785953876289
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,32647,0.00467821986142987,0.0118290445558167,-0.0185067074679709,0.0278631471908307,0.692493955723555
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL21R,Interleukin-21 receptor,31355,-0.00910281923268019,0.0230452244135661,-0.0542714590832697,0.0360658206179093,0.69285555059104
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL4A1,Collagen alpha-1(IV) chain,32729,0.00626453704459763,0.0158605312384111,-0.0248221041826882,0.0373511782718835,0.692869733008148
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEZ6L,Seizure 6-like protein,32720,0.00430492609720125,0.0109065666650463,-0.0170719445662895,0.025681796760692,0.693066749758567
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RPL14,60S ribosomal protein L14,31388,0.00684016595494288,0.0173661803082958,-0.0271975474493169,0.0408778793592027,0.693681861802756
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPINT3,Kunitz-type protease inhibitor 3,31560,-0.0242217683157037,0.0615307358862936,-0.144822010652839,0.0963784740214318,0.693848030899602
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRIM58,E3 ubiquitin-protein ligase TRIM58,31548,-0.0140729155019292,0.0358070650533451,-0.0842547630064855,0.0561089320026271,0.694315136674607
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PBK,Lymphokine-activated killer T-cell-originated protein kinase,31326,0.00518856949289024,0.0132047338242341,-0.0206927088026086,0.0310698477883891,0.694380531606744
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCT5,T-complex protein 1 subunit epsilon,32526,0.00731679602961451,0.0186552885734349,-0.0292475695743179,0.043881161633547,0.694912491317569
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,32720,-0.00720925097320936,0.018485762417989,-0.0434413453124678,0.029022843366049,0.69655377660511
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACHE,Acetylcholinesterase,31417,-0.00533858956041171,0.013701217000378,-0.0321929748811525,0.0215157957603291,0.696811192843835
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FAM171A2,Protein FAM171A2,31555,-0.02582224599071,0.0665936286964146,-0.156345758235683,0.104701266254263,0.698205480049528
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAEA,E3 ubiquitin-protein transferase MAEA,32526,-0.00618536060821466,0.0159522895528821,-0.0374518481318636,0.0250811269154343,0.698217053147643
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EVPL,Envoplakin,31456,0.00510487175182811,0.0131925535213721,-0.0207525331500613,0.0309622766537175,0.698803325221075
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MORF4L2,Mortality factor 4-like protein 2,31326,-0.00604913801757517,0.0156377564624718,-0.0366991406840198,0.0246008646488695,0.698893815968896
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,32718,-0.00422685173907606,0.010929537162905,-0.0256487445783699,0.0171950411002177,0.698960527939903
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF19,Fibroblast growth factor 19,32756,-0.012134862408285,0.0313953674555811,-0.073669782621224,0.049400057804654,0.699122607147717
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,32655,0.00388142911431819,0.0100445631123609,-0.0158059145859092,0.0235687728145456,0.699194322137736
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF20,Fibroblast growth factor 20,31355,-0.00694514935284386,0.0180116819543659,-0.0422480459834011,0.0283577472777133,0.699810259214822
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRP1,Prolow-density lipoprotein receptor-related protein 1,32668,0.00419175226564383,0.01087120779599,-0.0171158150144966,0.0254993195457843,0.699814881404522
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ABCA2,ATP-binding cassette sub-family A member 2,31313,-0.00583282958428743,0.0151595479402268,-0.0355455435471319,0.0238798843785571,0.700424166877995
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC4G,C-type lectin domain family 4 member G,32728,0.00512873477376314,0.0133861908420509,-0.0211081992766566,0.0313656688241829,0.701627936879794
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LIF,Leukemia inhibitory factor,32502,0.00794922997971991,0.0209776582713379,-0.0331669802321023,0.0490654401915422,0.70474328116341
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NEK7,Serine/threonine-protein kinase Nek7,31456,-0.0118085940354264,0.0311891071294785,-0.0729392440092042,0.0493220559383514,0.704986024001411
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HBZ,Hemoglobin subunit zeta,31571,0.0165062696303755,0.0437482740874752,-0.0692403475810758,0.102252886841827,0.705960277358106
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VSTM1,V-set and transmembrane domain-containing protein 1,32502,-0.00760391538857215,0.0201955119046424,-0.0471871187216712,0.0319792879445269,0.706543227747313
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEP290,Centrosomal protein of 290 kDa,31456,-0.00810300782069306,0.0216182669587293,-0.0504748110598024,0.0342687954184163,0.70780311721289
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNTN2,Contactin-2,32794,-0.00681162756338831,0.0182107579201528,-0.0425047130868879,0.0288814579601113,0.708380341869499
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STAU1,Double-stranded RNA-binding protein Staufen homolog 1,31326,-0.010528183723634,0.0281772510189939,-0.065755595720862,0.044699228273594,0.708681837764107
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDCD6,Programmed cell death protein 6,32729,0.010609792630238,0.0284043729741782,-0.0450627783991512,0.0662823636596272,0.708765380750202
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAM,Peptidyl-glycine alpha-amidating monooxygenase,32797,0.00410723775170422,0.0110021218059644,-0.017456920987986,0.0256713964913944,0.708924176884442
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGHMBP2,DNA-binding protein SMUBP-2,31313,-0.00901892196674299,0.0242005065368768,-0.0564519147790216,0.0384140708455356,0.709400998104558
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TSNAX,Translin-associated protein X,31313,0.00629949694326998,0.016908643887993,-0.0268414450771963,0.0394404389637363,0.709485988152798
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MORC3,MORC family CW-type zinc finger protein 3,31548,-0.0042183748384669,0.0113398589510405,-0.0264444983825062,0.0180077487055725,0.709906561539442
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PARK7,Parkinson disease protein 7,32718,-0.00804504935025625,0.0216625695835108,-0.0505036857339375,0.034413587033425,0.710363255614862
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNX9,Sorting nexin-9,32729,-0.0104994606086824,0.0282781482344823,-0.0659246311482676,0.0449257099309029,0.710428650966888
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UGDH,UDP-glucose 6-dehydrogenase,31313,0.0158590609252296,0.0427680658874367,-0.0679663482141463,0.0996844700646055,0.710785508786217
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UPK3BL1,Uroplakin-3b-like protein 1,31444,-0.00796459878892508,0.0215175009209282,-0.0501389005939443,0.0342097030160942,0.71128467233152
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CES1,Liver carboxylesterase 1,32747,-0.0121113079670174,0.0327521174889548,-0.0763054582453689,0.0520828423113341,0.711549997646205
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGFBP1,Fibroblast growth factor-binding protein 1,32720,-0.00479221241332081,0.0129691255771552,-0.0302116985445449,0.0206272737179033,0.711756979057045
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDT,D-dopachrome decarboxylase,31571,0.00634063689158791,0.0171604799830382,-0.0272939038751669,0.0399751776583427,0.711772187690785
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIFBP,KIF-binding protein,32668,-0.0125456323729889,0.0339540615262264,-0.0790955929643926,0.0540043282184148,0.711772589169232
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,31355,0.00701307899229199,0.019018526943576,-0.030263233817117,0.044289391801701,0.71232460219434
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BRD2,Bromodomain-containing protein 2,31342,0.00517971644146505,0.0140470091004607,-0.0223524213954379,0.032711854278368,0.712330780278312
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBFOX3,RNA binding protein fox-1 homolog 3,31555,0.00568383050816886,0.0154418772204787,-0.0245822488439693,0.035949909860307,0.712824463753713
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGDCC3,Immunoglobulin superfamily DCC subclass member 3,31342,-0.00748103895618285,0.0203773845680982,-0.0474207127096554,0.0324586347972897,0.713536468557653
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPA2,Carboxypeptidase A2,32786,0.00969069996978432,0.0265162068068939,-0.0422810653717278,0.0616624653112964,0.714774270358636
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SELL,L-selectin,31598,0.00346010452803365,0.00949572231000161,-0.0151515111995695,0.0220717202556368,0.715580039258809
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLU,Clusterin,31598,0.00491898376004196,0.0135291882327297,-0.0215982251761083,0.0314361926961922,0.71617930531414
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DBN1,Drebrin,31355,-0.00794810337657487,0.0218631633897967,-0.0507999036205764,0.0349036968674267,0.716212851789952
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SORD,Sorbitol dehydrogenase,32760,0.0102012652295645,0.0280867563741394,-0.0448487772637487,0.0652513077228777,0.716459983014777
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENPEP,Glutamyl aminopeptidase,31313,-0.00671080120607669,0.018529625588129,-0.0430288673588095,0.0296072649466561,0.717238220313057
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL6A3,Collagen alpha-3(VI) chain,32834,-0.00470256121959726,0.0129990705044597,-0.0301807394083382,0.0207756169691437,0.717538898516643
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCRN1,Secernin-1,32728,0.00835840202511517,0.0231674315005664,-0.0370497637159951,0.0537665677662254,0.718270698493171
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FOXO1,Forkhead box protein O1,32728,0.0125813754980943,0.0349806008800846,-0.0559806022268715,0.0811433532230601,0.719104572139832
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LGALS9,Galectin-9,32708,0.00462041119132156,0.0128524831225392,-0.0205704557288553,0.0298112781114984,0.719232944474533
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRG3,Proteoglycan 3,31571,-0.00747534846519105,0.0207941188660135,-0.0482318214425776,0.0332811245121955,0.719235859306487
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCARA5,Scavenger receptor class A member 5,32806,-0.00430625839287766,0.0119933634257992,-0.0278132507074441,0.0192007339216888,0.719563585546096
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GFRA1,GDNF family receptor alpha-1,32786,-0.00391831414954101,0.0109262225755425,-0.0253337103976043,0.0174970820985222,0.71989113671761
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OSCAR,Osteoclast-associated immunoglobulin-like receptor,32721,0.0047857014335494,0.0133612160617229,-0.0214022820474275,0.0309736849145263,0.720218205939287
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSPG4,Chondroitin sulfate proteoglycan 4,31571,0.00485870584684649,0.0135717031446774,-0.0217418323167213,0.0314592440104143,0.720351120979771
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COLEC12,Collectin-12,32702,0.00355429680797547,0.00993249386989232,-0.0159133911770135,0.0230219847929644,0.720467587283793
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HAVCR2,Hepatitis A virus cellular receptor 2,32718,0.00487794114993066,0.0136344975922493,-0.0218456741308779,0.0316015564307392,0.720527977189618
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANKRD54,Ankyrin repeat domain-containing protein 54,32526,0.00862158026563007,0.0241248581278559,-0.0386631416649674,0.0559063021962276,0.720821061544428
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCTN2,Dynactin subunit 2,32668,0.0139014237025139,0.0389352591899313,-0.0624116843097515,0.0902145317147793,0.721070822667553
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DSC2,Desmocollin-2,32610,0.0048226006172485,0.0135647200082394,-0.0217642505989007,0.0314094518333977,0.722204694078546
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OMD,Osteomodulin,32756,0.00633527500929427,0.0179352718735755,-0.0288178578629137,0.0414884078815022,0.723924433449175
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL13,C-C motif chemokine 13,32817,-0.00992953323062637,0.0281468983400424,-0.0650974539771095,0.0452383875158567,0.72426513082368
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGB1BP1,Integrin beta-1-binding protein 1,32526,-0.00585584814347725,0.0166517280602101,-0.0384932351414891,0.0267815388545346,0.725097242380277
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDX25,ATP-dependent RNA helicase DDX25,31356,-0.0054166471957504,0.0154212228619555,-0.0356422440051832,0.0248089496136824,0.725413462810583
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PGM2,Phosphoglucomutase-2,31356,-0.00855041470205946,0.0243491121747351,-0.0562746745645403,0.0391738451604213,0.725478787550693
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PGLYRP2,N-acetylmuramoyl-L-alanine amidase,31489,-0.00440729430865722,0.0125897225198602,-0.0290831504475832,0.0202685618302687,0.726295223793228
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",32657,-0.0109951262098734,0.0314232579589132,-0.0725847118093433,0.0505944593895965,0.726419060424901
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",31555,-0.00587031146659684,0.0167976114058724,-0.0387936298221067,0.027053006888913,0.726743808806612
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C9,Complement component C9,31586,-0.00769301665167445,0.0220436887479733,-0.0508986465977022,0.0355126132943533,0.727106677606602
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAPKAPK2,MAP kinase-activated protein kinase 2,31456,0.0106702723616079,0.0305910729292332,-0.0492882305796891,0.070628775302905,0.727246526266954
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPOCK1,Testican-1,32647,-0.00356870303175915,0.0102518788239771,-0.0236623855267542,0.0165249794632359,0.727771664037921
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL5,Interleukin-5,32596,0.0201901385979916,0.0581237009902782,-0.0937323153429538,0.134112592538937,0.728325502410163
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RFC4,Replication factor C subunit 4,31548,0.00328711669975819,0.00946888338150664,-0.0152718947279948,0.0218461281275112,0.728488623218864
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARG1,Arginase-1,32663,0.00751153639849718,0.0216580668689651,-0.0349382746646743,0.0499613474616687,0.728731869878154
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYOM2,Myomesin-2,31313,0.00742867126438876,0.0214742829498911,-0.0346609233173977,0.0495182658461752,0.729402546883607
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTH,Parathyroid hormone,31356,-0.0113620427097285,0.0328513696527316,-0.0757507272290825,0.0530266418096254,0.729456081237561
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAMTSL5,ADAMTS-like protein 5,31571,-0.00568351488834607,0.0164522284532574,-0.0379298826567306,0.0265628528800385,0.729761287371404
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AAMDC,Mth938 domain-containing protein,31388,0.00771605642473179,0.022339706082428,-0.0360697674968271,0.0515018803462906,0.729805954120425
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HDGFL2,Hepatoma-derived growth factor-related protein 2,31548,-0.0090490208402169,0.0263705612915657,-0.0607353209716858,0.042637279291252,0.731496063147036
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCGB3A1,Secretoglobin family 3A member 1,31417,0.00352365831136084,0.0102880361316372,-0.0166408925066481,0.0236882091293697,0.731983735243596
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD164,Sialomucin core protein 24,32718,-0.00381792475315204,0.0111581088118411,-0.0256878180243606,0.0180519685180565,0.732234136078714
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRPV3,Transient receptor potential cation channel subfamily V member 3,31313,-0.0070171374859698,0.0206541701398324,-0.0474993109600413,0.0334650359881017,0.73405863770249
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HCG22,Protein PBMUCL2,31313,0.00763359356809285,0.0224824149996418,-0.036431939831205,0.0516991269673907,0.734215404687949
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,32729,0.00915135220827061,0.0270412842387141,-0.043849564899609,0.0621522693161502,0.735053578618783
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BRME1,Break repair meiotic recombinase recruitment factor 1,31342,0.00552787941029967,0.0163387277321297,-0.0264960269446745,0.0375517857652738,0.735124119691544
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,31571,0.00443308893550107,0.0131047123752263,-0.0212521473199424,0.0301183251909446,0.735159860759829
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCN,Decorin,32598,0.00294260160623134,0.00870026796670917,-0.0141099236085186,0.0199951268209813,0.735205792912494
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD6,T-cell differentiation antigen CD6,32820,-0.00717831047061821,0.0212389027730336,-0.048806559905764,0.0344499389645276,0.735386670506327
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL1R1,Interleukin-1 receptor type 1,32704,0.00300216922953641,0.00898601774920623,-0.0146104255589078,0.0206147640179806,0.738317001210514
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATG4A,Cysteine protease ATG4A,32526,0.00826142813485521,0.0247692026794712,-0.0402862091169082,0.0568090653866187,0.738737565161792
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MEGF10,Multiple epidermal growth factor-like domains protein 10,32702,-0.00548854007265976,0.0164703210073658,-0.0377703692470966,0.0267932891017771,0.738962388656487
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DEFA1_DEFA1B,Neutrophil defensin 1,32525,0.00699146016237385,0.0210087745589421,-0.0341857379731526,0.0481686582979003,0.739302651923863
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLASP1,CLIP-associating protein 1,31326,0.0101341247148627,0.0305126439518253,-0.0496706574307148,0.0699389068604403,0.739801404439049
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NTF4,Neurotrophin-4,32526,0.00546600386906013,0.0164660519488511,-0.0268074579506881,0.0377394656888084,0.739930551649936
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLIC5,Chloride intracellular channel protein 5,31356,-0.0045439795609992,0.0136886744467328,-0.0313737814765954,0.022285822354597,0.739934966989511
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UNC79,Protein unc-79 homolog,31326,-0.00787021667337017,0.0238094511327339,-0.0545367408935287,0.0387963075467883,0.740993611905652
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSG1,Pregnancy-specific beta-1-glycoprotein 1,32647,0.0145640505400274,0.044178744974763,-0.0720262896105081,0.101154390690563,0.741663276898585
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TDGF1,Teratocarcinoma-derived growth factor 1,32502,0.018948691355639,0.057530757035596,-0.093811592434129,0.131708975145407,0.741886834803042
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDIA2,Protein disulfide-isomerase A2,31326,-0.00546960200271104,0.0166212766266976,-0.0380473041910383,0.0271081001856163,0.742110258489528
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL1R2,Interleukin-1 receptor type 2,32686,0.00259876757484284,0.00791769742116009,-0.0129199193706309,0.0181174545203166,0.742751114688349
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TTR,Transthyretin,31510,-0.003410618791746,0.0103983539245985,-0.023791392483959,0.016970154900467,0.742923641593043
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C7orf50,Uncharacterized protein C7orf50,31548,-0.00329780099660865,0.0100598191360534,-0.0230150465032733,0.016419444510056,0.743057360949812
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BSND,Barttin,31326,0.00459363548113679,0.0140543208670437,-0.0229528334182689,0.0321401043805425,0.743791540838646
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HNMT,Histamine N-methyltransferase,32608,-0.006122045598759,0.0187965304519592,-0.0429632452845991,0.0307191540870811,0.74465850497083
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STIP1,Stress-induced-phosphoprotein 1,32701,-0.00868137796872282,0.0267122433674337,-0.0610373749688928,0.0436746190314471,0.745191626811014
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,32668,-0.00581737647360931,0.017941419262676,-0.0409825582284542,0.0293478052812356,0.745761901224391
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC10A,C-type lectin domain family 10 member A,32647,0.00478166059342996,0.014750589950006,-0.0241294957085817,0.0336928168954417,0.745819007041269
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MDH1,"Malate dehydrogenase, cytoplasmic",31542,0.00548567938411855,0.0169372539128398,-0.0277113382850475,0.0386826970532846,0.746035844434563
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD101,Immunoglobulin superfamily member 2,31560,-0.00552444173208279,0.0170716213699953,-0.0389848196172736,0.027935936153108,0.746246790843099
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FUCA1,Tissue alpha-L-fucosidase,32773,-0.0105559839533941,0.0326250201500202,-0.0745010234474338,0.0533890555406455,0.746282655636854
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SKIV2L,Helicase SKI2W,31313,-0.00537525281598452,0.016631087759668,-0.0379721848249338,0.0272216791929648,0.746548966509755
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1QA,Complement C1q subcomponent subunit A,32793,0.00301028708705178,0.00931766221548378,-0.0152523308552964,0.0212729050294,0.746647356750581
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL8,Interleukin-8,32633,-0.00891670783982559,0.0276135343825767,-0.0630392352296759,0.0452058195500248,0.746770509986916
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ASRGL1,Isoaspartyl peptidase/L-asparaginase,31388,-0.0136739458526789,0.0424281441387011,-0.096833108364533,0.0694852166591752,0.747245898306487
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),F13B,Coagulation factor XIII B chain,31555,0.00344072827536136,0.0106833606343087,-0.0174986585678837,0.0243801151186064,0.747412787624859
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TANK,TRAF family member-associated NF-kappa-B activator,32596,-0.00929976186156089,0.0289979311441652,-0.0661357069041247,0.0475361831810029,0.748442142244142
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPC5,Glypican-5,32647,-0.00734857906453392,0.0229158129693858,-0.0522635724845302,0.0375664143554623,0.748462642212645
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TFF2,Trefoil factor 2,32739,0.00732552709457177,0.0229249054717376,-0.037607287630034,0.0522583418191775,0.749321182317695
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRRN1,Leucine-rich repeat neuronal protein 1,32596,-0.00511000920573856,0.0160248067806226,-0.0365186304957589,0.0262986120842818,0.749824244044626
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPSG1,Tryptase gamma,31355,-0.00354127237122924,0.0111059589940681,-0.0253089519996027,0.0182264072571442,0.749839768159831
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BPIFB1,BPI fold-containing family B member 1,32709,-0.00826082945777942,0.0259129939353971,-0.0590502975711576,0.0425286386555988,0.749892521416518
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNM3,Dynamin-3,31555,-0.00739748611066357,0.0232254028259782,-0.0529192756495808,0.0381243034282537,0.750107960897848
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STXBP3,Syntaxin-binding protein 3,32526,0.00563508269312934,0.0176986538735543,-0.029054278899037,0.0403244442852957,0.750196440156944
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITPA,Inosine triphosphate pyrophosphatase,31313,-0.00897682887843372,0.0283570861088455,-0.0645567176517708,0.0466030598949034,0.751583421270494
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CENPF,Centromere protein F,31456,-0.00721496803330588,0.0228279859957806,-0.0519578205850359,0.0375278845184242,0.751967154420721
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDC,Aromatic-L-amino-acid decarboxylase,32719,0.00622071254986954,0.0197029568773631,-0.0323970829297622,0.0448385080295013,0.752218821928923
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENDOU,Poly(U)-specific endoribonuclease,30982,-0.00681385875126406,0.0215836199372686,-0.0491177538283106,0.0354900363257824,0.752242644546541
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNF5,E3 ubiquitin-protein ligase RNF5,31388,-0.00965772286837149,0.0305980868764157,-0.0696299731461462,0.0503145274094032,0.752290905257588
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ESM1,Endothelial cell-specific molecule 1,32702,-0.00435870402203226,0.0138383688617546,-0.0314819069910712,0.0227644989470067,0.75279005478374
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MRPL46,"39S ribosomal protein L46, mitochondrial",32502,0.0035466586537442,0.0112604092077602,-0.0185237433934658,0.0256170607009542,0.752794223267292
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SUGT1,Protein SGT1 homolog,32526,-0.010429265944257,0.0332039475887536,-0.075509003218214,0.0546504713297001,0.753454800086678
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,32765,-0.0145088200410841,0.0461955855031975,-0.105052167627351,0.076034527545183,0.753472395114813
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SESTD1,SEC14 domain and spectrin repeat-containing protein 1,32502,-0.00807677463762044,0.0257238766217417,-0.0584955728162342,0.0423420235409934,0.753544047911611
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,31326,0.00724088744281915,0.0230661299270561,-0.0379687272142107,0.052450502099849,0.753591626090448
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,31342,-0.00765575452040197,0.0244805021118379,-0.0556375386596043,0.0403260296188004,0.754495538364691
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PROC,Vitamin K-dependent protein C,32742,-0.00322378647178175,0.0103322195605243,-0.0234749368104093,0.0170273638668458,0.755037993242849
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UBXN1,UBX domain-containing protein 1,31417,-0.00898201216520073,0.0288935994335059,-0.0656134670548724,0.0476494427244709,0.75591173796625
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LARP1,La-related protein 1,31548,0.00832713294834114,0.0267955931521905,-0.0441922296299523,0.0608464955266346,0.755987691292133
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIMP4,Metalloproteinase inhibitor 4,32718,-0.00497283954900693,0.0161661130960061,-0.0366584212171788,0.026712742119165,0.758387212884005
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMEM25,Transmembrane protein 25,31555,0.00564936147394934,0.0183679147131132,-0.0303517513637526,0.0416504743116513,0.758420279825123
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RGMB,RGM domain family member B,32806,0.0031848152883588,0.0103961429320626,-0.0171916248584838,0.0235612554352014,0.759348458724873
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AREG,Amphiregulin,32668,-0.00571657223393055,0.0187566704126252,-0.0424796462426759,0.0310465017748148,0.760544398911872
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CENPJ,Centromere protein J,31456,-0.00925301348951984,0.0305719892661995,-0.0691741124512708,0.0506680854722311,0.762154897825612
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PODXL2,Podocalyxin-like protein 2,32720,-0.00339846224376408,0.0112291386824798,-0.0254075740614244,0.0186106495738962,0.762166193303103
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,32702,-0.00465056899738768,0.0153752223640951,-0.034786004831014,0.0254848668362387,0.762299650779505
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DTX2,Probable E3 ubiquitin-protein ligase DTX2,31356,-0.00828259426275128,0.027435649098421,-0.0620564664956564,0.0454912779701538,0.762743011610207
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PFDN2,Prefoldin subunit 2,32502,-0.00674256450279785,0.0223611849220519,-0.0505704869500196,0.0370853579444239,0.763017754482863
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MLLT1,Protein ENL,31326,0.00895556663072145,0.0297398604672466,-0.049334559885082,0.0672456931465249,0.763323688457743
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),USP25,Ubiquitin carboxyl-terminal hydrolase 25,31548,-0.00905601573151397,0.0301160793981597,-0.0680835313519069,0.0499714998888789,0.763648597940911
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LTO1,Protein LTO1 homolog,32596,-0.00516095684767816,0.0171763406256108,-0.0388265844738754,0.0285046707785191,0.763826635187874
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOD,Apolipoprotein D,31235,-0.00543254738297449,0.0182748965206109,-0.0412513445633719,0.0303862497974229,0.766270055171091
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINA6,Corticosteroid-binding globulin,31598,0.00219410811977124,0.0074128061739779,-0.0123349919812254,0.0167232082207679,0.76724652425545
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGL1,Fibrinogen-like protein 1,31586,0.00760070169744859,0.025869826053483,-0.0431041573673781,0.0583055607622753,0.768914290697159
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GSTP1,Glutathione S-transferase P,32448,0.00820066299262927,0.0279342433734954,-0.0465504540194218,0.0629517800046803,0.769093400474138
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FAM3D,Protein FAM3D,31560,-0.0102186873178601,0.0348778058432683,-0.078579186770666,0.0581418121349458,0.769541219080481
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL34,Interleukin-34,32489,-0.00425970711536486,0.0145615368149925,-0.0328003192727501,0.0242809050420204,0.769887369771693
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KDR,Vascular endothelial growth factor receptor 2,32720,-0.00311110076040014,0.0106757530484288,-0.0240355767353205,0.0178133752145202,0.770738890121451
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SV2A,Synaptic vesicle glycoprotein 2A,31356,-0.00745082413772997,0.0256060706104704,-0.057638722534252,0.0427370742587921,0.771075570725006
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DEFB116,Beta-defensin 116,31342,0.00895911863996358,0.0308332037148132,-0.0514739606410703,0.0693921979209974,0.771390377938653
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TADA3,Transcriptional adapter 3,31548,-0.00489900955528565,0.0168907614717204,-0.0380049020398576,0.0282068829292863,0.771792865591574
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTN,Pleiotrophin,32598,0.00590294643245649,0.0203618308228023,-0.034006241980236,0.045812134845149,0.771897678741107
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GHR,Growth hormone receptor,31417,-0.00343447395108587,0.0118733191798113,-0.026706179543516,0.0198372316413443,0.772390506493884
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,31313,-0.00791782992473569,0.0274230192280175,-0.0616669476116499,0.0458312877621785,0.772796547056239
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRKCQ,Protein kinase C theta type,32596,-0.00508919165305358,0.0176321746708976,-0.0396482540080128,0.0294698707019057,0.772870642188039
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRIM5,Tripartite motif-containing protein 5,32728,0.0101848451413593,0.0353434785309224,-0.0590883727792487,0.0794580630619673,0.773225188506024
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGBL1,Integrin beta-like protein 1,31571,0.00419878710680825,0.0146017643645437,-0.0244206710476973,0.0328182452613138,0.773696341323487
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCL7A,B-cell CLL/lymphoma 7 protein family member A,31326,0.0075221460166077,0.0261839781872456,-0.0437984512303936,0.058842743263609,0.773905534789876
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCER2,Low affinity immunoglobulin epsilon Fc receptor,32718,-0.00563129525128561,0.0196166350541371,-0.0440798999573942,0.032817309454823,0.774067473372628
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLAU,Urokinase-type plasminogen activator,32718,-0.00343283305587964,0.0120494670941505,-0.0270497885604147,0.0201841224486554,0.775731238839796
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WASF3,Wiskott-Aldrich syndrome protein family member 3,32502,-0.0100235080580901,0.0352568347777202,-0.0791269042224217,0.0590798881062414,0.776187516450747
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",32666,0.00779287298674905,0.027520828479751,-0.0461479508335629,0.061733696807061,0.777058751066989
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRIM40,E3 ubiquitin ligase TRIM40,31356,0.00858916265971527,0.0303923932626878,-0.0509799281351529,0.0681582534545834,0.777484413845017
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ISM2,Isthmin-2,31571,0.00514049826080236,0.0181963130950058,-0.030524275405409,0.0408052719270137,0.777566051469638
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAX,Protein max,32502,-0.0121463408246412,0.0430370258400409,-0.0964989114711214,0.072206229821839,0.777773896564531
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,31548,0.00536096833738814,0.0190512448715619,-0.0319794716108731,0.0427014082856494,0.778413283368704
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TSLP,Thymic stromal lymphopoietin,32598,-0.00690316701609875,0.0246447495107789,-0.0552068760572253,0.0414005420250278,0.779402039827291
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),S100A16,Protein S100-A16,32489,0.00698996113963309,0.0249560484258331,-0.0419238937749997,0.0559038160542659,0.77941450850038
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FNDC1,Fibronectin type III domain-containing protein 1,31548,-0.00540396938576571,0.0193522103194619,-0.043334301611911,0.0325263628403796,0.780065852932758
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL20RB,Interleukin-20 receptor subunit beta,31355,-0.00489516374905507,0.0175411960323709,-0.039275907972502,0.0294855804743919,0.780201334895292
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPRY2,Protein sprouty homolog 2,32596,-0.0107381218841131,0.0385163903802971,-0.0862302470294954,0.0647540032612692,0.780409850091577
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCIN,Adseverin,31342,-0.00860962512476799,0.030894019512556,-0.0691619033693778,0.0519426531198419,0.780496132382409
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL17RA,Interleukin-17 receptor A,32718,0.00500731197823396,0.0179737682501055,-0.0302212737919728,0.0402358977484407,0.780565995889741
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,32715,0.00672639956348313,0.0241746739524063,-0.0406559613832333,0.0541087605101996,0.780833412065298
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,32668,0.00514586962839914,0.0185086721780712,-0.0311311278406204,0.0414228670974187,0.780999857536424
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC12A2,Solute carrier family 12 member 2,31313,-0.00322599892183266,0.0116069219442861,-0.0259755659326334,0.0195235680889681,0.781068042721899
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UNC5D,Netrin receptor UNC5D,31355,0.00316286540438121,0.0113891014287983,-0.0191597733960635,0.0254855042048259,0.781242774903845
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",31313,-0.00982188335723865,0.0353908539265734,-0.0791879570533226,0.0595441903388452,0.781383915167389
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIGIT,T-cell immunoreceptor with Ig and ITIM domains,31456,0.00414757733587645,0.0149722590300993,-0.0251980503631181,0.033493205034871,0.781774228532163
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PALM2,Paralemmin-2,31548,0.00437238070436402,0.0157883200623073,-0.0265727266177582,0.0353174880264863,0.781835405674297
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UPK3A,Uroplakin-3a,31342,0.0055406458495182,0.02005825324558,-0.0337735305118185,0.044854822210855,0.782380786002584
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSP90B1,Endoplasmin,32458,-0.00763610299265649,0.0276665226443684,-0.0618624873756186,0.0465902813903056,0.782550736861454
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CES3,Carboxylesterase 3,32668,0.00776364930887008,0.0281588083798905,-0.0474276151157153,0.0629549137334554,0.782777711813939
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,31571,-0.00839388329004246,0.0304541198051009,-0.0680839581080402,0.0512961915279553,0.782844335991437
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLB1,"Phospholipase B1, membrane-associated",31548,-0.00680586723700572,0.0247066772842714,-0.0552309547141777,0.0416192202401663,0.782965097456584
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSAPL1,Proactivator polypeptide-like 1,31560,0.00573346985102869,0.0208957409393077,-0.0352221823900144,0.0466891220920718,0.783796424941285
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF23,Fibroblast growth factor 23,32774,-0.00676227878670171,0.0246616950411784,-0.0550992010674114,0.041574643494008,0.783935972945222
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SOD2,"Superoxide dismutase [Mn], mitochondrial",32718,-0.00424478350487554,0.0155110700728787,-0.0346464808477179,0.0261569138379668,0.784351107899238
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",32777,0.00816705697587543,0.0298754607950557,-0.0503888461824337,0.0667229601341846,0.784575084310362
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDGFC,Platelet-derived growth factor C,32526,0.00326875695879224,0.0119579038835896,-0.0201687346530434,0.0267062485706278,0.78458658846782
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRKD2,Serine/threonine-protein kinase D2,31313,-0.00559303311349916,0.020500916383645,-0.0457748292254434,0.0345887629984451,0.785000151683042
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COPE,Coatomer subunit epsilon,32502,0.00503678564365251,0.0184645785810036,-0.0311537883751146,0.0412273596624196,0.785028106815999
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINC1,Antithrombin-III,31582,0.00162212549155503,0.00602704186187136,-0.0101908765577128,0.0134351275408229,0.787828190201401
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL9A2,Collagen alpha-2(IX) chain,31456,0.00488153093116649,0.0181534149198637,-0.0306991623117664,0.0404622241740994,0.788010647907795
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCRL6,Fc receptor-like protein 6,32728,-0.00722163307972758,0.0268809898606332,-0.0599083732065687,0.0454651070471136,0.788203702019812
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCSK7,Proprotein convertase subtilisin/kexin type 7,31548,0.00501093108935227,0.0186560993906404,-0.0315550237163028,0.0415768858950074,0.788248729174628
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VASH1,Tubulinyl-Tyr carboxypeptidase 1,32728,-0.00903794443768028,0.0337150750100107,-0.0751194914573012,0.0570436025819406,0.788652944466001
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GAL,Galanin peptides,32756,-0.00707146946191909,0.0264154461916838,-0.0588457439976194,0.0447028050737812,0.788934867318147
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC4M,C-type lectin domain family 4 member M,31556,-0.0053307568020818,0.0199137551794081,-0.0443617169537217,0.0337002033495581,0.788943433013045
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHRDL1,Chordin-like protein 1,32739,0.0033226614834472,0.0124740298422654,-0.021126437007393,0.0277717599742874,0.789963282790138
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERP44,Endoplasmic reticulum resident protein 44,32657,-0.00285284361204212,0.0107424250316287,-0.0239079966740344,0.0182023094499502,0.790578207637327
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),THBS4,Thrombospondin-4,32727,0.00485570310655325,0.0183052435708577,-0.0310225742923277,0.0407339805054343,0.790813062079206
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGFBP4,Insulin-like growth factor-binding protein 4,32610,0.00412311041361752,0.0156561561461592,-0.0265629556328545,0.0348091764600895,0.792283989089745
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),YOD1,Ubiquitin thioesterase OTU1,31313,0.00680770278107876,0.0260200692753962,-0.0441916329986978,0.0578070385608553,0.793611807312348
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC4C,C-type lectin domain family 4 member C,32728,-0.00484806363203786,0.0185304795873634,-0.0411678036232701,0.0314716763591943,0.793615524279295
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PGLYRP4,Peptidoglycan recognition protein 4,31313,0.0067103126282902,0.0256528745016961,-0.0435693213950342,0.0569899466516146,0.793651479808144
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMED4,Transmembrane emp24 domain-containing protein 4,31313,0.00641424108089243,0.0245690861176676,-0.0417411677097361,0.0545696498715209,0.794046060565846
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CASQ2,Calsequestrin-2,31313,-0.00526478135563646,0.0201811471886755,-0.0448198298454404,0.0342902671341675,0.794195172780014
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IRAK1,Interleukin-1 receptor-associated kinase 1,32596,-0.00752424216093858,0.0289797032138737,-0.0643244604601311,0.0492759761382539,0.795148874077126
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAGR1,PAXIP1-associated glutamate-rich protein 1,31388,-0.00485040842444133,0.0186922938485053,-0.0414873043675118,0.0317864875186291,0.79526655836765
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,32728,-0.00654692359404842,0.0253446821993551,-0.0562225007047844,0.0431286535166876,0.796169439576293
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",32596,-0.00766262349797701,0.0296757318509891,-0.0658270579259157,0.0505018109299617,0.796249550815685
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AIDA,"Axin interactor, dorsalization-associated protein",31356,0.0091910482457697,0.0356041233138502,-0.0605930334493767,0.0789751299409161,0.796301616822059
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCRLB,Fc receptor-like B,32526,-0.00613578110568953,0.0238070112561203,-0.0527975231676854,0.0405259609563063,0.796621407984567
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IDI2,Isopentenyl-diphosphate delta-isomerase 2,32502,-0.00490328499118985,0.0190835370548093,-0.0423070176186161,0.0325004476362364,0.79723278646994
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADRA2A,Alpha-2A adrenergic receptor,31313,-0.00771513758999735,0.0300484058275739,-0.0666100130120422,0.0511797378320476,0.797373477942678
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SUMF1,Formylglycine-generating enzyme,31355,0.00732023022694861,0.0286259928761126,-0.0487867158102321,0.0634271762641293,0.798174302053662
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF2,Fibroblast growth factor 2,32728,0.00699770554869094,0.0273768052866117,-0.0466608328130679,0.0606562439104498,0.798260170918096
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSPB6,Heat shock protein beta-6,32794,0.00392526441397085,0.0153782864712299,-0.0262161770696397,0.0340667058975814,0.79853806079975
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),INPP1,Inositol polyphosphate 1-phosphatase,32668,0.00568173705883855,0.0223453748434164,-0.0381151976342576,0.0494786717519348,0.799293650265396
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RSPO3,R-spondin-3,32794,-0.00279005700036909,0.0109832457649938,-0.0243172186997569,0.0187371046990187,0.799479417660955
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SFTPA2,Pulmonary surfactant-associated protein A2,32526,0.00509261316714286,0.0201387210426189,-0.0343792800763902,0.0445645064106759,0.800369498847945
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRSS53,Serine protease 53,31548,-0.00396283166287819,0.0156768801341636,-0.0346895167258388,0.0267638534000824,0.800443507712178
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAIP2B,Polyadenylate-binding protein-interacting protein 2B,31311,0.0057153980354323,0.0226444469450305,-0.0386677179768275,0.0500985140476921,0.800740922674902
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",31555,-0.0080832670871016,0.0321859923533372,-0.0711678120996426,0.0550012779254394,0.801710728163475
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STX3,Syntaxin-3,31548,0.00382899039574388,0.0153285333266659,-0.0262149349245213,0.0338729157160091,0.80275259013237
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DLL1,Delta-like protein 1,32720,-0.0029113753393582,0.0116599452888483,-0.0257648681055008,0.0199421174267844,0.802832641896962
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFYA,Nuclear transcription factor Y subunit alpha,31313,-0.00398568685632676,0.0160154903534696,-0.0353760479491272,0.0274046742364737,0.80347246057967
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PEBP1,Phosphatidylethanolamine-binding protein 1,32718,-0.006038765015389,0.0243071662432189,-0.0536808108520981,0.0416032808213201,0.80380316431161
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYL1,"Myosin light chain 1/3, skeletal muscle isoform",31313,0.00430461507321354,0.0173388092492575,-0.0296794510553312,0.0382886812017582,0.803936413783805
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDC27,Cell division cycle protein 27 homolog,32526,0.00624705823337749,0.0252485212568856,-0.0432400434301183,0.0557341598968733,0.804586941011733
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,31417,0.00379745916637445,0.0153632897714388,-0.0263145887856455,0.0339095071183945,0.804777591832062
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TBL1X,F-box-like/WD repeat-containing protein TBL1X,32526,-0.00858995301720912,0.03491329932571,-0.0770200196956006,0.0598401136611824,0.80565964844009
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK10,Kallikrein-10,32698,-0.00394675934200946,0.0161034848759225,-0.0355095896988176,0.0276160710147986,0.806394540260337
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL10RA,Interleukin-10 receptor subunit alpha,32596,-0.00602015948224233,0.0246927145555014,-0.0544178800110252,0.0423775610465405,0.807389071641732
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TP73,Tumor protein p73,31356,0.00356951157041267,0.0146531255456841,-0.0251506144991282,0.0322896376399535,0.807546755884665
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BAX,Apoptosis regulator BAX,32489,-0.00896625808559579,0.0369236088278759,-0.0813365313882325,0.0634040152170409,0.808140806606606
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CREB3,Cyclic AMP-responsive element-binding protein 3,31326,0.00543076665558314,0.0225427680941102,-0.0387530588088728,0.0496145921200391,0.809631885633687
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PITHD1,PITH domain-containing protein 1,31311,-0.00798606300684544,0.0332025233769503,-0.0730630088256681,0.0570908828119772,0.809929293478369
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DLL4,Delta-like protein 4,31388,0.00897195903746792,0.037368673660214,-0.0642706413365516,0.0822145594114874,0.810264654974946
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL3,C-X-C motif chemokine 3,32708,-0.0093393776801719,0.0390833218755279,-0.0859426885562066,0.0672639331958628,0.81114159669836
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,32647,-0.00406539796114305,0.0170405648398641,-0.0374649050472767,0.0293341091249906,0.811443209509009
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAP3K5,Mitogen-activated protein kinase kinase kinase 5,32526,-0.00958919053170302,0.0402359576807091,-0.0884516675858929,0.0692732865224869,0.811635517212908
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DENR,Density-regulated protein,31355,0.00573891512642615,0.0241316896948294,-0.0415591966754395,0.0530370269282918,0.812029884465236
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FLT3,Receptor-type tyrosine-protein kinase FLT3,32526,0.00301402302114131,0.0126794454768407,-0.0218376901134666,0.0278657361557492,0.812112133796606
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),THAP12,52 kDa repressor of the inhibitor of the protein kinase,31311,-0.00891115357984541,0.037539274813189,-0.0824881322136959,0.0646658250540051,0.812366866540927
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,32784,0.00337086293828832,0.0142257622118484,-0.0245116309969346,0.0312533568735112,0.812697278699575
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL4A4,Collagen alpha-4(IV) chain,31446,0.00496554988983433,0.0209796042046992,-0.0361544743513761,0.0460855741310448,0.812907849079036
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STX16,Syntaxin-16,32526,-0.00557764408230741,0.0235789183959014,-0.0517923241382741,0.0406370359736593,0.813009828296798
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NAP1L4,Nucleosome assembly protein 1-like 4,31548,-0.00398345923701889,0.0169102604917923,-0.0371275698009319,0.0291606513268941,0.813776797574801
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EFCAB2,Dynein regulatory complex protein 8,31456,0.00344288243500723,0.0146624381101691,-0.0252954962609243,0.0321812611309387,0.81436278146724
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIT,Mast/stem cell growth factor receptor Kit,32742,0.00278908392156211,0.0118952063409759,-0.0205255205067507,0.026103688349875,0.814624553422302
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HEPACAM2,HEPACAM family member 2,31548,0.00402383569904284,0.017164084379422,-0.0296177696846242,0.0376654410827099,0.814654727314858
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CALCA,Calcitonin,32636,-0.00589425612983673,0.0251717842912201,-0.0552309533406281,0.0434424410809546,0.81486526961941
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC3B,Tetranectin,31415,-0.0020666235523757,0.00883586650337775,-0.0193849218989961,0.0152516747942447,0.815076473648486
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHEK2,Serine/threonine-protein kinase Chk2,32598,0.00323803635002749,0.0138910103089729,-0.0239883438555593,0.0304644165556143,0.815686875644665
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNTNAP2,Contactin-associated protein-like 2,32728,-0.00387135138586947,0.016642527213548,-0.0364907047244235,0.0287480019526845,0.816063417350673
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOBR,Apolipoprotein B receptor,31388,-0.00411527578310241,0.0177498526346636,-0.0389049869470431,0.0306744353808383,0.816662027940832
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD48,CD48 antigen,32739,-0.00275759233586426,0.0119210300155337,-0.0261228111663104,0.0206076264945819,0.817070258507258
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ASPSCR1,Tether containing UBX domain for GLUT4,31555,-0.00650896710117637,0.0283094484090119,-0.0619954859828398,0.048977551780487,0.818158434322939
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GOT1,"Aspartate aminotransferase, cytoplasmic",31571,-0.0039477368435108,0.0172586019544009,-0.0377745966741366,0.029879122987115,0.819076878607962
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF6,Fibroblast growth factor 6,31355,-0.00373348408737742,0.016339296548331,-0.0357585053221063,0.0282915371473514,0.819265938941388
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LACRT,Extracellular glycoprotein lacritin,31535,0.00460897136655324,0.0202220285540315,-0.0350262045993485,0.044244147332455,0.8197157888561
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAP3,Cytosol aminopeptidase,32596,-0.0045268095277389,0.0199850322452867,-0.0436974727285007,0.034643853673023,0.82081008688764
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TP53INP1,Tumor protein p53-inducible nuclear protein 1,32598,0.00278222916493858,0.0122908940841461,-0.0213079232399878,0.0268723815698649,0.82092278358735
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANK2,Ankyrin-2,31313,-0.00666586669711614,0.0295295115154099,-0.0645437092673196,0.0512119758730873,0.821413133696493
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRYZL1,Quinone oxidoreductase-like protein 1,31388,0.00860446516027259,0.038258342611905,-0.0663818863590611,0.0835908166796063,0.822059840669679
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCTN6,Dynactin subunit 6,32502,-0.0064545695680951,0.0287497813392766,-0.0628041409930773,0.0498950018568871,0.82236698070599
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VPS37A,Vacuolar protein sorting-associated protein 37A,32668,-0.00734032948792847,0.0327191017488839,-0.0714697689157409,0.056789109939884,0.822494956371828
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PFDN4,Prefoldin subunit 4,31326,-0.00507229883740996,0.0227459062656615,-0.0496542751181066,0.0395096774432866,0.823542916118516
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GID8,Glucose-induced degradation protein 8 homolog,31555,0.0029288863157959,0.0131353197692895,-0.0228163404320115,0.0286741130636033,0.823558607491118
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SUOX,"Sulfite oxidase, mitochondrial",31555,0.00584593458263298,0.0262594784469518,-0.0456226431733925,0.0573145123386584,0.823835710843338
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIT1,Signaling threshold-regulating transmembrane adapter 1,32596,0.00498032335676315,0.0225004279044148,-0.0391205153358899,0.0490811620494162,0.824830158668874
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDCD1LG2,Programmed cell death 1 ligand 2,32668,-0.00285354207740458,0.0129255124145169,-0.0281875464098578,0.0224804622550486,0.825278044348771
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPT1,Translationally-controlled tumor protein,32596,-0.00571908592349632,0.0260092052783497,-0.0566971282690617,0.0452589564220691,0.825964304651372
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCN3,CCN family member 3,32824,-0.00289422208965914,0.0132153062773181,-0.0287962223932026,0.0230077782138844,0.826650906787706
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NTRK3,NT-3 growth factor receptor,32806,0.00189118715751796,0.00867413332695567,-0.0151101141633151,0.0188924884783511,0.827413775673081
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCL2L15,Bcl-2-like protein 15,31355,-0.00526805650694191,0.0241755358767425,-0.0526521068253572,0.0421159938114734,0.827506280071288
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SDC4,Syndecan-4,32729,-0.00405038549142662,0.01861656660647,-0.0405388560401078,0.0324380850572546,0.827770041065543
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GCLM,Glutamate--cysteine ligase regulatory subunit,31313,-0.00416196606488905,0.0191396430611097,-0.0416756664646641,0.033351734334886,0.827861558028837
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NME3,Nucleoside diphosphate kinase 3,32721,0.00211776355991067,0.00974041845362333,-0.0169734566091911,0.0212089837290124,0.827885909778225
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNGB3,Cyclic nucleotide-gated cation channel beta-3,31342,-0.00481181003428431,0.0221357197299583,-0.0481978207050026,0.038574200636434,0.82791999953913
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEPTIN8,Septin-8,31525,-0.00293740618964654,0.0135779494829781,-0.0295501871762837,0.0236753747969906,0.828731209727152
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSV,Cathepsin L2,32758,0.00362590661621338,0.0168094616709901,-0.0293206382589273,0.0365724514913541,0.829221641978429
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLXDC1,Plexin domain-containing protein 1,32526,0.00316252592807135,0.0147481665550076,-0.0257438805197435,0.0320689323758862,0.830212745892993
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EHBP1,EH domain-binding protein 1,31571,-0.00667030238642008,0.0311201871450548,-0.0676658691907275,0.0543252644178873,0.830287557928919
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL12RB1,Interleukin-12 receptor subunit beta-1,32596,-0.0032230734763481,0.0150620962813633,-0.0327447821878202,0.026298635235124,0.830563189170749
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NOTCH2,Neurogenic locus notch homolog protein 2,31571,0.00190074267007017,0.00889510126622778,-0.0155336558117363,0.0193351411518766,0.830798976527694
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNTF,Ciliary neurotrophic factor,31342,0.00303969226096923,0.014268581802164,-0.0249267280712722,0.0310061125932107,0.831306290563132
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPRR1B,Cornifin-B,31456,0.00771144537059682,0.0362510472750314,-0.0633406072884648,0.0787634980296585,0.831548436272541
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IMPACT,Protein IMPACT,31548,-0.00492667272571826,0.0231840352682812,-0.0503673818515495,0.040514036400113,0.831720416733738
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GLRX,Glutaredoxin-1,32679,0.00495935300294015,0.0233853711674401,-0.0408759744852425,0.0507946804911228,0.832056746352266
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERCC1,DNA excision repair protein ERCC-1,31326,0.00286258694723165,0.0135107613053441,-0.0236185052112427,0.029343679105706,0.832210661985538
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC28A1,Sodium/nucleoside cotransporter 1,31326,0.0051496088889476,0.0243229200329207,-0.0425233143755769,0.0528225321534721,0.832332537800373
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TGFB1,Transforming growth factor beta-1 proprotein,32820,-0.00337175699000187,0.0159731105027668,-0.0346790535754248,0.0279355395954211,0.832822181171123
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FABP2,"Fatty acid-binding protein, intestinal",32729,0.00673581353345202,0.0319697590939799,-0.0559249142907486,0.0693965413576526,0.833131455850645
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB39B,Ras-related protein Rab-39B,31313,0.00792732518957956,0.0376335963450529,-0.065834523646724,0.0816891740258832,0.833170130661097
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK14,Kallikrein-14,32794,-0.0039039445132971,0.0185398079949688,-0.0402419681834359,0.0324340791568417,0.833226904511202
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL15RA,Interleukin-15 receptor subunit alpha,32596,-0.00299011581840731,0.0142101674814375,-0.0308420440820249,0.0248618124452102,0.833344111980956
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPR1,Atrial natriuretic peptide receptor 1,31313,-0.00365769725975708,0.0174299452053873,-0.0378203898623163,0.0305049953428021,0.833789441903874
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNX15,Sorting nexin-15,31417,0.00475053974539657,0.0228522578895304,-0.0400398857180831,0.0495409652088762,0.835327844672151
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MOCS2,Molybdopterin synthase catalytic subunit,31417,-0.0058748490374241,0.0283318294374692,-0.0614052347348638,0.0496555366600155,0.835735384317782
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",32668,0.00358672419983885,0.0173084773120308,-0.0303378913317416,0.0375113397314193,0.835840062729753
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HMCN2,Hemicentin-2,31397,-0.0049178020971997,0.0238343678297484,-0.0516331630435065,0.0417975588491071,0.836536851842094
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARHGEF10,Rho guanine nucleotide exchange factor 10,31555,-0.00793732103607423,0.0385671777130461,-0.0835289893536446,0.0676543472814962,0.836948618325792
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HEPH,Hephaestin,31571,0.00222547477448036,0.0108135210641139,-0.0189690265111829,0.0234199760601437,0.836948807616583
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPPK1,Epiplakin,31388,-0.0064388126808722,0.0316552783812282,-0.0684831583080794,0.055605532946335,0.838824711068746
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FRMD4B,FERM domain-containing protein 4B,31313,-0.0059719328302777,0.0293814562633387,-0.0635595871064216,0.0516157214458661,0.838941143503406
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIGLEC10,Sialic acid-binding Ig-like lectin 10,32728,0.00273763948386557,0.0135184907702248,-0.0237586024257751,0.0292338813935063,0.839522113646185
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TP53,Cellular tumor antigen p53,32526,0.00356480489380005,0.017662721107906,-0.0310541284776957,0.0381837382652958,0.840057113840677
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OLR1,Oxidized low-density lipoprotein receptor 1,32653,-0.0050579091264285,0.0250908342182014,-0.0542359441941032,0.0441201259412462,0.840246667428886
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AK1,Adenylate kinase isoenzyme 1,32729,0.005221871134755,0.026014085932593,-0.0457657372931273,0.0562094795626373,0.840912389569414
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ST13,Hsc70-interacting protein,31417,-0.00459069854180518,0.0230266886280638,-0.0497230082528102,0.0405416111691999,0.841983186079873
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRG1,Leucine-rich alpha-2-glycoprotein,31598,0.00210304423951487,0.0105722094820915,-0.0186184863453845,0.0228245748244142,0.842329046430777
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINA11,Serpin A11,32834,0.00328713323884724,0.0166945499864648,-0.0294341847346238,0.0360084512123183,0.843911361381253
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CST5,Cystatin-D,32548,-0.00435929321116206,0.0223669008291594,-0.0481984188363144,0.0394798324139903,0.845476343123669
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSRP3,Cysteine and glycine-rich protein 3,31313,0.00789919400339113,0.0405579069751698,-0.0715943036679417,0.087392691674724,0.845583520551455
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FDX1,"Adrenodoxin, mitochondrial",31313,0.00538435084944474,0.0277612168198184,-0.0490276341173993,0.0597963358162888,0.846218545707005
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GGACT,Gamma-glutamylaminecyclotransferase,31571,-0.00573875613322312,0.0295991832365996,-0.0637531552769583,0.0522756430105121,0.846273192330097
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDLIM5,PDZ and LIM domain protein 5,31555,-0.00953639389572822,0.049401502035605,-0.106363337885514,0.0872905500940576,0.846933878597671
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),INSL4,Early placenta insulin-like peptide,31548,0.00396503931996573,0.0207093232334028,-0.0366252342175037,0.0445553128574352,0.848169050668152
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GNPDA2,Glucosamine-6-phosphate isomerase 2,31417,0.0029319534523462,0.0153512482583499,-0.0271564931340196,0.033020400038712,0.848537611892166
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NECTIN4,Nectin-4,32720,0.00224035937376498,0.0117741862815904,-0.0208370457381521,0.0253177644856821,0.849096266561878
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCARB2,Lysosome membrane protein 2,32479,0.0021439987676716,0.0112758079302898,-0.0199565847756964,0.0242445823110396,0.849202747234969
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RCOR1,REST corepressor 1,32598,0.0034641298499786,0.0183121845845161,-0.032427751935673,0.0393560116356302,0.849963378633412
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LEFTY2,Left-right determination factor 2,32786,0.00420664721929639,0.0222810382391731,-0.039464187729483,0.0478774821680758,0.850254314405402
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NIT1,Deaminated glutathione amidase,31388,0.00366191764385241,0.0194015028869078,-0.034365028014487,0.0416888633021918,0.85029853667805
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHM,Rab proteins geranylgeranyltransferase component A 1,31356,-0.00480190542283837,0.0255481513474296,-0.0548762820638003,0.0452724712181236,0.850916933796164
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PADI4,Protein-arginine deiminase type-4,32489,-0.00562304483046766,0.0299422215646773,-0.0643097990972351,0.0530637094362997,0.851040584249745
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZNF75D,Zinc finger protein 75D,31456,0.00481205397792585,0.0256430934269881,-0.0454484091389709,0.0550725170948226,0.851152142496087
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL1RN,Interleukin-1 receptor antagonist protein,32684,-0.00416851834942299,0.0222317052128003,-0.0477426605665116,0.0394056238676657,0.851270338584003
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNPO1,Transportin-1,31456,0.00286815606960397,0.0153311495582524,-0.0271808970645707,0.0329172092037787,0.8516026696124
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCP2,Non-specific lipid-transfer protein,32526,-0.00599720756590697,0.03208885004802,-0.0688913536600261,0.0568969385282122,0.851748264591557
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ICAM4,Intercellular adhesion molecule 4,32728,0.00403858149587234,0.0216477246648253,-0.0383909588471852,0.0464681218389298,0.852010551464124
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXADR,Coxsackievirus and adenovirus receptor,32728,0.00382326166971976,0.0205872085897689,-0.0365276671662272,0.0441741905056667,0.85267600803589
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIGLEC9,Sialic acid-binding Ig-like lectin 9,32785,0.00231425310406447,0.0124656361152473,-0.0221183936818203,0.0267468998899493,0.852722971451107
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1RL,Complement C1r subcomponent-like protein,31586,-0.00148318376866074,0.00799224300280895,-0.0171479800541663,0.0141816125168448,0.852780647922863
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAK4,Serine/threonine-protein kinase PAK 4,32502,0.00466576695956991,0.0252344654067732,-0.0447937852377056,0.0541253191568455,0.853314473358776
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,31313,0.0039664736797228,0.0214667742977588,-0.0381084039438845,0.0460413513033301,0.85341235492109
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEP112,Centrosomal protein of 112 kDa,31313,-0.003483974240784,0.0188598330071562,-0.0404492469348102,0.0334812984532422,0.853445953484801
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",32596,-0.00931551777469147,0.0504420100069586,-0.10818185738833,0.0895508218389473,0.853486072322847
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EDAR,Tumor necrosis factor receptor superfamily member EDAR,32728,-0.00703872742064645,0.0381350837544784,-0.0817834915794241,0.0677060367381312,0.853567761608719
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LMOD1,Leiomodin-1,31555,-0.00256349493881379,0.0139239736773798,-0.0298544833464781,0.0247274934688506,0.853934709065168
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",31555,-0.00481012814017057,0.0261366656335072,-0.0560379927818447,0.0464177365015035,0.853988839735436
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SOX9,Transcription factor SOX-9,31356,-0.00204435769087831,0.0111276686640447,-0.0238545882724059,0.0197658728906493,0.854239327973786
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IMPG1,Interphotoreceptor matrix proteoglycan 1,31342,0.00228373155612267,0.0124993181921777,-0.0222149321005455,0.0267823952127909,0.855031703877755
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,31548,-0.00462887684960721,0.0256162958422104,-0.0548368167003395,0.0455790630011251,0.856607448240531
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCN3B,Sodium channel subunit beta-3,31342,-0.00349024309817341,0.0193186414460445,-0.0413547803324207,0.0343742941360739,0.856633770405931
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADIPOQ,Adiponectin,31598,0.00499847949765201,0.0277665117315773,-0.0494238834962395,0.0594208424915436,0.857142936362468
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GLO1,Lactoylglutathione lyase,32598,-0.00430110374112251,0.0240521564301192,-0.0514433303441562,0.0428411228619112,0.858080015586257
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCDC80,Coiled-coil domain-containing protein 80,32729,-0.00234254446155764,0.0131370550528556,-0.0280911723651547,0.0234060834420394,0.858479044906959
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NRN1,Neuritin,31555,0.00245564572984513,0.0138985371897537,-0.0247854871620722,0.0296967786217625,0.859761452084639
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDZD2,PDZ domain-containing protein 2,31313,-0.00441234264350243,0.0249894575377199,-0.0533916794174334,0.0445669941304286,0.859852399886545
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BRD1,Bromodomain-containing protein 1,31456,0.00219315869104155,0.0124889774453047,-0.0222852371017557,0.0266715544838388,0.860606953869886
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",31326,-0.00383098118104602,0.021831366744429,-0.0466204600001269,0.0389584976380349,0.860706777573112
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FETUB,Fetuin-B,32742,-0.00239240541521384,0.0137349738503179,-0.0293129541618369,0.0245281433314092,0.861725245175901
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL7R,Interleukin-7 receptor subunit alpha,32718,0.00365663967527957,0.0210014176750593,-0.0375061389678367,0.0448194183183958,0.861779893182948
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMEM132A,Transmembrane protein 132A,31388,0.00462298055100687,0.0265823741893245,-0.0474784728600692,0.0567244339620829,0.861939691403765
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF12,Fibroblast growth factor 12,31355,-0.00343915141553913,0.0198032946594057,-0.0422536089479742,0.035375306116896,0.862132949303321
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,31548,-0.00495294143265593,0.0286120724676543,-0.0610326034692584,0.0511267206039466,0.862572116068019
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MBL2,Mannose-binding protein C,31484,0.00773838210852857,0.0447842733380067,-0.0800387936339646,0.0955155578510218,0.86281919725581
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,31342,0.00436979773238704,0.025348339635206,-0.0453129479526167,0.0540525434173908,0.863135674664854
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL13RA1,Interleukin-13 receptor subunit alpha-1,32593,-0.00161443573827091,0.00940366126920984,-0.0200456118259222,0.0168167403493804,0.863691819442257
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SYT1,Synaptotagmin-1,31548,-0.00258250752953733,0.015067292764643,-0.0321144013482376,0.026949386289163,0.863915145904628
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NTproBNP,N-terminal prohormone of brain natriuretic peptide,32729,0.00648862537034409,0.0379083805892169,-0.0678118005845211,0.0807890513252093,0.86409715616844
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF5,Fibroblast growth factor 5,32596,0.0023388236021593,0.0136706576721098,-0.0244556654351758,0.0291333126394944,0.864162092627514
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSMC3,26S proteasome regulatory subunit 6A,31326,0.00214686215759514,0.012625671805303,-0.0225994545807987,0.026893178895989,0.864983727174233
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD99,CD99 antigen,32718,0.00131546585568504,0.0077789787080756,-0.0139313324121431,0.0165622641235132,0.865717745439577
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",32502,0.00208913820498679,0.0123630589354259,-0.0221424573084481,0.0263207337184216,0.86581451403994
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IQGAP2,Ras GTPase-activating-like protein IQGAP2,32668,-0.00380576128833078,0.0226118073837685,-0.048124903760517,0.0405133811838555,0.866344385345519
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSME2,Proteasome activator complex subunit 2,32610,0.00253048887167145,0.0150851313431903,-0.0270363685609814,0.0320973463043243,0.866786021681371
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP2B4,Plasma membrane calcium-transporting ATPase 4,31313,0.00442683742633273,0.0264757405919748,-0.0474656141339378,0.0563192889866033,0.867214439011461
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPPC,C-type natriuretic peptide,32728,-0.00308185028153676,0.0185437044073352,-0.0394275109199138,0.0332638103568403,0.868008160200116
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYOM3,Myomesin-3,31417,-0.00654199129909097,0.0393877010510821,-0.083741885359212,0.07065790276103,0.868088808104824
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CETN2,Centrin-2,32502,0.00457598420702273,0.0277655876171352,-0.0498445675225622,0.0589965359366076,0.86909915320154
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MGMT,Methylated-DNA--protein-cysteine methyltransferase,32728,-0.00828028145338811,0.0503347824001324,-0.106936454957648,0.0903758920508713,0.869338015847185
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCDC50,Coiled-coil domain-containing protein 50,31555,-0.00520866762137264,0.031722003936519,-0.0673837953369499,0.0569664600942046,0.869580133486066
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,32375,-0.00251513379286512,0.0153571586578817,-0.0326151647623133,0.0275848971765831,0.869911384186966
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADD1,Alpha-adducin,31417,-0.00468823378766217,0.0287725756415655,-0.0610824820451306,0.0517060144698063,0.870569203515366
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MKI67,Proliferation marker protein Ki-67,31355,0.00272549804106944,0.0167283413018093,-0.0300620509104768,0.0355130469926157,0.870580324272727
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VAV3,Guanine nucleotide exchange factor VAV3,31342,-0.0067003821901667,0.0412327567479932,-0.0875165854162333,0.0741158210358999,0.870915385694221
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STK24,Serine/threonine-protein kinase 24,32502,0.00410721427116231,0.0254088437745017,-0.0456941195268611,0.0539085480691857,0.871589143887519
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNASE3,Eosinophil cationic protein,32687,-0.00739866644268252,0.0462461092164466,-0.0980410405069178,0.0832437076215528,0.872896846289877
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLINT1,Clathrin interactor 1,31326,-0.00307550029948918,0.0192658647801931,-0.0408365952686676,0.0346855946696892,0.873173171102083
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SOD3,Extracellular superoxide dismutase,31586,0.00391763469388742,0.024617464941396,-0.0443325965912488,0.0521678659790237,0.87356237164008
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GIGYF2,GRB10-interacting GYF protein 2,31555,-0.0051058501997852,0.0321997426600458,-0.068217345813475,0.0580056454139046,0.874013368728976
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TP53I3,Quinone oxidoreductase PIG3,31251,-0.00350976027095238,0.0221533990620708,-0.0469304224326112,0.0399109018907065,0.874122401603367
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYBPC1,"Myosin-binding protein C, slow-type",31571,-0.00453877896764916,0.0288216760618488,-0.0610292640488728,0.0519517061135745,0.874872293794731
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD7,T-cell antigen CD7,31340,0.00273721691665084,0.0173926706972604,-0.0313524176499795,0.0368268514832812,0.87495150728683
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LYPD3,Ly6/PLAUR domain-containing protein 3,32652,0.0022206803666544,0.0141296119436753,-0.0254733590429492,0.029914719776258,0.875118425581753
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CGREF1,Cell growth regulator with EF hand domain protein 1,32729,0.00267626869999825,0.017043521350438,-0.0307290331468602,0.0360815705468567,0.875228268370631
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFAT5,Nuclear factor of activated T-cells 5,31355,-0.00581781503960996,0.0370554033189908,-0.0784464055448319,0.066810775465612,0.875246594626333
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCRIB,Protein scribble homolog,31388,-0.00600166473051887,0.0382879874950685,-0.081046120220853,0.0690427907598153,0.875445616211832
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EXTL1,Exostosin-like 1,31313,-0.00301301930431522,0.0193204479403535,-0.040881097267408,0.0348550586587776,0.876076842406821
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,31313,0.00330674785657722,0.0212174507370246,-0.0382794555879911,0.0448929513011455,0.876155175517955
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRLF1,Cytokine receptor-like factor 1,32756,0.00164628485588653,0.0106518464203612,-0.0192313341280215,0.0225239038397945,0.877176488483709
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,32647,-0.00205422059125417,0.0133488786561965,-0.0282180227573994,0.0241095815748911,0.87770226792665
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STAM,Signal transducing adapter molecule 1,31548,-0.0023808142765336,0.0154713004659574,-0.0327045631898101,0.0279429346367429,0.877703777591958
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLIN3,Perilipin-3,32729,0.00274707265930552,0.0178712008276367,-0.0322804809628624,0.0377746262814734,0.877837909131354
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RILP,Rab-interacting lysosomal protein,32777,-0.00380191076331746,0.0247720867414602,-0.0523552007765794,0.0447513792499445,0.87802670718405
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BRAP,BRCA1-associated protein,31488,0.00696074047577267,0.04541052447945,-0.0820438875039494,0.0959653684554947,0.878177788093777
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,31342,0.00372095784885273,0.024376968824235,-0.0440579010466478,0.0514998167443533,0.878684440483316
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TEK,Angiopoietin-1 receptor,32720,-0.00136059367117242,0.00891970648943542,-0.0188432183904658,0.016122031048121,0.878766140568236
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRTN3,Myeloblastin,32532,-0.00296975154368989,0.0195604083049861,-0.0413081518214627,0.0353686487340829,0.87932879559635
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNX5,Sorting nexin-5,31388,0.00194986985919149,0.012889336726987,-0.023313230125703,0.027212969844086,0.879760673652624
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BMP10,Bone morphogenetic protein 10,31417,0.00174699821838944,0.0115505482451176,-0.020892076342041,0.0243860727788198,0.879784063066595
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GLOD4,Glyoxalase domain-containing protein 4,32685,-0.00223841499325706,0.0148291082332015,-0.0313034671303319,0.0268266371438178,0.88002067708734
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CABP2,Calcium-binding protein 2,31356,0.00405644685759013,0.0269461264656603,-0.048757961015104,0.0568708547302843,0.880343319277635
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ODAM,Odontogenic ameloblast-associated protein,32489,0.00316384511052828,0.0210495694344003,-0.0380933109808963,0.0444210012019529,0.880527892062474
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACTN4,Alpha-actinin-4,32596,0.00191781981345463,0.0128338299653424,-0.0232364869186164,0.0270721265455256,0.881214064585564
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPCDC,Phosphopantothenoylcysteine decarboxylase,32806,0.00292346364181438,0.0197015750771802,-0.0356916235094588,0.0415385507930876,0.882040462236452
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NEO1,Neogenin,31555,-0.0013981314489204,0.00942434645248867,-0.0198698504957982,0.0170735875979574,0.882067961781851
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDHR5,Cadherin-related family member 5,32729,0.00233938919363384,0.0157851234136283,-0.0285994526970776,0.0332782310843453,0.882186605961808
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,31356,0.0018986790074746,0.0128493709137792,-0.0232860879835325,0.0270834459984817,0.882532715141377
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,31560,-0.0043660163715078,0.0298038142254477,-0.0627814922533853,0.0540494595103697,0.883536945259401
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIMP2,Metalloproteinase inhibitor 2,31571,0.00149611778193993,0.0102659893698826,-0.01862522138303,0.0216174569469099,0.884134105757828
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),S100A4,Protein S100-A4,32720,-0.00340816935925078,0.0234385570949602,-0.0493477412653728,0.0425314025468712,0.884391529287136
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRAME,Melanoma antigen preferentially expressed in tumors,31326,0.00155289819733308,0.0106979939290308,-0.0194151699035672,0.0225209662982334,0.884590133117402
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NRXN3,Neurexin-3,31356,0.00211161090534088,0.0145652949271977,-0.0264363671519666,0.0306595889626483,0.884734113769319
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMFR,E3 ubiquitin-protein ligase AMFR,32502,-0.00385522194475416,0.0268453637845767,-0.0564721349625245,0.0487616910730162,0.885812990656272
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GAS2,Growth arrest-specific protein 2,31456,-0.0030469006449687,0.0212715432900444,-0.0447391254934558,0.0386453242035184,0.886105746914376
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPK1,Thiamin pyrophosphokinase 1,31571,0.00160230717214568,0.0113046431256764,-0.0205547933541801,0.0237594076984714,0.887289985725377
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),B4GAT1,"Beta-1,4-glucuronyltransferase 1",32718,0.00139939701775485,0.0099179788137604,-0.0180398414572155,0.0208386354927252,0.887796525138275
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,31598,-0.00112517887224695,0.0079889976104401,-0.0167836141887095,0.0145332564442156,0.887999173121357
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSMD9,26S proteasome non-ATPase regulatory subunit 9,32668,0.00321821688262445,0.023048756158926,-0.0419573451888704,0.0483937789541194,0.888958303368265
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LIFR,Leukemia inhibitory factor receptor,32728,0.00134697913913592,0.00967225605948676,-0.0176106427374581,0.02030460101573,0.889246163529786
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GP1BA,Platelet glycoprotein Ib alpha chain,32691,0.00183343915591445,0.0132142377100175,-0.0240664667557198,0.0277333450675487,0.889653041958754
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RUVBL1,RuvB-like 1,32526,-0.00575571063832144,0.0416031132529297,-0.0872978126140637,0.0757863913374208,0.889968546759811
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD3D,T-cell surface glycoprotein CD3 delta chain,31342,-0.00206318207786918,0.0149361940988548,-0.0313381225116246,0.0272117583558862,0.890138981561129
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LEP,Leptin,32729,0.00380171035294756,0.027715993898282,-0.0505216376876852,0.0581250583935803,0.890902175628266
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACRV1,Acrosomal protein SP-10,31355,0.00415796537413143,0.0303347319137949,-0.0552981091769065,0.0636140399251693,0.890979572314915
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MILR1,Allergin-1,32596,0.00278157428351916,0.0203709028933972,-0.0371453953875394,0.0427085439545777,0.891392460377767
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TTN,Titin,31313,0.00391452172636739,0.0288692429418139,-0.052669194439588,0.0604982378923227,0.892145209811793
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IPCEF1,Interactor protein for cytohesin exchange factors 1,32632,-0.00495963447959264,0.0365842728124425,-0.07666480919198,0.0667455402327947,0.892166394897442
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYOC,Myocilin,32718,-0.00249805667222895,0.0185273644248365,-0.0388116909449085,0.0338155776004506,0.892748831719799
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SOD1,Superoxide dismutase [Cu-Zn],32528,0.00274009228730066,0.0203392322906127,-0.0371248030023003,0.0426049875769016,0.892836740804241
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GAST,Gastrin,31548,0.00642073796056044,0.0477174902657461,-0.0871055429603019,0.0999470188814228,0.892965404793274
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEMA3F,Semaphorin-3F,32729,-0.0014030478504577,0.0104805764543828,-0.0219449777010481,0.0191388820001327,0.8935074237648
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TLR3,Toll-like receptor 3,32833,-0.00336996339294562,0.0252014998274735,-0.0527649030547937,0.0460249762689025,0.893626397254222
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MMP3,Stromelysin-1,32718,-0.00256511504883596,0.0192024288002486,-0.0402018754973232,0.0350716453996513,0.893735485733354
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",31355,-0.00252740461531537,0.0192279856398352,-0.0402142564693924,0.0351594472387616,0.895427559343373
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HK2,Hexokinase-2,32598,0.00150409417974402,0.0114465037917626,-0.0209310532521106,0.0239392416115987,0.895460284198294
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPHA2,Glycoprotein hormone alpha-2,31560,0.00259671054533481,0.0198828649056447,-0.0363737046697288,0.0415671257603985,0.89609482063378
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PODXL,Podocalyxin,32668,0.000811026830423036,0.00621535969461627,-0.0113710781710249,0.0129931318318709,0.896183712562864
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GAD1,Glutamate decarboxylase 1,31326,0.00143243582745209,0.0110302314818399,-0.0201868178769541,0.0230516895318582,0.896677105984178
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAMDC2,MAM domain-containing protein 2,31571,-0.00176592307305215,0.0136503456209572,-0.0285206004901283,0.024988754344024,0.897069542180367
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,31456,-0.00355538731310866,0.0275760414837356,-0.0576044286212304,0.0504936539950131,0.897416213934811
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDH3,Cadherin-3,32806,-0.00178194138839748,0.0139578457938944,-0.0291393191444304,0.0255754363676355,0.898416221426094
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD8A,T-cell surface glycoprotein CD8 alpha chain,32806,-0.00248787583980638,0.0196484572858224,-0.0409988521200183,0.0360231004404055,0.899244488448824
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRR5,Proline-rich protein 5,31355,0.00242547042803708,0.0191732454075947,-0.0351540905708486,0.0400050314269228,0.899337276574087
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ABHD14B,Protein ABHD14B,32614,-0.00297116663031309,0.0235473310794487,-0.0491239355460325,0.0431816022854063,0.899593537114109
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPL,Periplakin,31355,-0.00170623208280849,0.013561579411244,-0.0282869277288467,0.0248744635632297,0.899882794834259
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD28,T-cell-specific surface glycoprotein CD28,32526,0.00178009294157847,0.0145235486690314,-0.026686062449723,0.0302462483328799,0.902453639255271
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRYBB1,Beta-crystallin B1,31571,0.00337212130482502,0.0275259942300162,-0.0505788273860068,0.0573230699956568,0.90250085820187
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAPRE3,Microtubule-associated protein RP/EB family member 3,31326,-0.00729935871026889,0.0595890109110442,-0.124093820095916,0.109495102675378,0.902510265091757
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLKB1,Plasma kallikrein,31447,0.00125367396247048,0.0103121394770378,-0.0189581194125236,0.0214654673374646,0.90324070687917
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZBP1,Z-DNA-binding protein 1,31355,-0.00211905569401907,0.0175017760264257,-0.0364225367058134,0.0321844253177752,0.903633601739252
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSBP1,Heat shock factor-binding protein 1,31388,-0.00483196451413894,0.0402075619401248,-0.0836387859167836,0.0739748568885058,0.904347319390949
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TEF,Thyrotroph embryonic factor,31313,0.002098008457608,0.0175392297587535,-0.0322788818695488,0.0364748987847648,0.904788944815323
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFNLR1,Interferon lambda receptor 1,32728,-0.00187707561233162,0.0157114695302454,-0.0326715558916127,0.0289174046669494,0.904904384062572
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPSD1,Tryptase delta,31555,0.00177444509500124,0.0149546519974205,-0.027536672819943,0.0310855630099455,0.905551740883681
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDA,Cytidine deaminase,31560,-0.0022779757847303,0.019476076763576,-0.0404510862413393,0.0358951346718787,0.906892610750256
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CIT,Citron Rho-interacting kinase,31356,0.00229721175624901,0.0196938580781144,-0.0363027500768552,0.0408971735893532,0.907143628675711
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TINAGL1,Tubulointerstitial nephritis antigen-like,32706,-0.00104147670682345,0.00901476451984768,-0.0187104151657249,0.016627461752078,0.908027580842991
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GLYR1,Putative oxidoreductase GLYR1,31548,0.00293244665096274,0.0255222407420082,-0.0470911452033734,0.0529560385052988,0.908529212090159
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL1RL2,Interleukin-1 receptor-like 2,32596,0.0018593104236944,0.0162456446154812,-0.0299821530226487,0.0337007738700375,0.908883886032413
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KRT17,"Keratin, type I cytoskeletal 17",31313,0.00189145625761008,0.0166038612005133,-0.030652111695396,0.0344350242106162,0.909306934485294
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AGBL2,Cytosolic carboxypeptidase 2,31342,-0.00427262521159857,0.0379861449269043,-0.078725469268331,0.0701802188451338,0.910447020779906
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ICA1,Islet cell autoantigen 1,32596,-0.00369502605814266,0.0329300699733512,-0.0682379632059109,0.0608479110896256,0.910660853088366
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CBLN1,Cerebellin-1,31342,-0.00454165523713273,0.0405947509519099,-0.0841073671028762,0.0750240566286108,0.910923225833304
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HDAC9,Histone deacetylase 9,31342,-0.00304792945948542,0.0272867742384973,-0.0565300069669402,0.0504341480479694,0.911064369274406
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,31342,-0.00151734653965642,0.0137733866571838,-0.0285131843877367,0.0254784913084238,0.91228139333408
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC1A,C-type lectin domain family 1 member A,32598,-0.00142351402046979,0.013005214114494,-0.0269137336848781,0.0240667056439385,0.91284239908955
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SH2B3,SH2B adapter protein 3,32526,-0.00440900779281921,0.0402809122833559,-0.0833595958681967,0.0745415802825583,0.912842954415239
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MFAP3L,Microfibrillar-associated protein 3-like,31356,0.00306443431481536,0.0281324215864404,-0.0520751119946078,0.0582039806242385,0.913261783504991
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPARC,SPARC,32720,0.00314638320671924,0.0289929200781838,-0.0536797401465211,0.0599725065599596,0.913583717290629
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRRC38,Leucine-rich repeat-containing protein 38,31356,-0.00214986128797691,0.0198779998155253,-0.0411107409264065,0.0368110183504527,0.91387738203281
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNTN3,Contactin-3,32718,-0.00142730565939206,0.0133458304291977,-0.0275851333006196,0.0247305219818355,0.914832905446188
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDC123,Cell division cycle protein 123 homolog,31326,-0.00290137755723377,0.0272717333119043,-0.0563539748485662,0.0505512197340987,0.915277593228147
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,31388,-0.00179991351553968,0.0169315182885231,-0.034985689361045,0.0313858623299656,0.915342800574796
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),H2AP,Huntingtin-interacting protein M,31326,0.00207871452597744,0.0195838605532408,-0.0363056521583746,0.0404630812103295,0.915470741092347
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIGAR,"Fructose-2,6-bisphosphatase TIGAR",32491,-0.00203922914736462,0.0192525090374409,-0.0397741468607488,0.0356956885660196,0.915648147417051
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRP2BP,LRP2-binding protein,31356,-0.00348240209944961,0.0330183019002815,-0.0681982738240014,0.0612334696251022,0.916006613746793
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GMPR,GMP reductase 1,32833,-0.00214299621673962,0.0203281944130351,-0.0419862572662884,0.0377002648328092,0.916044982723866
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",31313,-0.00288599593019647,0.0275737206592779,-0.0569304884223811,0.0511584965619881,0.916644668796189
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTLA4,Cytotoxic T-lymphocyte protein 4,31571,-0.00123180452359444,0.0118457683096894,-0.0244495104105857,0.0219859013633968,0.917182462316509
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,32733,-0.002180382527965,0.0211657652992072,-0.0436652825144111,0.0393045174584811,0.917953723398846
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNASE1,Ribonuclease pancreatic,31586,0.000953532153886059,0.00939353342561941,-0.017457793360328,0.0193648576681001,0.919148712213506
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,32754,-0.00159113422261873,0.0157747668421306,-0.0325096772331947,0.0293274087879572,0.91965927864037
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,32728,0.00599340773009003,0.0596911026585175,-0.111001153480604,0.122987968940784,0.920023440049838
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATXN3,Ataxin-3,31548,0.00258942694226084,0.0260905344328681,-0.0485480205461607,0.0537268744306824,0.920944147417652
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,31560,0.00120102572165297,0.0121545706814456,-0.0226219328139805,0.0250239842572864,0.921289571523381
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFNL2,Interferon lambda-2,31342,0.00252446902961756,0.0255936042290521,-0.0476389952593246,0.0526879333185597,0.921429360633166
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MNAT1,CDK-activating kinase assembly factor MAT1,31456,-0.00180444793586059,0.0183877970079815,-0.0378445300715043,0.0342356341997831,0.921829348500977
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDH23,Cadherin-23,31548,0.00106951988188291,0.0109652429204547,-0.0204223562422082,0.022561396005974,0.922302279095723
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FSHB,Follitropin subunit beta,31388,0.00260635281393981,0.0269560313601705,-0.0502274686519944,0.055440174279874,0.922975917126518
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARID3A,AT-rich interactive domain-containing protein 3A,31342,-0.00158181587351414,0.016583803832784,-0.0340860713857708,0.0309224396387425,0.924013033425906
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZNF830,Zinc finger protein 830,31548,-0.00322645580419871,0.0339056452095161,-0.0696815204148503,0.0632286088064529,0.924190347551273
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPBGL,Trophoblast glycoprotein-like,31356,0.00161922093305602,0.0170227037888431,-0.0317452784930764,0.0349837203591885,0.924221058806177
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GIPR,Gastric inhibitory polypeptide receptor,31355,0.00182098090401791,0.0193534869903272,-0.0361118535970234,0.0397538154050592,0.925039714726146
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GNAS,Neuroendocrine secretory protein 55,31555,-0.00345050177702398,0.03711036460734,-0.0761868164074105,0.0692858128533625,0.92592229713919
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EGFR,Epidermal growth factor receptor,32834,0.000597949546441273,0.00647498472476064,-0.0120930205140896,0.0132889196069721,0.926423901608432
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PZP,Pregnancy zone protein,31598,-0.00208226524717287,0.0229805904452271,-0.047124222519818,0.0429596920254723,0.927805040312925
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CORO6,Coronin-6,31342,-0.00140509123093735,0.0155364448430277,-0.0318565231232716,0.0290463406613969,0.927941262874105
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NAA10,N-alpha-acetyltransferase 10,31313,-0.00188056602414451,0.0208744093390382,-0.0427944083286594,0.0390332762803704,0.928218478730792
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,32647,-0.00389730448528355,0.0432894598114367,-0.0887446457156995,0.0809500367451324,0.928266263728686
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BAMBI,BMP and activin membrane-bound inhibitor homolog,32526,0.00107244171858483,0.0119362791697073,-0.0223226654540415,0.0244675488912112,0.928410685591743
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC11A,C-type lectin domain family 11 member A,32707,-0.00173087236252321,0.0194109341743031,-0.0397763033441573,0.0363145586191109,0.928948851432617
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPHS2,Podocin,31355,0.00370615956081655,0.0426758103985031,-0.0799384288202496,0.0873507479418827,0.930797432537473
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LYZL2,Lysozyme-like protein 2,31326,-0.00131598562059436,0.0155810305479586,-0.0318548054945932,0.0292228342534045,0.932692367951472
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MRPS16,"28S ribosomal protein S16, mitochondrial",31355,-0.00108640333968287,0.0129364311740905,-0.0264418084409002,0.0242690017615345,0.933074462433914
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,32526,0.00152544203465929,0.0184542282125802,-0.0346448452619979,0.0376957293313165,0.934123131266455
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC16A1,Monocarboxylate transporter 1,32502,-0.00193919033257917,0.0234889381139773,-0.0479775090359747,0.0440991283708164,0.934205229258412
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PMCH,Pro-MCH,31313,-0.00276859387595685,0.0336428169086293,-0.0687085150168703,0.0631713272649566,0.934415326850306
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSTB,Cystatin-B,32589,-0.00147457055171339,0.0179535300846401,-0.0366634895176079,0.0337143484141812,0.93454313298287
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL13RA2,Interleukin-13 receptor subunit alpha-2,31342,0.00101257215637578,0.0123356731980098,-0.0231653473117234,0.025190491624475,0.934581418555009
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPQ,Carboxypeptidase Q,31564,-0.00121707970913542,0.0148358330552085,-0.0302953124973441,0.0278611530790733,0.934619825475779
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VCAN,Versican core protein,32806,0.000981613329650201,0.0121741184672569,-0.0228796588661732,0.0248428855254736,0.935737086094169
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERMAP,Erythroid membrane-associated protein,31355,-0.00152102791290036,0.0188679919290491,-0.0385022920938366,0.0354602362680358,0.935750932184527
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ING1,Inhibitor of growth protein 1,32491,0.00151163293020177,0.0187682549142194,-0.0352741467016682,0.0382974125620718,0.935808054878733
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UBQLN3,Ubiquilin-3,31313,-0.00155572380056091,0.0193407115308263,-0.0394635184009804,0.0363520707998586,0.935891243919265
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HLA_A,,31555,-0.00107182193952557,0.013395133171308,-0.0273262829552893,0.0251826390762382,0.936226791651257
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SATB1,DNA-binding protein SATB1,31555,0.00103201184758141,0.0129106835471499,-0.0242729279048323,0.0263369515999952,0.936291255888269
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WASL,Neural Wiskott-Aldrich syndrome protein,31355,0.00193709286701535,0.0243069074013931,-0.0457044456397151,0.0495786313737459,0.936483472893642
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL12A_IL12B,Interleukin-12,32668,-0.00241326097870866,0.030289746404196,-0.0617811639309328,0.0569546419735155,0.936499511295908
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEBPB,CCAAT/enhancer-binding protein beta,32598,-0.00123145859665604,0.0155628907875901,-0.0317347245403326,0.0292718073470205,0.936932717790138
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCDC134,Coiled-coil domain-containing protein 134,31548,-0.00159402741068271,0.0202463236749017,-0.0412768218134901,0.0380887669921247,0.937248082592215
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NSFL1C,NSFL1 cofactor p47,32806,-0.00206990895729229,0.0269497774624242,-0.0548914727836437,0.0507516548690592,0.93877946670804
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCTN1,Dynactin subunit 1,32794,0.00204469289075924,0.0267030895731972,-0.0502933626727073,0.0543827484542258,0.938966228071839
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TET2,Methylcytosine dioxygenase TET2,31448,0.00296694258785214,0.0391582348478553,-0.0737831977139442,0.0797170828896485,0.939605643188313
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDX53,Probable ATP-dependent RNA helicase DDX53,31356,-0.00111082801108058,0.0147650074623948,-0.0300502426373744,0.0278285866152133,0.940030678485817
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAD51,DNA repair protein RAD51 homolog 1,31456,0.00163847929019958,0.0218128261639171,-0.0411146599910779,0.0443916185714771,0.940124868393634
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KRT19,"Keratin, type I cytoskeletal 19",32709,0.00199862361660418,0.0266372078069876,-0.0502103036850916,0.0542075509183,0.940191525635526
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,31119,-0.00156745646710989,0.0211523051748489,-0.0430259746098138,0.039891061675594,0.940930199277844
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ELOB,Elongin-B,31313,0.00121588713625404,0.0164396962121681,-0.0310059174395955,0.0334376917121035,0.941043849549471
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPDC1,Neural proliferation differentiation and control protein 1,32729,0.000829991018157686,0.0117969274975988,-0.0222919868771359,0.0239519689134513,0.943911466665392
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSME1,Proteasome activator complex subunit 1,32635,-0.00107678368467646,0.0153638054666696,-0.0311898423993488,0.0290362750299959,0.944127013186597
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KITLG,Kit ligand,32729,0.00105721659842487,0.0150944579339716,-0.0285279209521596,0.0306423541490093,0.944163361159842
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FMR1,Synaptic functional regulator FMR1,32526,-0.00100628125091481,0.0143953735990477,-0.0292212135050484,0.0272086510032187,0.944272398033761
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYO9B,Unconventional myosin-IXb,32596,-0.00188579947035657,0.0272190152413413,-0.0552350693433855,0.0514634704026724,0.944766398056537
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,31548,0.00248933717519096,0.0361513220280197,-0.0683672539997277,0.0733459283501096,0.945103792771576
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FAM20A,Pseudokinase FAM20A,31571,-0.000795767139621084,0.0116107894565759,-0.0235529144745099,0.0219613801952678,0.945360050024015
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UBE2B,Ubiquitin-conjugating enzyme E2 B,31548,0.000812629321948004,0.012018471288888,-0.0227435744042726,0.0243688330481686,0.946093847195101
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOE,Apolipoprotein E,31598,-0.0020547863050686,0.0305225382555975,-0.0618789612860396,0.0577693886759024,0.946328459079916
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CASP4,Caspase-4,31456,-0.00460516853783204,0.0684646474614517,-0.138795877562277,0.129585540486613,0.946373742227522
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPRR3,Small proline-rich protein 3,31548,-0.00184824465132277,0.0275030615785829,-0.0557542453453452,0.0520577560426997,0.94642310625811
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADM,Pro-adrenomedullin,32794,0.000718760608386304,0.0108058646359703,-0.0204607340781156,0.0218982552948882,0.946968676380205
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CARHSP1,Calcium-regulated heat-stable protein 1,32502,-0.00142362284769901,0.0214934554482654,-0.0435507955262991,0.0407035498309011,0.947192122386205
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MCTS1,Malignant T-cell-amplified sequence 1,31560,-0.000664749337545893,0.0101385578573553,-0.0205363227379622,0.0192068240628704,0.947724695643984
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MEGF9,Multiple epidermal growth factor-like domains protein 9,32801,-0.000546554844209124,0.00849385800504851,-0.0171945165341042,0.016101406845686,0.948695316096941
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HLA_DRA,,32702,0.000919015245379981,0.0143599828664984,-0.0272265511729568,0.0290645816637168,0.94897298533337
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRX,Cone-rod homeobox protein,32598,0.00272536822566224,0.0428875902602113,-0.0813343086843519,0.0867850451356763,0.949332563676157
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FAM172A,Cotranscriptional regulator FAM172A,31388,-0.00163303194590134,0.0258725164177579,-0.0523431641247069,0.0490771002329042,0.94967389493653
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),S100A13,Protein S100-A13,31355,-0.000889636575179428,0.0141642505715662,-0.0286515676954491,0.0268722945450903,0.949920602164677
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BGLAP,Osteocalcin,31571,-0.00220792324091335,0.0363796178051076,-0.0735119741389242,0.0690961276570975,0.951606700272994
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),YAP1,Transcriptional coactivator YAP1,31548,-0.000655206745097539,0.0108724467510703,-0.0219652023771952,0.0206547888870002,0.95194770082342
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TSPAN1,Tetraspanin-1,32598,-0.000986295916650262,0.0165646322307576,-0.0334529750889352,0.0314803832556347,0.952521554822146
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TXN,Thioredoxin,31459,0.00106258307298389,0.0179844955929557,-0.0341870282892093,0.0363121944351771,0.952887325862973
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL1RAP,Interleukin-1 receptor accessory protein,32718,0.00104303485230613,0.0176583385125952,-0.0335673086323805,0.0356533783369927,0.952899634593567
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSMG3,Proteasome assembly chaperone 3,32728,0.00123049708343197,0.0208566598295673,-0.0396485561825199,0.0421095503493839,0.952955188294243
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),YY1,Transcriptional repressor protein YY1,31355,-0.000686208894684615,0.0117397950356881,-0.0236962071646333,0.0223237893752641,0.953390534049748
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NMT1,Glycylpeptide N-tetradecanoyltransferase 1,31555,0.00157826320631558,0.0272237362913453,-0.0517802599247212,0.0549367863373523,0.953771010214493
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRELD2,Protein disulfide isomerase CRELD2,32739,-0.00120662277111827,0.0211852681197593,-0.0427297482858466,0.04031650274361,0.954581728252924
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NENF,Neudesin,31548,-0.00261910956145903,0.0460101975587784,-0.0927990967766648,0.0875608776537467,0.954606781242394
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,31548,0.00229510389826039,0.0403741911823598,-0.0768383108191648,0.0814285186156856,0.954669493203524
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MUC13,Mucin-13,32502,0.00115804316293854,0.0205004427333963,-0.0390228245945181,0.0413389109203952,0.954953810786684
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LSM1,U6 snRNA-associated Sm-like protein LSm1,32526,0.00126051847682758,0.0226279063166734,-0.0430901779038523,0.0456112148575075,0.955577010632104
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PVR,Poliovirus receptor,32806,0.000841266032024187,0.0151642193083242,-0.0288806038122912,0.0305631358763396,0.955759658444669
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK4,Kallikrein-4,32794,0.00138376792991676,0.0249654151503531,-0.0475484457647753,0.0503159816246088,0.955799210645774
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGB5,Integrin beta-5,32720,-0.000864790858925903,0.0156601348110426,-0.0315586550885693,0.0298290733707175,0.955962496609601
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RANBP1,Ran-specific GTPase-activating protein,31388,0.00119804854221933,0.0220402352965371,-0.0420008126389934,0.0443969097234321,0.956651909517754
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",31356,-0.00109312440995191,0.0201698155156005,-0.0406259628205289,0.038439714000625,0.95678040881834
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPTX2,Neuronal pentraxin-2,31571,0.00074724318098669,0.0139893331138093,-0.0266718497220795,0.0281663360840529,0.957402469544174
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FES,Tyrosine-protein kinase Fes/Fps,32526,0.00102476515834374,0.0193148045505155,-0.0368322517606666,0.0388817820773541,0.957688557745781
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,31417,-0.00142554809590951,0.0276560935769832,-0.0556314915067966,0.0527803953149776,0.95889218197837
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL17A,Interleukin-17A,32583,0.000892264503161876,0.0173597672211953,-0.0331328792503809,0.0349174082567046,0.959009225396092
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUB1,NEDD8 ultimate buster 1,32728,0.00171063041424791,0.0344249005832064,-0.0657621747288366,0.0691834355573325,0.960369222651171
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFE2,Transcription factor NF-E2 45 kDa subunit,31388,-0.00148749710259564,0.0311190100811745,-0.0624807568616977,0.0595057626565064,0.96187668889726
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINI1,Neuroserpin,31402,-0.000604760615320389,0.0127262032140058,-0.0255481189147717,0.0243385976841309,0.962099332529415
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GCG,Pro-glucagon,32526,-0.00231944960002503,0.0503559233332847,-0.101017059333263,0.096378160133213,0.963262606099662
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PENK,Proenkephalin-A,31417,-0.000547214578803105,0.0119509403020544,-0.0239710575708298,0.0228766284132236,0.963480104832885
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EDN1,Endothelin-1,31388,0.000537420463415088,0.0117787078276336,-0.0225488468787467,0.0236236878055769,0.963609208130891
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TCP11,T-complex protein 11 homolog,31456,0.00113690451568348,0.0253355242232776,-0.0485207229619407,0.0507945319933076,0.964208977088626
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FLT3LG,Fms-related tyrosine kinase 3 ligand,32833,-0.000600249192429055,0.0134772046276741,-0.0270155702626703,0.0258150718778122,0.964476467532134
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYBPC2,"Myosin-binding protein C, fast-type",31388,-0.00155888153104656,0.0351805786454458,-0.0705128156761204,0.0673950526140273,0.964657794113004
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCN2B,Sodium channel subunit beta-2,31356,-0.000519804813930555,0.0118656419267146,-0.0237764629902912,0.0227368533624301,0.965058968145374
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENOPH1,Enolase-phosphatase E1,31548,0.000959936304208121,0.022612236728073,-0.0433600476828149,0.0452799202912311,0.966139420616578
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSC,Dipeptidyl peptidase 1,32688,0.000733694114599302,0.0176143385513451,-0.033790409446037,0.0352577976752356,0.966776079709279
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPHA2,Ephrin type-A receptor 2,32388,0.000495913977202009,0.012156726549321,-0.0233312700594672,0.0243230980138713,0.967461571148804
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,31571,0.00230081395171048,0.0574199966424798,-0.11024237946755,0.114844007370971,0.968038430253611
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCT,Secretin,31356,0.000725759999759622,0.0183130042203774,-0.0351677282721801,0.0366192482716994,0.968388484080969
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSH1,Chorionic somatomammotropin hormone 1,31586,0.00052947689821074,0.0135161386629507,-0.0259621548811726,0.0270211086775941,0.968752929556796
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNF31,E3 ubiquitin-protein ligase RNF31,31355,-0.000605958155859913,0.0157362353949546,-0.0314489795299709,0.0302370632182511,0.969284327066719
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MSLN,Mesothelin,32657,0.000810481914884561,0.0215419528691945,-0.0414117457087366,0.0430327095385057,0.969988789323009
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PREB,Prolactin regulatory element-binding protein,32596,0.000417777912398546,0.011439100672657,-0.0220028594060092,0.0228384152308063,0.970867035696407
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACYP1,Acylphosphatase-1,31391,-0.00100208466982445,0.0276036629573731,-0.0551052640662757,0.0531010947266268,0.971042040838787
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AOC1,Amiloride-sensitive amine oxidase [copper-containing],32596,0.000821208908560792,0.0231495391162082,-0.0445518877592072,0.0461943055763288,0.971702514472422
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLSPN,Claspin,32491,0.000487208009159186,0.0139752876590512,-0.0269043558025811,0.0278787718208995,0.972190500621275
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MRPL52,"39S ribosomal protein L52, mitochondrial",31314,-0.000364137434337203,0.0104508464742952,-0.0208477965239557,0.0201195216552813,0.972205972880375
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRRC25,Leucine-rich repeat-containing protein 25,32668,-0.000545489611277655,0.0157290268422069,-0.0313743822220032,0.0302834029994479,0.972335342008773
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENOX2,Ecto-NOX disulfide-thiol exchanger 2,31313,-0.000406066091671078,0.0118071621415586,-0.0235481038891259,0.0227359717057837,0.972565877402435
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTK7,Inactive tyrosine-protein kinase 7,32502,-0.000527630784148281,0.0154622074844749,-0.0308335574537191,0.0297782958854225,0.972779140168718
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,31403,-0.000702264815655453,0.0206262666282181,-0.0411297474069629,0.039725217775652,0.972840483164887
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),S100A3,Protein S100-A3,31548,-0.000606391233135276,0.0179234886205171,-0.0357364289293488,0.0345236464630782,0.973011828968301
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFNG,Interferon gamma,32596,0.00156115524899267,0.0462126966137823,-0.0890157301140207,0.092138040612006,0.973051797136773
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEP43,Centrosomal protein 43,32523,-0.000972468464920778,0.0287867970029248,-0.0573945905906535,0.0554496536608119,0.973051964945978
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIAA2013,Uncharacterized protein KIAA2013,31548,-0.00078825003556999,0.0234528655053484,-0.0467558664260529,0.045179366354913,0.973189046761957
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ECM1,Extracellular matrix protein 1,31382,0.000499257635892967,0.0149527513042834,-0.0288081349205025,0.0298066501922885,0.973365255530985
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEMA3G,Semaphorin-3G,31417,-0.000607703883325818,0.0182241907673701,-0.0363271177873711,0.0351117100207195,0.973399551316133
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADGRV1,Adhesion G-protein coupled receptor V1,31342,0.000932355392459527,0.0280370158280056,-0.0540201956304314,0.0558849064153505,0.973472568553295
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRYGD,Gamma-crystallin D,31548,-0.00132858690691314,0.0400763880101291,-0.0798783074067661,0.0772211335929398,0.973554743678185
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF14,Tumor necrosis factor receptor superfamily member 14,32721,-0.00038845856278506,0.0118265422475352,-0.023568481367954,0.0227915642423839,0.973797868327772
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C2orf69,UPF0565 protein C2orf69,31356,-0.000778648917327225,0.0241446855184251,-0.0481022325334405,0.046544934698786,0.974274109043394
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PYDC1,Pyrin domain-containing protein 1,31388,-0.000554058483855103,0.0173453698105113,-0.0345509833124572,0.033442866344747,0.97451856832579
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HIF1A,Hypoxia-inducible factor 1-alpha,31355,-0.000879140563234062,0.027958856437277,-0.055678499180297,0.0539202180538289,0.974916223733147
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HS1BP3,HCLS1-binding protein 3,31388,0.00111111052078175,0.0380523537396964,-0.0734715028090233,0.0756937238505868,0.976706236890725
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AP2B1,AP-2 complex subunit beta,31356,0.000594965828268179,0.0208939999906687,-0.0403572741534424,0.0415472058099788,0.97728371472672
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BRD3,Bromodomain-containing protein 3,31313,0.000528820996999037,0.0191435231111985,-0.0369924843009501,0.0380501262949481,0.977962766224502
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRYBB2,Beta-crystallin B2,31548,-0.000606159336041227,0.0225915867087818,-0.0448856692852536,0.0436733506131711,0.978595066162793
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB6A,Ras-related protein Rab-6A,32728,0.00050595039845605,0.0193791800065669,-0.0374772424144151,0.0384891432113272,0.979171834363113
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",31548,-0.000263248800855495,0.0111532562308113,-0.0221236310132457,0.0215971334115347,0.981169999424097
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MRC1,Macrophage mannose receptor 1,31586,0.000256988001013817,0.0117740315817147,-0.0228201138991471,0.0233340899011747,0.982586776603715
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MSTN,Growth/differentiation factor 8,32598,-0.000445493942789375,0.0211689182950464,-0.0419365738010803,0.0410455859155015,0.983210463252639
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHAD,Chondroadherin,31417,-0.000433004087685255,0.0209939943421472,-0.0415812329982939,0.0407152248229234,0.983545229850074
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SULT1A1,Sulfotransferase 1A1,32806,-0.00107733164368208,0.0530350298295698,-0.105025990109639,0.102871326822275,0.983793670923435
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPA4,Carboxypeptidase A4,31259,0.000357822509227828,0.0180165625957461,-0.0349546401784344,0.0356702851968901,0.984154988634893
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARID4B,AT-rich interactive domain-containing protein 4B,32502,-0.000336396662218726,0.0173480544833385,-0.0343385834495622,0.0336657901251247,0.984529612946124
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZBTB17,Zinc finger and BTB domain-containing protein 17,32598,-0.000330201756395045,0.0176378510382014,-0.0349003897912698,0.0342399862784797,0.985063942616278
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LGALS4,Galectin-4,32702,0.000399656885002461,0.0215946675526794,-0.0419258915182492,0.0427252052882541,0.985234649376935
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PI16,Peptidase inhibitor 16,31586,-0.00018053429124075,0.0100453410724217,-0.0198694027931873,0.0195083342107058,0.985661700578923
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRISP3,Cysteine-rich secretory protein 3,31517,0.000190834969990348,0.0111251377525957,-0.0216144350250973,0.021996104965078,0.986314611038951
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PXN,Paxillin,32502,0.000370824322569501,0.0216215111680418,-0.0420073375667925,0.0427489862119315,0.9863167780172
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ASGR2,Asialoglycoprotein receptor 2,31586,0.000164077409288979,0.010537982569347,-0.0204903684266312,0.0208185232452091,0.987577764075011
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLNS1A,Methylosome subunit pICln,31356,0.000220131960656724,0.0144183459266166,-0.0280398260555118,0.0284800899768253,0.987819184530113
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),INSL5,Insulin-like peptide INSL5,31560,0.000464741891709345,0.0403318884192878,-0.0785857594100947,0.0795152431935134,0.990806526819612
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),QDPR,Dihydropteridine reductase,32689,0.000202725177009404,0.0179342814572949,-0.0349484664792886,0.0353539168333074,0.990981335701061
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PALLD,Palladin,31355,-0.000190153515949005,0.0176068509290467,-0.0346995813368805,0.0343192743049825,0.991383323181875
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPING1,Plasma protease C1 inhibitor,31582,-8.18990814684805e-05,0.00768417113569396,-0.0151428745074286,0.0149790763444917,0.991496459582609
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HMMR,Hyaluronan mediated motility receptor,31314,0.000214203289104817,0.0201913151091556,-0.0393607743248402,0.0397891809030498,0.991535937198655
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACAN,Aggrecan core protein,32653,0.000110850666759605,0.0114461138632131,-0.0223235325051381,0.0225452338386573,0.992273173295925
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MTSS1,Protein MTSS 1,31560,-0.000377682939299961,0.0461027212591109,-0.0907390166071572,0.0899836507285573,0.993463851523452
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL12B,Interleukin-12 subunit beta,32833,-0.000165405269822064,0.0213994182704088,-0.0421082650798233,0.0417774545401792,0.993833041709152
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GSR,"Glutathione reductase, mitochondrial",31548,5.71272071391958e-05,0.00948019516647384,-0.0185240553191495,0.0186383097334279,0.995192170866724
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,32409,-0.000150340591543286,0.0250465312868779,-0.049241541913824,0.0489408607307375,0.995210905362199
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VAT1,Synaptic vesicle membrane protein VAT-1 homolog,32668,-4.70861694865168e-05,0.00812050499947047,-0.0159632759684486,0.0158691036294756,0.995373680479757
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FBP1,"Fructose-1,6-bisphosphatase 1",32729,-0.00014335788835779,0.0297971489806953,-0.0585457698905206,0.058259054113805,0.996161398516127
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NMRK2,Nicotinamide riboside kinase 2,31326,-8.6466202628028e-05,0.0181805314893241,-0.0357203079217033,0.0355473755164472,0.996205420180566
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL18BP,Interleukin-18-binding protein,32754,-2.91603630012344e-05,0.012060177061122,-0.0236671074028003,0.0236087866767979,0.998070846999356
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD5,T-cell surface glycoprotein CD5,32785,-3.07365559496828e-05,0.0134214181884905,-0.026336716205391,0.0262752430934916,0.998172807469508
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPACA5_SPACA5B,Sperm acrosome-associated protein 5,31555,2.61193420474757e-05,0.0121545639055895,-0.0237968259129079,0.0238490645970029,0.998285456654846
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINB5,Serpin B5,32598,-4.20380046977451e-05,0.0201388092740991,-0.0395141041819319,0.0394300281725364,0.99833453455623
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LGALS7_LGALS7B,Galectin-7,32691,3.35118514732545e-05,0.0167905069256846,-0.0328758817228685,0.032942905425815,0.998407563612156
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENO2,Gamma-enolase,32806,4.12700412397135e-05,0.0270456141411621,-0.0529681336754381,0.0530506737579175,0.998782508854059
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GIP,Gastric inhibitory polypeptide,31388,-1.98989744152041e-05,0.0182373908896597,-0.0357651851181482,0.0357253871693178,0.999129450361173
